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Abstract 
Circadian rhythms are recurring patterns (~24hrs) in behaviour and physiology 
that are driven primarily by an endogenous biological timekeeping system, with the 
master pacemaker located in the suprachiasmatic nucleus. Studies have indicated 
bidirectional relationships between the circadian and the immune systems, however 
while there is much evidence regarding the regulation of immune function by the 
circadian system, information regarding the impact of immune processes on the 
timekeeping system is more limited, including that regarding the long-term 
modulation of the circadian system following immune challenge. The current set of 
studies address this gap in the literature by examining the long-term impact of sepsis, 
a substantial immune challenge, on circadian timekeeping processes, following 
sepsis induction by peripheral treatment with lipopolysaccharide (5mg/kg).  
Following recovery, post-septic circadian behaviour, SCN molecular oscillations and 
SCN responsiveness were assessed.  SCN neurochemistry was also assessed both in 
the acute phase and in the long-term post LPS treatment. 
LPS induced sepsis did not affect core circadian locomotor rhythmicity 
parameters, but did result in long-term attenuations in post-septic resetting in 
response to phase advancing photic stimulation, and alterations in re-entrainment to 
advances of the photoperiod.  Perturbations were observed in SCN neurochemistry in 
the acute phase following septic LPS treatment, and chronic attenuations were also 
found in post-septic SCN clock gene protein product expression.  LPS induced sepsis 
caused attenuations in SCN functional activation in response to both photic and 
immune stimulation, as well as alterations in circadian resetting in response to phase 
resetting immune stimuli. 
Overall, these data provide further insight into immune circadian 
communication, and the long-term impact of immune challenge on timekeeping 
processes, and describe a previously unknown impact of the chronic effects of 
experimental sepsis on the circadian timekeeping system. 
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Chapter One 
General Introduction 
The term Chronobiology, derived from Greek (chronos meaning time, bios 
meaning life, logos meaning study) refers to the study of biological rhythms and 
timekeeping mechanisms.  The term circadian coined by Franz Halberg in 1959, 
comes from the two Latin words ‗circa‘ meaning about, and ‗dies‘ meaning day, 
literally translated, circadian then means ‗about a day‘, and describes the endogenous 
~24hr recurring rhythms in behavioural, endocrine and physiological parameters 
(Levi and Schibler, 2007) which serve to synchronize the internal state with the 
external environment, and ensure that internal processes do not occur all at once, but 
at specific times.  Circadian rhythms have been conserved throughout evolution and 
are seen to occur in all eukaryotic organisms including plants and animals, along 
with certain fungi and cyanobacteria.  These biological rhythms enable organisms to 
react to and not merely adapt to changes in their surroundings, conferring advantages 
onto organisms and increasing fitness.  Mammalian circadian rhythms are generated 
by endogenous oscillators and entrained daily by environmental time cues or 
―Zeitgebers‖, of which environmental light is the most potent, in order to keep the 
rhythm in phase with the environment (Golombek and Rosenstein, 2010).  In order 
for a rhythm to be circadian, there are three properties that it must exhibit.  The 
rhythm must be self-sustaining and persist in the absence of external environmental 
cues, be capable of being reset or synchronized by external cues, and must be 
temperature compensated.   
While there are many early documented observations of circadian patterns in 
physiology in both plants and animals, it was not until the 17
th
 century that much of 
the investigations into chronobiology began, and human circadian rhythm studies did 
not begin until the late 1930‘s.  In 1938, Nathaniel Kleitman and Bruce Richardson 
utilised the Mammoth Caves in Kentucky, isolated from the external environment 
and maintained under constant environmental conditions of temperature, humidity 
and darkness.  At this time, artificial light was not recognised as an ―entraining‖ 
stimulus or ―Zeitgeber‖ for circadian rhythms and hence subjects were allowed 
access to artificial lighting.  Studies by Jurgen Aschoff (Aschoff, 1960) utilizing an 
underground bunker in Germany, similarly shielded from external environmental 
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cues and maintained under constant environmental conditions concluded that 
circadian rhythms regulate various mammalian behavioural and physiological 
parameters (Aschoff, 1960).  These studies and those that followed in the proceeding 
20 years were key in the development of chronobiological studies.   
1.1  The Master pacemaker 
It was first reported by Richter (1967) that anterior hypothalamic lesions 
disrupted behavioural circadian rhythm expression in the rat, and it was then found 
that loss of the Suprachiasmatic Nucleus (SCN) specifically, impaired 
neuroendocrine and behavioural circadian rhythmicity in the hamster (Rusak, 1979) 
and in the rat (Moore and Eichler, 1972; Moore and Klein, 1974; Stephan and 
Zucker, 1972).  The SCN is bilaterally distributed in the anterior hypothalamus at the 
base of the third ventricle, above the optic chiasm (Klein et. al, 1991) (Figure 1.1).  
 
Figure 1.1: The location of the mammalian circadian clock. (A) Coronal section 
through a rodent brain showing the location of the SCN.  The SCN of the anterior 
hypothalamus sits directly above the optic chiasm (OC) and surrounding the third 
ventricle (3v) (Kriegsfeld and Silver, 2006). Dashed line outlines the SCN.  The 
approximate rostral-caudal location depicted in the coronal section is depicted by 
the sagittal schematic in the upper right corner. (B) Pictomicrogaph of the SCN 
immunostained for the clock gene protein CLOCK (scale bar approx 100µm). 
 
A biological timekeeping role of the SCN was then indicated by a variety of 
studies. When SCN connections were severed to the rest of the brain, SCN neurons 
retained their rhythmic electrical activity but those outside of the SCN were 
abolished (Inouye and Kawamura, 1979), highlighting that SCN projections convey 
rhythmicity to neurons outside of the SCN.  Further, foetal SCN transplants from 
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wild-type hamsters to tau mutant hamsters which show shortened circadian free 
running periods (FRP), showed the donor phenotype to be expressed by the mutant 
host (Ralph et. al 1990).  The restoration of drinking, eating and motor activity 
circadian rhythms was also shown following transplantation of foetal SCN tissue to 
SCN lesioned ahrrythmic rodents (Aguilar-Roblero et. al 1992; Aguilar-Roblero et. 
al 1994; DeCoursey and Buggy, 1989; Griffioen et. al., 1993; Lehman et. al 1987).   
These studies and those that followed established the SCN as the location of the 
principal circadian oscillator in the body.   The SCN is now known to serve as the 
master oscillator, coordinating peripheral circadian clocks in individual cells and 
organs throughout the body and orchestrating coherent circadian rhythms.  The SCN 
is positioned so as to receive both direct and indirect retinal input serving to convey 
photic input for entrainment to the environmental photoperiod (Reppert and Weaver, 
2001).  The SCN contain about 20,000 neurons, 10,000 neurons in each nucleus 
(Reppert and Weaver, 2001), which generate coherent circadian rhythms of neuronal 
firing (Meijer and Schwartz, 2003).  SCN neurons have cell body diameters of 7-
12µm, are of high density, and show a broad phenotypic heterogeneity, expressing a 
wide and differential variety of neuroactive compounds, however GABA is 
expressed by almost all neurons (Okamura et al., 1989; Moore & Speh, 1993; 
Shirakawa et al., 2001; Guilding and Piggins, 2007). 
1.1.1. Subdivisions of the SCN 
The SCN can be subdivided into two distinct anatomical regions, the 
dorsomedial SCN (dmSCN) or ―shell‖ and the ventrolateral SCN (vlSCN) or ―core‖ 
(Van den Pol, 1980), with each subregion containing neurons expressing different 
populations of neuropeptides.  The core contributes 43% to the total neuronal 
population of the SCN, with the shell contributing 57% (Moore et al., 2002).  The 
different neuropeptide and neuronal compositions of the subdivisions of the SCN 
indicate regional differences in circadian rhythm generation and regulation. 
The dorsomedial ―shell‖ receives input from non-visual cortical and 
subcortical regions, receiving projections from the limbic forebrain and the 
hypothalamus, and the neurons in the shell express arginine vasopressin (AVP) or 
somatostatin expressing neurons, as well as gamma amino butyric acid (GABA) and 
calretinin (CAR) (Moore et. al., 2002).  Further, the SCN shell also contains neurons 
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that synthesize angiotensin II (AII) and met-enkephalin (mENK), and the shell 
receives input from Vasoactive Intestinal Polypeptide (VIP) immunoreactive fibres 
and galanin (GAL) (Abrahamson and Moore, 2001).   
The retinorecipient ―core‖ receives dense visual input from the retina and 
from the intergeniculate leaflet and midbrain raphe afferents and contains neurons 
synthesizing VIP, calbindin (CalB), Gastrin Releasing Peptide (GRP) (Card and 
Moore, 1984) colocalized with GABA and neuromedin S (Miyazato et. al., 2008; 
Mori et. al., 2005) and neurotensin, and receive input from fibres containing 5-
hydroxytryptamine (5-HT) and neuropeptide Y (NPY) (Abrahamson and Moore, 
2001). (Figure 1.2).  RHT fibres are seen throughout the SCN, and the RHT 
projections terminate upon all VIP and GRP neurons, as well as the AVP, CalR, 
CalB and mENK neurons, except those that are most medial (Morin et al., 2006). 
The different subregions also show variation in clock gene and immediate 
early gene (IEG) expression. The SCN core is retinorecipient, and in response to 
photic stimulation the VIP, GRP and CalB neurons of the core are thought to display 
robust short latency electrical responses, and the induction of various IEGs and 
photically sensitive clock genes occurs in the SCN core, but not in the shell (Hamada 
et al., 2001; Kornhauser et al., 1990; Rea, 1992). The AVP neurons of the SCN shell 
are thought to show robust spontaneous rhythmicity in gene expression, 
neurotransmitter release and electrical activity (Antle and Silver, 2005; Lee et. al., 
2003).  The cells of the core show relatively low amplitude expression of clock 
genes which may allow environmental signals to more easily reset these cells (Lakin-
Thomas et al., 1991; Pulivarthy et al., 2007; Colwell, 2011).   
Figure 1.2: SCN functional and neurochemical subdivisions. (A) Neurochemicals 
of the SCN core are illustrated in the left SCN while those of the SCN shell are 
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illustrated in the right SCN. The SCN core is directly innervated by the RHT, the 
raphe nuclei, and the IGL. The SCN shell is innervated by ventrolateral SCN and 
other hypothalamic areas. RHT, retinohypothalamic tract; 3V, third ventricle; OC, 
optic chiasm; IGL, intergeniculate leaflet; VL, ventrolateral; DM, dorsomedial; 
other abbreviations as in text (adapted from Golombek and Rosenstein, 2010). (B) 
Immunofluorescent staining in the mouse SCN, with the SCN shell region delineated 
by immunofluorescent labeling for AVP (red) and the SCN core region delineated by 
green fluorescent protein (GFP) expressed in GRP expressing neurons (green) 
(Welsh et al., 2010). 
 
1.1.2. SCN Coupling and Electrical Activity 
A core to shell signalling model exists (Moore, 1996; Speh et al., 2002), and 
studies have shown the SCN core to show numerous efferents to the SCN shell while 
there are fewer projections innervating the core from the shell region (Moore et al., 
2002).  The light sensitive neurons within the core convey light information to the 
SCN shell which in turn projects to efferent regions, and it is thought that projections 
from the SCN to other brain regions are the initial steps involved in the regulation of 
rhythmicity both in the CNS and the periphery (Bartness et al., 2001; Aston-Jones et 
al., 2001; Kalsbeek and Buijs, 2002; Buijs et al., 2003; Deurveilher and Semba, 
2005).   
The two SCN nuclei also appear to be coupled, since unilateral SCN lesions 
disrupt behavioural circadian rhythms, altering the FRP (Pickard and Turek, 1982, 
1983), and projections between the two nuclei have been identified (Abrahamson 
and Moore, 2001; Kalsbeek et al., 1993), with each core and shell of an individual 
SCN nucleus projecting contralaterally to the core or shell of the other nucleus (Leak 
et al., 1999).  Rhythmic electrical activity of similar period with small phase 
differences is found in each nucleus (Inouye and Kawamura, 1982), and each can 
produce rhythmic circadian behavioural activity (Pickard and Turek, 1982, 1983; 
Davis and Gorski, 1984). 
The presence of multiple circadian oscillators is supported by the observation 
of locomotor activity rhythm ‗splitting‘ in the golden hamster (Pittendrigh and Daan 
1976a) and in the ground squirrel (Pittendrigh 1960) following prolonged housing 
under constant conditions, and it is suggested that each nucleus may be oscillating 
independently, each oscillation producing a behavioural rhythm (Pittendrigh and 
Daan, 1976a).  In animals with split behavioural activity the left and right SCN 
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display antiphase c-Fos and clock gene expression (de la Iglesia et al., 2000, 2003; 
Mendoza et al., 2004; Ohta et al., 2005).  Furthermore, rodent housing under 
constant light (LL) results in lengthening of the FRP and can result in circadian 
arrhythmicity, which is probably due to the decoupling of neurons resulting in 
oscillator desynchrony within the SCN (Aschoff, 1960; Pittendrigh and Daan 1976a; 
Ohta et. al., 2005).   
The circadian timing mechanism is expressed autonomously within 
individual SCN neurons, and these independent oscillators are ‗coupled‘ to eachother 
creating a network of oscillators, enabling the generation of coherent, robust 
circadian outputs when they oscillate in synchrony (Welsh, 2009).  The SCN has 
been shown to display a circadian pattern of electrical activity which is high during 
the light phase and low during the dark phase, and is in antiphase to neuronal activity 
patterns outside of the SCN (Inouye and Kawamura, 1979; Inouye and Kawamura, 
1982), and is seen to persist in constant lighting conditions.  The electrical activity 
pattern has been shown to be an endogenous property of the pacemaker (Inouye and 
Kawamura, 1979), and to be maintained and persist in vitro, and the day night 
rhythm in electrical SCN firing has been demonstrated in in vitro slice preparations, 
confirming peak electrical firing in the middle of the subjective day, and a nadir 
approximately 12 hours later in the subjective night (Green and Gillette, 1982; 
Shibata et al., 1982; Groos and Hendricks, 1982; Brown and Piggins, 2007).  
Individual SCN neurons dissociated in culture have been shown to display 
independent circadian rhythms in firing, showing a range of phases (Welsh et al., 
1995).  Communication between individual SCN cells is essential for accurate 
pacemaker function, and individual neurons adapt their amplitude in response to 
feedback from other SCN cells. The individual oscillators must then be synchronized 
together, resulting in rhythmic electrical activity and the generation of rhythmic, 
coherent circadian output rhythms such as behavioural outputs (Schwartz et al., 
1987).   
Ionic currents drive spontaneous electrical firing rhythms of SCN neurons.  A 
number of voltage sensitive currents play roles in the electrical firing rate of neurons 
within the SCN, including those that supply the excitatory drive necessary for 
spontaneously active neurons, currents that convert the excitatory drive into a regular 
pattern of action potentials, and those that hyperpolarize the membrane and underlie 
the silencing of electrical firing at night (Colwell, 2011).  Studies by Wheal and 
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Thompson (1984) and Kim and Dudek (1991, 1992, 1993), have shown GABAA 
receptors to be involved in modulating inhibitory input on rodent SCN neurons, 
while the major excitatory inputs to SCN neurons are from glutamatergic sources.  
Optic nerve stimulation was seen to induce an excitatory postsynaptic potential 
(EPSP) from rodent SCN neurons which was mediated via both N-methyl-D-aspartic 
acid (NMDA) and non-NMDA receptors. 
SCN neuronal firing rhythms are crucial in transmitting circadian timing 
information to the brain and periphery (Schwartz et. al., 1987).  In Clock mutant 
mice, individual oscillators do not show rhythmic electrical activity, correlating with 
the arrhythmic locomotor behaviour exhibited by these animals (Herzog et al., 1998), 
while in tau mutant hamsters exhibiting shortened circadian free running periods, the 
period of the electrical activity rhythm is seen to reflect this in in vitro recordings of 
SCN neurons (Liu et al., 1997). 
Neural activity may be required for the generation of circadian oscillations in 
the core clock genes in the SCN, since various studies have shown that perturbations 
in these lead to alterations in molecular oscillations.  In transgenic mice and 
Drosophila models where clock cells are hyperpolarized, perturbations have been 
observed in behavioural and molecular rhythms (Nitabach et al., 2002; Pakhotin et 
al., 2006), and further, molecular rhythms have been shown to be attenuated by 
hyperpolarizing Ca
2+
 neurons in culture or by blocking Ca
2+
 channels (Lundkvist et 
al., 2005).  Other studies by Yamaguchi and colleagues (2003) have shown electrical 
firing rhythms to be involved in the generation of robust rhythmic clock gene 
expression in individual neurons in SCN cultures. Studies by Belle and colleagues 
(2009) have shown a dissociation between clock gene expression and action 
potential generation.  These authors show that in the middle of the day, at the 
supposed peak of electrical firing, Per1 expressing SCN neurons show depolarized 
membrane states but do not generate action potentials, while at this time, Per1 
mRNA expression as measured by GFP fluorescence signal in Per1::GFP mice was 
shown to be high. 
There are a number of ways in which SCN neurons are coupled.  Synaptic 
transmission between cells is the principal mechanism involved in coupling of SCN 
cells (Welsh, 2009). Both calcium dependent GABA release (Shirakawa et al., 2000) 
and sodium-dependent action potentials (Honma et. al., 2000) have been shown to 
play roles in synchronization of circadian and spike to spike firing patterns, and 
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GABA transmits information between the core and shell regions of the SCN (Albus 
et al., 2005).  Tetrodotoxin (TTX) has been used to block neuronal firing rates in 
cultured SCN neurons causing cells to lose rhythm synchrony (Yamaguchi et. al 
2003; Honma et al., 2000). Gap junctions play a role in intercellular communication 
within the SCN, as shown by application of the gap junction blocker halothane 
(Colwell, 2000), and further in mice lacking the gap junction protein Connexin36 
electrical synapses were blocked and perturbations in circadian locomotor activity 
rhythms were observed (Long et al., 2005).   
This coupled system is synchronized to the environmental light dark cycle 
via signalling from light sensitive retinal ganglion cells allowing environmental 
entrainment (Morin and Allen, 2006; Berson 2003). The retinorecipient core plays a 
crucial role in SCN coupling (Welsh, 2009), and circadian rhythms have been shown 
to be abolished at the entire animal level as a result of SCN core lesions, consistent 
with loss of SCN output signals (LeSauter and Silver 1999).  In rostral SCN slices 
lacking a core, SCN coupling has been shown to be disrupted (Yan et al., 2007), 
while separation of the SCN subregions has shown loss of coupling in shell neurons, 
and those in the core remain coupled (Yamaguchi et. al 2003).  In knockout mice 
lacking VIP or its receptor, coordination between SCN neurons has been shown to 
be severely disrupted (Aton et. al. 2005; Ciarlegio et. al 2009; Maywood et. al 2006), 
and these animals show altered circadian locomotor activity rhythms (Colwell et al., 
2003; Harmar et al., 2002).   
1.2   Afferent input to the SCN 
Input to the SCN is via three main projections, the Retinohypothalamic Tract 
(RHT), the Geniculohypothalamic Tract (GHT) and the raphe nuclei. 
1.2.1 The Retinohypothalamic Tract 
The importance of the RHT for circadian rhythm regulation was established 
through ablation studies which highlighted that the RHT is both sufficient and 
necessary for the photic entrainment of the master pacemaker in the SCN (Johnson et 
al., 1988a).  The retina transmits information to the brain via the optic nerve formed 
by the axons of retinal ganglion cells (Foster and Hankins, 2002).  The RHT is 
formed from a small number of retinal ganglion cells dispersed throughout the retina, 
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distinct from those involved in primary visual pathways (Moore et al., 1995), and 
these cells send a random projection to the SCN and contain the photosensitive 
protein melanopsin which functions as the circadian photoreceptor (Berson et al., 
2002; Gooley et al., 2001; Hannibal et al., 2002; Hattar et al., 2002; Provencio et al., 
2000) and is involved in photic entrainment (Freedman et al., 1999).  Monosynaptic 
RHT projections terminate in the SCN (Moore and Lenn, 1972), and are seen to 
project to the vast majority of the SCN in both the rat and the mouse, with 
approximately equal contralateral and ipsilateral retinal projections seen to the 
mouse SCN, while in the rat, these projections are seen to be predominantly 
contralateral (Morin et al., 2006).  Bilateral RHT innervation is received by the entire 
SCN in the hamster (Muscat et al., 2003).  These projections are coextensive with 
GRP and VIP immunoreactive perikarya in the SCN.  
The RHT terminates in other brain regions including the subparaventricular 
zone (sPVZ), the anterolateral hypothalamus and the supraoptic region (Abrahamson 
and Moore, 2001; Johnson et al., 1988b; Levine et al., 1991).  The RHT also projects 
to specific regions of the thalamus, including the intergeniculate leaflet (IGL) which 
subsequently projects to the SCN (Morin, 1994; Moore and Card, 1994). 
The main neurotransmitters involved in the RHT are the excitatory amino 
acid neurotransmitter glutamate, and pituitary adenylate cyclase-activating 
polypeptide (PACAP).  Glutamate is released by RHT terminals in response to 
photic stimulation into the VIP containing SCN core (Mikkelsen et al., 1995; Ding et 
al., 1994; De Vries et al., 1994).  In vivo and in vitro studies indicate that glutamate 
acts through NMDA and non-NMDA receptors, activating various intracellular 
signalling molecules including, among others, nitric oxide (NO), protein kinase G 
(PKG), protein kinase C (PKC), calmodulin, cAMP-responsive element binding 
protein (CREB) and calcium (Gillette 1996; Gillette and Mitchel, 2002) as well as 
inducing the expression of immediate early genes (Kornhauser et al., 1996b) 
subsequently leading to increased transcription of certain clock genes (Shigeyoshi et 
al., 1997; Moriya et al., 2000).  Application of glutamate receptor (GluR) antagonists 
in vivo has been shown to inhibit both photically induced Fos in the SCN as well as 
photic phase responses (Abe et al., 1992; Colwell and Menaker, 1992), while 
application of glutamate receptor agonists causes excitation of SCN neurons (Bos 
and Mirmiran, 1993; Scott and Rusak, 1996). PACAP colocalizes extensively with 
glutamate and melanopsin in the RHT and the retina (Hannibal, 2002), and may be 
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involved in mediating photic information, as well as potentiating the effects of 
glutamate release on the SCN (Harrington et al., 1999; Minami et al., 2002).  The 
effects of PACAP on the circadian gene expression and phase-shifting are both dose 
and phase dependent, with PACAP administration blocking the effects of glutamate 
at high doses, as well as inducing non-photic like phase advances during the 
subjective day, and at low does, potentiating and or mimicking the effects of 
glutamate on rhythmic phase-shifting (Hannibal et al., 1997, 2001; Chen et al., 1999; 
Harrington et al., 1999; Nielsen et al., 2001; Piggins et al., 2001; Bergstrom et al., 
2003). 
Substance-P (SP) is also thought to be released via RHT terminals, and plays 
a role in RHT transmission, and its administration mimics photic phase shifts and 
appears to be dependent on SP induced glutamate release, since administration of the 
NMDA channel blocker, MK-801, blocks phase-shifting effects (Hamada et al., 
1999; Piggins and Rusak, 1997; Kim et al., 2001).  Light and glutamate induced 
phase-shifting and gene expression are blocked by selective SP antagonists both in 
vitro and in vivo (Abe et al., 1996; Challet et al., 1998, 2001; Kim et al., 2001).  
1.2.2 The Intergeniculate Leaflet 
The IGL located between the dorsal lateral and ventral lateral geniculate 
complex (LGN) is a retinorecipient region (Harrington, 1997; Moore and Card, 
1994; Morin, 1994; Rosenwasser, 2009) involved in the indirect integration of photic 
information to the SCN.  The IGL consists of geniculate neurons that contain the 
inhibitory neurotransmitters GABA and NPY that project to the SCN via the 
geniculohypothalamic tract (Morin and Allen, 2006). Terminal fields of the GHT are 
seen in the SCN core (Moga and Moore, 1997).  These IGL neurons are sensitive to 
alterations in overall radiance levels and receive direct binocular input from the 
retina (Harrington and Rusak, 1989; Pickhard, 1982).  
The IGL has widespread connections, extending from the optic chiasm 
through the lateroanterior hypothalamus to the midline, the SCN included, and to the 
subparaventricular zone and adjacent perifornical anterior hypothalamus (Morin and 
Allen, 2006).  The IGL is involved in the integration of both photic and non-photic 
phase-shifting events (Harrington et al., 1985; Pickard et al., 1987; Morin and Pace, 
2002).  The IGL has been shown to modulate photic phase-shifting effects by lesion 
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studies, altering photic phase-shifting responses and contributing to the effects of 
constant lighting conditions on the circadian system, with IGL lesions attenuating 
the period lengthening response (Edelstein and Amir, 1999; Harrington and Rusak, 
1986, 1988; Morin and Pace, 2002; Pickard et al., 1987; Pickard, 1989; 
Rosenwasser, 2009).  
The IGL is thought to be involved in mediating the effects of non-photic 
stimuli on the circadian system, and NPY and GABA release from the GHT in the 
SCN may play a role, since non-photic phase-shifting effects have been mimicked by 
NPY and GABAergic drugs, as well as serotonergic drugs (Rosenwasser, 2009).   
Under constant dark (DD) conditions, lesions of the IGL have been shown to either 
shorten (Harrington and Rusak, 1986; Harrington and Rusak, 1988; Pickard et al., 
1987) or lengthen (Lewandowski and Usarek, 2002; Pickard, 1994) the FRP.  Lesion 
studies targeting the non-photic phase-shifting responses such as induced wheel 
running activity, and the benzodiazepine, triazolam, have further highlighted that the 
GHT is necessary to communicate non-photic information to the SCN (Janik and 
Mrosovsky, 1994; Wickland and Turek, 1994; Johnson et al., 1988c; Marchant et al., 
1997). Further, IGL lesions have been shown to compromise phasic effects 
following saline injection (Maywood et al., 1997). NPY antiserum infused onto the 
SCN in vivo has also been shown to block the phase-shifting effects of novel wheel 
running (Biello et. al., 1994).  Additionally, the IGL is thought to play a role in sleep 
and arousal since it projects to areas believed to modulate sleep and arousal 
processes (Saper et al., 2001; Morin and Blanchard 2005).  
1.2.3. Midbrain raphe nuclei projection 
Serotonergic projection to the SCN via the midbrain raphe nuclei, provides 
another source of major input to the SCN core (Moga and Moore, 1997), where the 
projection is seen to extensively terminate upon core VIP neurons (Reghunandanan 
and Reghunandanan, 2006). A projection is also seen from the SCN to the raphe 
nuclei (Bons et al., 1983).  The IGL is also innervated by serotonergic projections 
extending from the dorsal raphe nucleus, which may serve as another route by which 
the SCN receives serotonergic input (Rosenwasser, 2009).   Serotonergic projections 
to the SCN and the IGL play a role in the subjective day non-photic effects on 
circadian timing, and subjective night photic effects (Mistlberger et al., 2000; Morin 
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and Allen, 2006; Rea and Pickard, 2000).  Serotonin (5HT) receptor agonists cause 
phase shifts in the SCN during the portion of the PRC where photic phase-shifting 
does not occur (Medanic and Gillette 1992; Edgar et al., 1993).  Further, non-photic 
phase shifts in the subjective day are seen in response to stimulation of the midbrain 
raphe nuclei (Meyer-Bernstain and Morin, 1999). 
Serotonergic projections may modulate SCN photic responses, and 
serotonergic mechanisms have been suggested to positively modulate RHT 
glutamate release and phase-shifting effects (Graff et al., 2005, Graff et al., 2007; 
Kennaway and Moyer, 1998; Kennaway et al., 2001; Kohler et al., 1999; 
Rosenwasser, 2009).  Photic phase-shifting and gene expression in the SCN have 
also been shown to be negatively regulated by mechanisms increasing serotonergic 
tone such as inhibition of serotonin reuptake (Gannon and Millan, 2007) and the 
application of serotonin agonists (Glass et al., 1995; Pickard et al., 1996; Pickard and 
Rea, 1997; Rea et al., 1994).  5HT antagonists enhance photically induced phase 
shifts (Rea et al., 1995) and photically induced increases in SCN electrical activity 
(Ying et al., 1994). 
 
 
 
 
 
 
 
 
 
Figure 1.3.: Afferent inputs and efferent pathways of the SCN. (Reghunandanan 
and Reghunandanan, 2006). 
 
1.3 Neurotransmitters of the SCN 
A large number of neurotransmitters have been shown to be present in the 
SCN (Card and Moore, 1984; Van den Pol, 1986, Rusak and Bina, 1990; 
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Reghunandanan et al., 1991; Abrahamson and Moore, 2001), and are implicated in 
the functioning of the pacemaker, with individual neurotransmitters playing various 
roles in timekeeping processes, and may be involved in afferent projections to the 
SCN and in entrainment of the pacemaker, within the pacemaker itself for 
integration and synchronized output, or in efferent projections of the SCN and in the 
regulation of overt rhythmicity (Reghunandanan and Reghunandanan, 2006).  
Additional neurotransmitters in the SCN include neuromedin S, neurotensin, 
histamine, acetylcholine, somatostatin, peptide histidine isoleucine (PHI) calretinin, 
galanin, angiotensin II, Met-Enkephalin and prokineticin 2 (Reghunandanan and 
Reghunandanan, 2006).  
 
The neurotransmitter GABA plays important roles in the regulation of SCN 
function (Reghunandanan and Reghunandanan, 2006).  GABA is synthesized from 
glutamic acid decarboxylase (GAD), and both GAD and GABA are known to be 
present in the majority of SCN neurons (Moore and Speh, 1993), and the SCN 
expresses GABA receptors and receptor subunits (Moore and Speh, 1993; Castel and 
Morris, 2000; Naum et al., 2001).  GABA has been shown to have both inhibitory 
and excitatory effects on SCN neurons (Wagner et al., 1997), and may play roles in 
synchronization of SCN cells (Shirakawa et al., 2000; Liu and Reppert, 2000). Direct 
application of GABA to SCN slices in culture promotes intercellular synchrony and 
phase shifts electrical activity rhythms of neurons (Liu and Reppert, 2000).  
Application of a GABA receptor antagonist continuously inhibits SCN neuronal 
resynchronization following a phase shift of the photoperiod (Albus et al., 2005). 
GABA has been suggested to modulate photic input to the SCN, since administration 
of GABA receptor agonsists and antagonists impacts upon SCN photically induced 
c-Fos (Gillespie et al., 1999) and photically induced phase shifts (Gillespie et al., 
1996; Gillespie et al., 1997).   GABAergic neurotransmission in the SCN has been 
shown to exert differential modulation during the subjective day and night, which 
may serve to provide a time dependent gating mechanism, promoting the 
potentiation of excitatory signals throughout the SCN at night and inhibiting daytime 
excitation (de Jeu and Pennartz, 2002).    
Vasoactive intestinal polypeptide is another major neurotransmitter involved 
in the function of the SCN, and is expressed by 9-24% of SCN neurons and shows 
circadian expression (Shirakawa et al., 2001; Herzog et al., 2004; Reghunandanan 
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and Reghunandanan, 2006).  This polypeptide in retinorecipient and activated by 
photic stimulation and found in the core of the SCN.  Exogenous application of VIP 
both in vivo and in vitro resets the circadian clock in a manner similar to photic 
stimulation (Piggins and Cutler, 2003), and VIP induces Per1 and Per2 expression in 
the SCN in a phase dependent manner (Nielsen et al., 2002).  The action of VIP with 
its receptor VPAC2, which is present in approximately 60% of SCN neurons and 
responsive to alterations in the firing rate of the polypeptide (Reed et al., 2002; 
Cutler et al., 2003), is seen to be involved in photic resetting and in the maintenance 
of SCN rhythmicity (Piggins and Cutler, 2003; Reghunandanan and Reghunandanan, 
2006).  VIP plays important roles in behaviour and physiology. Alterations in VIP 
signalling cause a significant reduction in rhythmic neuronal populations, and those 
that continue to show rhythmicity display a decrease in rhythm amplitude (Aton et 
al., 2006; Brown et al., 2007). Coherent clock gene expression rhythms, wheel 
running and SCN neuronal activity are not observed in Vipr2
-/-
 mice, lacking the 
VPAC2 receptor gene (Harmar et al., 2002; Cutler et al., 2003). Further, these Vipr2
-
/-
 mice show perturbations in gating of photic input to the SCN (Hughes et al., 2004).  
Additionally, perturbations are seen in sleep parameters (Hu et al., 2011) and 
cardiovascular and body temperature rhythms in Vipr2
-/-
 or VIP deficient mice (Hu 
et al., 2011; Sheward et al., 2010; Hannibal et al., 2011), as well as disrupted 
metabolic and endocrine rhythms (Asnicar et al., 2002; Bechtold et al., 2008; Loh et 
al., 2008; Fahrenkrug et al., 2012), highlighting the importance of VIP signalling in 
physiological function. 
The ventrolateral region of the hamster SCN is seen to be densely packed 
with CalB containing cells in its caudal aspect (Silver et al., 1996a; Hamada et al., 
2001).  CalB cells receive direct retinal input (Bryant et al., 2000) and show photic 
induced c-Fos expression (Silver et al., 1996a). Per1 and Per2 mRNA are induced in 
response to photic stimulation in the CalB subregion (Hamada et al., 2001).  CalB 
cells colocalize with GRP, SP and VIP (LeSauter et al., 2002), and do not show 
rhythmic expression of clock genes (Hamada et al., 2001; Hamada et al., 2004), or 
rhythmic electrical activity (Jobust and Allen, 2002), but may play roles in the 
maintenance of locomotor rhythmicity, since half-SCN transplants that contain cells 
of the CalB subregion restore rhythmic locomotor behaviour in SCN lesioned hosts, 
while transplantation of SCN tissue lacking these cells does not restore rhythmic 
behaviour (LeSauter and Silver, 1999). Further, CalB cells have been suggested to be 
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involved in the gating of photic input to the SCN, since administration of CalB 
antisense oligodeoxynuclotides blocks subjective night photically induced phase 
shifts and Per expression normally, and these are instead enhanced during the 
subjective day (Hamada et al., 2003).  CalB deficient mice show altered photic 
induced locomotor phase delays and Per2 expression in the SCN, indicating a role in 
resetting (Stadler et al., 2010).   
Rodent SCN neurons synthesize GRP and the GRP receptor BB2 (Battey and 
Wada, 1991; Ladenheim et al., 1992) and GRP has been suggested to play roles in 
photic entrainment (Tanaka et al., 1997; Aioun et al., 1988).  GRP application in 
vitro phase shifts rhythmic electrical activity, causing early subjective night phase 
delays and a phase advance in the late subjective night, and further, application of a 
GRP receptor antagonist inhibits phase-shifting effects (McArthur et al., 2000; 
Reghunandanan and Reghunandanan, 2006). 
 
Arginine vasopressin is expressed in cells of the SCN shell, co-localized with 
somatostatin and GABA, and is thought to be one of the major transmitters of the 
SCN (Ingram et al., 1998), and may play roles in SCN output.  The synthesis and 
release of AVP shows circadian variation and approximately one third of SCN 
neurons are seen to synthesize AVP in rats (Reghunandanan and Reghunandanan, 
2006).  AVP has been shown to play an excitatory role through its activation of V1a 
receptors (Ingram et al., 1998) and to be involved in electrical firing acitivity in the 
SCN (Mihai et al., 1994).  A reduction in SCN AVP content and AVP neurons has 
been shown to accompany perturbations in the sleep wake cycle, a reduction in the 
amplitude of rhythmic activity and an increase in rhythm fragmentation (Hofman et 
al., 1994; Hofman et al., 1995; Lucassen et al., 1995).  AVP deficient rats show 
reduced amplitude of circadian sleep rhythms (Brown and Nunez, 1989), 
highlighting the roles this neuropeptide plays in output rhythms.  
Prokineticin 2 (PK2) is involved in output from the SCN, and may play roles 
in the timing of locomotor behaviour in nocturnal animals (Cheng et al., 2002), and 
PK2 SCN expression is regulated by the circadian clock and by light (Cheng et al., 
2005). 
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1.4 Other sources of input to the SCN 
Other SCN afferent systems provide input the circadian system, including 
noradrenergic input from the brainstem (Cagampang et al., 1994; Moga and Moore, 
1997, Rosenwasser, 2009), cholinergic projections arising from the pontine 
tegmentum and basal forebrain (Bina et al., 1993; Rosenwasser, 2009), and input 
from the posterior hypothalamus via histaminergic projections (Panula et al., 1989; 
Wada et al., 1991; Rosenwasser et al., 2009).  These afferents target the SCN shell 
and may be involved in the regulation of the circadian clock (Moga and Moore, 
1997; Moore, 1996; Rosenwasser, 2009). Further, the IGL also projects via 
noradrenergic and cholinergic inputs.  Studies have suggested that histamine may 
play roles in photic effects on the circadian system (Cote and Harrigton, 1993; 
Harrington et al., 2000; Eaton et al., 1995; Meyer et al., 1998) or possibly be 
involved in entrainment downstream from glutamate release (Jacobs et al., 2000; 
Rosenwasser et al., 2009).  Various cholinergic effects on the circadian system have 
been described.  Application of the cholinergic agonist cabechol has mimicked both 
photic and non-photic phase-shifting effects (Bina and Rusak, 1996), while the free 
running period is perturbed upon near SCN implantation of a cabechol secreting 
pellet (Furukawa et al., 1987).  Studies inhibiting cholinergic transmission have 
shown SCN gene expression and photic induced phase shifts to be attenuated (Keefe 
et al., 1987; Zhang et al., 1993; Beaule and Amir, 2002; Erhardt et al., 2004). The 
noradrenergic system may play roles in the modulation of photic input, and has been 
shown to alter the FRP under constant conditions (Dwyer and Rosenwasser, 2000; 
Rosenwasser, 1996; Rosenwasser et al., 1995; Rosenwasser et al., 2009). 
1.5.  The Molecular Circadian Clock 
The circadian clock system is composed of three integral components, input 
pathways receiving and subsequently conveying environmental information to the 
pacemaker and adjusting the time, a central pacemaker which generates the circadian 
rhythm and output pathways affecting circadian physiology and behaviour 
(Balsalobre et. al 1998).   
  The molecular mechanisms governing the clock were unknown until the early 
1970‘s, when the first circadian rhythm mutants were isolated, the period mutants in 
Drosophila, fruitfly (Konopka and Benzer, 1971) and frequency in Neurospora, 
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fungi, (Feldman and Hoyle, 1973), with the isolation of the period and frequency 
genes occurring later.  In the years that followed several other clock genes involved 
in the molecular clockworks were identified in both flies and mammals, and there is 
a general conservation in the molecular clock mechanism between the organisms 
(Reppert and Weaver, 2001).  ―Clock genes‖ of the molecular clock are involved in 
the generation and maintenance of circadian rhythms and must display certain 
properties in order to be considered a core clock gene.  Clock genes are usually 
rhythmically transcribed and if this gene is deleted or mutated circadian rhythms are 
disturbed.  Further, clock proteins feedback and regulate their own transcription and 
in order to generate circadian oscillations of expression, there must be a delay 
between when a gene is activated and when it is inhibited or a steady state will result 
(Allada et al., 2001).  Clock genes are expressed both in the SCN, in oscillators in 
other regions of the brain and in peripheral tissues, and the molecular clock 
mechanism is similar for the master circadian pacemaker in the SCN and in 
peripheral oscillators (Balsalobre et al., 2000b; Nagoshi et al., 2004; Welsh et al., 
2004; Brown et al., 2005; Ko and Takahashi, 2006).   
At a molecular level, the set of clock genes and proteins are interconnected to 
form complex transcription-translation autoregulatory loops that produce accurate 
and robust circadian rhythms.  These transcription translation feedback loops that 
underpin the molecular circadian clock drive expression of the core clock genes 
(Lowrey and Takahashi 2004; Reppert and Weaver, 2002), and the oscillations of 
clock gene protein products are required for the generation and regulation of 
circadian rhythms in single cells throughout the organism (Takahashi, 2004).    
1.5.1 Transcription/Translation Feedback loop in mammals 
The Transcription/translation clock feedback loop is comprised of both 
positive and negative limbs. Three basic helix-loop-helix (bHLH)-PER-ARNT-SIM 
(PAS) protein-containing transcription factors, ―circadian locomotor output cycle 
kaput‖ (CLOCK or its homolog NPAS2) and ―brain-muscle-arnt-like protein 1‖ 
(BMAL1) comprise the positive elements limb of the transcription/translation 
feedback loop.  CLOCK and BMAL1 bind to each other forming heterodimers, and 
initiate transcription of target genes containing E-box cis-regulatory enhancer 
sequences (CACGTG) which comprise the negative feedback loop, the Period genes 
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(Per 1, Per2 and Per3) and the Cryptochrome genes (Cry1 and Cry2) (Gekakis et al., 
1998; Zheng et. al 2001; Bunger et al., 2000; Kume et al., 1999).  Once transcribed, 
PER and CRY bind each other forming PER:CRY heterodimers which then 
translocate back to the nucleus and act on the CLOCK:BMAL1 complex, repressing 
their own transcription, comprising the negative component of the feedback loop 
(Lee et. al 2001; Kume et. al 1999; Okamura et al.,1999; Shearman et al., 2000b; 
Sato et al., 2006).  While the CRY proteins turn off CLOCK:BMAL1-mediated 
transcription, PER2 may contribute to Bmal1 transcription, promoting 
CLOCK:BMAL1 heterodimerization, restarting the transcriptional cycle (Reppert 
and Weaver, 2001).   
Another regulatory loop is induced by CLOCK:BMAL1 heterodimers 
activating the retinoic acid-related orphan nuclear receptors transcription of Rev-erbα 
and Rorα (Preitner et. al 2002; Sato et. al 2004; Akashi et. al 2005; Ko and 
Takahashi, 2006), the protein products of which then compete to bind retinoic acid-
related orphan receptor response elements (ROREs) located in the Bmal1 promoter, 
and form an auxillary or stabilizing feedback loop regulating Bmal1 transcription 
levels (Preitner et al., 2002; Sato et al., 2004; Son et al., 2011).  The circadian 
oscillation of Bmal1 is regulated by RORs and REV-ERBs, with REV-ERBα/β 
repressing the transcription of Bmal1 (Guillamound et al., 2005; Ko and Takahashi, 
2006) and RORα activating Bmal1 transcription (Guillamound et. al 2005, Akashi et. 
al 2005). As previously stated, CLOCK:BMAL1 heterodimers activate the gene 
encoding REV-ERBα, which in turn represses Bmal1 transcription. The inhibition of 
CLOCK:BMAL1 heterodimers by the action of PER:CRY in the nucleus indirectly 
activates Bmal1 through inhibition of Rev-erbα gene expression (Cermakian and 
Boivin, 2003; Preitner et. al., 2002). The renewal of BMAL1 levels at the end of the 
night may increase CLOCK:BMAL1 heterodimers at the appropriate circadian time 
driving Per/Cry transcription and restarting the oscillation, therefore BMAL1 
availability is required at the start of a new circadian day (CT 0) to renew the 
transcription/translation feedback loops (Reppert and Weaver, 2001). (Figure 1.4). 
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Figure 1.4.: A network of transcriptional–translational feedback loops constitutes 
the mammalian circadian clock (Ko and Takahashi, 2006). 
 
The majority of the components of the molecular clock show rhythmic 
circadian expression in the SCN both under constant conditions and in LD (Guilding 
and Piggins, 2007).  Per1 mRNA shows peak expression in the SCN between ZT/CT 
4 and 6 (where ZT0 is the time at lights on under a 12:12 LD cycle and where CT0 is 
the start of the subjective day in constant conditions (Thresher et al., 1998; Shearman 
et al., 1997; Zheng et al., 1999; Bunger et al., 2000; Guilding and Piggins, 2007).  
Both Cry1 mRNA (Miyamoto and Sancar, 1998; Thresher et al., 1998) and Per2 
mRNA expression peak at approximately ZT/CT10 (Albrecht et al., 1997; Shearman 
et al., 1997; Bunger et al., 2000; Bae et al., 2001; Oster et al., 2003).  Peak Bmal1 
mRNA expression is seen in the SCN at approximately ZT/CT18 (Abe et al., 1998; 
Honma et al., 1998; Reppert and Weaver, 2002).  Rev-erbα mRNA shows peak 
expression at approximately ZT/CT4 (Onishi et al., 2002).  Cry2 is not expressed in 
rhythmic fashion in the SCN, while Clock is expressed constitutively across the 24hr 
circadian cycle (Oster et al., 2003; Gekakis et al., 1998). With regard to mRNA 
levels, the expression of protein products is seen to be delayed by 4-6 hours 
(Guilding and Piggins, 2007). 
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1.5.2. Post-translational modifications and clock control 
The precise ~24hour period of the molecular clock is governed by 
posttranslational modifications of the clock gene transcripts involved in the feedback 
loops, creating time lags between transcription, translation and translocation of 
proteins from the cytoplasm to the nucleus (Lee et al., 2001; Reppert & Weaver, 
2002; Ko and Takahashi, 2006; Guilding and Piggins, 2007).  Post-translational 
modifications involved in the localization, degradation and activity of the core 
circadian clock components include phosphorylation, ubiquitination, methylation, 
sumoylation and histone acetylation (reviewed in Gallego and Vishrup, 2007).  
Evidence of posttranscriptional/posttranslational control in the molecular clock is 
seen in Drosophila, where peak levels of PER proteins are seen 4-6 hours following 
peak Per RNA levels (Harms et al., 2004).  
Various key processes are tuned to generate a 24hr cycle including the 
transcription rate of PER and CRY proteins and protein stability (Hasting et al., 
2007; Gallego and Virshup, 2007).  Casein kinase 1 epsilon (CKIε) and Casein 
kinase 1 delta (CK1δ) are accepted as components of the core molecular clock 
(Akashi et al., 2002) and are essential in regulation of mammalian circadian protein 
turnover (Ko and Takahashi, 2006; Lowrey et al., 2000; Eide et al., 2002; Akashi et 
al., 2002).  Casein Kinase 1 (CK1) plays roles in regulating the nuclear entry of PER 
in mammals, and CKIε and CK1δ phosphorylate PER1 and PER2 to modulate 
nuclear translocation times and target proteins for degradation.  CKIε is 
constitutively expressed in the SCN, and has been shown to bind and phosphorylate 
PER regulating its subcellular localization, impacting on its ability to repress 
transcription and targeting it for ubiquitination and subsequent degradation through a 
proteasomal pathway involving the F-box proteins β-TrCP1 and β-TrCP2 
(Etchegaray et al., 2009; Vielhaber et al., 2000; Vanselow et al., 2006). CK1δ is also 
seen to phosphorylate PER proteins, reducing their stability in vitro (Camacho et al., 
2001; Xu et al., 2005).  
CKIε and CK1δ mutations highlight the importance of post translational 
modifications in the molecular clock mechanism.  A mutation in CK1ε in hamsters 
known as the tau mutation is seen to cause a 20% decrease in the FRP and an altered 
phase angle of entrainment (Ralph and Menaker, 1988).  Furthermore, this mutation 
results in decreased PER stability and their accelerated proteasomal degradation 
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(Lowrey et al., 2000) and enhanced clearance from the nucleus sufficient to explain 
the shortened FRP phenotype (Dey et al., 2005).  Mutations in CK1ε and CK1δ are 
implicated in Familial Advanced Sleep Phase Syndrome (FASPS) in humans (Xu et 
al., 2005).  Currently a model based on the doubletime (Dbt) mutation in Drosophila, 
for the tau mutant and FASPS, suggests that reduced efficacy of PER 
phosphorylation results in prevention of PER degradation, allowing PER to rapidly 
enter the nucleus, leading to acceleration of the clock (Lowrey et al., 2000).  The 
absence of CK1δ has been shown to reduce PER protein turnover, and this possibly 
underlies the increase in period length that has been observed in CK1δ-deficient 
fibroblasts and CK1δ-deficient liver explants in vitro (Etchegaray et. al, 2009) 
 In vitro studies have shown CLOCK and BMAL1 to be subject to post-
translational modifications. Casein Kinase (CK)2α has been shown to phosphorylate 
BMAL1 and is important in the entry of BMAL1 to the nucleus and disruption of 
this phosphorylation attenuates clock gene expression in cultured fibroblasts in vitro 
(Tamaru et al., 2009).  In cells in culture, PKC mediated phosphorylation of CLOCK 
followed by the recruitment of co-factors of the CLOCK:BMAL1 heterodimer have 
been shown to be important in resetting clock gene mRNA oscillations (Jung et al., 
2003; Shim et al., 2007; Lee et al., 2010;  Son et al., 2011). 
Following phosphorylation, proteins to be degraded by the proteasomal 
pathway are poly ubiquitinlyated (Hastings et al., 2007).  PER proteins are thought 
to be targeted for ubiquitination and subsequent degradation through a proteasomal 
pathway involving the F-box proteins βTrCP (Hastings et al., 2007).  The CRY 
proteins are also regulated by phosphorylation and degradation events to impact 
upon circadian period length, and CRY1 stability has been shown to be regulated by 
the F-box protein FBXL3, (Busino et al., 2007; Siepka et al., 2007).  The F-Box 
protein‘s interaction with the ubiquitin ligase complex and the leucine-rich repeat 
region (LRR) of its targets reduces affinity for CRY proteins, slowing down their 
clearance from the cells, prolonging the negative feedback phase, reducing the 
expression of Per mRNA required, thereby lengthening the period of circadian 
oscillations (Hastings et al., 2007)  
A self-sustaining cycle of the core clock components which takes 
approximately 24hrs to complete one oscillation is produced as a result of the 
processes outlined above (Guilding and Piggins, 2007). 
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1.5.3. Mutations or deletions of the core clock genes  
Mice with targeted disruptions or deletions in the circadian clock genes 
exhibit attenuations in circadian behaviour and altered expression profiles of 
circadian genes (Lowrey and Takahashi, 2004). 
1.5.3.1.  Cry mutations 
In mammals, cryptochromes are involved in photoreception for circadian 
entrainment, and are essential components of the negative feedback loop of the 
circadian timekeeping mechanism and are crucial for the maintenance of circadian 
rhythmicity.  Deletion of Cry2 lengthens the circadian period (Thresher et.al 1998; 
Van der Horst et. al 1999), while deletion of Cry1 shortens the circadian period (Van 
der Horst et.al 1999; Vitaterna et al. 1999).  While rhythmicity can be maintained 
through the presence of either CRY1 or CRY2, double knockout mice for Cry1 and 
Cry2 show complete arrhythmicity in DD (Van der Horst et.al 1999; Vitaterna et al. 
1999) necessitating the functional importance of the proteins for circadian 
timekeeping processes.   
1.5.3.2.  Per mutations 
Mice with a null mutation in the Per1 gene show a shorter circadian period 
along with an attenuation in the precision and stability of the period, indicating that 
PER1 plays a role in functionally regulating the circadian clock and in maintenance 
of the circadian period.  The circadian clock in Per1 mutant mice still appears to be 
partially functional with no perisistant loss of circadian rhythmicity (Zheng et al., 
2001).  During prolonged housing in DD, Per1 deficient mice and mPer2
ldc
 mutant 
mice display perturbed locomotor activity rhythms (Bae et al., 2001).  Locomotor 
activity rhythms of Per1/Per3 double-mutant mice resemble activity rhythms of 
mice with disruption of Per1, while Per2/Per3 double-mutant mice have a 
phenotype identical to Per2 knockout mice, indicating that Per3 functions outside 
the molecular clock mechanism (Cermakian and Boivin, 2003).  Per1/Per2 double-
mutant mice have been shown to exhibit immediate arrhythmia (Bae et al., 2001), 
and Per1/Per2 mutants display complete loss of a functional circadian clock in DD 
(Zheng et al., 2001). 
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PER2 is thought to play a critical role in mammals in the maintenance of 
circadian behavioural rhythmicity in both mice and humans.  Per2 mutant mice show 
delayed loss of circadian rhythmicity in mice and unstable circadian rhythms (Zheng 
et al., 1999), and exposure to a light pulse during arrhythmia in DD re-establishes 
circadian rhythmicity (Zheng et al., 2001).  Per2 mutant mice show reduced levels of 
SCN gene expression (Bae et al., 2001; Shearman et al., 2000b; Zheng et al., 1999).  
A Per2 mutation in humans affecting the phosphorylation of hPER2 by casein kinase 
1epsilon is implicated in Familial Advanced Sleep Phase Syndrome (Toh et al., 
2001).  Per3 knockout mice display only subtle circadian locomotor activity 
alterations, with slight shortening of the FRP under constant conditions (Shearman et 
al., 2000a).  
1.5.3.3. Clock and Npas2 mutations 
CLOCK has been shown to be necessary for rhythm maintenance in 
peripheral tissues since Clock
-/-
 mice show loss of functional peripheral oscillators 
(DeBruyne et al., 2007b).  Heterozygous Clock mutant mice, in DD display 
abnormally long free running periods (~24.5 hours) while homozygotes, Clock 
Δ19/Δ19
 
show free running periods of ~28 hours initially, followed by degeneration into 
arrhythmia (Vitaterna et al., 1994).  Clock
-/- 
mutants display altered photic 
behavioural phase-shifting, with decreased phase delays and exaggerated magnitudes 
of phase advances, and an altered phase angle of entrainment under LD (DeBruyne 
et al., 2006), indicating that CLOCK plays roles in conveying photic information to 
the SCN or in regulating SCN sensitivity to photic stimulation.  Clock
-/-
 mice also 
defy Aschoff‘s Rule which states that nocturnal rodents lengthen their FRP under LL 
(Dallman et al., 2011).   
NPAS2 (also known as MOP4) is a CLOCK related protein, both being 
paralogs of Drosophila CLOCK, and shares sequence homology within the b-H-L-H 
PAS domain (King et al., 1997) and heterodimerizes with BMAL1 to drive gene 
expression (Kume et al., 1999; Hogenesch et al., 1998).  NPAS2 deficient mice show 
strong circadian rhythms and slight shortening of circadian period (Dudley et al., 
2003; DeBruyne et al., 2007a, Dallman et al., 2011).  Mice missing both CLOCK 
and NPAS2 show arrhythmia, indicating functional redundancy of NPAS2 in the 
SCN (DeBruyne et al., 2007a).  NPAS2 deficient mice show attenuations in Per2 
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(Reick et al., 2001) and accelerated re-entrainment to a 4 hour phase advance of the 
photoperiod, and therefore show altered photic responses, similar to Clock mutant 
mice (Dudley et al., 2003), however, Npas2
m/m 
mice show normal phase angles of 
entrainment under LD (Dallman et al., 2011). 
The expression of several core clock genes and clock controlled genes are 
downregulated in Clock mutant mice, implicating CLOCK as a critical 
transcriptional activator in the core clock mechanism (Kume et al., 1999; Shearman 
et al., 2000b, Zylka et al., 1998; DeBruyne et al., 2006). Npas2 mRNA levels and 
nuclear protein levels are elevated in the livers of CLOCK deficient mice, however, 
bioluminescence recordings of liver and lung rhythms exhibit arrhythmicy, 
indicating that NPAS2 is unable to maintain rhythmicity in peripheral tissues in 
Clock
-/-
 animals, highlighting the necessity of CLOCK in peripheral oscillations 
(DeBruyne et al., 2006).   
1.5.3.4. Bmal1 mutations 
BMAL1 (MOP3) plays roles in both the master circadian pacemaker and in 
peripheral clocks and is involved in the generation and maintenance of behavioural 
rhythms and is suggested to function in behavioural output.  Mop3
-/-
 mutant mice, 
show arrhythmicity in DD, attenuations in activity distribution in LD and DD, 
altered entrainment to the LD cycle, and perturbations in peripheral expression of 
Dbp, and impaired Per1 and Per2 rhythmicity in the SCN (Bunger et al., 2000).  
Bmal1
-/-
 mice also show signs of premature aging and reduced lifespan (Kondratov 
et al., 2006), impaired glucose homeostasis (Rudic et al., 2004), progressive 
arthropathy (Bunger et al., 2005) and infertility (Kennaway et al., 2005). 
1.5.3.5. Other components of the molecular clock mechanism and their mutations 
Dec1 and Dec2 are two basic helix-loop-helix factors that have also been 
shown to be involved in the regulation of the molecular clock (Honma et al., 2002).  
Dec1 and Dec2 are expressed in the SCN in a circadian manner, and Dec1 is induced 
in a phase dependent manner in the SCN in response to photic stimulation (Honma et 
al., 2002).  These factors suppress the activity of CLOCK:BMAL1 dimers through 
association with them and or competition with the E-box elements in target 
promoters, and have been shown to suppress the transactivation of the mouse Per1 
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promotor (Honma et al., 2002).  Recent studies have suggested DEC1 and DEC2 to 
be involved in the finer regulation and robustness of the molecular clock (Nakashima 
et al., 2008).  In vitro, alterations in Dec1 affect the oscillations of clock genes, and 
Dec2 knock down is seen to affect the phase of expression of certain clock genes, 
while double knockout of Dec1 and Dec2 was seen to decrease the amplitude of 
circadian expression of several clock genes (Nakashima et al., 2008).  Further, mice 
deficient in Dec1 show longer free running periods in DD as well as accelerated 
reentrainemnt to an LD phase advance (Nakashima et al., 2008).  Rossner et al 
(2008) have also shown that Dec mutant mice display attenuations in the FRP and in 
photic entrainment.  More recently, studies have shown interactions of Dec1/2 genes 
with Per1 to be important for accurate entrainment of activity to the LD cycle (Bode 
et al., 2011).   
Dbp is a clock controlled gene (Ripperger et al., 2000), and its product, the 
basic leucine zipper (bZip) transcription factor, albumin site D-Binding Protein 
(DBP) is shown to oscillate in peripheral tissues (Wuarin et al., 1992; Fonjallaz et 
al., 1996) in the SCN (Lopez-Molina, 1997), and regulates a number of genes 
(Mueller et al., 1990; Lopez-Molina, 1997).  The Thyroid Embryonic Factor (TEF) 
and the Hepatocyte Leukemia Factor (HLF) which share extensive sequence 
similarity with DBP also show circadian expression in several tissues (Falvey et al., 
1995; Fonjallaz et al., 1996; Lopez-Molina et al., 1997).  Mice homozygous for a 
Dbp-null allele show perturbations in locomotor activity, with reduced levels of 
activity and a shortened free running period (Lopez-Molina et al., 1997). 
 Rev-erbα deficient mice show perturbations in phase-shifting of locomotor 
behaviour and a reduction in the free running period in constant conditions (Preitner 
et al., 2002), however these studies show that REV-ERBα is not required for 
circadian rhythm generation.  As previously mentioned, mutations in CK1ε (tau 
mutation) also causes a shortened free running period and altered phase angle of 
entrainment (Ralph and Menaker, 1988). 
Together, these studies highlight the impact of perturbations in components 
of the molecular clock mechanism on circadian output rhythms. 
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1.6 Entrainment 
1.6.1 Phase Response Curves (PRC) 
PRCs outline the time across the circadian cycle at which a stimulus will 
impact upon circadian rhythmicity, resulting in phase shifts of circadian locomotor 
activity, thereby resetting the phase of the oscillator.  The PRC is an intrinsic species 
specific property, with species variation seen in the shape and amplitude of the PRC 
(Golombek and Rosenstein, 2010).  Two general categories of PRCs exist, those to 
photic stimuli and those to non-photic stimuli, and the sensitivity of the clock to 
phase resetting stimuli varies across the circadian cycle.   
1.6.1.1.   Non-photic stimuli and the non-photic PRC 
A variety of non-photic Zeitgebers have been shown to cause phase advances 
during the subjective day when the clock does not show responses to photic 
stimulation (Hastings et al., 1998).  In rodents, locomotor activity rhythms can be 
entrained by scheduled feeding (Mistlberger, 1994; White and Timberlake, 1995; 
Abe et al., 1989; Mistlberger, 1993) and restricted exercise (Edgar and Dement, 
1991; Marchant and Mistlberger, 1996; Hastings et al., 1998), acute exposure to 
sexual odours and social interaction (Mrovosky et al., 1989).  Phase advances are 
seen in response to behavioural arousal or saline injection in the subjective day 
(Hastings et al., 1992), as well as single exposure to novel running wheels 
(Mrovosky et al., 1996; Turek, 1989; Wickland and Turek, 1994).  The IGL and 
NPY neurotransmission in the SCN, and serotonergic projection from median raphe 
to the SCN are involved in non-photic phase-shifting (Van Esseveldt et al., 2000; 
Meyer-Bernstein and Morin, 1996; Mintz et al., 1997). (Figure 1.5). 
1.6.1.2.   The Photic PRC 
The photic PRC describes where photic stimulation at different circadian 
phases will induce a phase delay, a phase advance or no alteration in circadian phase. 
In nocturnal animals, photic PRC‘s display phase shifts of locomotor behaviour 
during the subjective night, while the subjective day comprises a ―dead zone‖ 
whereby light falling on this phase of the circadian cycle causes no alterations in 
behaviour (Daan and Pittendrigh, 1976).   In response to photic stimuli, the internal 
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oscillator resets rapidly within one cycle, however overt behaviour exhibits transient 
cycles until steady state entrainment is achieved (Johnson et al., 2003).  Pittendrigh 
and Daan (1976a) modelled the circadian oscillator of rodents as an intricate 
timekeeper comprised of two mutually coupled oscillators, a morning oscillator 
which is accelerated by light and synchronized to dawn, and an evening oscillator 
decelerated by light and synchronized to dusk (Pittendrigh and Daan, 1976a; Meijer 
and Schwartz, 2003). Phase advancing photic stimulation applied during the late 
subjective night advances the morning oscillator with a later shift of the evening 
oscillator and the morning peak of SCN electrical activity and the offset of 
locomotor behaviour would also be advanced. (Pittendrigh and Daan, 1976a; Meijer 
and Schwartz, 2003).  At the behavioural level, these phase advances following light 
application in the late portion of the subjective night cause locomotor activity to 
begin earlier on the next cycle (Daan and Pittendrigh, 1976; Rusak and Boulos, 
1981).  Phase delaying photic stimulation would delay the evening oscillator with a 
later shift of the morning oscillator (Pittendrigh and Daan, 1976a; Meijer and 
Schwartz, 2003). These phase delays occur in response to light in the early part of 
the subjective night, delaying the phase of locomotion, causing activity onset of the 
subsequent cycle to occur later (Daan and Pittendrigh, 1976; Rusak and Boulos, 
1981).  Coupled with the delay in the evening oscillator would be a delay in SCN 
electrical activity and the offset of locomotor activity offset (Pittendrigh and Daan, 
1976a; Meijer and Schwartz, 2003). (Figure 1.5). 
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Figure 1.5: Phase response curves of circadian rhythms. In the top panel, 
actograms represent behavioural responses to photic stimulation during 1) the 
subjective day, 2) the early subjective night (inducing a phase delay of the rhythm), 
and 3) the late subjective night (inducing a phase advance). The bottom 
panel represents the phase-shifting effects of non-photic stimuli (e.g. novel running 
wheel) presented 4) in the middle of the subjective day (inducing a phase advance) 
or 5) during the subjective night (no response). The central graphs illustrate both the 
photic PRC (solid line), and the non-photic PRC (dashed line), with number 
corresponding to acrogram respresentations (Golombek and Rosenstein, 2010). 
 
1.6.2 Photic Entrainment 
Environmental light is the principal Zeitgeber, entraining or synchronizing an 
organism‘s activity to the 24hr solar day. The linear model of entrainment of the 
circadian system starts with environmental light stimulating specialized retinal 
ganglion cells (Rollag et al., 2003) which in turn causes synaptic transmission and 
innervation of the SCN‘s core clock cells, resulting in the activation of the proteins 
involved in the resetting of the transcription-translation feedback loop underpinning 
circadian oscillations (Meijer and Schwartz, 2003).  
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1.6.2.1.  Intracellular Signalling Pathways underlying photic entrainment 
The molecular mechanisms that underpin entrainment of the circadian clock 
are thought to begin with glutamate activating SCN NMDA receptors, which 
subsequently leads to an influx of Ca
2+  
into SCN neurons (Ding et al. 1997; Schurov 
et al. 1999; Gau et al., 2002).  The excitatory glutamatergic input activates various 
intracellular signalling molecules and their signalling pathways including, among 
others, the activation of NO, PKG, PKC, calmodulin, CREB and calcium (Gillette 
1996; Gillette and Mitchel, 2002). These signalling pathways underlying photic 
entrainment converge on CREB which, following its phosphorylation becomes 
activated, resulting in its translocation to the nucleus and binds to cAMP-responsive 
elements (CRE) on promotor regions of photically inducible genes (Ding et al., 
1997; Gau et al., 2002; Ginty et al., 1993; Obrietan et al., 1999; Travnickova-
Bendova et al., 2002) and IEGs (Rusak et al., 2002).  Per1 and Per2 are known to be 
induced in response to photic stimulation and to be involved in photic phase-shifting 
(Yan and Silver, 2002), as are a variety of immediate early genes (Rusak et al., 
2002).   
The extracellular signal related kinases (ERKs) are members of the mitogen-
activated protein kinase (MAP) kinase superfamily.  The ERK pathway is implicated 
in the phase-shifting response following photic stimulation.  Active, phosphorylated 
ERK (p-ERK) shows variation across the circadian cycle (Obrietan et al., 1998) and 
phase dependent photic induction, being rapidly upregulated in the SCN upon 
exposure to light during the subjective night, but not during the subjective day 
(Obrietan et al. 1998; Butcher et al. 2003; Coogan and Piggins 2003; Nakaya et al. 
2003).  This photic regulation of p-ERK mirrors the pattern of photic phase-shifting 
of circadian locomotor behaviour (Pittendrigh and Daan, 1976b; Schwartz and 
Zimmerman, 1990).   
Activation of ERK results in the phosphorylation of the cAMP response 
element binding protein (CREB) (Kornhauser et al., 1996a; Obrietan et al., 1998; 
Coogan & Piggins, 2003; Coogan and Piggins, 2004; Dziema et al., 2003; Lee et al., 
2003; Antle et al., 2005), subsequently leading to the transcription of photically 
inducible genes (Grewal et al., 1999; West et al., 2001). The phorphorylation of 
CREB in the SCN is regulated by photic and circadian stimuli (Ginty et al. 1993; 
Obrietan et al. 1999; Gau et al. 2002) and further, CRE mediated transcription shows 
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both photic and circadian regulation (Obrietan et al., 1999).  As well as containing 
CRE in their promotor regions, both the Per1 and Per2 gene promotor regions also 
contain Serum response element (SRE) consensus sequences (Wilsbacher et al. 
2002), and these are known to be targets for phosphorylated Elk-1, which is a 
substrate for ERK (Coogan and Piggins, 2004), and is phosphorylated in response to 
photic stimulation in the hamster (Coogan and Piggins, 2003).   Photically inducible 
IEGs contain both CREs and SREs in their promotor regions (Coogan and Piggins, 
2003) and these include Egr-1 junB, c-Fos and fosB (Greenberg et al., 1992; Perez-
Albuerne et al., 1993) and are induced in response to subjective night photic 
stimulation (Rusak et al., 2002).   
The activation of ERK has been shown to be necessary for photic 
entrainment of the circadian timekeeper (Obrietan et al., 1998; Wang and Sehgal, 
2002; Coogan and Piggins, 2004) and ERK plays roles in the molecular events that 
underlie photic phase-shifting.  In NIH3T3 fibroblast cells in culture in vitro, the 
oscillations of both Per1 and Per2 are perturbed following blockade of the ERK 
cascade (Akashi and Nishida 2000; Oh-Hashi et al. 2002). Administration of the 
MEK (MAP kinase kinase) inhibitor U0126 attenuates the induction of photically 
induced IEGs in the SCN in mice during the delay portion of the PRC (Dziema et al. 
2003).  Inhibition of ERK signalling attenuates the phosphorylation of CREB by 
glutamate (Obrietan et al., 1999).  Further, mice lacking the CREB phosphorylation 
site show perturbations in photic induced phase shifts of locomotor behaviour, as 
well as attenuations in Per1 in the SCN and c-Fos (Gau et al., 2002).  MEK 
inhibitors also impact upon photically induced behavioural responses (Coogan and 
Piggins, 2003; Butcher et al., 2002).   
Additionally, other members of the MAP kinase superfamily have been 
shown to be under circadian and photic control, including P38 and c-jun-N-terminal 
kinase (JNK) (Pizzio et al., 2003; Coogan and Piggins, 2004).  More recently, 
MAPK has been shown to be autonomously activated in the SCN, and its inhibition 
attenuates SCN autonomous neuronal firing rhythms and further, impacts upon 
circadian clock gene oscillations in individual neurons in culture, suggesting that 
MAPK signalling contributes to the robustness of the SCN autonomous circadian 
system (Akashi et al., 2008) and highlighting the importance of these signalling 
cascades in the circadian timekeeping system. 
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1.6.3 Photically induced Per genes 
Photic resetting of the circadian clock in mammals involves the acute 
induction of the clock genes Per1 and Per2 (Dunlap, 1999; Lowrey and Takahashi, 
2000), by a mechanism independent of the CLOCK:BMAL1 controlled E-box 
activation (Travnickova-Bendova et al., 2002; Guilding and Piggins, 2007). The 
protein products of these genes then function in the core molecular feedback loop to 
reset the circadian oscillator (Yan and Silver, 2004). The protein products of these 
genes show phase dependent photic induction across the circadian cycle, induced 
upon exposure during subjective night, but not in response to subjective day photic 
stimulation, and their pattern of photic induction is similar to the pattern of photic 
phase-shifting of circadian locomotor behaviour (Pittendrigh and Daan, 1976b; 
Schwartz and Zimmerman, 1990) as well as the pattern of p-ERK photic induction 
(Obrietan et al. 1998; Butcher et al. 2003; Coogan and Piggins 2003; Nakaya et al. 
2003).  Phase-shifting of the molecular clock is seen to result in photically induced 
Per1 gene expression in the SCN shell following a phase advancing light pulse, 
while Per2 gene expression is seen to be induced in the SCN shell in association 
with phase delays (Yan and Silver, 2002).  The PER proteins have been shown to be 
differentially increased in the different SCN subregions in response to phase 
resetting photic stimulation depending on the portion of the PRC at which photic 
stimulation occurs, and PER2 induction has been suggested to be important for phase 
delays, while PER1 induction is important for phase advances (Yan and Silver, 
2004).  Therefore, the induction of PER1 and PER2 in response to light may play 
roles in photic entrainment (Yan and Silver, 2004) 
1.6.4 Photically induced immediate early genes 
Light induced phase shifts are marked by the induction of photically 
inducible IEGs, including egr-1 jun-B, c-fos and fosB, which contain cAMP-
responsive elements (CRE) in their promotor regions, and as previously described, 
bind CREB and are subsequently transcribed in response to photic stimulation in the 
subjective night (Greenberg et al., 1992; Perez-Albuerne et al., 1993; Rusak et al., 
2002). Inhibition of ERK signalling attenuates photic IEG induction in the SCN 
(Dziema et al. 2003), highlighting the importance of this signalling pathway in IEG 
induction.  c-Fos is the most extensively studied IEG in response to photic 
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stimulation, and a pattern of c-Fos mRNA and immunoreactive Fos protein are 
photically elevated in response to a light pulse during the subjective night and in 
response to lights on at dawn in the light:dark cycle.  Photic stimulation during the 
subjective night causes rapid induction of c-Fos in the SCN within an hour of 
exposure and is associated with photic induced phase shifts of free running 
locomotor activity (Kornhauser et al., 1990; Rusak et al., 1990; Ebling et al., 1991; 
Mead et al., 1992). Light pulses as short as 5 minutes have been shown to cause c-
Fos induction, while a saturating light pulse in mice shows an upper limit of c-Fos 
photically induced cells to be approximatey 20% of the SCN‘s cellular population 
(Castel et. al., 1997).   c-Fos expression is observed in the SCN core in response to 
photic stimulation (Cai et al., 1997; Guido et al., 1999b; Schwartz et al., 1995; 
Schwartz et al., 2000; Takahashi, 1993) and is suggested to be involved in circadian 
function and photic entrainment (Aronin and Schwartz, 1991; Schwartz et al., 2000; 
Kornhauser et al., 1990).  
1.7 SCN Pacemaker Connectivity 
Both humoral and neuronal SCN signalling are involved in output from SCN 
to target sites (Kalsbeek et al., 2006).  
1.7.1 SCN Efferent Projections 
SCN efferent projections travel short distances, and it is mainly other 
hypothalamic regions that receive output information from the SCN (Abrahamson 
and Moore, 2001). These regions serve as relay stations, projecting SCN timing 
information throughout the nervous and endocrine systems, thereby allowing SCN 
communication to the CNS and the periphery (Dibner et al., 2010; Deurveilher and 
Semba, 2005; Kalsbeek et al., 2006).  The SCN‘s principal efferent pathway extends 
to the subparaventricular zone (SPZ) and dorsomedial hypothalamus (DMH) which 
then extends to the hypothalamic paraventricular nucleus (PVN) (Watts, 1991). The 
SPZ and DMH receive input from the dorsomedial shell region of the SCN, while 
efferents from the SCN core terminate in the lateral SPZ (Leak et al., 1999).  These 
SCN outputs must communicate SCN timing information to regions of the CNS 
involved in the regulation of various behavioural and physiological parameters 
including neuroendocrine and autonomic systems, body temperature, sleep wake 
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behaviour, locomotor activity and feeding behaviour (Rosenwasser et al., 2009).  
The dorsal SPZ (dSPZ) regulates body temperature (Lu et al., 2001), while the 
ventral SPZ (vSPZ) is involved in the regulation of locomotor activity and circadian 
rhythms of sleep and wakefulness (Saper et al., 2005).  The DMH is involved in the 
regulation of circadian rhythms of sleep and wakefulness, locomotor activity, 
feeding and corticosterone secretion (Chou et al., 2003). Additionally, independent 
of the DMH and SPZ relay stations, the SCN is also seen to show direct but sparse 
projections to target areas of the DMH and SPZ involved in the circadian regulation 
of behaviour and physiology including, sleep and wakefulness rhythm regulation via 
the ventrolateral preoptic nucleus (VLPO), rhythmic hormonal release via the PVN 
and feeding rhythms via projections to orexin neurons (reviewed in Saper et al., 
2005). 
1.7.2 Humoral SCN Outputs 
Signalling independent of neural projections has also been shown to convey 
circadian timing information. It has been shown that locomotor rhythmicity can be 
restored within SCN lesioned hamsters upon transplantation of viable SCN tissue 
encapsulated within a membrane and therefore preventing neural outgrowth and 
therefore neural communication with the adjacent hypothalamus (Silver et al., 
1996b), indicating the presence of a secretory signal. Various neurochemical outputs 
from the SCN have been proposed, and these include signalling via AVP, VIP, PK2, 
cardiotrophin like cytokine (CLC) and TGF-α, which act upon their targets both 
synaptically and humorally (Cheng et al., 2002; Gerhold et al., 2005; Kalsbeek et al., 
1992; Kramer et al., 2001; Kriegsfeld et al., 2002; Kraves and Weitz, 2006; Son et 
al., 2011).  Further glucocorticoid (GC) signalling may serve to communicate 
information between the SCN and the periphery (Son et al., 2011), since GC‘s are 
seen to impact upon clock gene expression in peripheral tissues in vivo (Koyanagi et 
al., 2006; Son et al., 2008) and in mammalian cells in vitro (Balsalobre et al., 2000a).  
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1.8 Non-SCN oscillators and Pacemaker Hierarchy 
1.8.1 Non-SCN neural oscillators 
While many brain regions display SCN-dependent rhythms, fewer regions 
within the CNS have been shown to display SCN independent rhythms 
(Rosenwasser et al., 2009; Guilding and Piggins, 2007).  The olfactory bulb shows 
persisting rhythmicity in vivo in the absence of the SCN and further, individual 
olfactory bulb neurons show autonomous rhythmicity in the expression of clock 
genes and in electrical activity in culture in vitro (Abraham et al., 2005; Granados-
Fuentes et al., 2004a; Granados-Fuentes et al., 2004b).  These oscillators are 
involved in the regulation of the free running period of SCN dependent locomotor 
activity behaviour and in the regulation of olfactory sensitivity with time of day   
(Granados-Fuentes et al., 2006). The lateral habenula and the arcuate nucleus have 
shown rhythms independent from the SCN (Guilding and Piggins, 2007; 
Rosenwasser et al., 2009).  The retina also displays autonomous oscillators that 
function in the regulation of retinal function and visual sensitivity with time of day 
(Tosini and Menaker, 1996; Tosini et al., 2008).  These oscillators then signal to the 
SCN regulating behaviour (Yamazaki et al., 2002; Tosini et al., 2007). 
1.8.2 Oscillators in the periphery 
Peripheral clocks are now known to be located in most tissues and organs.  
The peripheral clocks require synchronization from the SCN in order to display 
robust circadian oscillations among the oscillator populations, since in non-SCN 
cells, dampening of circadian molecular oscillations occurs readily as a result of 
gradual phasing out of individual rhythms between the cells (Guo et al., 2006; 
Nagoshi et al., 2004; Son et al., 2011).  SCN communication to peripheral tissues 
ensures that peripheral oscillators are entrained to the environmental cycle via 
circadian regulation of gene transcription, enabling peripheral tissues to execute 
appropriate functions at the appropriate phase (Desai et al., 2004; Yamamoto et al., 
2004; Kita et al., 2002; Storch et al., 2002). Clock genes within the SCN generate 
circadian rhythms in physiology and behaviour by synchronizing peripheral 
oscillators and their expression of clock genes via neural and endocrine signalling 
(Terazono et al., 2003; McNamara et al., 2001; Balsalobre et al., 2000a).  Peripheral 
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oscillators have also been seen to be directly entrained by specific Zeitgebers 
including body temperature alterations and feeding-fasting schedules (Buhr et al., 
2010; Damiola et al., 2000; Son et al., 2011).   
1.10.   The Immune Response 
The mammalian immune system has evolved to defend the body against 
infection. The function of the immune system is to distinguish between ―self‖ and 
―non-self‖ antigens and in the case of non-self antigens, to launch an appropriate 
immune response resulting in protection of the body against this microorganism.  In 
this way, the immune system protects the body against bacteria, viruses, parasites, 
fungus etc. The immune system is comprised of two interdependent subdivisions, the 
innate immune system and the adaptive immune system which act in synergy 
forming a complex system.  The non-specific innate immune system provides the 
first line of defence to pathogen invasion and comprises the physical barriers of the 
mammalian body such as the skin epithelial layer, and the non-specific protective 
cells.  Cells of the immune system originate from the bone marrow, including those 
of myeloid and lymphoid origin. The myeloid cells include the phagocytic cells, the 
macrophages, neutrophils, eosinophils, basophils and dendritic cells, while the B 
lymphocytes, T lymphocytes and Natural Killer (NK) cells are of lymphoid origin.  
The adaptive immune system is antigen specific, and comprises the second set of 
host responses to invading microorganisms, and demonstrates immunological 
memory.   
Inflammation followed by activation of the complement cascade are the first 
steps in the immune response.  In response to infection and or tissue damage, the 
cells of the innate immune system react rapidly, adopting a complex 
pathophysiological state known as inflammation (Nathan, 2002; Foster and 
Medzhitov, 2009; Biswas and Lopez-Collazo, 2009).  Pathogen recognition 
receptors (PRRs) are expressed in innate immune cells such as dendritic cells and 
macrophages (Medzhitov, 2001), and recognise pathogen-associated molecular 
patterns (PAMPs), structures that are present on the surface of invading microbes, 
leading to the activation of the innate immune response.  PRR signalling following 
microbial recognition causes the production of inflammatory cytokines and type 1 
interferon, leading to DC maturation and antigen presentation and consequently 
36 
 
adaptive immunity (Akira et al., 2001).  The PRR Toll like receptor 4 (TLR4) is the 
primary PRR that detects Gram-negative bacteria and the endotoxins associated with 
them, such as lipolysaccharide (LPS) and Lipid A (Beutler, 2004; O‘Neill and 
Bowie, 2007; Biswas and Lopez-Callazo, 2009).  TLR signalling occurs via 2 
pathways, an MyD88 dependent pathway resulting in the the early phase activation 
of the NF-κB signalling pathway (Akira and Takeda, 2004) and the production of 
proinflammatory cytokines, and an MyD88-independent pathway leading to late 
phase NF-κB activation as well as the activation of interferon regulatory factor 
(IRF3), resulting in the induction of IFN-inducible genes and maturation of dendritic 
cells (Yamamoto et al., 2003; Akira and Takeda, 2004).  The TLR4 pathway signals 
through the adaptors MyD88, and TRIF, which is involved in the MyD88-
independent pathway (O‘Neill and Bowie, 2007; Akira, 2009; Biswas and 
Tergaonkar, 2007).  (Figure 1.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: TLR4 signalling: MyD88-dependent and MyD88-independent 
pathways. (Akira and Takeda, 2004).  
 
Under normal conditions, the translocation of NF-κB to the nucleus from the 
cytosol is prevented by tight association with inhibitors known as the I-KappaB‘s 
(IκBs) (Baeuerle and Baltimore 1988), and in response to signals that activate NF-
κB, the enzyme IkappaB kinase (IκK) becomes activated and subsequently 
phosphorylates IκB which then dissociates from NF-κB and becomes degraded, 
allowing NF-κB to translocate to the nucleus and subsequent NF-κB DNA binding 
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and the induction of the transcription of different components of the inflammatory 
response including cytokines such as IL-6, NOS, IL-1β, TNF-α,  immunoglobulins, 
Rel family proteins, IκB and neurotransmitters, as well as various other genes (Beg 
et al., 1993; Verma et al., 1995; Nomura, 2001; Marpegan et al., 2004; Yamamoto et 
al., 2003). 
1.11.   Cytokines and the CNS  
The Blood Brain Barrier (BBB) forms a tight separation between the central 
nervous system (CNS) and the peripheral immune system and this lead to the historic 
view of the brain as an immunologically privileged organ, not susceptible to immune 
activation or inflammation.   Far from now being considered an immunoprivileged 
site, the brain is known to contain a variety of immune components and is sensitive 
to inflammatory mediators (Schmidt et al., 2005).  Immune mediators of the 
peripheral immune system such as cytokines, chemokines and complement activated 
proteins are synthesized in the CNS by neurons, microglia and astrocytes, and 
furthermore, these brain cells express receptors for these immune mediators 
(Schmidt et al., 2005).  Cytokine receptors expressed in the brain are functionally 
and structurally similar to those in the periphery (Dantzer, 2004).   
1.11.1.  Neuroinflammation ensues following a systemic immune challenge. 
Systemic cytokines transmit information to the brain following an immune 
insult, altering cytokine expression in regions of the CNS (Dantzer et al., 2004; 
Turrin et al., 2001). Cytokines can be either pro or anti-inflammatory and belong to 
five basic families, the chemokines, the growth and cell stimulating factors, tumour 
necrosis factors (TNF), interleukins (IL) and interferons (IFN).  Activated 
macrophages release the proinflammatory cytokines TNF-α, IL-1β and IL-6, while 
T-cells release the anti-inflammatory cytokines IL-10 and IL-4 (Jacob et al., 2011).  
The CNS carries out immune surveillance of the local environment and in response 
to an insult following infection, disease or injury, a neuroinflammatory response is 
initiated, whereby the CNS cells produce inflammatory mediators including 
prostaglandins, free radicals, proinflammatory cytokines, and complement, 
subsequently inducing chemokines, adhesion molecules, immune cell recruitment 
and glial activation (Lucas et al., 2006; Schmidt et al., 2005). The brain contains a 
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cytokine network, whereby cytokines stimulate their own synthesis and that of 
others, subsequently leading to a cascade of proinflammatory mediator release 
(Taylor and Grossberg, 1998).   The peripheral cytokines produced in response to an 
immune insult communicate with, and exert their effects on the CNS by a number of 
mechanisms including neural and humoral mechanisms and by peripherally activated 
immune cells (Capuron and Millar, 2011).  Cytokine action at the brain endothelium, 
which contains saturable cytokine specific transport molecules and can actively 
transport cytokines across may be one mechanism, cytokines can cross the blood 
brain barrier at areas where it has become compromised, cytokine information may 
be communicated to the CNS via afferent nerves, for example, the vagus nerve 
which is seen to communicate various aspects of the immune response following 
LPS treatment, and peripherally activated monocytes may access the brain 
parenchyma causing the release of secondary messengers such as nitric oxide and 
prostaglandins following the activation of endothelial cells (Rivest et al., 2000; 
Konsman et al., 2002; Watkins et al.,1995; Plotkin et al., 1996; Quan and Banks, 
2007; D'Mello et al., 2009; Capuron and Miller, 2011).  (Figure 1.7). 
 
 
 
Figure 1.7:  Depiction of the routes by which the systemic immune response may 
be communicated to the CNS.  (Capuron and Millar, 2011). 
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1.11.2. Microglia in the CNS 
Microglia are the resident innate immune cells of the CNS and comprise 
approximately 12% of cells in the CNS (del Rio-Hortega, 1932).  Microglia are of 
mesodermal/mesenchymal origin, and are derived from progenitors that migrated 
from the periphery, entering the brain early in development (Chan et al., 2007; 
Kettenmann et al., 2011).  These microglial cells migrate throughout the CNS and 
adopt a ramified ―resting‖ morphology (Kettenmann et al., 2011).   A stable 
population of microglial cells exist in the healthy CNS, however it has been shown 
that following BBB damage, a subpopulation of monocytes enter the CNS and 
transform into microglial cells (Kettenmann et al., 2011; Mildner et al., 2007).  In 
response to an immune challenge within the CNS, microglia become activated, and 
activated microglia are phenotypically and functionally distinct from those in the 
resting state.  The activation of microglia sees the cells progress through a series of 
morphological phenotypes, the end stage of which they appear hypertrophic and are 
seen to resemble phagocytic cells (Kreutzberg, 1996).  In the healthy mature CNS, 
the resting ramified morphology of microglia is characterized by a small soma with 
fine cellular processes that are motile and actively scan the environment of the CNS 
(Kettenmann et al., 2011).  Compared to resting microglia, activated microglia 
exhibit an amoeboid morphology with a larger cell body and processes that are 
shorter and denser than those seen to project from resting microglia (Dheen et al. 
2007; Kaur and Ling 1991; Kaur et al. 1985). Reactive microglia are generally 
evidenced as small, spherical cells with no processes, however an ameboid-like or 
rod-shaped morphology may also be observed (Davis et al. 1994). (Figure 1.8). 
 
 
 
 
 
 
 
 
Figure 1.8: Morphology of microglia.  Images from left to right illustrate the 
transformation of microglia from a resting state into an activated state.  These 
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activated microglia resemble phagocytic cells at the end stage (adapted from 
Kreutzberg, 1996).   
 
Microglia can communicate with neurons and cells of the immune system, 
and contain receptors for immune mediators such as cytokines and chemokines, as 
well as receptors for a variety of neuroactive compounds (reviewed in Kettenmann et 
al., 2011).  Microglial activation in the CNS parenchyma seems to be vital for 
communication between the immune system and the brain (Konsman et al., 2002; 
Combrinck et al., 2002), playing either harmful or beneficial roles.  Following CNS 
insult, the activation of microglia is essential for host defence and neuronal survival.   
Activated microglial cells can become motile and follow a chemotactic gradient 
migrating to the site of injury, as well as provide additional defence and protection 
by increasing microglial numbers through proliferation of local microglial densities, 
and further, can phagocytose cells and cellular compartments (Kettenmann et al., 
2011).  Microglial activation may also play a beneficial role by the release of 
neurotrophic molecules, promoting aspects of regeneration (Streit et al., 1999; 
Schwartz, 2003; Ekdahl et al., 2003).   
However in response to a diverse range of stimuli such as neuronal injury or 
environmental toxins (Block et al., 2007), the overactivation or dysregulation of 
these cells can be harmful and have neurotoxic consequences (Polazzi and 
Contestabile, 2002), releasing a variety of inflammatory mediators which have been 
shown to be neurotoxic in vitro (Ekdahl et al., 2003), such as IL-1β, IL-6, TNF-α, 
NO, and reactive oxygen species (ROS) (Pocock and Liddle, 2001; Hanisch, 2002; 
Gebicke-Haerter, 2001; Vallieres et al., 2002), as well as induce the activation of the 
complement cascade (Jacob et al., 2007). Overactivation of microglia can contribute 
to neuronal damage during neurodegenerative disease (reviewed in Block et al., 
2007). 
 Following microglial activation, microglial cells can go through an 
intermediate ―primed‖ state (Perry, 2004).   On-going pathology within the CNS 
primes microglia, whereby these are excessively reactive to subsequent immune 
challenges including those in the periphery (Cunningham et al., 2005; Lunnon et al., 
2011).   In the CNS, studies indicate the presence of ―primed‖ microglia in chronic 
inflammatory conditions such as in aging, in obesity and in Alzheimer‘s Disease 
patients (Dilger and Johnson, 2008; Bilbo and Tsang, 2010; Holmes et al., 2009; 
Holmes et al., 2011) and the stimulation of these cells may have detrimental 
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consequences, such as impact upon cognitive decline or result in delerium (Perry et 
al., 2003). 
1.11.3. The presence of inflammatory cytokines in the brain under normal 
conditions 
As well as their role in immunomodulations, cytokines play roles within the 
brain in the absence of immune challenge.  In the brain under normal physiological 
conditions, proinflammatory cytokines may play roles in sleep processes.  Various 
studies show that non-REM sleep is increased following the activation of TNF 
and/or IL-1 systems, while NREM sleep is decreased following inhibition of these 
(Opp, 2005). REM sleep is seen to be diminished while non-REM sleep is increased 
following injection of TNF-α into the preoptic area of the hypothalamus (Kubota et 
al., 2002). Non-REM sleep is increased following injection of IL-1β into the dorsal 
raphe nucleus of rats (Manfridi et al., 2003).  Double knockout mice for the IL-1 
type 1 receptor and the TNF receptor show attenuations in REM and non-REM sleep 
following sleep deprivation studies (Baracchi and Opp, 2008).  Additionally, 
administration of an NF-κB inhibitor peptide is seen to inhibit spontaneous sleep, 
supporting the involvement of a brain-cytokine network in sleep regulation (Kubota 
et al., 2000). 
1.12.   Immune-Circadian Communication 
A bidirectional communication is suggested to exist between the immune 
system and the circadian system (Coogan and Wyse, 2008), with circadian variation 
and regulation seen in components of the immune system and immune cells 
themselves acting on peripheral oscillators and on the master pacemaker in the SCN.   
1.12.1 Circadian regulation of immune function 
Immune function is thought to be strongly influenced by the circadian 
timekeeping system and light:dark cycles (Roberts, 2000), and disruption of the 
circadian system is seen to impact upon immune processes as evidenced through 
jetlag and sleep deprivation studies (Silver et al., 2012), and  alterations in cellular 
adhesion molecule expression on monocytes and lymphocytes have been shown in 
studies of acute sleep disruption (Redwine et al., 2004), while studies in humans 
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have shown that early night sleep deprivation reduces natural killer and cellular 
immune responses (Irwin et al., 1996). 
Furthermore, some cells of the immune system contain molecular clocks 
which play roles in the regulation of immune function (Logan and Sarkar, 2012).  
Circadian variation of immune components is seen in the blood in hormone levels, 
cytokines and numbers of circulating haematopoietic cells (Haus and Smolensky, 
1999), and these oscillate in accordance to the rest activity pattern of the species, i.e. 
whether they are diurnal or nocturnal (Scheiermann et al., 2013).  Both mice and 
humans have shown circadian variations in different immune parameters such as 
diurnal variations in cytokine levels (Scheff et al., 2010; Petrovsky et al., 1998; 
Petrovsky and Harrison, 1998; Holzheimer et al., 2002), and circadian regulation of 
natural killer cell activity, antigen presentation and lymphocyte proliferation has also 
been shown (Esquifino et al., 1996; Arjona and Sarkar, 2005; Silver et al., 2012). 
Further, cytokine production, apoptosis and leukocyte trafficking and proliferation 
are known to be modulated by the neuroendocrine and autonomic nervous systems, 
both of which show circadian oscillations (Petrovsy, 2001).  The proinflammatory 
cytokines IL-1β and TNF, as well as levels of glucocorticoids, noradrenaline and 
adrenaline show circadian variation in expression which peaks at the onset of the 
activity phase (Haus and Smolensky, 1999; Haus et al., 1983; Scheiermann et al., 
2013), and it is thought that the circadian regulation of immune pathway components 
may serve to enhance immune responsiveness at the time of the circadian cycle at 
which infection is most likely to occur. 
1.12.2  Communication of circadian information to the immune system 
Circadian timing signals are transmitted to immune cells through endocrine 
and neural signals (Logan and Sarkar, 2012) and the SCN communicates with the 
PVN and arcuate nuclei through axonal connections to regulate stress and immune 
function (Saeb-Parsy et al., 2000; Kalsbeek and Buijs, 2002).    
The SCN and the arcuate nuclei (ARC) are thought to comprise a 
neuroimmune axis. The ARC and the SCN exhibit bidirectional inhibitory and 
excitatory connectivity allowing for feedback control and regulation of circadian 
networks (Saeb-Parsy et al., 2000; Logan and Sarkar, 2012).  Opioids are thought to 
be involved in the SCN-ARC circadian regulation of the immune system, and 
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perikarya producing the endogenous opioid peptide beta endorphin (β-EP) are found 
in the ARC, and project to the hypothalamus along with other regions of the brain 
(O‘Donohue and Dorsa, 1982; Wilcox et al., 1986).  β-EP is derived from precursor 
proopiomelanocortin (POMC) (Nakanishi et al., 1979), and POMC peptides are also 
found in the pituitary gland (Rossier et al., 1977), in macrophages (Mousa et al., 
2004) and in lymphocytes (Sitte et al., 2007; Labuz et al., 2010; Logan and Sarkar, 
2012).  The ARC are thought capable of generating circadian oscillations in 
electrical activity and hormonal output, including POMC oscillations, independent of 
the SCN (Wyse and Coogan, 2010; Guilding and Piggins, 2007; Chen et al., 2004).  
Oscillations in NK cytokine expression and cytolytic activity have been shown to 
mirror those in ARC POMC (Chen et al., 2004) and abolishing or dampening ARC 
POMC oscillations similarly affects oscillations in NK cells (Arjona et al., 2004; 
Arjona and Sarkar, 2006a,b; Chen et al., 2004; Logan and Sarkar, 2012).  
Hypothalamic β-EP stimulation of NK cytotoxicity appears to involve corticotrophin 
releasing hormone (CRH) neurons in the PVN that regulate sympathetic signalling, 
since blocking the function of these neurons inhibits this stimulation (Boyadjieva et 
al., 2006). As well as NK cytotoxicity enhancement (Boyadjieva et al., 2006), β-EP 
is also known to enhance the production of granzyme B (GZMB) and interferon 
gamma (IFN-γ) (Dokur et al., 2004; Boyadjieva et al., 2001; Logan and Sarkar, 
2012) and to stimulate the proliferation of spleenic lymphocytes (Boyadjieva et al., 
2002), and it has been suggested that the SCN, ARC oscillators, and peripheral β-EP 
may regulate the rhythmicity of immunocompetent cells, in particular NK cells 
(Logan and Sarkar, 2012). (Figure 1.9). 
The SCN, PVN and sympathetic nervous system are thought to form a 
network via which the circadian system regulates stress and the immune system 
(Logan and Sarkar, 2012), with the SCN regulating sympathetic and parasympathetic 
outflow to peripheral tissues, thereby modulating this neuroimmune system (Buijs et 
al., 2003, 2008).  Circadian information is passed to the immune system through 
SCN regulation of the PVN‘s endocrine and autonomic neuronal activity (Arjona 
and Sarkar, 2008; Boyadjieva et al., 2001).  Inhibitory and excitatory SCN efferents 
regulate sympathetic and parasympathetic neurons in the SCN (Kalsbeek et al., 
2008).  CRH and oxytocin producing neurons in the PVN govern autonomic inputs 
to the periphery by modulating sympathetic preganglion neurons and 
parasympathetic neurons in the dorsal nucleus of the vagus (Buijs et al., 2003; 
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Dibner et al., 2010; Logan and Sarkar, 2012) and are thought to be the PVN‘s 
neuronal targets for SCN projections (Stanley et al., 2010).  The lymph nodes, spleen 
and thymus receive autonomic input (Bellinger et al., 1993).  The spleen releases 
norepinephrine (NE) upon sympathetic noradrenergic innervation by hypothalamic 
neurons, mediating the activity of various lymphocytes including macrophages and 
NK cells (Bellinger et al., 1993; Dokur et al., 2004; Elenkov et al., 2000; Nance and 
Burns, 1989; Logan and Sarkar, 2012).  A circadian pattern of expression is observed 
in NE input to the spleen, and abolishing this has been shown to attenuate expression 
patterns of certain cytokines and cytolytic factors in splenocytes and NK cells 
(Logan et al., 2011).  The liver which contains large quantities of lymphocytes, also 
receives clock regulated sympathetic input (Cailotto et al., 2005, Gao et al., 2009; 
Terazono et al., 2003). (Figure 1.9). 
 
Figure 1.9: Conceptual framework of biological clocks regulating immune 
function. Oscillators in the SCN, ARC, and immune cells regulate circadian rhythms 
of immune function. The SCN and ARC project to the PVN of the hypothalamus 
modulating autonomic nervous system (ANS) endocrine and neural signalling to 
immune tissues in the periphery. When activated, cytokines and immune mediators 
modulate clocks in the SCN and ARC. ADR, adrenals; β-EP, beta-endorphin; CRH, 
corticotropin releasing hormone; NK, natural-killer cells; POMC, 
proopiomelanocortin. (Logan and Sarkar, 2012) 
Immune function can also be influenced by endocrine hormones which act on 
circadian oscillations of immune cells.  Pineal melatonin and glucocorticoid which 
show antiphase rhythms play strong roles in the circadian regulation of the immune 
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response (Logan and Sarkar, 2012).  The SCN modulation of autonomic input to 
adrenal glands and PVN neurons producing CRH regulates the rhythmic expression 
of peripheral glucocorticoid (Dibner et al., 2010), and further, local oscillators in the 
adrenal gland regulate the sensitivity of the gland to Adrenocorticotropic hormone 
(ACTH) and adrenal GC release (Dickmeis, 2009). Peripheral glucocorticoids show 
peak expression levels during the day and are known to regulate immune processes 
such as the production of cytokines, cellular proliferation, leukocyte distribution and 
apoptosis (Fu and Lee, 2003; Logan and Sarkar, 2012) and may then be important in 
communicating circadian information to immune cells (Haus and Smolensky, 1999).  
SCN autonomic outputs generate circadian oscillations in pineal melatonin which 
exhibits night-time peaks (Logan and Sarkar, 2012), and rhythmic melatonin plays 
roles in the regulation of pro and anti-inflammatory cytokines in the spleen (Naidu et 
al., 2010), as well as in the regulation of expression patterns of NK cell activity, 
cytokine production and leukocyte proliferation in bone marrow cells (del Gobbo et 
al., 1989; Drazen et al., 2001; Haldar et al., 1992; Matsumoto et al., 2001; Logan and 
Sarkar, 2012).   
Circadian regulation of immune system transcription factors has been shown, 
including that of signal transducer and activation of transcription 3 and 5 (STAT 3 
and 5) which play roles in the adaptive and innate immune response in cytokine 
signalling pathways (Alexander and Hilton, 2004; Fu, 2006; Logan and Sarkar, 
2012), and studies have suggested Cry2 to regulate STAT3 (Hoffman et al., 2009).  
Further, both Egr-1 and NF-κB pathways which play roles in the immune system 
show circadian regulation (Bozek et al., 2009, Logan and Sarkar, 2012).  A direct 
molecular link has previously been shown between the circadian system and the 
innate immune system with circadian control seen in the expression and function of 
Toll-like receptor 9 (TLR9), an innate immune pathogen-recognition receptor (Silver 
et al., 2012).  Per2
brdm1
 transgenic mice which exhibit a defective molecular clock 
show altered TLR9 expression and function (Silver et al., 2012). Studies by Spengler 
and colleagues (Spengler et al., 2012) have shown the clock gene protein product 
CLOCK to be a positive regulator of NF-κB mediated transcription independent of 
BMAL1, and stimulation of NF-κB is seen to be reduced in cell lines isolated from 
Clock deficient mice compared to wild type controls. Further, these studies show that 
CLOCK is found in protein complexes with the NF-κB subunit p65. 
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Circadian variations in aspects of the LPS-TLR4 response pathway, 
including FOS, JUN, RELA and IκBα, have been shown in peritoneal macrophages, 
indicating a role for circadian regulation in macrophage LPS activated pathways 
(Keller et al., 2009).  Further, these studies show macrophages to be important in the 
circadian variation in responsiveness to LPS, and macrophage expression of TNF-α 
and IL-6 resulting from LPS stimulation is known to depend on circadian clock 
phase (Keller et al., 2009).  Endotoxin treatment shows phase dependent variation in 
the induction of inflammatory mediators, showing markedly increased levels in 
serum at the beginning of the active phase compared to at the beginning of the 
resting phase, and this temporal gating has been shown to be dependent on clock 
genes, in particular Rev-erbα, implicating the circadian clockwork, in the regulation 
of innate immune responses (Gibbs et al., 2012).   
Many inflammatory diseases display time of day variation in symptom 
severity and these circadian patterns are outlined in the table below adapted from a 
recent review by Scheiermann and colleagues (2013). 
Table 1: Influence of circadian timing on disease manifestations. (Scheiermann et 
al., 2013). 
 
Species 
Disease or 
model 
Oscillating parameter Acrophase Refs 
Human 
Rheumatoid 
arthritis 
Stiffness, pain, serum 
TNF, serum IL-6 
Time of Day 
(TOD) 5–8 
Cutulo, 2012. 
Allergic rhinitis 
Sneezing, nasal 
congestion 
TOD 6 
Smolensky et al., 
2007. 
Bronchial 
asthma 
Bronchoconstriction TOD 6 
Smolensky et al., 
2007. 
Sputum eosinophils, 
serum IL-5 
TOD 7 
Panzer et al., 
2003. 
Myocardial 
infarction 
Pain TOD 9 
Muller et al., 
1985. 
Ischaemic stroke Hypertension TOD 6–CT12 
Gupta & Shetty, 
2005. 
Sickle cell vaso-
occlusive crisis 
Hospital admission TOD 18 
Auvil-Novak et 
al., 1996. 
Mouse 
LPS-induced 
inflammation 
Lethality CT16 
Halberg et al., 
1960. 
Lethality, leukocyte 
recruitment, ICAM1 
ZT13 
Scheiermann et 
al., 2012. 
Pneumococcal 
infection 
Lethality CT16 
Feigin et al., 1969 
Shackelford & 
Feigin, 1973. 
CLP-induced 
sepsis 
Lethality, TLR9 on splenic 
macrophages 
ZT19 
Silver et al., 
2012. 
Coxsackie B3 Gross myocardial lesions CT16 Feigin et al., 
47 
 
Species 
Disease or 
model 
Oscillating parameter Acrophase Refs 
virus infection 1972. 
TNF-induced 
inflammation 
Lethality ZT10 
Hrushesky et al., 
1994. 
Sickle cell vaso-
occlusion 
Lethality, leukocyte 
adhesion, RBC–WBC 
interactions 
ZT13 
Scheiermann et 
al., 2012. 
1.12.3 The effects of circadian misalignment on the immune system 
Given the proportion of immune processes regulated by the circadian system, 
it is not surprising that dysfunction of timekeeping activities perturbs immune 
system function.  Chronic disruption of the circadian system is known to impact on 
health and can lead to a higher risk of many pathologies.   
Human studies of those working rotating shifts highlight an increased risk for 
developing certain cancers, including prostate (Conlon et al., 2007; Kubo et al., 
2006), breast (Davis et al., 2001; Hansen, 2001; Schernhammer et al., 2001), non-
Hodgkins Lymphoma (Lahti et al., 2008) endometrial (Viswanathan and 
Schernhammer, 2009) and colon cancer (Kloog et al., 2009; Schernhammer et al., 
2003).  Furthmore, shift workers show a higher prevalence for diseases such as 
diabetes, obesity and cardiovascular disease (Tuchsen et al., 2006; Morikawa et al., 
2005; Chaput et al., 2006).  Inflammation is a key risk factor in the development of 
many of the pathologies associated with chronic circadian misalignment.  The 
robustness of circadian oscillations in salivary cortisol and in sleep wake cycles 
strongly predict survival in colon and breast cancer patients (Mormont et al., 2000; 
Sephton et al., 2000), pointing to attenuations of the circadian system during the 
pathogenesis of the disease.   
Murine studies using chronic jet lag (CJL) paradigms or SCN ablation to 
induce impairment of molecular clock function to assess the effects of circadian 
disruption on immune processes have further highlighted the importance of circadian 
regulation of immune function in health.  Clock genes are known to regulate certain 
tumour suppressor proteins, and disruption of the molecular clock through 
downregulation of clock gene expression in affected tissues and tumour cells is 
involved in cancer progression (Filipski et al., 2006; Fu and Lee, 2003), and further, 
restoration of clock gene expression phase in peripheral tissues slows the rate of 
tumour growth (Yasuniwa et al., 2010).  CJL subjected mice and Clock mutant mice 
show attenuations in DNA repair, apoptosis and cellular proliferation, linked with an 
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increase in tumour growth (Filipski et al., 2006; Fu and Lee, 2003; Miyazaki et al., 
2010; Sukumaran et al., 2010).   An increase in the oncogenic activation of tumour 
cell proliferation pathways has been shown in another study (Lee et al., 2010) where 
sympathetic output to peripheral tissues is impacted upon by CJL paradigms. CJL 
mice show altered clock gene expression in the SCN, liver, thymus and peritoneal 
macrophages, and is associated with inflammatory response perturbations (Castanon-
Cervantes et al., 2010). These studies show an enhanced sensitivity to endotoxin 
administration both in vitro in macrophages isolated from chronically shifted mice, 
and in vivo, with an increase in LPS induced mortality observed in chronically 
shifted mice compared to controls.  Chronically phase shifted aged mice also show 
an increase in mortality rates compared to un-shifted aged matched controls 
(Davidson et. al, 2006).   
In other studies of the impacts of clock gene mutations on immune 
parameters, loss of IFN-γ circadian expression is seen in mutant Per2 animals 
(Arjona and Sarkar, 2006a, b), along with endotoxic shock resistance following LPS 
treatment, as well as alterations in NK cell function and decreases in production of 
IL-1β (Liu et al., 2006), indicating a role for this clock gene in mediating the LPS 
induced immune response. Circadian rhythmicity is seen to be suppressed in various 
immune related genes and in circulating leukocytes following Clock mutation (Oishi 
et al., 2003, 2006). Further, in mouse embryonic fibroblasts derived from Clock 
mutant mice possessing a defective clock system, increased levels of the NF-κB 
component, RelB, are observed as well as altered responsiveness to LPS treatment in 
vitro, with significantly reduced LPS induced levels of IL-1β, Cxcl1 (Chemokine (C-
X-C motif) ligand 1) and IL-6 (Bellet et al., 2012).  More recently, Logan and 
colleagues (2013) have described significantly altered rhythms of cytokine and 
cytolytic factors in splenic NK cells and perturbations in the expression of Per2 and 
Bmal1 in Per1 deficient mice, indicating that Per1 acts via NK cellular clocks to 
modulate immune pathways.  
1.12.4 The immune system impacts upon the circadian system 
Many studies have highlighted the ability of immune mediators themselves to 
impact upon circadian timekeeping processes, acting on the expression of clock 
genes in the SCN and in the periphery and in cell lines (Okada et al., 2008; Cavadini 
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et al., 2007; Murphy et al., 2007; Tsuchiya et al., 2005; Ohdo et al., 2001; Koyanagi 
and Ohdo, 2002), as well as phase-shifting SCN rhythmicity resulting in phase 
advances or delays of circadian locomotor behaviour depending on circadian phase 
of administration (Marpegan et al., 2005; Sadki et al., 2007; Boggio et al., 2003).  
Cytokine expression and that of their corresponding receptors is seen to oscillate in 
the brain in a circadian manner, however their role in timekeeping processes remains 
unclear.  IL-1β shows diurnal variation in expression in the hypothalamus, similar to 
TNF-α in this region which is also seen to oscillate in the brain stem and forebrain 
(Taishi et al., 1997; Logan and Sarkar, 2012).  IL-1β and TNF-α are found to be 
expressed within the site of the master oscillator itself, and in the areas surrounding 
the SCN where circadian oscillations of their receptors are also seen (Beynon and 
Coogan, 2010; Sadki et al., 2007; Lechan et al., 1990).   
1.12.5 Inflammatory mediators cause functional alterations in the SCN  
The SCN has been shown to be functionally activated following an immune 
challenge.  Protein synthesis of the immediate early gene c-fos is rapidly induced in 
neurons in response to metabolic activation (Morgan and Curran, 1991; Sagar et al., 
1988) and is used as a marker of neuronal metabolic activation (Hoffman et al., 
1993).  Acutely, following low dose peripheral LPS administration, c-Fos expression 
is induced in the SCN shell at CT15 (Marpegan et. al., 2005), while a septic LPS 
treatment has been shown in the acute stages following administration to induce 
significant expression of c-Fos in the SCN, along with expression of the p65 subunit 
of the NF-κB pathway (Beynon and Coogan, 2010).  Photically induced c-Fos was 
impaired in the SCN of mice following chronic treatment with 1mg/kg peripheral 
LPS (Palomba and Bentivoglio, 2008).  Trypanosomiasis has been shown to affect 
SCN functional activation, altering photic induced c-Fos (Peng et al., 1994) and 
basal c-Fos expression patterns in the SCN (Bentivoglio et al., 1994).  Central 
administration of  TNF-α/IFN-γ  has been shown to induce c-Fos expression in the 
SCN shell in the subjective night, and in the SCN core in the subjective day, while in 
aged mice at both times in the circadian cycle the treatment resulted in c-Fos 
induction in the dorsomedial shell (Sadki et al., 2007).  The SCN projects to the 
PVN which is involved in regulation of autonomic and endocrine outputs, including 
production of glucocorticoids (Kalsbeek et al., 2006) and in this way the circadian 
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system may be involved in the modulation of the immune system (Coogan and 
Wyse, 2008). The PVN may be directly stimulated by and respond to an immune 
challenge (Leone et al., 2012), since administration of cytokines or LPS, causes c-
Fos activation in the PVN (Marpegan et al., 2005; Sadki et al., 2007; Beynon and 
Coogan, 2010).  Treatment with 50 μg/kg LPS injection in subjective night has been 
shown to induce PER1 expression in this hypothalamic region at CT15 (Paladino et 
al., 2010) and at ZT 22 (Takahashi et al., 2001).  The LPS receptor TLR-4 is 
expressed in the PVN and circumventricular organs (Laflamme and Rivest, 2001) 
and AVP secretion in the rat SCN is increased following LPS slice treatment in vitro, 
indicating that LPS can directly modulate neuroendocrine signalling (Nava et al., 
2000).  These studies highlight that the circadian system is directly responsive to 
inflammatory mediators. 
1.12.6 Neuroinflammation and the Circadian System 
Modulations of the circadian system are seen in many conditions with a 
neuroinflammatory component.  Neuroinflammation can play a harmful role within 
the CNS due to the activation or over activation of cells involved in the 
inflammatory response, subsequently causing impairments in neuroprotection and 
repair and increased neurodegeneration (Taupin, 2008) and there is evidence that 
inflammation within the brain contributes to both acute and chronic degenerative 
disorders and may contribute to psychiatric diseases (Lucas et al., 2006).  
Modulation of circadian timekeeping processes and constituents of the clock have 
been shown in Alzheimer‘s Disease (AD) and may be due to underlying 
neuroinflammation (Hatfield et al., 2004; Ancoli-Israel et al., 1989; Prinz et al., 
1982; Okawa et al., 1991; Satlin et al., 1991; Witting et al., 1990; Satlin et al., 1995; 
Swaab et al., 1985; Zhou et al., 1995).  A chronic low grade neuroinflammation is 
seen to occur in the normal, healthy aging brain including in the SCN (Godbout and 
Johnson, 2009; Deng et al., 2010) as well as circadian timkeeping impairments 
(Vitiello et al., 1986; Weitzman et al., 1982; Weinert et al., 2000; Hofman et al., 
2006; Kolker et al., 2003; Rosenberg et al., 1991; Zee et al., 1992; Sellix et al., 
2012).  Altered circadian function is seen in diseases characterized by chronic 
infection and neuroinflammation, such as Simian immunodeficiency virus (Huitron-
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Resendiz et al., 2007), and African trypansomiasis (Lundkvist et al., 2002; Lundkvist 
et al., 2010).   
1.13 Sepsis 
1.13.1 Sepsis and Septic Encephalopathy 
Sepsis is a profound pathophysiological state elicited by overwhelming 
infection and successive massive systemic inflammation associated with multisystem 
organ failure and high mortality rates (Mann et al., 2012).  Sepsis is the leading 
cause of death in critically ill patients, with a mortality rate of severe sepsis up to 
70% (Doi et al., 2009).  Classically, gastrointestinal, cardiovascular, pulmonary and 
renal dysfunction comprise the sepsis induced multiple organ failure (Bone et al., 
1997; Wheeler and Bernard, 1999).  Human sepsis is characterized by an imbalance 
between the anti-inflammatory and pro-inflammatory responses to a pathogen 
(Hotchkiss and Karl, 2003), and is seen to involve an inflammatory response stage 
consisting of a proinflammatory response and an immunosuppressed stage.  During 
the immunosuppressed stage the immune response is depressed and can result in 
nosocomial infection and death due to decreased lymphocyte proliferation and 
responsiveness, increased lymphocyte apoptosis and altered antigen presentation 
(AP) (Hotchkiss and Karl, 2003; Riedemann et al., 2003).  A circadian component in 
sepsis progression and severity exists, with septic patients displaying an increased 
mortality risk between 2 and 6 a.m. (Hrushesky and Wood, 1997).   
Septic encephalopathy is a neurological complication due to sepsis and 
systemic inflammatory response syndrome (SIRS) evident in up to 70% of patients 
with severe septic illness and is the most common form of encephalopathy seen in 
patients in intensive care units (Wilson and Young, 2003; Jacob et al., 2010).  The 
manifestations of SE range from confusion and agitation to delirium, stupor or in life 
threatening cases, coma (Ebersoldt et al., 2007).  Up to 50% of sepsis survivors are 
seen to suffer from post-septic encephalopathy which is characterized by long-lasting 
cognitive impairment including attenuations in concentration, attention and memory 
and/or a global loss of cognitive function (Streck et al., 2008). Neuroinflammation 
has been implicated in the pathogenesis of various disorders associated with 
cognitive impairment (Nelson et al., 2002; Katsuse et al., 2003; Perry et al., 2003), 
including Septic Encephalopathy (SE) (Jacob et al., 2010) and post-septic 
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encephalopathy is characterized by long-lasting cognitive impairment (Streck et al., 
2008). 
1.13.2 The CNS is accessed by peripheral inflammatory mediators during sepsis. 
SE is suggested to be caused by the immune mediators of the sepsis response, 
as opposed to in response to a particular infectious agent, since encephalopathy 
occurs in patients in situations where infection is due to both gram negative and 
gram positive bacteria, when no causative agent is identifiable and also in response 
to fungal infections (Jacob et al., 2010).  Multiple factors are thought to contribute to 
this condition including disruption of the blood brain barrier, reduced cerebral blood 
flow (Davies, 2002), oedema (Gardenfors et al., 2002; Bartynski et al., 2006), 
increases in proinflammatory mediators (Boos et al., 2005) and inflammation.  SE is 
probably due to the effects of inflammatory mediators on the brain or as a result of 
brain cells cytotoxic response to these mediators, since reducing inflammation that 
occurs during the septic state has been shown to alleviate the severity of sepsis 
(Jacob et al., 2010).  The inflammatory process may disrupt the BBB through its 
effects on cerebrovascular endothelium and astroglial function (Sharshar et al., 2005; 
Esen et al., 2005), resulting in abnormal neurotransmitter composition and 
attenuations of neuronal function (Shimizu et al., 1999; Stocchetti, 2005; Semmler et 
al., 2008).  Studies have suggested that inflammation, increased permeability of the 
BBB, leukocyte recruitment and neuronal apoptosis are contributed to by cytokines 
and the complement cascasde (Ward, 2008a; Ward, 2008b; Annane, 2009; Bengtson 
and Heideman, 1988; Guo et al., 2004; Huber-Lang et al., 2002; Jacob et al., 2007; 
Jacob et al., 2010). Activated leukocytes enter the CNS by adhering to intracellular 
adhesion molecules (ICAMs) whose expression is increased on the microvessels on 
the BBB during sepsis (Hofer et al., 2008; Bohatschek et al., 2001).  Proteins of the 
complement cascade and inflammatory mediators such as angiopoietin 1, IL-1β and 
TNF attract leukocytes to the sites of injury (Smedegard et al., 1989; Boos et al., 
2005) and activated leukocytes themselves secrete cytokines (Merrill and 
Benveniste, 1996).  Compromises in the integrity of the BBB during sepsis allows 
entry of cytokines to the CNS which would normally be prevented due to their size 
and hydrophilicity (Pan et al., 1997; Gimenez et al., 2004) and further, these can 
increase BBB permeability themselves and stimulate their own production at 
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vascular sites (Jacob et al., 2011).  Cytokines such as TNF-α stimulate glia to express 
iNOS in models of SE (Jacob et al., 2007), leading to an increase in NO levels which 
may play a role in neuronal dysfunction.  Excess NO during SE has been shown to 
be involved in alteration of the regulation of cerebral blood flow, and synaptic 
transmission, leading to neuroendocrine, behavioural activity and memory formation 
perturbations (Jacob et al., 2011).  
Complement proteins are involved in crosstalk with cytokines and may 
enhance the inflammatory response by modulating the production of cytokines and 
chemokines leading to apoptosis, cell necrosis and edema (Jacob et al., 2011).  The 
complement system is implicated in the pathogenesis of sepsis and the complement 
proteins C3 and C5, and their by-products the anaphylatoxins, C3a and C5a that are 
generated following complement activation mediate the effects of this (Jacob et al., 
2011). Following complement activation, C3 is seen to be up-regulated leading to 
breakdown of the BBB, increased water content, increased glial activation, and an  
increase in the expression of TLR4 followed by perturbations in aquaporin 4, TNF 
and iNOS expression (Ducruet et al., 2009; Komotar et al., 2009; Mocco et al., 
2006). In patients with septic shock C3a was seen to be increased (Stove et al., 
1996). C5a is increased following administration of endotoxin initially within the 
cerebral endothelium, then within neighbouring microglial cells and finally deeper 
within the brain parenchyma, and C5a inhibition is seen to prevent BBB damage.  
The peripherally induced sepsis pituitary response is prevented, along with a 
reduction in sepsis induced PVN and amygdala neuronal activation following 
inhibition of the complement cascade (Flierl et al., 2009; Jacob et al., 2011). 
Humoral signalling following sepsis induction exerts immunomodulatory 
effects.  The sympathetic nervous system is stimulated to release epinephrine, which 
binds to receptors on immune cells modulating the immune response (Padgett and 
Glaser, 2003).  The afferent vagus nerve regulates the release of these hormones by 
recognizing the proinflammatory cytokines and stimulating components of the 
central stress response system (Elenkov et al., 2000), leading to the secretion of 
cortisol via HPA axis activation (Webster et al., 2002), and epinephrine via 
sympathetic nervous system stimulation (Padgett and Glaser, 2003), both of which 
play immunoregulatory roles.  Crosstalk between the neuroendocrine pathways, 
cytokines and the autonomic nervous system has been suggested to play important 
roles during sepsis in the modulation of inflammation (Elenkov et al., 2008).  The 
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HPA axis through the production and release of glucocorticoids inhibits pro-
inflammatory cytokine expression (Webster et al., 2002).  The cholinergic anti-
inflammatory pathway also plays roles in the modulation of the inflammatory 
response, whereby the parasympathetic nervous system is stimulated to release 
acetylcholine which regulates the immune response (Pavlov et al., 2003). 
 Altered neurotransmission may impact upon the CNS during SE.  
Neurotransmitters of the sympathetic nervous system modulate inflammation during 
sepsis, and epinephrine action through its activation of adrenergic receptors and 
increased levels of intracellular cAMP is seen to have a net anti-inflammatory effect 
(Van der Poll et al., 1996; Van der Poll, 2000).  Glutamatergic neurotransmission is 
thought to play roles in SE, since inhibition of its synaptic release in a rat model has 
been shown to reduce sepsis induced neurological effects and improve survival 
(Toklu et al., 2009).  Further, increased levels of tryptophan and indolamine have 
been shown in the brain of rats during sepsis (Freund et al., 1985), highlighting 
further that sepsis causes alterations in neurotransmitters. 
1.13.3 Experimental Sepsis Models  
Experimental sepsis in animal models can be induced by a variety of 
mechanisms, the most commonly used methods being cecal ligation and puncture 
(CLP) or peripheral administration of endotoxin, a high dose of LPS (Dejager et al., 
2011).   
LPS administration is a widely used experimental sepsis model attempting to 
mimic the pathophysiological changes seen in septic patients.  LPS, also known as 
endotoxin, is a toxic, soluble component of the gram negative bacterial cell wall 
(Marpegan et. al., 2005).  LPS effects are dose dependant and comprise fever, acute 
phase responses and septic shock in animals (Rivest et. al., 2000). At low doses, LPS 
induces fever and a brain mediated acute phase reaction termed ―sicknesss 
behaviour‖ which is mediated by temporarily expressed proinflammatory cytokines 
in the brain (Dantzer, 2004) and characterised by lethargy, piloerection, grooming, 
decreased social interaction and anhedonia.  After LPS administration in mice, the 
onset of systemic clinical signs that compromise sickness behaviour are seen to 
occur rapidly (Remick et al., 2000).  High-dose LPS administration quickly results in 
a hypodynamic cardiovascular state,  which is characterized by decreased cardiac 
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output and increased peripheral vascular resistance (Brackett et al., 1985; D‘Orio et 
al., 1987).  A decrease in total white blood cell count is seen with reduced levels of 
neutrophils and lymphocytes (Remick et al., 2000). High-dose LPS treatment 
induces a rapid increase in systemic cytokine levels which has been shown to be 
transient (Buras et al., 2005).  Peripheral LPS treatment has been shown to induce 
the expression of various inflammatory mediators including TNF-α, IL-6, IL-1α and 
IL-1β both in the brain and the periphery (Zetterstrom et al., 1998), and TNFα, IL6 
and IL-1β have been shown to be essential in the LPS induced acute behavioural 
alterations known as sickness behaviour (Dantzer, 2001). Cytokine production 
exhibits a bell-shaped curve over an 8-h period after injection, with levels reaching a 
peak between 1.5 to 4.5 h and then declining (Remick et al., 2000).   
The use of endotoxin administration as a sepsis model has various 
advantages.  Endotoxin models are reproducible, and the use of LPS can be easily 
standardized in experimental settings, and LPS is a relatively pure compound that is 
reliably measured (Fink et al., 1990).  The value of endotoxin administration as a 
sepsis model is supported by studies in healthy human volunteers, where low-dose 
endotoxin injection results in pathophysiologic perturbations similar to those 
reported in sepsis patients (Fink et al., 1990). A single endotoxin administration 
offers the advantage of avoiding the need for a surgical procedure, and therefore 
presents fewer concerns than surgical models with respect to animal welfare 
(Nemzek et al., 2008), in general, however, these experimental animal models show 
a more rapid disease progression than is observed in human sepsis patients (Buras et 
al., 2005; Deitch, 1998; Hollenberg, 2005).  Further, experimental animal models of 
LPS may not accurately replicate some features of human sepsis such as the initial 
hyperdynamic cardiovascular state and the magnitude and rate of induction of the 
cytokine response state (Buras et al., 2005; Deitch, 1998; Fink et al., 1990).   
In the CLP model, perforation of the bowel results in leakage of faecal 
contents into the peritoneum, which establishes an infection with mixed bacterial 
flora and provides an inflammatory source of necrotic tissue (Wichterman et al., 
1980; Ayala et al., 2000).  The severity of CLP induced sepsis can be adjusted by 
increasing the size of the needle and subsequently the puncture size or the number of 
punctures (Wichterman et al., 1980).  Sickeness behaviour symptoms are observed 
within a few hours of CLP in experimental animal models (Ebong et al., 1999a; 
Ebong et al., 1999b; Nemzek et al., 2004).   The CLP model of sepsis is thought to 
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very closely mimic the clinical situation, in relation to the onset and progression of 
the sepsis (Buras et al., 2005; Hubbard et al., 2005), reproducing the cardiovascular 
function changes seen in humans sepsis patients, and is seen to induce a progressive 
release of proinflammatory mediators, in line with what is observed in the clinical 
situation (Chaudry et al., 1979; Ebong et al., 1999a; Ebong et al., 1999b). The 
haemodynamic and metabolic phases of human sepsis are recreated by the CLP 
model (Wichterman et al., 1980), as well as cell specific apoptosis and immune 
responses (Hotchkiss et al., 2003; Ayala and Chaudry, 1996). Following CLP in rats, 
a mixed population of enteric bacteria is seen, including Proteus mirabilis, E. coli, 
Bacteriodes fragilis and Enterococcus, and several bacterial species may be present 
in blood cultures (Wichterman et al., 1980).  
A limitation of CLP as a sepsis model is that surgical intervention is required, 
raising various issues in relation to animal welfare.  Additionally, the state induced 
by CLP can be affected post-surgery, anesthesia and postoperative hypothermia can 
modulate outcome, as can the use of anesthetic drugs which can impact upon the 
inflammatory response (Gallos et al., 2004; Hansbrough et al., 1985), and post-
surgical treatments such as antibiotic administration can affect bacteria 
dissemination, as well as sepsis severity depending on the antibiotic used (Enoh et 
al., 2006; Newcomb et al., 1998; Nemzek et al., 2008).  Further, the CLP model is 
not standardized within the published sepsis literature and care must be taken when 
making comparisons between studies, due to potential differences in surgical 
technique and postoperative care (Nemzek et al., 2008).  During CLP, the amount of 
caecum ligated can induce variability into the technique, since increased mortality is 
associated with larger amounts ligated (Singleton and Wischmeyer, 2003).  
Additionally, it is difficult to control for the leaked amount of faecal material 
between studies, which could account for variability in disease severity.   
1.13.4 The acute systemic immune response to a septic LPS treatment  
The body recognizes LPS as a PAMP and consequently the innate immune 
system mounts an immune response (Banks and Robinson, 2010).  LPS exerts its 
effects by binding through TLR4 present on macrophages and monocytes which 
subsequently triggers intracellular signalling pathways, leading to activation of 
nuclear transcription factors (Dantzer, 2004).  LPS administration induces NF-κB 
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dependant signalling which results in transcription of proinflammatory cytokines 
(Rivest et al., 2003).  As described, high-dose LPS treatment induces a rapid increase 
in systemic cytokine levels which has been shown to be transient (Buras et al., 
2005), both in the brain and the periphery (Zetterstrom et al., 1998).  In plasma, TNF 
levels increased following LPS treatment, peaking at 1.5hrs then quickly declining, 
while IL-6 levels peaked approximately 4hrs post LPS, and rapid induction of the 
chemokines MIP-2 and CXCL1 was seen in plasma (Remick et al., 2000).  The 
susceptibility of mice to LPS induced endotoxic shock differs depending on the time 
of the light dark cycle at which it is administered, and susceptibility to lethal doses 
has been shown to increase dramatically during the resting period in mice (Halberg 
et al., 1960).  Most inflammatory immune cells and factors show increased 
expression during the rest phase (Leone et. al., 2007) and mortality following LPS 
administration in L:D is directly proportional to the induction of inflammatory 
cytokines and chemokines such as IL-1β, IL-6, MCP1 and MIP1α in serum 
(Marpegan et. al., 2009). 
Peripheral administration of LPS in humans and animals has been shown to 
activate HPA axis activity, increasing circulating levels of corticosterone and ACTH 
(Linthorst and Reul, 1998).  The HPA axis through the production and release of 
glucocorticoids inhibits pro-inflammatory cytokine expression (Webster et al., 
2002).  1 mg/kg LPS i.p. treatment causes increased levels of corticosterone and 
blood vessel inflammation 24hrs following treatment (Chung et al., 2010).  
Cytokines can impair the expression of glucocorticoid receptors (GR) and reduce 
their function (Pace et al., 2007).   It has been shown that activation of NF-κB, 
STAT5 and p38 MAPK by cytokines disrupts the translocation of glucocorticoid 
receptors to the nucleus from the cytoplasm and nuclear protein-protein interactions 
which inhibit GR-DNA binding, reducing the function of glucocorticoids (Pace et 
al., 2007).   Further, it has been suggested that cytokine mediated alterations of the 
function of the HPA axis and glucocorticoid receptor function may further modulate 
inflammation since glucocorticoids play an essential role in regulation of 
inflammatory processes (Capuron and Miller, 2011).   
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1.13.5 LPS treatment impacts upon the CNS. 
LPS may affect the brain by a number of mechanisms including crossing the 
BBB and directly activating cells within the CNS that respond to LPS including 
microglia (Marzolo et al., 2000), astrocytes (Chakravarty & Herkenham, 2005) and 
brain endothelial cells (Reyes et al., 1999; Verma et al., 2006) and those that express 
TLR4 (Chakravarty & Herkenham, 2005).  Indeed, TLR4 and the monocyte CD14, 
both known to recognize LPS, are expressed in the choroid plexus, leptomininges 
and circumventricular organs, that is in those regions close to the BBB (Rivest et al., 
2003).  BBB breakdown leads to alterations in ionic homeostatis and allows 
inflammatory cells and toxic metabolites to access the brain leading to neuronal 
damage and inflammation within the CNS (Nishioku et al., 2009).  However, other 
studies have shown that minimal amounts of peripherally administered LPS cross the 
BBB and do not appear sufficient to induce the neuroimmune reactions seen 
following peripheral LPS treatment, except possibly at the highest experimentally 
used doses and for the most sensitive CNS functions, and therefore suggest that these 
neuroimmune reactions in response to peripherally administered LPS are likely 
mediated through LPS receptors located outside the BBB (Banks and Robinson, 
2010).   
Outside of the brain, LPS may also indirectly impact upon the brain through 
interactions with the afferent and vagal nerves (Romeo et al., 2001; Goehler et al., 
1999), acting at circumventricular organs (Blatteis et al., 1983), causing the release 
of inflammatory mediators in the periphery able to cross the BBB (Qin et al., 2007) 
or by altering the permeability of the BBB (Xaio et al., 2001) and the response of 
cells comprising the BBB to LPS and the subsequent release of substances such as 
cytokines at these sites (Quan et al., 2003; Verma et al., 2006).  Studies have shown 
the long-lasting effects of LPS on the brain to be mediated by TNF-α, since studies 
in TNF-α receptor knockout mice have shown that TNF-α receptors are necessary for 
a systemic LPS treatment to produce TNF-α mRNA production and activation of 
microglia in the brain (Qin et. al 2007).   IL-1β has also been suggested to be 
involved in the transmission of the peripheral inflammatory response following LPS 
treatment to the brain via the cerebral vasculature (Turrin et al., 2001) subsequently 
leading to upregulation of proinflammatory cytokine synthesis in the brain (Turrin et 
al., 2001; Shaw et al., 2001; Terrazzino et al., 2002). 
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1.13.6 The effects of LPS treatment on the brain and behaviour 
Central and peripheral LPS administrations induce similar neuroimmune 
responses (Gottschall et al., 1992; Banks and Robinson, 2010).  Peripheral LPS 
treatment induces central upregulation of expression of a variety of substances 
including nitric oxide, prostaglandins and interleukins (Singh and Jiang, 2004; 
Larson & Dunn, 2001; Sugita et al., 2002) including proinflammatory cytokines such 
as IL-1, IL-6, IL-8 and also TNF-α (Qin et al,. 2007, Herber et al., 2006), and the 
chemokine MCP-1 (Thompson et al., 2008; Qin et al., 2008) acutely in the brain 
following LPS treatment and these temporarily expressed proinflammatory cytokines 
in the brain mediate sickness behaviour (Dantzer, 2004). Systemic LPS impacts on 
sleep architecture and sleep-wake behaviour (Krueger and Majde, 1994).  Sickness 
behaviour can also be induced by central or peripheral treatment with TNF-α (Porter 
et al., 1998) or IL-1β (Bluthe et al., 1995; Swiergiel et al., 1997).   Behavioural 
output is altered during sickness behaviour, and hypoactivity is exhibited (Franklin 
et al., 2007).  Alterations in cytokine levels in the CNS and the neuroinflammatory 
response may lead to neurobehavioral impairments and delirium (Lemstra et al., 
2007). 
Microglial activation and cytokine release in the CNS has previously been 
shown in response to LPS induced sepsis (Godbout et al., 2005; Van Dam et al., 
1992; Buttini et al., 1996).  Further, peripheral LPS treatment and subsequent 
microglial activation and cytokine release have been associated with behavioural 
deficits (Bluthe et al., 1992; Godbout et al., 2005; Combrinck et al., 2002).   
Activated microglia have been shown in the brains of human sepsis patients, 
irrespective of age (Lemstra et al., 2007).  Neuronal and glial cells (microglia and 
astrocytes) form a cytokine network within the CNS, capable themselves of releasing 
cytokines, and containing cytokine receptors, responding to cytokine information 
and in turn modulating this (Rothwell et al., 1996; Haas & Schauenstein, 1997).  
Microglia and astrocytes also synthesize complement proteins, and activation of the 
complement cascade has been shown to play roles in the brain following LPS 
treatment, leading to upregulation of CD45, TNF-α and TLR4, along with an 
upregulation in activated microglia and iNOS (Jacob et al., 2007).  Activated 
microglia release inflammatory mediators which are shown to be neurotoxic in vitro 
(Ekdahl et al., 2003) such as IL-1β, IL-6, TNF-α, nitric oxide, and reactive oxygen 
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species (Pocock and Liddle, 2001; Hanisch, 2002; Gebicke-Haerter, 2001; Vallieres 
et al., 2002).  Studies have shown an upregulation in glia in various regions of the 
CNS both acutely (Chung et al., 2010; Jacob et al., 2007; Semmler et al., 2005) and 
chronically (Hauss-Wegrzyniak et al., 2000; Weberpals et al., 2009) following LPS 
treatment.  In SE models, increases in levels of the immune signaller nitric oxide are 
seen, due to elevated iNOS (NOS2) expression as a result of cytokines such as TNF-
α stimulating glia to express iNOS (Jacob et al., 2007).  24hrs following 10mg/kg 
LPS treatment in rats an upregulation of iNOS is seen in the striatum, cerebellum, 
hippocampus and midbrain (Semmler et al., 2005).   
It has been suggested that inflammatory cytokines and nitric oxide generation 
may cause perturbations in neuronal function and cause neurodegeneration during 
septic encephalopathy (Semmler et al., 2008).  Sustained nitric oxide generation 
impacts upon neuronal survival (Boje et al., 1992; Leist et al., 1997; Heneka et al., 
1998), and NO also plays roles in neuronal activity (Mori et al., 2001; Wang et al., 
2004).  Inflammatory cytokines TNF-α and IL-1β also influence neuronal viability 
(de Bock et al., 1998; Venters et al., 2000) and the function of neurons (Pickering et 
al., 2005; Tancredi et al., 1992; Kelly et al.,2001). Acutely, following sepsis 
induction, Semmler et al. (2008) have also shown neuronal loss in the hippocampus 
and cortex, along with up-regulated microglial activation in the cortex associated 
with an increase of the immunomediators iNOS, MCP-1, Il-1β, TNFα and TGF-β.  
Further, a single septic i.p. LPS treatment has been shown to irreversibly damage 
dopaminergic neurons which are subsequently seen to degenerate between 7 and 
10months post-treatment (Qin et al., 2007).  Three months following 10mg/kg LPS 
treatment, neuronal loss in the prefrontal cortex and hippocampal subregions, and 
reduced cholinergic innervation of the parietal cortex was evidenced in rats 
(Semmler et al., 2007).   
Together, these studies highlight that sepsis is a profound pathophysiological 
state and highlight the impact of sepsis on the CNS both acutely and in the long 
term. 
1.14 Aims of Study: 
A bidirectional communication is suggested to exist between the immune 
system and the circadian system (Coogan and Wyse, 2008), and while there is much 
61 
 
evidence regarding the regulation of immune function by the circadian system 
(reviewed in Scheiermann et al., 2013), there is less information regarding the 
impact of immune processes on the timekeeping system.  Various studies have 
assessed the acute impact of immune mediators on the circadian timekeeping system, 
however there is a gap in the literature as to the chronic effects of an immune 
challenge on the circadian timekeeping system. The current set of studies sought to 
address this gap, and examine the long term impact of sepsis, a substantial immune 
challenge, on circadian timekeeping processes, utilizing a septic endotoxin model 
known to chronically impact on the innate immune system in the CNS (Weberpals et 
al., 2009; Qin et al., 2007; Bossu et al., 2012).  These studies will enhance our 
knowledge of the impact of immune processes on timekeeping processes, and 
describe a previously unknown impact of the chronic effects of experimental sepsis 
on the circadian timekeeping system. 
  
The specific aims of this study were: 
 
 To examine post-septic locomotor behavioural rhythmicity as an output measure of 
the functional activity of the post-septic endogenous oscillator, assessing core 
circadian locomotor behaviour parameters and circadian resetting behaviour in the 
long term following the induction of sepsis (Chapter Two). 
 To examine the neurochemistry of the SCN both in the acute phase and in the long 
term following a septic LPS treatment, and examine the possibility of a chronic 
neuroinflammation within the SCN that could play a role long term in circadian 
timekeeping processes (Chapter Three). 
 To examine the long-lasting impact of LPS induced sepsis on the rhythmic 
expression of clock gene and IEG protein product expression patterns in the SCN, 
and to assess post-septic SCN responsiveness and function (Chapter Four).  
 To assess the response of the post-septic circadian system to further immune 
challenge, assessing a priming effect of previous CNS insult following LPS induced 
sepsis (Chapter Five).  
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Chapter Two 
Analysis of the Effects of Sepsis Induction on Circadian 
Locomotor Behaviour 
 
2.1. Introduction 
The LPS induced sepsis model used in the current set of studies is one that is 
known to induce a long-lasting neuroinflammation (Qin et al., 2007; Weberpals et 
al., 2009; Bossu et al., 2012), and modulation of circadian timekeeping processes, 
including locomotor behaviour, has been shown in response to immune mediators 
and in conditions of chronic neuroinflammation.  It is therefore possible that 
endotoxin induced sepsis and the post-septic CNS state could chronically attenuate 
circadian timekeeping processes. 
2.1.1 The direct effect of immunomediators on the circadian system 
SCN function is modulated by immune factors, which can impact upon the 
rhythmic expression of clock genes and subsequently affect circadian locomotor 
behaviour.  Treatment with endotoxin has been shown to alter clock gene expression 
both in the SCN and in the periphery (Okada et al., 2008; Cadivini et al., 2007; 
Murphy et al., 2007), and further, other inflammatory mediators have been shown to 
impact upon molecular clock gene oscillations both in the site of the master 
pacemaker and in peripheral tissues and in cell lines (Tsuchiya et al., 2005; Cavadini 
et al., 2007; Ohdo et al., 2001; Koyanagi and Ohdo, 2002).   TNF-α is seen to 
interfere with Dbp in the SCN, as well as cause an increase in the number of rest 
episodes during the subjective night in mice, and a reduction in total locomotor 
activity under a 12:12 LD cycle, but no effect on the FRP under constant conditions 
(Cavadini et al., 2007).  Low dose peripheral LPS has been shown to acutely impact 
upon circadian behaviour, transiently suppressing locomotor wheel running 
behaviour (Marpegan et al., 2005).  A single treatment with IFN-α directly decreases 
locomotor behaviour in mice (Crnic and Segall, 1992), while chronic administration 
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of the cytokine is seen to significantly alter locomotor rhythmicity and cause a 
decrease in total activity levels (Koyanagi and Ohdo, 2002).   
   Additionally, direct administration of immune factors is capable of phase-
shifting SCN rhythmicity resulting in phase advances or delays depending on the 
circadian phase at which they are administered, and inflammatory mediators have 
been suggested to play roles in entrainment of the circadian timekeeping system 
(Leone et al., 2012).   In hamsters, i.c.v. administration of IFN-γ leads to phase 
advances during the subjective day, but not during the subjective night (Boggio et 
al., 2003), while centrally administered IL-1β and TNF-α in the early subjective 
night induce phase delays of locomotor behaviour (Leone et al., 2012).   
LPS treatment also induces phase resetting responses.  Low dose peripheral 
treatment administered in the early subjective night, at CT15, but not at other phases, 
has been shown to induce photic like phase delays that were non additive to the 
effects of light (Marpegan et. al., 2005; Leone et al., 2012).  IL-1β has been shown 
not to be involved in mediating phase shifts of behaviour following an endotoxin 
induced immune challenge, however TNF-α plays an essential role in this response, 
since its inhibition blocks LPS induced phase delays (Leone et al., 2012).   Further, 
TLR4 is suggested to play a role in these LPS induced circadian behavioural 
responses, since in TLR4 deficient mice, the low dose LPS induced phase delay at 
CT15, along with the induction of PER1 and c-Fos in the PVN was seen to be 
decreased or absent (Paladino et al., 2010).  Additionally, the immune related 
transcription factor NF-κB has been implicated in the LPS effects on the circadian 
system and its presence and action upon the SCN has been shown during LPS 
induced and photic induced phase shifts (Marpegan et al., 2004, 2005; Paladino et 
al., 2010).   LPS administration has been shown to cause functional activation of the 
SCN (Marpegan et. al., 2005; Beynon and Coogan, 2010), and to impact upon SCN 
responsiveness (Palomba and Bentivoglio, 2008).  No alterations in period or phase 
of rhythmic core body temperature or locomotor behaviour are seen in response to a 
lethal dose of LPS (Marpegan et. al., 2009).  
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2.1.2. Circadian rhythm perturbations in chronic inflammatory states 
As described previously, dysfunction of timekeeping activities has been shown 
to perturb immune function, as has been shown by a wide variety of chronic jet lag 
studies (Filipski et al., 2003; Filipski et al., 2006; Fu and Lee, 2003; Miyazaki et al., 
2010; Sukumaran et al., 2010; Castanon-Cervantes et al., 2010), and inflammation is 
a key risk factor in the development of many of the pathologies associated with 
chronic circadian misalignment.  The LPS induced sepsis model used here induces a 
long-lasting neuroinflammation (Qin et al., 2007; Weberpals et al., 2009; Bossu et 
al., 2012), and  modulation of circadian timekeeping processes is seen in many 
conditions with a neuroinflammatory component.  Neurological diseases and 
disorders such as Alzheimer‘s Disease, are well documented as having underlying 
neuroinflammation. Alzheimer‘s patients show alterations in the circadian system 
(Hatfield et al., 2004), including sleep-wake cycle disturbances (Ancoli-Israel et al., 
1989; Prinz et al., 1982), perturbations in the phase and amplitude of the sleep 
rhythm (Okawa et al., 1991; Satlin et al., 1991; Witting et al., 1990; Satlin et al., 
1995) and reductions in the neuropeptides vasopressin (Swaab et al., 1985) and 
vasoactive intestinal polypeptide in the SCN (Zhou et al., 1995),  highlighting 
modulations of the circadian system in AD patients, possibly due to underlying 
neuroinflammation.  
A chronic low grade neuroinflammation is seen to occur in the normal, 
healthy aging brain including in the SCN (Godbout and Johnson, 2009; Deng et al., 
2010), along with an increase in microglial activity (Jurgens and Johnson, 2010).  In 
healthy aging, circadian impairments are seen, including alterations in core body 
temperature (CBT) rhythms, (Vitiello et al., 1986; Weitzman et al., 1982), damped 
circadian amplitude (Weinert et al., 2000) and functional alterations of peripheral 
oscillators (Sellix et al., 2012) and decreases in the neuropeptides AVP and VIP in 
the SCN (Hofman et al., 2006).  Furthermore, attenuations are found in the senescent 
SCN in photic responsiveness (Kolker et al., 2003), photic induced resetting 
(Rosenberg et al., 1991) and synchronization (Zee et al., 1992; Sellix et al., 2012).  
Altered circadian function is seen in diseases characterized by chronic 
infection and neuroinflammation, such as Simian immunodeficiency virus, which 
shows alterations in clock controlled rhythms of CBT and locomotor activity 
(Huitron-Resendiz et al., 2007), and  African trypansomiasis (Lundkvist et al., 2002; 
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Lundkvist et al., 2010).  Trypanosomiasis has been shown to affect SCN functional 
activation, altering photic induced c-Fos (Peng et al., 1994) and spontaneous c-Fos 
expression in the SCN (Bentivoglio et al., 1994).  Human African trypanosomiasis 
(HAT) consists of a hemolymphatic stage followed by a meningoencephalitic stage 
whereby the parasite Trypanosoma brucei (Tb.) and inflammatory cytokines cross 
the BBB, invading the CNS (Etet et al., 2012).  T.b. brucei infected rodent models 
show alterations in some, but not all circadian rhythms (Kristensson et al., 2010) 
including perturbations in CBT (Berge et al., 2005; Chevrier et al., 2005; Etet et al., 
2012) and in ultradian and circadian organization of rhythmic locomotor behaviour 
(Grassi-Zucconi et al., 1995).  Trypanosomes secrete prostaglandins which interact 
with the host‘s immune response causing the release of proinflammatory cytokines 
and neuroinflammatory signalling has been suggested to be involved in the 
attenuations in circadian rhythms and in sleep patterns that characterize the disease 
(Kennedy, 2009; Kristensson et al., 2010).  Indeed studies in an experimental rat 
model of African trypanosomiasis utilizing the T.b. brucei parasite, show that it is at 
the same time that CNS parenchyma invasion by the parasite and inflammatory 
mediators occurs that alterations in circadian rhythms become more marked, 
including perturbations in the oscillations of CBT, rest-activity, total sleep time and 
Slow Wave Activity (SWA) become significant and more severe (Etet et al., 2012), 
supporting the role of neuroinflammation in the circadian alterations.   
Given the bidirectional communication between the immune system and the 
circadian system, the impact of centrally acting inflammatory mediators on circadian 
timekeeping, and the fact that peripheral LPS induced sepsis is characterized by 
significant increases in proinflammatory cytokines (Qin et al,. 2007, Herber et al., 
2006) and activation of the HPA axis (Linthorst and Reul, 1998), dysfunction of the 
innate neuroimmune system following sepsis and SE could perturb the circadian 
timekeeper and circadian output.  Inflammatory mediators might impact upon the 
SCN, modulating SCN output and locomotor activity rhythms, affecting 
synchronization and entrainment of the post-septic circadian timekeeping system, or 
core circadian locomotor behavioural parameters.    The primary aim of this portion 
of the study was to examine locomotor behavioural rhythmicity as an output measure 
of the functional activity of the post-septic endogenous oscillator, examining the 
long-term effects of a substantial immune challenge on circadian organization and 
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the SCN‘s ability to coordinate timekeeping processes.  For the purposes of these 
experiments, we have studied the core circadian parameters as well as the 
entrainment and resetting properties of circadian locomotor behaviour in the long 
term post-sepsis. These studies are the first to document the long-lasting effects of 
sepsis on the circadian pattern of locomotor activity. 
2.2.  Materials & Methods 
2.2.1 Ethical Approval 
All protocols were approved by the Research Ethics Committee at the National 
University of Ireland, Maynooth and were licensed by the Department of Health and 
Children, Ireland. Animals were  treated in accordance with the Cruelty to Animals 
Act, 1876 and the SI No.17 – European Communities (Amendment of Cruelty to 
Animals Act, 1876) regulations, 1994 (European Directive 86/609/EC). All efforts 
were made to minimize the number of animals used and any potential suffering.  
Where experimental procedures allowed, all animals were treated with a single intra-
peritoneal (i.p.) drug administration.  To ensure minimisation of animal usage, 
animals used for behavioural monitoring were also used for Immunohistochemical 
analysis.  Brain sections not relevant for the purposes of these experiments were 
supplied for Immunohistochemical analysis for use in another related project. 
2.2.2 Animals and housing 
The animal model used in this study is the C57BL/6 strain of mouse (Mus 
musculus) which is a naturally melatonin-deficient inbred strain. C57/BL6 mice are 
well characterised from a chronobiological aspect with extensive characterization of 
their circadian parameters having previously been performed (Schwartz and 
Zimmerman, 1990). For the purposes of these experiments, adult C57BL/6 male 
mice (24-30g) were obtained from Charles River, UK or Harlan, UK, at 6 weeks old. 
Animals were group housed on arrival.  At the beginning of each experiment these 
animals were between 8 and 10 weeks old and were used for the duration of these 
experiments up until the age of 4-5 months. 
For the purpose of behavioural monitoring, animals were individually housed 
in polypropylene cages (33cm long x 15cm wide x 13cm high) equipped with steel 
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running wheels (11.5cm diameter) with food and water available ad libitum.  The 
lighting conditions were adjusted via a timer on the outside of the cabinet therefore 
the cabinet was not unnecessarily opened. The light source was standard fluorescent 
light bulbs with an average 150 lux luminance level in each individual cage.   Group 
housed animals were housed in groups of 10 in polypropylene cages (44.5cm long x 
28.5cm wide x 10.2cm high) equipped with appropriate environmental enrichment 
with food and water available ad libitum.  Animals were maintained on a 12:12 light 
dark (LD) photoperiod for at least 2 weeks prior to any experimentation.  When 
animals were housed in constant darkness, daily checks were carried out with the aid 
of a red safety light (<1 lux). Temperature and humidity were kept constant with an 
average temperature of 21 +1
o
C and humidity of 50+10%.  Cages were ventilated via 
axial fans to prevent the build-up of pheromones and these fans produced white 
noise at the level of 50dB.  
2.2.3 Treatments 
2.2.3.1.    Sepsis induction 
For the purposes of these experiments, animals were treated with the 
endotoxin Lipopolysaccaride from Gram Negative Bacteria, Escherichia coli. 
(serotype 0111.B4; Sigma, Ireland) to induce sepsis.  The introduction of bacterial 
components into the abdominal cavity (e.g. LPS administration) is a commonly used 
experimental animal model of sepsis (Nemzek et al., 2008).  A single i.p. injection 
was utilized, LPS 5mg/kg dissolved in 0.9% sterile saline (NaCl).  This is a recently 
described model whereby a single treatment i.p. LPS (5mg/kg) in mice induces 
septic shock followed by a long-lasting neuroinflammation and central upregulation 
of TNF-α and components of the IL-1system (Qin et al, 2007; Weberpals et al, 
2009), thereby inducing a chronic effect as a result of an acute treatment.  Control 
animals were treated in parallel with an equal volume of 0.9% NaCl.  The model 
avoids the stress of repeated i.p. injections to the animals.  All treatments were at 
Zeitgeber Time (ZT) 6-8, where ZT0 = lights on.   LPS treatment elicited the full 
spectrum of sickness behaviour evident 1hr after treatment.  ~10% of LPS 5mg/kg 
treated animals displayed a significant moribundity requiring euthanasia or mortality 
in the first 72hrs following treatment.  Following LPS treatment, animals were 
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allowed to recover for at least two weeks prior to any experimentation or 
manipulation of the photoperiod. 
2.2.3.2.   Non-photic phase-shifting treatment. 
8-hydroxy-2-dipropylaminotetralin hydrobromide (8-OH-DPAT) a selective 5-
HT1A agonist (Tocris Bioscience, Bristol, UK) is known to induce non-photic phase 
shifts of the mouse circadian system when applied 6hrs prior to activity onset 
(Horikawa and Shibata, 2004; Gardani and Biello, 2008).  A single i.p. injection of 
the serotoninergic agonist was therefore utilized at CT6 at a dose of 5mg/kg which 
has previously been shown in mice to induce maximal non-photic phase shifts 
(Horikawa and Shibata, 2004). 
2.2.3.3.   NF-B inhibition 
Animals were treated with ammonium pyrrolidinedithiocarbamate (PDTC) 
(C5H12N2S2), a potent antioxidant and pharmacological inhibitor of the transcription 
factor Nuclear Factor κB (NF-κB) (Zhu et al., 2002), 10 minutes prior to LPS 
5mg/kg i.p. treatment.  Animals received a single 200mg/kg i.p. injection of PDTC 
dissolved in 100mM DMSO, a dose previously shown in rats to maximally inhibit 
NF-B activation and the expression of the proinflammatory genes TNF-α, COX-2, 
cytokine-induced neutrophil chemoattractant, and ICAM-1 and their products when 
administered prior to LPS treatment (Liu et al., 1999).   Control animals were treated 
in parallel with an equal volume of sterile Saline (0.9% NaCl) to DMSO i.p.   
2.2.4 Sepsis scoring 
A sepsis score was calculated for control and LPS treated animals and PDTC 
and LPS treated animals immediately after and 1hr post-treatment and subsequently 
at regular intervals for 48 hrs post-treatment.    Scores were assigned on a five point 
scale assessing alterations in the parameters of behaviour, appearance, dehydration 
and respiration.  Each parameter was graded on a scale from 0-4 as follows: 0, 
absent; 1, mild; 2, moderate; 3, severe; 4, very severe.  These scores were seen to 
revert back to zero approximately 48hrs following LPS treatment.  At this time any 
animals that continued to display a high sepsis score or significant moribundity were 
humanely culled.  
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2.2.5 Circadian Behavioural Analysis 
Animals were singly housed in cages equipped with steel running wheels for 
the purposes of behavioural monitoring.  The cages were fitted with micro-switches 
connected to a data acquisition system computer using the Chronobiology Kit by 
Stanford System (Santa Cruz, California) for recording of daily rhythms of 
locomotor activity. Each wheel revolution generated a switch closure measured by 
the data acquisition system and collected every 5 minutes which then produced 
actograms or actigraphs of activity rhythms.  Onset of activity was defined as ZT12 
(where ZT0 is the time at lights on under a 12:12 LD cycle).  Using the actogram 
data for each animal, phase shifts were calculated by fitting a line-of-best-fit through 
activity onsets for one week prior to treatment and for one week post-treatment (Fig. 
2.1).  The difference between the two lines was calculated by two to three 
researchers and the results averaged to exclude experimenter bias. 
 
 
 
 
 
Figure 2.1: Line of Best Fit Analysis. Sample double plotted actogram illustrating 
the line of best fit method utilized to assess locomotor activity onsets following 
application of a phase-shifting stimulus to a subject free running in DD.  The 
application of the stimulus is indicated by the yellow circle.  The lines illustrate the 
lines of best-fit through activity onsets.  The blue line highlights the line of best fit 
through activity onsets for the 7 cycles prior to the stimulus.  The red line indicates 
the line of best fit for the 10 days post the phase resetting stimulus.  Note the 
exclusion of transient days from analysis of the locomotor phase resetting response.  
 
The Chronobiology Kit Chi Squared periodogram is a mathematical time-
series analysis which calculates the free running period and rhythm amplitude from 
the actogram data. (Figure 2.2). 
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Figure 2.2: Chi-Square Periodogram. Sample chi-square periodogram calculated 
by the Chronobiology Kit showing the free running period and amplitude values of 
the activity rhythm. 
 
2.2.6. Jetlag Experiments 
For the purposes of these experiments, adult male mice were housed in 
individual cages equipped with running wheels and were allowed to habituate to a 
12:12 LD cycle (150 lux, lights on 0500h) for two weeks prior to being treated with 
either LPS 5mg/kg i.p (n=11) or saline (n=12).   
Actogram data and circadian behavioural parameters were examined the 
week beginning 7 days following septic LPS treatment (n=5-8 per group).   The 
average FRP, rhythm amplitude and total wheel running average in the week 
beginning 7 days post-treatment were calculated for each animal by two independent 
researchers blind to the experimental procedure and differences assessed between 
groups by independent t-test.  Actogram data and the phase angles of entrainment 
were examined for each animal in both treatment groups under the LD photoperiod 
in the 7 days beginning one week post-treatment.  The time of activity onset for each 
daily cycle was calculated for each animal in both treatment groups and compared to 
the known dark cycle onset time for the photoperiod.  This was done for each cycle 
over a 7 day period starting 7 days following LPS treatment or saline vehicle.  
Chi-Square Periodogram 
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Activity onset prior to onset of the dark cycle was defined as a positive phase angle 
of entrainment, and a negative phase angle if locomotor activity began after lights 
off.  Differences between the onsets were assessed for each daily cycle and a weekly 
average was then calculated.  The weekly average phase angle of entrainment was 
quantified by two independent researchers blind to the experimental procedure and 
analysed for each group by means of independent samples t-test. 
The animals were allowed to recover for two weeks following the immune 
challenge prior to experimental manipulation of the photoperiod. Two different 
―jetlag‖ protocols were adhered to, a 6hr jetlag manipulation was applied to one 
group of experimental animals (12 saline, 11 LPS), consisting of a 6hr phase 
advance of the L:D cycle followed two weeks later by a 6hr phase delay of the L:D 
cycle.  The second group of experimental animals (8 saline, 8 LPS), were subject to a 
10hr jetlag protocol consisting of a 10hr phase advance of the L:D cycle followed by 
a 10hr delay of the photoperiod 14days later.  For the purpose of a phase advance of 
the photoperiod, the dark phase of the light dark cycle is shortened so that lights on 
occurs earlier, resulting in a ―short day‖.  For the first cycle following the 6hr phase 
advance of the LD cycle, the dark phase of the cycle consists of 6 hrs of in total and 
consists of 2hrs in total following a 10hr advance of the LD cycle.  The animals were 
maintained under these 12:12 LD photoperiods for a further two weeks, following 
which the photoperiod was delayed, whereby lights off occurred later resulting in a 
―long day‖.  For the first cycle following the 6hr phase delay of the photoperiod the 
dark phase of the cycle was lengthened by 6hours and so the animals, dark phase of 
the cycle was 18hrs in total.  Following a 10hr delay of the LD cycle the dark phase 
of the cycle was lengthened by 10hrs resulting in a dark phase of 22hrs in total. This 
12:12 LD schedule was maintained for a further 14 days. 
Following each phase shift paradigm, circadian locomotor activity rhythms 
were analysed. The animals‘ rates of re-entrainment to these ‗jetlag‘ protocols were 
monitored.  The first day of the shifted cycle was defined as the day of the change in 
light onset.   The time taken to re-entrain to a shift of the light dark photoperiod was 
determined by calculating the total duration of the activity rhythm and subsequently, 
calculating the rhythm midpoint for each animal prior to and following the phase 
shift. The effects of masking can impact upon activity onset while activity offset is 
an unmasked index of behaviour and so to assess re-entrainment to a phase shift of 
the light:dark cycle it is more accurate to utilize the midpoint between activity onset 
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and offset.  When activity midpoint following the phase shift was seen to show a 
difference of 6 or 10hrs to the activity midpoint prior to the phase shift, depending 
on protocol, the animal was determined to have a resynchronized rhythm.  The 
number of days taken for this difference to be seen was calculated for each animal by 
two researchers blind to the experimental procedure and analysed by independent 
samples t-tests. Further, in order to assess the rate of change in activity onset, the 
time of activity onset for each daily cycle was assessed for each animal in both 
treatment groups and was analysed in the 7 days following manipulation of the 
photoperiod by mixed between-within ANOVA, with the time of activity onset as 
the dependant variable for 8 days following the shift of the light/dark cycle. 
Following each phase shift of the light dark cycle, the circadian parameters of free 
running period and rhythm amplitude were calculated for each animal using the 
Chronobiology Kit Chi Squared procedure and analysed for each group by 
independent samples t-test.  In order to assess locomotor activity levels, total wheel 
revolutions were calculated for each animal for each day during the course of the 
experiments using the Chronobiology Kit and analysed for each group by 
independent samples t-test.  
2.2.7. Photic Phase Response Curve 
To facilitate construction of the photic phase response curve, 30 adult male 
mice were singly housed in cages equipped with running wheels and housed under a 
12:12 LD cycle (150 lux, lights on 0500h) for 2 weeks to allow for habituation.  
Animals were then treated with either LPS 5mg/kg i.p (n=14) or Saline (n=16).  
Following recovery, animals were transferred into constant darkness (0 lux) and 
allowed to free-run for a duration of 20 weeks.  During this time the animals were 
subjected to an Aschoff type 1 protocol (Aschoff, 1965), receiving a 30 minute light 
pulse (~150 lux) every 14 days at random times across the circadian cycle.  Each 
animal received 6 light pulses (LP) in total.  The animals‘ locomotor activity was 
examined under DD in the 14 days following each light pulse prior to administration 
of the next light pulse.  Actograms and phase shift magnitudes were assessed and 
quantified by three independent researchers blind to the CT at which each light pulse 
was applied. The photic phase shift magnitudes were calculated for each animal 
utilizing the line of best fit method, fitting the line through activity onsets 7 days 
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prior to the light pulse and the onsets for 7 cycles starting 4 days after the light pulse 
to minimise interference from transients.  Following quantification of the phase 
shifts, the time of the circadian cycle at which the light pulses were administered 
were calculated and grouped in 3hr CT bins and a phase response curve was 
constructed plotting phase shift magnitude against circadian time of the light pulse.  
Phase shift magnitudes were examined between groups by two-way factorial 
ANOVA and independent t-tests with Bonferroni corrections were used for analysis 
of phase shift magnitude at the individual circadian time bins.  The free running 
period and rhythm amplitude were assessed for each animal 10 days before the light 
pulse and 10 days after the light pulse using the Chronobiology Kit Chi Squared 
procedure and analysed for each group by independent samples t-test. 
2.2.8. Non-photic Phase Shifts 
In order to examine the effects of a non-photic stimulus on circadian 
locomotor activity following the induction of sepsis, animals were singly housed in 
running wheel cages under a 12:12 light dark cycle (150 lux, lights on 0500h) and 
allowed to habituate for 2 weeks prior to being treated with either LPS 5mg/kg i.p 
(n=7) or saline (n=7).  The animals were allowed to recover for two weeks following 
the immune challenge prior to being transferred into constant darkness (0 lux).  
Animals were maintained under constant dark conditions for 14 days and then 
received a 5mg/kg i.p. injection of the serotoninergic agonist 8-OH-DPAT at CT6 
(where CT12 is the onset of activity).  Animals were left to free run for a further two 
weeks in DD, during which time their locomotor activity rhythms were monitored 
and the phase-shifting effects of 8-OH-DPAT treatment assessed.  Using the 
actogram data for each animal, the magnitudes of the non-photic phase shifts 
following administration of 8-OH-DPAT at CT6 were quantified for each animal for 
each treatment group.  The line of best fit method was used to assess the non-photic 
phase shift magnitudes, fitting the line through activity onsets 7 days before the light 
pulse and the onsets for 7 cycles starting 4 days after the light pulse to minimise 
interference from transients. The actograms and differences between the lines were 
rated by two independent researchers blind to the experimental procedure.  The 
animals were then transferred to a 12:12 light dark cycle and maintained under these 
lighting conditions for two weeks prior to treatment with a 5mg/kg i.p. 8-OH-DPAT 
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injection at CT6, 1hr after which they were culled.  Phase shift magnitudes were 
assessed between groups by independent samples t-test. 
2.2.9. Skeleton Photoperiods 
In order to verify that rhythmicity exhibited by the animals under L:D cycles is 
in fact truly entrained circadian behaviour and not owing to masking by the light 
dark cycle, 16 male mice were individually housed in cages equipped with running 
wheels and habituated to a 12:12 LD cycle for 2 weeks (150 lux, lights on 0500h).  
The animals were then treated with either LPS 5mg/kg i.p injection (n=7) or saline 
(n=9) and allowed to recover for 14 days prior to manipulation of the photoperiod.  
The light dark cycle was initially shortened to a skeleton photoperiod whereby light 
occurred during only the first and last hour of the previous light cycle followed by 
the original dark phase (1L:10D:1L:12D).  The animals were maintained under these 
conditions for 21 days and their locomotor activity patterns monitored.  Following 3 
weeks under the skeleton photoperiod, the light:dark cycle was then made a half 
skeleton photoperiod where the first light phase was removed so that the only light 
phase occurred during the final hour of the original light cycle (IL:23D).   Actogram 
data and the phase angles of entrainment were examined and calculated as described 
previously for each animal in both treatment groups under both photoperiods for 
each cycle over the 42 day period.  Differences between the onsets were assessed for 
each daily cycle and a weekly average was then calculated for each animal for each 
week under the two skeleton photoperiods.  The weekly average phase angle of 
entrainment was quantified by two independent researchers blind to the experimental 
procedure and analysed for each group by means of independent samples t-test. 
2.2.10. The effects of sepsis on circadian parameters exhibited under constant 
conditions 
In order to assess free-running circadian parameters, animals previously 
treated with either LPS 5mg/kg i.p. or saline upon recovery were housed in 
individual running wheel cages under a 12:12 LD cycle (150 lux, lights on 0500h) 
for two weeks to allow for habituation prior to experimentation.   Animals were then 
transferred into either constant dark (8 saline, 7 LPS) or constant light (8 saline, 7 
LPS) with light intensity levels of either 0 lux or 150 lux (LL) and were maintained 
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under these conditions for a period of 14 days during which time their locomotor 
activity patterns were monitored. Using the actogram data, the circadian parameters 
of free running period and rhythm amplitude were quantified for each animal in each 
treatment group under both lighting conditions by two independent researchers blind 
to the experimental procedure using the Chronobiology Kit Chi square periodogram 
and analysed for each group by independent samples t-test.  
2.2.11. Behavioural responses following treatment with PDTC prior to LPS 
treatment 
The involvement of NF-B in the LPS mediated effects on circadian 
rhythmicity was examined by administration of PDTC prior to LPS treatment and 
monitoring of locomotor activity rhythms.  Animals were housed in individual cages 
equipped with running wheels under a 12:12 LD (150 lux, lights on 0500h) cycle for 
two weeks prior to treatment to allow for habituation. PDTC 200mg/kg i.p. injection 
or saline vehicle was administered 10 minutes prior to LPS 5mg/kg (i.p.) or control.  
Three experimental groups consisting of PDTC and LPS (n=5), PDTC and control 
(n=6) and control and LPS (n=5) were examined.  Mixed between within ANOVA 
was used to assess statistically significant differences between sepsis scores 
following treatment with a control injection followed by a septic LPS treatment and 
the sepsis score reached when PDTC was administered prior to a septic LPS 
treatment.  The animals were allowed to recover for two weeks following the 
immune challenge and re-entrainment to a 6hr phase advance of the photoperiod was 
assessed as outlined above (Section 2.2.6).   
The animals were then transferred into constant darkness (0 lux) and allowed 
to free-run in order to assess whether treatment with PDTC prior to LPS 5mg/kg 
would attenuate the enhanced late subjective night photic induced phase shifts.  The 
animals were held under these conditions for 14 days prior to receiving a light pulse 
for 30 mins at CT22, the advance portion of the phase response curve at which post-
septic animals have previously exhibited larger phase shift magnitudes in a response 
to a 30 min light pulse compared to controls.  Animals were maintained for a further 
two weeks in DD following application of the light pulse and their locomotor 
activity rhythms monitored. The magnitudes of the resultant phase shifts were 
quantified for the three treatment groups.  The line of best fit method was used to 
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assess the photic phase shift magnitudes, fitting the line through activity onsets 7 
days before the LP and the onsets for 7 cycles starting 4 days after the LP to 
minimise interference from transients. The actograms and differences between the 
lines were rated by two independent researchers blind to the experimental procedure.  
Phase shift magnitudes were compared between groups using one way ANOVA.   
 
2.3.  Results 
2.3.1.  The acute effects of LPS 5mg/kg treatment on circadian locomotor activity 
Animals exhibited the classic symptoms of sickness behaviour following i.p. 
LPS 5mg/kg treatment, including lethargy, piloerection, grooming and decreased 
social interaction, and these behaviours were scored for each animal and contributed 
part of the sepsis score quantified for each animal across the following 48hrs.  
Further, LPS treated animals did not display wheel running activity for a number of 
cycles following treatment, which can be clearly observed from the representative 
actogram for LPS treated animals Figure 2.4.  When locomotor activity resumed, it 
did so as would be expected following a period of entrainment, with the onset of 
locomotor activity continuing in phase with the onset of running wheel activity 
displayed on the last cycle prior to LPS 5mg/kg i.p. treatment, i.e. no alterations in 
the phase relationship between the activity onset and the onset of the dark phase of 
the entraining L:D cycle (Figure 2.3).  Saline control animals displayed entrained 
circadian locomotor activity with no interruption in wheel running following 
treatment.  
Independent t-tests showed that there were no significant differences between 
the phase angles of entrainment in the week beginning 7 days post-treatment 
between the treatment groups (LPS, 4.25 + 3.82 min. vs. saline controls, 5.09 + 4.01 
min, P>0.05). Independent t-test analysis showed that there were no significant 
differences between the mean free running period values in the week beginning 7 
days post-treatment between the treatment groups (LPS, 23.8 + 0.00 hrs. vs. saline, 
23.9 + 0.17 hrs, P>0.05), nor were there any differences observed at this time in the 
mean rhythm amplitude between groups (LPS, 1365.2 + 116.6 vs. saline, 768.9 + 
224.9, P>0.05).  Independent t-test analysis was also used to examine whether there 
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were statistically significant differences between the average total wheel running 
values in the week 7 days post-treatment between the treatment groups (LPS, 9472.1 
+ 3333.5 vs. saline, 5090.9 + 4599.9 revolutions, P>0.05). (Fig.2.3). 
 
 
 
 
 
 
 
Figure 2.3: Examination of behavioural parameters in the week beginning 7 days 
following septic LPS treatment. (A) Bar graphs showing the average phase angle of 
entrainment, FRP, amplitude and total wheel running average in the week beginning 
7 days post-treatment (n=5-8 per group). 
2.3.2.   Jetlag Experiments 
2.3.2.1.   Locomotor Activity following implementation of a 6hr Jetlag paradigm 
When exposed to a 6 hour advance of the L:D cycle, post-septic animals re-
entrainment to the new photocycle was faster than that seen in control animals.  
Mixed between within ANOVA was utilized to analyse the time of onset of wheel 
running activity for each individual animal in both treatment groups for the 7 days 
following the phase advance shift and revealed a significant time x treatment 
interaction (F6,126=2.53, P<0.01;  Figure 2.4).  The time to entrain to the new 
photoperiod was 5.09+0.48 days for post-septic animals vs. 7.08+0.46 days for 
controls (P<0.01; Fig. 2.4 C).  When these animals were then exposed to a 6 hour 
delay of the L:D photoperiod, mixed factorial ANOVA analysis of the time of onset 
of wheel running activity for each individual animal in both treatment groups for the 
7 days following the shift revealed no time x treatment interaction (F6,78=0.37, 
P>0.05) (Fig. 2.4).  Independent t-test found the mean time to re-entrain was  
3.1+0.2 days for post-septic animals vs. 3.2 + 0.3 days for controls (P>0.05; Fig. 2.4 
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D).  Visual inspection of actogram data showed saline controls exhibited transient 
days as expected following a phase advance of the photoperiod with locomotor 
activity showing gradual advances in locomotor behaviour onset until entrainment 
was achieved, however this is not seen in some of the post-septic animals (Fig. 2.4). 
 
Figure 2.4: Altered rates of re-entrainment to 6hr phase shifts of the light:dark 
cycle in post-septic animals. (A) and (B) Sample double plotted actograms from 
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saline and LPS treated animals who then underwent a 6hr advance of the L:D cycle, 
followed by a 6hr delay of the L:D cycle. The shaded area of the graphs is the dark 
phase of the L:D cycle.  Note suppression of wheel running activity for a number of 
cycles following LPS treatment, but resumption of activity at the expected phase.  (C) 
and (D) illustrate the activity onsets for the periods following the shift of the 
light:dark cycle. The post-septic animals show accelerated re-entrainment to the 
advanced schedule. Note the more rapid adjustment of the activity onsets in the LPS 
group vs. controls following the advance (C) but not the delay (D).  (E) and (F) Bars 
graphs showing the average number of days to re-entrain (+/-SEM) to the shift of 
the L:D cycle for control and post-septic animals. (**=P<0.01). 
 
2.3.2.2.   Re-entrainment following 10hr phase shifts of the photoperiod 
When exposed to a 10 hour advance of the L:D cycle, post-septic animals 
showed more rapid re-entrainment to the new photoperiod than controls.  
Independent t-test analysis found the mean time to re-entrain was 8.9 + 0.6 days for 
control animals and 7.1 + 0.3 days for post-septic animals (P<0.05).  When these 
animals were then exposed to a 10 hour delay of the L:D photoperiod, t-test 
assessment found there to be no significant difference in the rate of re-entrainment 
displayed between the treatment groups, with average time taken to entrain to the 
new photoperiod of 4.88 + 0.23 days for post-septic animals and 4.71 + 0.29 days for 
controls (P>0.05). (Fig. 2.5). 
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Figure 2.5: Altered rates of re-entrainment to 10hr phase shifts of the light:dark 
cycle in post-septic animals. (A) and (B)are sample double plotted actograms from 
saline and LPS treated animals who then underwent a 10hr advance of the L:D 
cycle, followed by a 10hr delay of the L:D cycle. The shaded area of the graphs is 
the dark phase of the L:D cycle.  (C) and (D) Bars graphs showing the average 
number of days to re-entrain to the phase shifts of the L:D cycle. (*=P<0.05). 
 
2.3.3. The effects of sepsis on the basic parameters of the circadian locomotor 
activity rhythm. 
Upon termination of circadian locomotor activity monitoring under 
experimental jetlag paradigms, the basic circadian parameters of free running period 
and rhythm amplitude were examined under the different lighting conditions.  When 
released into both LL and DD conditions, monitoring of actogram data revealed no 
differences between the treatment groups in their transition to the different 
conditions, with locomotor activity continuing in phase with that of the previous L:D 
cycle, showing the appropriate advance (under DD) or delay (under LL) from 
activity onset on the last cycle of the L:D photoperiod to the onset of activity on the 
initial cycle under the new housing conditions.  The free running periods and rhythm 
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amplitudes were examined for 14 days under constant light and constant dark 
conditions by Chi
2
 periodogram analysis and subsequent assessment by t-tests for 
both treatment groups.  Under LL, there were no significant differences between 
post-septic animals and saline controls with mean free running periods of 24.99 + 
0.19 hrs and 25.13 + 0.10 hrs respectively (P>0.05).  Independent t-test analysis of 
rhythm amplitude revealed that there were no significant differences between that of 
LPS treated (708.24 + 76.83) and saline controls (748.83 + 85.53, P>0.05). (Figure 
2.6). 
 
 
 
 
 
 
 
 
 
Figure 2.6. Locomotor activity Rhythms under LL. (A) and (B) are sample double 
plotted actograms from a control and an LPS-treated animal respectively, showing 
locomotor behaviour under LL conditions. 
 
Comparison of mean free running periods in DD between post-septic treated 
animals and saline controls by independent t-test found no significant differences 
between the treatment groups, with free running periods of 23.6 + 0.11 hrs and 23.73 
+ 0.14 hrs respectively (P>0.05).  Under housing in DD conditions, rhythm 
amplitude was not found to be significantly different between post-septic animals 
(1382.7 + 227.7) and saline controls (1357.48 + 232.7, P>0.05, independent t-test). 
(Figure 2.7). 
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Figure 2.7. Locomotor activity Rhythms under DD. (A) and (B) are sample double 
plotted actograms from a control and an LPS-treated animal respectively, showing 
locomotor behaviour under DD conditions. 
   
Independent t-test was utilized to analyse the mean wheel revolutions per hour 
for a period of 14 days while maintained under a 12:12 LD cycle for both treatment 
groups as a measure of overall activity levels.  There were no differences in the 
amount of wheel running between the post-septic animals and saline controls, with 
mean revolutions in LPS-treated animals of 7676.48 + 2095.7 vs. 9055 +3641.73 in 
controls (P>0.05).  Analysis of rhythm amplitude under a 12:12 L:D cycle revealed 
that there were no significant differences between the mean rhythm amplitude of 
LPS treated animals (885.67 + 38.2) and saline controls (865.93 + 42.3, P>0.05, 
independent t-test).  (Table 2).  
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Table 2: Assessment of core circadian parameters under various lighting 
conditions. Table illustrating the average free running period values, rhythm 
amplitude and total wheel-running activity for saline and post-septic animals under 
different lighting conditions.  (n.s.) denotes not significant.  
 
2.3.4. Locomotor activity rhythms under Skeleton Photoperiods 
2.3.4.1.   Assessment of the phase angle of entrainment under skeleton and half 
skeleton photoperiods 
An apparently normal pattern of circadian locomotor activity is exhibited by 
both post-septic animals and saline controls under a 12:12 L:D cycle.  In order to 
examine whether this pattern of activity reflects appropriate circadian entrainment, 
or whether underlying circadian abnormalities were being masked by the L:D cycle, 
we assessed the entrainment of a group of animals to skeleton photoperiods.  
The phase angle of entrainment was firstly assessed under a 12:12 LD cycle 
and independent t-test analysis showed no significant differences between the phase 
angle of entrainment for LPS treated animals (2.10 + 5.69 min) vs. controls (-0.54 +  
1.47 min, P>0.05).  Upon transfer from the 12:12 LD photocycle to the skeleton 
photoperiod (1L:10D:1L:12D), all animals maintained their entrained activity 
profiles, no alterations were seen in the relationship between locomotor activity 
onset on the first cycle of the new photoperiod and the onset of running wheel 
behaviour on the last cycle under the 12:12 LD cycle.  Both saline and LPS animals 
began activity after the second light phase in the evening despite being exposed to 
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10hrs of darkness following the morning light phase.  Comparison of mean phase 
angle relationship values during the first week under the skeleton photoperiod in 
post-septic animals and saline controls by independent t-test revealed no significant 
differences between the treatment groups, with mean phase angles of 18.01 + 
5.31min and 10.17 + 1.90 min  respectively (P>0.05).  Independent t-tests showed 
that there were no significant differences between the phase angles of entrainment 
during the second (LPS, 21.11 + 4.13 min. vs. saline controls, 15.29 + 2.47 min, 
P>0.05) or third weeks (LPS, 26.08 + 2.16 min. vs. saline controls, 18.25 + 4.38 
min, P>0.05) of housing under the skeleton photoperiod seen between the groups. 
(Fig. 2.8).  
When the morning light pulse was removed under the half skeleton 
photoperiod (1L:23D), control and LPS animals remained entrained, with the onset 
of locomotor activity on the first cycle of the new photoperiod continuing in phase 
with the onset of running wheel behaviour on the last cycle under the skeleton 
photoperiod.  Assessment of the phase angle relationship values during the first week 
under the skeleton photoperiod by independent t-test in post-septic animals and 
controls showed there to be no significant differences between  the groups, with 
mean phase angle values of 39.11 + 5.43 min and 28.63 + 3.95 min  respectively 
(P>0.05).  Independent t-tests assessed that there were no significant differences 
between the phase angles of entrainment during the second (LPS, 46.76 + 11.89 min. 
vs. saline controls, 42.77 + 5.19 min, P>0.05) or third (LPS, 67.77 + 12.33 min vs. 
saline controls, 51.39 + 6.55 min, P>0.05) weeks of housing under the skeleton 
photoperiod, seen between the groups (Fig. 2.8).  The similarities in circadian 
behaviour in post-septic animals under skeleton and half skeleton photoperiods when 
compared to controls at any point during this experiment indicate that normal 
entrainment is exhibited by post-septic animals.  
2.3.4.2.   The Free Running Period and Rhythm Amplitude in DD following 
maintenance under skeleton photoperiods 
Upon termination of analysis of locomotor behaviour under skeleton and half 
skeleton photoperiods, the animals transfer into DD conditions was assessed and the 
free running periods and rhythm amplitudes were examined for 14 days under these 
conditions by Chi
2
 periodogram analysis and subsequent assessment by t-tests.  
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Visual monitoring of actogram data revealed no differences between the treatment 
groups in their transition to constant conditions, with locomotor activity continuing 
in phase with the previous photocycle. 
Comparison of mean free running periods in DD following prolonged housing 
under skeleton and half skeleton photoperiods by Chi
2
 analysis and independent t-
test found no significant differences between post-septic animals and saline controls, 
with mean free running period values of 23.98 + 0.04 hrs. and 23.93 + 0.03 hrs. 
respectively (P>0.05).  Rhythm amplitude was not found to be significantly different 
between post-septic animals (1513.08 + 206.75) and saline controls (1234.28 + 
234.38, P>0.05, independent t-test) maintained under DD. 
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Figure 2.8:  Entrainment to skeleton photoperiods. (A) and (B) are sample double 
plotted actograms from a control and an LPS-treated animal respectively showing 
entrainment to a 12:12 L:D cycle, then a 1:10:1:12 skeleton photoperiod and 
subsequently a 1:11:12 half skeleton photoperiod.  White bars in figures represent 
light phase.  (C) Graph illustrating the average phase-angles of entrainment for 
each week under the experimental photoperiods for the control and post-septic 
animals.  
 
2.3.5.  Locomotor Activity rhythms in response to a non-photic stimulus applied 
in the subjective day. 
We examined the phase shifts elicited by a non-photic stimulus following 
application of the 5-HT1a/7 agonist 8-OH-DPAT at CT6.  Comparison of 8-OH-
DPAT induced phase shifts following administration in the early subjective day by 
independent t-test found that phase shifts of similar magnitudes were induced 
between the treatment groups, with a modest mean phase advance of 0.62 + 0.23 hrs 
exhibited by saline controls which was shown not to differ significantly from those 
induced in post-septic animals, with a mean phase shift value of 0.77 + 0.13 hrs 
(P>0.05, independent t-test; Fig. 2.9). 
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Figure 2.9: Phase resetting following application of a non-photic phase-shifting 
stimulus. (A) and (B) are sample double plotted actograms of a control animal and 
a post-septic animal free running in DD and treated i.p. with 8-OH-DPAT at CT6 
(CT6 treatment indicated by blue circle, with lines indicating the line of best-fit 
through activity onsets for the 7 days before and 10 days after non-photic stimulus.  
Note exclusion of transient days from analysis).  (C) Bar graph illustrating the 
modest phase advance induced following 8-OH-DPAT treatment in saline controls 
and post-septic animals. 
 
2.3.6. Construction of the Photic Phase Response Curve  in post-septic animals 
Two Way Factorial ANOVA with independent t-test and Bonferroni 
corrections were used for analysis of phase shift magnitude at the individual 
circadian time bins for each individual animal in both treatment groups, and found a 
significant effect of time (F7,94=106.4, P<0.05), no main effect of treatment 
(F1,94=0.31, P>0.05), but a significant interaction effect between CT of photic 
stimulation and treatment interaction term (F7,94=2.4, P<0.05).  Subsequent analysis 
of phase shift magnitudes exhibited by each treatment group at each individual CT 
bin found a statistically significant increase in phase shift magnitude in post-septic 
animals compared to controls at one time bin only, CT22-CT24.  At CT22-CT24, 
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there was a statistically significant difference seen in the magnitude of photic phase 
advances elicited between post-septic animals and controls with average phase 
advance magnitudes of 1.45 + 0.11 hrs and 0.87 + 0.06 hrs respectively (P<0.001, 
independent t-test, Fig. 2.10). There were no differences in photic induced phase 
shift magnitude observed at any other circadian time bin of the PRC between the 
treatment groups (P>0.05).  
At other circadian time bins during the subjective night when photic 
stimulation produces phase shifts of circadian behaviour, there were no alterations 
seen between treatment groups in phase shift magnitude elicited.  At CT12-CT14, 
photic phase delay magnitudes were found to be similar between post-septic animals 
and controls with average phase delays of 1.97 + 0.34 hrs and 1.55 + 0.12 hrs 
respectively (P>0.05, independent t-test).  There were no differences seen in the 
magnitude of photic phase delays between post-septic animals and controls at CT15-
CT17 with average phase delays of 2.03 + 0.10 hrs and 2.04 + 0.22 hrs respectively 
(P>0.05, independent t-test, Fig. 2.10).  At CT18-CT20, the mean magnitudes of 
photic phase shifts for post-septic animals and controls were 0.54 + 0.33 hrs and 1.23 
+ 0.30 hrs respectively (P>0.05, independent t-test). (Figure 2.10). 
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Figure 2.10: Altered photic phase-shifting in post-septic animals. (A) and (B) are 
sample double plotted actograms illustrating the locomotor responses to photic 
stimulation in a saline and a post-septic animal respectively, free running in DD and 
subjected to light pulses (light pulse indicated by yellow circles, with lines indicating 
the line of best-fit through activity onsets for the 7 days before and 10 days after the 
light pulse.  Note the exclusion of transient days from analysis of the locomotor 
response). (C) Shows the photic phase response curve for saline and post-septic 
animals.  Responses were grouped into 3 hour time bins according to LP time.  
(***=P<0.001). 
 
2.3.7. Behavioural responses following treatment with PDTC prior to LPS 
treatment 
2.3.7.1.  Re-entrainment a 6hr phase shift of the photoperiod   
Sepsis was scored in control and LPS treated animals (n=6) and in PDTC and 
LPS treated animals (n=6) and mixed between within ANOVA was used to assess 
statistically significant differences in mean sepsis scores between groups at regular 
intervals for 48hrs post-treament.  ANOVA revealed a main effect of time for sepsis 
score post-treatment (F8,80=25.43, P<0.001), as well a main effect of treatment 
(F1,10=8.12, P<0.05), and a significant time treatment interaction (F8,80=6.55, 
P<0.01). (Figure 2.11). 
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Figure 2.11: Sepsis scoring across 48hrs following treatment. (A) Graph 
illustrating the sepsis scores for both control + LPS treated animals (n=6) and 
PDTC + LPS treated animals (n=6) quantified at regular intervals over 48hr 
following treatment. Note the lower sepsis scores for the PDTC + LPS treatment 
group.   
 
When exposed to a 6 hour advance of the L:D cycle, vehicle and LPS 5mg/kg 
treated animals re-entrainment to the new cycle was faster than was seen in animals 
treated with either PDTC 200mg/kg prior to LPS 5mg/kg, or control and 200mg/kg 
PDTC, or 200mg/kg PDTC prior to a control i.p. injection. One Way ANOVA with 
the Tukey post-hoc test was utilized to assess statistically significant differences 
between groups in the mean time taken for each group to re-entrain to the new 
photoperiod, finding a significant between groups effect (F2,13=5.11, P<0.05).  Post 
Hoc analysis (Tukey) revealed that the mean time taken to entrain to the new 
photoperiod of 5.4 + 0.51 days for control and LPS treated animals differed 
significantly to the rate of re-entrainment seen for PDTC and LPS treated animals 
7.0 + 0.32 days (P<0.05).  Control and LPS treated animals re-entrainment was also 
shown to be significantly different to the time taken for PDTC and control treated 
animals which took 7.0 + 0.37 days  synchronize to the new photoperiod (P<0.05).  
Comparison of the rates of re-entrainment between PDTC and LPS treated animals 
and PDTC and control treated animals revealed no significant differences between 
the groups (P>0.05). (Fig. 2.12) 
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Figure 2.12: Re-entrainment to a 6hr phase advance of the light:dark cycle in 
PDTC + CTRL, CTRL + LPS and PDTC + LPS treated animals. (A), (B) and (C) 
are sample double plotted actograms showing a PDTC + CTRL treated animal, a 
CTRL + LPS treated animal and a PDTC + LPS treated animal respectively. (D) 
Bar chart illustrating the average rate of re-entrainment of each group following a 
6hr advance of the L:D cycle. (*=P<0.05). 
 
2.3.7.2.   Phase advance resetting following PDTC treatment prior to LPS.  
One Way ANOVA with Tukey post hoc test was used to assess whether there 
were statistically significant differences between groups in the mean phase advance 
magnitude, finding a significant between groups effect (F2,16=22.79, P<0.001).  Post 
Hoc analysis (Tukey) revealed that the mean phase advance magnitude of 1.3 + 0.18 
hrs revealed for control and LPS treated animals differed significantly from the mean 
phase shift magnitude seen for PDTC and LPS treated animals 0.92 + 0.4 hrs 
(P<0.001).  Control and LPS treated animals mean phase advance magnitude was 
also shown to be significantly different to that for PDTC and vehicle treated animals 
(0.89 + 0.04 hrs; P<0.001).  Comparison of the mean phase advance magnitude 
between PDTC and LPS treated animals and PDTC and control treated animals were 
not found to differ significantly between the groups (P>0.05). (Figure 2.13) 
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Figure 2.13: Phase resetting to photic stimulation at CT22 in PDTC + CTRL, 
CTRL + LPS and PDTC + LPS treated animals. (A), (B) and (C) are sample 
double plotted actograms showing a PDTC + CTRL treated animal, a CTRL + LPS 
treated animal and a PDTC + LPS treated animal respectively, free running in DD 
and subjected to light pulses at CT22 (light pulse indicated by yellow circles, with 
lines indicating the line of best-fit through activity onsets for the 7 days before and 
10 days after the light pulse.  Note the exclusion of transient days from analysis). (D) 
Bar chart illustrating the average phase shift magnitude of each group following a 
light pulse at CT22. (***=P<0.001). 
 
2.4.  Discussion: 
These experiments performed in post-septic animals reveal long-lasting 
perturbations in circadian behaviour up to three months following a single septic 
treatment with LPS.  Post-septic animals exhibit alterations in photic phase-shifting, 
with exaggerated phase shift magnitudes in response to a phase advancing light 
pulse, and accelerated re-entrainment rates to phase advances of the photoperiod.   
 
Acutely, visible sickness behaviour ensued following peripheral 
administration of LPS 5mg/kg and sepsis scoring allowed us to confirm successful 
induction of sepsis in LPS treated animals compared to vehicle treated controls.  The 
induction of sickness behaviour following a septic LPS treatment inhibited rhythmic 
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wheel running behaviour in LPS treated animals for 2-3 cycles.  Once recovered 
from the initial stages of the septic treatment, locomotor wheel running behaviour 
resumed in phase with that of the previous activity pattern and in line with that of the 
entraining light dark cycle.  The assessment of total wheel running activity, phase 
angle of entrainment, FRP and rhythm amplitude in the week starting 7 days post-
treatment found these post-septic behavioural parameters to be similar to controls 
and therefore there were no perturbations in the short term and no alterations prior to 
experimental manipulation of the photoperiod.  However there was some variability 
in the average total wheel running values obtained within the groups, and the sample 
sizes may need to be increased and this parameter reassessed in order to confirm that 
there were no differences between groups. 
For assessment of wheel running activity under experimental jetlag 
paradigms, we sought to characterize locomotor behaviour in animals having 
experienced septic shock in response to rapid 6hr and 10hr phase shifts of the light 
dark cycle, mimicking eastward and westward trans meridian travel.  The rates of 
resetting in post-septic animals in response to phase advances of the photoperiod 
were found to be significantly more rapid than in controls, however there were no 
alterations found in resetting rates between post-septic animals or saline controls in 
response to either 6hr or 10hr phase delays of the light dark cycle.  It must be pointed 
out that re-entrainment to a phase delay of the photoperiod has been shown to occur 
much faster than resetting to a phase advance, 3 days vs. 7 days respectively 
following a single one hour phase shift (Reddy et al., 2002) and it may be that 
synchronisation to the new light dark cycle following a phase delay simply takes 
place too quickly for any alterations in resetting to be observed between the groups.  
With respect to a 6hr phase delay of the photoperiod, given the short period of time 
that is required to reset activity to a phase delay of the light dark cycle, it is indeed 
possible that re-entrainment to this phase delay might occur too rapidly to observe 
any between groups differences.  We would anticipate however, re-entrainment to an 
abrupt 10hr phase delay of the photoperiod which would require a longer time for 
resetting of locomotor behaviour to be completed, would highlight any differences in 
delay resetting between the groups, however no variations in resetting rates were 
observed.   
The resetting rates to the 6hr phase delay shown by both treatment groups 
and the re-entrainment to a 6hr phase advance shown by our control animals, but not 
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post-septic animals, are in line with previously published results showing that re-
entrainment to an abrupt phase advance of the photoperiod takes approximately 7 
cycles, while resetting to a phase delay takes approximately 3 cycles (Reddy et al., 
2002).  Photic stimulation resulting in a phase advance causes transient shifts of 
locomotor activity onset over several cycles but an immediate shift in offset of 
activity, while the opposite is seen for onsets and offsets following a phase delay 
(Meijer and Schwartz, 2003).  Large phase advances of the photoperiod cause 
gradual daily advances in locomotor behaviour of approximately 1-2 hours until re-
entrainment to the new photoperiod has been achieved (LeGates et al., 2009).  While 
this gradual advancing is seen in control animals, some post-septic animals appear to 
exhibit unstable advances in behaviour in the cycles following the 6hr advance shift 
(see Fig. 2.4).   
Alterations in the basic circadian parameters and entrainment properties 
could account for the significantly more rapid re-entrainment rates of locomotor 
activity to shifts of the light dark photoperiod.   The more rapid resetting visible in 
our post-septic animals and the unstable daily advances could be due to alterations in 
the free running period, since proportionately larger daily phase advances would be 
required of an animal with a shorter endogenous free running period (LeGates et al., 
2009).  However there are no alterations observed in the period between the groups 
under either LD, LL or DD conditions and therefore altered resetting cannot be 
attributed to perturbations in this parameter. Additionally, there were no alterations 
in total wheel running activities between the groups under any lighting condition. A 
damped or weak oscillator resulting in a decrease in pacemaker amplitude could 
result in decreased resistance of the SCN to external perturbing stimuli and a more 
robust response (Pulivarthy et al., 2007; Abraham et al., 2010) and could underlie 
enhanced resetting.  Our experimental analysis of locomotor rhythmicity in LL 
would indicate that there is no decrease in pacemaker amplitude of post-septic 
animals, since post-septic animals display rhythmic, robust locomotor behaviour 
throughout the 14 days they were maintained under LL, and no alterations were 
observed in the FRP or rhythm amplitude between groups, and were there an 
underlying weakened pacemaker arrhythmicity would be expected to be observed.  
Further, no alterations were observed in the FRP or rhythm amplitude under DD, and 
additionally, the examination of actogram data of post-septic animals while free 
running in DD indicated that the post-septic behaviour was not being masked by the 
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presence of light. Were there an effect of masking of locomotor activity due to the 
presence of an entraining stimulus, upon removal of that stimulus, animals 
locomotor activity would exhibit an alteration in the phase relationship with 
perturbations in the phase of activity onset on the first day of constant conditions to 
that of the previous activity onset on the last cycle when under the influence of a 
Zeitgeber.  Upon transfer to DD constant conditions there were no alterations in the 
phase angle relationship in either post-septic animals or controls.  Furthermore, 
assessment of locomotor behaviour under skeleton and half skeleton photoperiods 
indicates that the behavioural rhythms of LPS treated animals are in fact entrained 
circadian patterns of locomotor activity and not merely due to the effects of negative 
masking.  There were no perturbations in entrainment properties in post-septic 
animals and no differences between the treatment groups in the phase angle 
relationship under any of the lighting schedules, along with appropriate timing of 
activity, with no unexpected bouts of wheel running during the subjective day.  
Increases were observed in the difference between activity onset and the time of 
application of the dark phase upon increasing time spent under half skeleton 
photoperiods in both post-septic animals and controls, which is standard locomotor 
behaviour under these conditions, since the phase angle of entrainment is known to 
be more stable under a two pulse skeleton photoperiod than under a one light pulse 
half skeleton photoperiod.   
That there were no alterations seen in entrainment properties under constant 
conditions or under housing in skeleton photoperiods was surprising, however, it is 
clear that the attenuations in resetting shown by post-septic animals cannot be 
contributed to alterations of the core circadian parameters examined in these studies. 
 
Given the phase dependency of locomotor activity attenuations in post-septic 
animals, mice were exposed to 30 minute light pulses at all CT‘s while free running 
in DD i.e. an Aschoff type 1 protocol (Aschoff, 1965) to fully characterize the photic 
responsiveness of these subjects and construct a Phase Response Curve.  
Construction and assessment of the photic phase response curve of the post-septic 
animals was required, since it seemed a reasonable explanation that alterations could 
be present within its shape, accounting for the altered resetting and impaired SCN 
functional activation. By and large, the overall shape of the PRC in post-septic 
animals remained unaffected, with no variations in the proportions of the phase 
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advance, phase delay, or unresponsive regions. Upon construction of the PRC, 
following a phase advancing light pulse in the CT22-24 portion of the late subjective 
night, we observed a significant increase in the magnitude of the phase advance 
response in post-septic animals compared to controls, but no alterations in phase 
shift magnitude at any other phase of the circadian cycle including no attenuations in 
phase delay responses at any point between the groups. The notably larger phase 
shifts exhibited by post-septic animals in response to photic stimulation at CT22-24, 
the time at which a phase advancing light pulse produces maximal responses, points 
to a role of altered light processing in post-septic animals or a decrease in the 
amplitude of the endogenous pacemaker and the increased capacity for a perturbing 
stimulus to impact upon the SCN and subsequent output from it. 
The significantly more rapid resetting to a phase advance of the light dark 
cycle and the enhanced phase shift magnitude to a phase advancing light pulse seen 
in post-septic animals was shown to be attenuated by administration of 200mg/kg 
PDTC, a potent inhibitor of the NF-κB pathway, prior to LPS 5mg.kg i.p. treatment, 
and values were seen to be in line with control animals.  NF-κB has been implicated 
in the LPS-induced effects on the circadian system and the presence and action of 
this immune related transcription factur upon the SCN has been shown during LPS 
induced and photic induced phase shifts (Marpegan et al., 2004, 2005, Paladino et 
al., 2010).  In hamsters, treatment with PDTC blocks light induced phase advances 
of locomotor behaviour (Marpegan et al., 2004), while application of sulfasalazine, 
an NF-κB inhibitor, has previously been shown to block the phase-shifting effects of 
peripheral LPS treatment in the early subjective night in mice (Marpegan et al., 
2005).  PDTC treatment was also shown to prevent the high sepsis scores elicited in 
LPS treated animals, with a significant decrease in sepsis scores between animals 
treated with a control injection and LPS, and those treated with PDTC prior to LPS.  
This is probably due to the inhibition of the release of proinflammatory cytokines 
following LPS treatment by PDTC administration and indicates that the induction of 
sepsis does indeed precede the alterations in photic resetting in LPS treated animals.    
Enhanced sensitivity to light in post-septic animals could be responsible for 
either the accelerated resetting to a single day shift of the photocycle or the 
exaggerated phase shift magnitude following a phase advancing light pulse, however 
there are no alterations observed in phase delay reentrainment or reentrainment in 
response to a phase delaying light pulse, and no alterations in entrainment under 
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skeleton or half skeleton photoperiods, which might be expected to be attenuated 
were there perturbations in photic sensitivity.  Further, it‘s possible that post-septic 
animals are not accurately perceiving or processing light information and the 
integrity of the retinohypothalamic tract or transmission from it may be 
compromised, however alterations in RHT transmission impact upon the phase angle 
of entrainment, and the current study observes no differences in this between post-
septic animals and controls.  The assessment of photic IEG induction in Chapter 
Three will shed further light on the photic sensitivity of post-septic animals.   
The question as to what is underlying this altered resetting then arises, since 
we know that it is not due to attenuations in core circadian parameters.   The 
resetting responses of the circadian system can involve various different components 
of the timekeeping system. Coupling and intercellular signalling in the SCN plays an 
important role in photic responsiveness and circadian entrainment.  Alterations in the 
expression of neuropeptides that play roles in input to (VIP) and output from (AVP) 
the SCN could result in a decrease in pacemaker amplitude which could underlie 
post-septic circadian behavioural changes, since perturbations in the expression of 
these neuropeptides have previously been shown to affect the amplitude of 
rhythmicity in the SCN and the amplitude of output rhythms (Aton et al., 2006; 
Brown et al., 2007; Brown and Nunez, 1989; Mihai et al., 1994).  The assessment of 
these neuropeptides was carried out and results from these data presented in Chapter 
Three.  At the electrophysiological level, intercellular synchronization can influence 
phase-shifting responses (VanderLeest et al., 2009) and SCN electrical activity has 
shown to be impaired following a cocktail of IFN-γ and TNF-α (Lundkvist et al., 
2002).  Alterations in the amplitude or in the functional output of the SCN could 
account for the changes seen in post-septic animals behaviourally.  Enhanced 
resetting in mice has previously been suggested to be due either to reduced 
pacemaker amplitude allowing increased efficacy of perturbing stimulants in phase-
shifting the oscillator or an increase in the strength of phase-shifting input to the 
pacemaker (Winfree, 2001; Vitaterna et al., 2006).  This enhanced resetting is a 
situation analogous to what we find in these studies and reduced pacemaker 
amplitude could therefore account for the exaggerated phase shift magnitudes in 
response to light and accelerated re-entrainment, since the circadian system appears 
to be more easily perturbed in post-septic animals.  However, pacemaker amplitude 
is not always responsible for the enhanced phase shift responses and while many of 
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our results may point to a reduction in the amplitude of the pacemaker, we have 
shown there to be no alterations in the free running period or rhythm amplitude 
under any lighting conditions, no effects of negative masking on locomotor activity, 
and no alterations in phase upon transfer to constant conditions, all of which could 
be affected from a reduction in pacemaker amplitude.  Furthermore, application of a 
non-photic stimulus, treatment with serotoninergic agonist 8-OH-DPAT, was found 
not to produce alterations in the magnitude of phase shifts elicited between groups, 
indicating that the circadian system of post-septic animals is not simply perturbed by 
any type of stimulus and ruling against a reduction in amplitude of the pacemaker. 
Any perturbations found in rhythmicity of post-septic animals were specific to phase 
advancing stimuli and all involve interactions between light and the timekeeping 
system.  
 
It is clear that alterations in behavioural rhythm resetting are only seen during 
the advance portion of the phase response curve or in response to phase advancing 
stimuli, with these animals showing accelerated re-entrainment to advances of the 
L:D cycle, and showing larger magnitude phase shifts in response to light pulses 
delivered in the late subjective night (but no changes at other phases).  The 
mechanisms by which the alterations in advance resetting occur in post-septic 
animals remain unclear.  Studies have suggested that the difference in direction of 
phase shift responses could be due to changes in the expression of clock genes or 
their protein products (Reddy et al., 2002; Yan and Silver, 2002; Yan and Silver, 
2004) and so alterations in these might cause alterations in behavioural responses.  
The circadian expression of clock gene protein products will be assessed in Chapter 
4 to examine whether alterations in these could be involved in the attenuation of 
rhythmic behaviour seen in post-septic animals.  
The intracellular signalling pathways underlying shifts of locomotor activity 
vary depending on the direction of the phase shift.   In the late subjective night, the 
portion of the phase response curve at which photic stimulation induces phase 
advances of locomotor behaviour, the activation of a cGMP-dependent pathway that 
involves the activation of guanylyl cyclase and of a cGMP dependent protein kinase 
(PKG) is involved in the phase shift of behaviour (Tischkau et al., 2003; Agostino et 
al., 2004; Golombek et al., 2004).  It‘s possible that alterations in the cGMP-PKG 
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pathway, associated with phase advances but not delays, could underpin the 
attenuations seen in advance resetting in post-septic animals. 
 
Glucocorticoid rhythms have been demonstrated to influence the speed of re-
entrainment to shifts in phase (Davidson et al., 2009), with faster resetting kinetics in 
rhythmic behavioural locomotor activity seen in response to manipulation of the 
photoperiod (Sage et al., 2004; Mohawk et al., 2005; Kiessling et al., 2010; Pezuk et 
al., 2012).  Further, impairment of the HPA axis is seen in humans and in 
experimental sepsis studies in rodents, both in the acute and post-acute phase 
(Carlson et al., 2006; Polito et al., 2011), and inflammatory mediators have been 
shown to alter corticosterone rhythms (Shinohara et al., 2008).  Examination of 
rhythmic corticosterone following the induction of the sepsis and during the time 
course at which manipulations of the light dark cycle resulted in altered resetting 
would be interesting, however would require further extensive studies. 
It may be that similiarties exist between results we present in these studies, 
and those reported from studies on the effects of healthy ageing on circadian 
rhythmicity.  In hamsters, it has previously been shown that ageing is associated with 
larger magnitude phase shifts following a phase advancing light pulse (Rosenberg et 
al., 1991) along with more rapid resetting to phase advances (Zee et al., 1992). These 
results however are not consistent, since other studies of aging have found slower 
rates of resetting or phase shifts of smaller magnitude along with a dampened 
circadian amplitude (Kiessling et al., 2010) which is in contrast with what we present 
in these studies.  Ageing is associated with a low-grade central neuroinflammation 
(Godbout and Johnson, 2009), including the presence of neuroinflammation in the 
SCN (Deng et al., 2010) and so assessment of SCN neurochemistry in post-septic 
animals will assess whether there are parallels between the post-septic and ageing 
SCN (Chapter 3). Moreover, phase shifts in locomotor behavioural rhythmicity have 
been induced following response of the SCN to central proinflammatory cytokines 
(Leone et al., 2012), so assessment of the SCN post-sepsis is important to discern 
whether any of the changes we observed in behavioural locomotor activity might be 
due to actions of immune mediators on the SCN.  Examination of the effects of 
sepsis induction on the acute and long term neurochemical composition of the SCN 
was performed and is presented in Chapter 3, the data from which further describes 
the effects of sepsis on circadian timekeeping. 
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Acute sepsis has been shown to affect cerebral glucose utilization, and 
analysis of glucose uptake has shown a decrease in cerebral metabolism associated 
with a decrease in cerebral blood flow and alpha activity in EEG (Semmler et al., 
2008).  Further studies have noted a consistent tendency for LPS induced sepsis to 
decrease cerebral glucose utilization in the long term following sepsis induction in 
the hippocampus, frontal cortex and striatum (Weberpals et al., 2009).  Alterations in 
neuronal metabolism could play a role in behavioural impairments following LPS 
treatment. Attenuations in synaptic plasticity in the post-septic brain could play a 
role in the attenuations in circadian behaviour, and studies have shown that two 
months following a single septic LPS treatment, synaptic alterations are evidenced in 
the post-septic brain (Weberpals et al., 2009).  Additionally, it is possible that the 
induction of sepsis might cause neuronal loss in the SCN which could account for 
attenuations in circadian rhythmicity.  TUNEL analysis has revealed a significant 
increase in apoptotic cells in the brain 24hrs post LPS treatment in the hippocampus, 
cerebellum, midbrain and cortex, however this was at a higher dose (10mg/kg) than 
that used in the current set of experiments (Semmler et al., 2005).  Further, 
experimental work using peripheral LPS 5mg/kg treatment has shown delayed 
neurodegeneration of dopaminergic neurons in the substantia nigra (Qin et al., 2007).  
Assessment of apoptotic markers in the SCN following LPS induced sepsis in 
Chapter 3 further clarifies this.  Attenuations in neurotransmission in the post-septic 
brain could cause alterations within the CNS as a result of LPS induced cytokine 
modulations, since studies of the CNS in sepsis have observed evidence for altered 
neurotransmission (Van der Poll et al., 1996, Van der Poll, 2000; Toklu et al., 2009; 
Freund et al., 1985) 
 
 To date there have been no comprehensive studies examining circadian 
parameters as output measures of post-septic encephalopathy. The results from the 
assessment of circadian activity patterns in post-septic animals show that the core 
circadian parameters do not differ significantly in the circadian systems of post-
septic mice and controls, but that an underlying mechanism is influencing resetting 
behaviour. 
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Chapter Three 
The Effects of a Septic LPS treatment on SCN 
Neurochemistry. 
3.1 Introduction 
3.1.1. Septic doses of LPS treatment induces a long-lasting neuroinflammation 
A single septic LPS treatment in the periphery has been shown to have a 
long-lasting impact on the innate immune system in the CNS (Weberpals et al., 
2009; Qin et al., 2007; Bossu et al., 2012).    In response to septic LPS treatment, the 
proinflammatory cytokine TNF-α is seen to rise in the periphery in the acute phase 
following treatment and to subside in the periphery approximately one week 
following LPS 5mg/kg treatment, but to stay elevated in the brain (Qin et al., 2007; 
Bossu et al., 2012).   Elevated levels of cytokines are observed in the CNS 8 weeks 
post LPS 5mg/kg treatment, including upregulation of TNF-α in the prefrontal cortex 
and cerebellum, and an increase in IL-1β in the prefrontal cortex (Weberpals et al., 
2009). Additionally, 5mg/kg LPS treatment results in an increase in NOS2 
expression in the hippocampus and frontal cortex, as well as a sustained microglial 
activation in the frontal cortex and synaptic alterations up to 8 weeks following the 
immune challenge, and nitric oxide appears to play a role in these long-lasting LPS 
consequences (Weberpals et al., 2009).  Acute sepsis has been shown to affect 
cerebral glucose utilization, and analysis of glucose uptake has shown a decrease in 
cerebral metabolism associated with a decrease in cerebral blood flow and alpha 
activity in EEG (Semmler et al., 2008).  Further studies have assessed cerebral 
glucose uptake two months following sepsis induction, and there was a consistent 
tendency for LPS induced sepsis to decrease cerebral glucose utilization in the 
hippocampus, frontal cortex and striatum however this didn‘t reach significance in 
the sample in these studies (Weberpals et al., 2009).  Alterations in neuronal 
metabolism could play a role in behavioural impairments following LPS treatment.  
Other studies using a model of chronic i.c.v. infusion of LPS to induce 
neuroinflammation in rats observes an increase in the level of GFAP positive 
astrocytes and reactive microglia throughout the brain, in particular in the 
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hippocampus (Hauss-Wegrzyniak et al., 1998), and a long-lasting upregulation of 
microglia has been shown 37 days following the final LPS administration (Hauss-
Wegrzyniak et al., 2000).  Additionally, this chronic neuroinflammation model 
causes the induction of TNF-α, IL-1β and β-amyloid precursor protein mRNA levels 
within the basal forebrain region and hippocampus, as well as degeneration of CA3 
hippocampal pyramidal neurons (Hauss-Wegrzyniak et al., 1998). Further, chronic 
LPS infusion has been shown to cause loss of NMDA receptors in the hippocampus 
and entrohinal cortex (EC) (Rosi et al., 2004) and a time-dependent, but not dose-
dependent, degeneration of nucleus basalis magnocellularis (NBM) cholinergic cells 
(Willard et al., 1999).  Additionally, following 10mg/kg LPS treatment in rats, 
TUNEL analysis revealed a significant increase in apoptotic cells in the brain 24hrs 
post-treatment, in the hippocampus, cerebellum, midbrain and cortex (Semmler et 
al., 2005).   
LPS 5mg/kg i.p treatment has been shown to cause elevated TNF-α levels in 
the brain up to 10 months following the immune challenge, along with irreversible 
damage to dopaminergic neurons in the substantia nigra (SN) which are seen to 
degenerate between 7 and 10months post-treatment (Qin et al., 2007).  Studies by 
Bossu and colleagues (2012) assessing the impact of a septic LPS treatment on the 
CNS have shown chronic region specific cytokine alterations in the CNS 10 months 
following treatment,  and have shown both TNF-α and IL-18 to be upregulated in the 
hippocampus, cerebellum and frontal cortex.   
At these timepoints, in the long-term following LPS treatment, when 
circulating levels of proinflammatory cytokines have returned to baseline levels, the 
elevation of inflammatory mediators in the brain is therefore independent of the 
initial systemic reaction, and is being propelled in the CNS itself, leading to the view 
of a self-propelling neuroinflammation (Qin et al., 2007; Bossu et al., 2012).  The 
precise mechanisms underlying the chronic neuroinflammatory state following a 
septic LPS treatment have not been fully elucidated, but have been suggested to 
involve the action of TNF-α in the periphery in the early stages, leading to microglial 
activation in the CNS and subsequently a self-propelling neuroinflammation by the 
further induction of cytokines in the CNS such as TNF-α, IL-1β (Qin et al., 2007) 
and IL-18 (Bossu et al., 2012), leading to a loss of neurons in the later stages 
following peripheral inflammation (Qin et al., 2007; Semmler et al., 2007) and 
lasting behavioural alterations (Bossu et al., 2012).   
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3.1.2. LPS induced neuroinflammation and subsequent cognitive alterations 
Peripheral LPS treatment and subsequent microglial activation and cytokine 
release is associated with behavioural deficits (Bluthe et al., 1992; Godbout et al., 
2005; Combrinck et al., 2002).  Alterations in cytokine levels in the CNS and the 
neuroinflammatory response may lead to neurobehavioral impairments and delirium 
(Lemstra et al., 2007).  Neuroinflammation and microglial activation are implicated 
in the pathogenesis of various disorders associated with cognitive impairment such 
as AD, Lewy body dementia and AIDS dementia (Nelson et al., 2002; Katsuse et al., 
2003; Perry et al., 2003).  LPS treatment causes alterations in cognitive function.  
The influences of cytokines on behaviour are mediated by cytokine action on the 
neuroendocrine pathway, neural plasticity, effects on neurocircuitry and function of 
neurotransmitters (Capuron and Miller, 2011).  
Peripheral LPS has been shown to exert effects on sleep architecture and 
sleep-wake behaviour (Krueger and Majde, 1994).  Promptly following LPS 
treatment, sickness behaviour is seen to develop and peaks between 2 and 6 hours, 
and is seen to slowly decline after 6hrs, while at 24hrs post LPS treatment depressive 
like behaviour is expressed (Frenois et al., 2007; Dantzer et al., 2008).  Sickness 
behaviour is mediated by temporarily expressed proinflammatory cytokines in the 
brain (Dantzer, 2004) and can be blocked by administration of the anti-inflammatory 
IL10 or the IL-1 receptor antagonist, IL-1RA, supporting the role that 
proinflamamtory cytokines are outlined to play in the acute phase reaction (Kent et 
al., 1992; Bluthe et al., 1995; Avitsur et al., 1997; Dantzer et al., 2008).   
Alterations in learning and memory are seen both acutely and chronically 
following LPS administration.  Administration of low dose endotoxin to healthy 
volunteers results in an increase in levels of systemic proinflammatory cytokines, as 
well as behaviour and memory perturbations (Reichenberg et al., 2001; Krabbe et al., 
2005).  Acutely in mice, when administered hours before assessment of cognitive 
function, LPS treatment causes learning and memory impairments (Arai et al., 2001; 
Sparkman et al., 2005).  Single LPS treatment has been shown to cause spatial 
memory deficits up to 11 days following the immune challenge (Shaw et al., 2001).  
In vivo and in vitro, LPS has been shown to reduce hippocampal long-term 
potentiation  (LTP) (Cunningham et al., 1996; Commins et al., 2001; Jo et al., 2001) 
which is an indicator of synaptic efficiency in the formation of learning and memory 
104 
 
(Malenka and Nicoll, 1999; Malenka and Bear, 2004).  In similar studies, the 
inflammatory suppression of LTP was ameliorated by the inhibition of NOS2 (Mori 
et al., 2001; Togashi et al., 2001; Wang et al., 2004).  Further, in a model of cerebral 
ischemia, inhibition of NOS2 by aminoguanidine was seen to attenuate learning and 
memory deficits (Mori et al., 2001).   
In the long term, LPS treated animals also show impaired spatial memory 
performance 2 months post-treatment, and this was protected in the absence of 
NOS2 derived nitric oxide (Weberpals et al., 2009), highlighting the role of immune 
mediators in LPS induced cognitive dysfunction. Further, chronic LPS infusion has 
been shown to cause significant impairment in spatial memory (Hauss-Wegrzyniak 
et al., 1998), while three months following 10mg/kg LPS treatment, memory deficits 
have been evidenced in studies in rats (Semmler et al., 2007).  More recently, it has 
been shown that ten months following a septic peripheral immune challenge with 
endotoxin, LPS induced cognitive impairments are evident, and these have been 
suggested to be possibly as a result of LPS induced delayed loss of neurons (Bossu et 
al., 2012).  
3.1.3. LPS treatment and its effects on the SCN and the circadian system 
As discussed previously, various proinflammatory cytokines are known to 
impact upon circadian behaviour including TNF-α (Cavadini et al., 2007; Nygard et 
al., 2009), IL-6 (Motzkus et al., 2002), IL-1β (Cavadini et al., 2007), IFN-α (Ohdo et 
al., 2001; Koyanagi and Ohdo, 2002) and IFN-γ (Lundkvist et al., 2002; Kwak et al., 
2008). The SCN expresses cytokine receptors and regulatory molecules (Lundkvist 
et. al., 1999; Sadki et. al., 2007) and responds in the acute phase to a substantial 
peripheral immune challenge, showing functional changes and alterations in clock 
gene expression following LPS administration (Beynon and Coogan, 2010; 
Marpegan et al., 2005; Okada et al., 2008). 
Septic doses of LPS have been shown to induce a substantial increase in the 
expression of the IEG c-Fos in the SCN acutely, as well as activation of the p65 
subunit of the NF-κB pathway (Beynon and Coogan, 2010), while low LPS doses are 
also seen to cause functional activation of the SCN as evidenced through c-Fos 
expression (Marpegan et. al., 2005).  Mice treated with LPS i.p. for 60 days exhibit 
altered SCN function as illustrated through a decrease in photically-induced c-Fos 
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expression, shown to be reversible over time (Palomba and Bentivoglio, 2008).  The 
first day following LPS treatment, the clock gene Per2 is shown to be suppressed in 
the SCN as is the clock controlled gene Dbp, with normal expression restored from 
48hrs post-treatment.  Per1, Per2 and numerous clock controlled genes expression 
was inhibited in the periphery in the liver 24hrs following LPS with restoration of 
rhythmicity 2days post the immune challenge (Okada et al., 2008).  The 
neurotransmitter AVP is increased in the SCN following in vitro treatment of SCN 
slices with LPS (Nava et al., 2000).   
The PVN has also been shown to be affected following LPS treatment.  In 
rats following 2.5mg/kg LPS treatment, Cox-2 mRNA levels have been shown in 
blood vessels in the PVN, peaking 2 h post-treatment (Quan et al., 1998).  Further, 
following either i.v. or i.p. LPS treatment, levels of TNF-α and IL-6 are significantly 
increased in the PVN in the acute phase (Kakizaki et al., 1999).  Additionally, the 
circadian clock gene Per1 has been shown to be induced in the PVN of the 
hypothalamus following LPS administration (Takahashi et al., 2001).   
Given the long-lasting neuroinflammation induced by LPS treatment, the 
influence of inflammatory mediators on the CNS and on behaviour and the 
consequences systemic LPS exerts on the SCN and circadian behaviour, we 
examined the possibility that LPS induced circadian attenuations may be due to 
alterations in the expression of immune mediators in the SCN.  The specific aims of 
this portion of the study were, to examine the neurochemistry of the SCN both in the 
acute phase following a peripheral septic LPS treatment, and in the long term, when 
attenuations in circadian locomotor behaviour are observed in post-septic animals. 
 
3.2.  Materials & Methods: 
3.2.1. Animals and Housing: 
Adult C57BL/6 male mice (8-10wks old) used to assess SCN neurochemistry 
in the acute phase, 24hrs following LPS 5mg/kg treatment, were group housed as 
outlined in section 2.2.2.  In order to examine SCN neurochemistry in the long term 
following LPS 5mg/kg treatment, adult C57BL/6 male mice (4-5mths old) housed 
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individually in polypropylene cages equipped with steel running wheels (described 
in section 2.2.2) and used for the assessment of circadian behavioural rhythmicity 
following a septic LPS treatment, were used upon termination of behavioural 
monitoring (approximately 3mths post-treatment) were terminally anaesthetized and 
subject to transcardiac perfusion and assessment of the SCN by 
immunohistochemistry. 
3.2.2. Treatment: 
LPS 5mg/kg treatment and PDTC administration prior to LPS treatment were 
performed as outlined previously (section 2.2.3.3 and section 2.2.3.1 respectively). 
3.2.3. Transcardiac perfusion and tissue preparation: 
All perfusions were carried out in the middle of the lights on phase (ZT4-8), 
unless otherwise noted. Animals were terminally anesthetised with an i.p. injection 
of sodium pentobarbital (Euthathal, Merial Animal Health, UK), the chest cavity 
opened and animals perfused transcardially with approximately 30mls of 0.9% NaCl 
at 4˚C, followed by perfusion with approximately 50mls of 4% paraformaldehyde 
(PFA, Sigma) in 0.1M Phosphate Buffer (PB) at 4˚C.  Brains were carefully 
removed, post-fixed overnight in 4% PFA for 24hrs at 4˚C and were then 
cryoprotected in 30% Sucrose (Sigma) in 0.1M PB for a further 24hrs at 4˚C.  The 
brain was removed from the 30% sucrose, and cut caudally removing the cerebellum 
and rostrally to remove the preoptic region with a single edged razor blade.  Brains 
were mounted on a freezing stage microtome (Leica), utilizing the minimal amount 
of mounting medium, with the caudal cut surface attached to the stage and the 
ventral aspect facing the blade.  Brains were quick frozen with dry ice and 30µm 
thick serial coronal sections were cut throughout the rostrocaudal extent of the SCN.  
All sections through the SCN were collected and divided in 4 series, obtaining 
approximately 5 or 6 sections through the SCN in each series.  The sections were 
stored in 0.1M PB, pH 7.4 (Sigma) with 0.1% sodium azide at 4°C to inhibit 
microbial growth prior to being processed for immunohistochemistry.   
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3.2.4. Immunohistochemistry Protocol:  
For immunohistochemistry purposes the avidin-biotin-peroxidase complex 
(ABC)/Nickel DAB colourometric protocol method (Beynon and Coogan, 2010,) 
was used following this protocol:   
Free floating sections in 12 well tissue culture plates were washed at room 
temperature for 10min in 0.1 M PB (pH 7.4) twice.  They were then washed for 10 
min in PBX consisting of 0.1 M PB and 0.03% Triton X-100 (Sigma).  PBX 
perforates the cell membrane.  Sections were incubated with 0.1M PB and 1.5% 
Hydrogen peroxide (H2O2) for 20 minutes.  H2O2 inactivates endogenous peroxidases 
and reduces non-specific background staining.  Sections were then subjected to 
another set of 10 minute washes as before, 2 x PB and 1x PBX.  A non-specific 
antibody blocking step was then carried out in 0.1M PBX with either 5% Normal 
Goat Serum (NGS, for rabbit and rat polyclonals) or Normal Horse Serum (NHS, for 
goat polyclonals) for 60min at room temperature.  Sections were incubated with 
primary antisera raised in either rabbit, rat or goat diluted in 0.1M PBX and 2% NGS 
or NHS (blocking solution) for 24-48hrs at 4°C.   
Table 3: Primary Antisera used for Immunohistochemical analysis 
Antibody Dilution Raised in Supplier Product Code 
c-Fos (4) 1:2000 Rabbit Santa Cruz 
Biotechnology 
sc-52 
Arc (H-300) 1:500 Rabbit Santa Cruz 
Biotechnology 
sc-15325 
Egr-1 (C-19) 1:3000 Rabbit Santa Cruz 
Biotechnology 
sc-189 
CD11b 1:1000 Rat AbD Serotec, 
Oxford, UK 
MCA74GA 
F4/80 1:100 Rat AbD Serotec, 
Oxford, UK 
MCA497GA 
GFAP 1:1000 Rabbit Sigma, St. Louis, 
MO, U.S.A 
G4546 
IBA-1 1:1000 
 
Rabbit Wako, Denmark 019-1974 
Cleaved 
Caspase-3 
(Asp175) 
1:200 Rabbit Cell Signaling 
Technology, 
Danvers, MA, 
U.S.A. 
#9661 
TNF- α 1:75 Rat AbD Serotec, 
Oxford, UK 
MCA1488 
IL-1β 1:50 Rabbit Peprotech, U.S.A. 500-P51 
IL-6 (M-19) 1:200 Goat Santa Cruz 
Biotechnology 
sc-1265 
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NOS2 (M-19) 1:100 Rabbit Santa Cruz 
Biotechnology 
sc-650 
NF-κB p65 
(C-20) 
1:200 Rabbit Santa Cruz 
Biotechnology 
sc-372 
p-IKK α/β (Ser 
180/ Ser 181)-
R 
1:200 Rabbit Santa Cruz 
Biotechnology 
sc-23470-R 
p-IκB- α 
(Ser32/36) 
1:200 Rabbit Santa Cruz 
Biotechnology 
sc-101713 
AVP 1:5000 Rabbit Millipore, 
Temecula, CA, 
U.S.A. 
AB1565 
VIP 1:1000 Rabbit Millipore, 
Temecula, CA, 
U.S.A. 
AB982 
 
 
Following incubation with the primary antisera, sections were put through a 
series of washes as before, two PB and one PBX wash, and incubated with the 
appropriate biotinylated secondary antibody (1:400 biotinylated goat anti-rabbit 
Jackson Immuno research Labs, 1:400 biotinylated anti-goat or 1:400 anti-rat) 
diluted in 0.1M PBX and 2% NGS or NHS (blocking solution) for 70 min at room 
temperature.  Due to the photosensitive nature of the biotinylated secondary 
antibody, sections were shielded from light for the remainder of the experiment.  
Sections were then treated using the avidin-biotin method (0.4%) in 0.1M PBX with 
a Vectastain Elite Universal Kit (Vector Laboratories) for 90min at room 
temperature.  Sections were washed twice for 10min in 0.1M PB and then in 0.1M 
sodium acetate (pH6, Sigma) for 10min.  Immunoreactivity was visualised with light 
sensitive nickel-enhanced diaminobenzidine, (3, 3‘-diaminobenzidene with 
ammonium nickel chloride, NiDAB), (pH6), as chromogen, 1000ul NiDAB and 60ul 
catalyst, glucose oxidase (5mg/ml) per well.  Once sufficient staining was obtained, 
sections were washed in 0.1M sodium acetate to stop the reaction and then 
underwent three final washes in 0.1M PB.  Tissue sections were finally stored in 
0.1M PB at 4˚C, then mounted onto gelatine coated slides(1% gelatine and 0.05% 
chromium potassium sulphate)  and allowed to dry before being put through 
dehydrating and delipifying steps.  They were dehydrated through a graded series of 
3min ethanol washes, 70%, 90% and 100%, and were subsequently cleared in a 
series of 3 min delipifying steps in 2% Histoclear (National Diagnostics, UK) 
washes.  Slides were left to air-dry overnight before being coverslipped using 
mounting media (Eukitt, Fluka Analytical).   
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All sections were treated in exactly the same manner at all stages of tissue 
processing to minimise any interassay variability.  As much as possible, tissue 
sections from different experimental groups were reacted in parallel when processed 
for the same antibody, otherwise standardised immunostaining procedures were 
ensured between assays, including immunoreactivity times when incubated in 
NiDAB. 
In parallel with IHC staining for an antibody of interest, immunizing peptide 
blocking experiments were performed where an immunizing blocking peptide for the 
antibody was available, in order to examine whether non-specific binding of the 
antibody to proteins other than the antigen might be taking place (see Section 3.5, 
Figure S1). 
3.2.5. Quantitative Analysis: 
Photomicrographs of the mid-rostrocaudal levels of the SCN were taken using 
a digital camera connected to an Olympus BX-51 light microscope equipped with an 
image analysis digital system (ImageJ 1.43, NIH, USA).  All images were taken 
using the same camera and magnification settings.  For analysis, brain sections were 
examined under either the 10X or 40X objective lens.  Between 3 and 6 images were 
evaluated for each individual animal and region depending on the rostro-caudal 
extent of the area being examined and a mean value obtained for each animal. 
Immunoreactive cells in each region of interest were quantified using either image 
analysis software or by quantification of immunoreactive (ir) cell number by an 
observer by manual counting for the purpose of analysing immunoreactive nuclear 
staining.  Brain sections were counted according to anatomical location throughout 
the rostro-caudal extent of the SCN.  The Suprachiasmatic nuclei were measured at 
the mid rostro-caudal level, including the core and shell regions of these structures.  
The observer was blinded to the experimental procedure during optical density 
measurements or quantification of immunoreactive cells per SCN.   The difference in 
integrated optical density (IOD) of immonostaining in the SCN or the number of 
immunoreactive cells that displayed clear nuclear staining in the SCN of all animal 
groups was evaluated for quantitative analysis.  The light intensity was kept constant 
while all measurements were taken to standardize IOD measurements for analysis.  
A previously described method whereby the image was binarised for analysis was 
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used for integrated optical density measurements (Vilaplana and Lavialle, 1999).  
Results are given as mean values (IOD or cell number) + standard error of the mean, 
statistical significance was accepted at P<0.05. 
3.2.6. Assessment of Acute effects of LPS on the SCN 
In order to examine whether a septic dose of LPS would cause the expression 
of immune factors in the SCN or would induce signs of apoptosis, adult male mice 
were group housed in colonies of ten in cages equipped with appropriate 
environmental enrichment under a 12:12 LD cycle (150 lux, lights on 0700) for one 
month, allowing for habituation.   Animals were treated at ZT6 with either an LPS 
5mg/kg i.p. injection (n=3-5) or saline vehicle i.p. (n=3-5) and, while still in the 
acute phase following sepsis induction, 24 hours later (ZT6), were terminally 
anaesthetized and perfused transcardially as previously outlined in section  3.2.3.  
The immunohistochemistry protocol outlined in section 3.2.4 was adhered to for 
staining purposes.  Brains were then processed by immunohistochemistry for the 
microglial marker F4/80, the proinflammatory cytokines TNF-α and IL-6, the 
immediate early genes protein products EGR-1 and ARC and for NOS2, a signaller 
known to be induced by neuroimmune processes (all outlined in Table 3).   
For each individual animal and each antibody, 3-6 SCN images were 
examined by means of manual quantification of the number of immunoreactive 
nuclei in the SCN or assessing the difference in IOD of antibody immunosignal in 
the SCN as previously outlined in section 3.2.5., and a mean value obtained for each 
animal for each antibody for all SCN regions of interest. These values were 
calculated for each animal by two researchers.  The observers were blinded to the 
experimental procedure during IOD or quantification of immunoreactive cells per 
SCN. The means calculated for each group were compared and analysed by 
independent samples t-test.  Results are given as mean values (IOD or cell number) + 
standard error of the mean, statistical significance was accepted at P<0.05. 
3.2.7. Assessment of apoptosis 24hrs following induction of sepsis 
TUNEL (Terminal deoxynucleotidyl transferase-mediated d-UTP Nick End 
Labeling) Analysis (DeadEnd Fluorometric TUNEL Staining kit, Promega, U.K.) 
was carried out for the detection and quantification of apoptotic cells in the SCN or 
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throughout the brain 24hrs following LPS 5mg/kg i.p. (n=4) injection or saline 
vehicle (n=4).  Nuclear DNA fragmentation occurs during apoptosis as a result of the 
activation of endonucleases that cleave chromosomal DNA, and DNA strand breaks 
are therefore an important apoptotic hallmark (Gavrieli et al 1992, Darzynkiewicz et 
al., 2008).  The TUNEL method (Gavrieli et al 1992) was utilized on 30 μm thick 
sections cut through the rostro-caudal extent of the SCN, obtained as previously 
described (section 3.2.3).   Sections were mounted on poly-L-Lysine-coated 
microscope slides.  A 1:10 dilution of Poly-L-Lysine (Sigma) was pipetted onto pre-
cleaned glass slides which were then allowed to air dry.  Once the slides were dry 
they were rinsed in deionized water and allowed to air-dry again for 60min.  Poly-L-
Lysine coated slides were stored at 4°C and used within 7 days. Brain sections 
containing the optimum mid SCN were floated on very dilute 0.1M PB before 
placement on Poly-L-Lysine coated slides.  The slides with mounted SCN sections 
were allowed to air-dry overnight at room temperature prior to TUNEL analysis.  
The TUNEL kit, was used according to manufacturer‘s instructions.  All solutions 
and reagents outlined below were supplied as part of the TUNEL analysis kit unless 
otherwise stated.  
Slides were immersed in Phosphate Buffered Saline (PBS) for 5 min at room 
temperature followed by fixation of the cells in 4% PFA in PBS for 5mins.  
Formaldehyde serves to crosslink low molecular weight DNA fragments to other 
cellular constituents, thereby preventing their extraction during rinses.  Slides were 
immersed 2X in PBS for 5 min. Permeabilization of the cells was achieved by 
treatment of the sections with cell permeabilization solution, 100µl of 20µg/ml 
Proteinase K solution (100mM Tris-HCl, pH8.0; 50mM EDTA) was added to each 
slide to cover the tissue sections and incubated for 15min at room temperature. The 
slides were tapped to remove excess liquid and incubated for 10min at room 
temperature in 100µl of Equilibration Buffer (200mM potassium cacodylate, pH 6.6 
at 25°C; 25mM Tris-HCl, pH 6.6 at 25C; 0.2mM DTT, 0.25mg/ml BSA and 2.5mM 
cobalt chloride) in order to equilibrate the tissue sections. Slides were then put 
through 2X 5min PBS rinses before being incubated with 100µl ice cold Terminal 
Deoxynucleotidyl Transferase Recombinant (rTdT) reaction mix (98µl Equilibration 
buffer, 1µl Biotinylated Nucleotide Mix, 1µl rTdT Enzyme). TdT catalytically 
incorporates biotinylated nucleotide to the 3‘-OH DNA ends.  Sections were covered 
with plastic coverslips to ensure even distribution of the reagent and placed for 1hr in 
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a humidified chamber (Memmert, Schwaback) at 37°C to facilitate the end-labelling 
reaction.  The slides were taken from the incubator, plastic coverslips removed and 
in order to stop the reaction, slides were immersed for 15min in 2X SSC made by 
diluting 20X SSC (87.7g NaCl, 44.1g sodium citrate in 400ml deionized H2O, 
adjusted to pH 7.2 with 10N NaOH and brought to a final volume of 500ml) 1:10 in 
deionized H2O.  Slides were put through 3X 5min PBS washes to remove 
unincorporated biotinylated nucleotides and endogenous peroxidases blocked by 
5min incubation of the slides in 0.3% H2O2 at room temperature.  Slides were 
washed 2X for 5min in PBS and 100µl Horseradish peroxidase-labelled streptavidin 
(Streptavidin HRP) diluted 1:500 in PBS was then added to the slides, which were 
incubated for 30 min at room temperature.  Streptavidin HRP binds to the 
biotinylated nucleotides. Slides were put through 3X 5min PBS washes and the DAB 
substrate kit utilized in order to observe TUNEL staining (Promega, U.K.).   The 
Streptavidin HRP bound biotinylated nucleotides were then detected using 
peroxidase substrate, hydrogen peroxide and the stable chromogen diaminobenzidine 
(DAB). 100µl DAB solution (50µl DAB substrate 20X Buffer in 950µl deionized 
water, 50µl DAB 20X Chromogen and 50µl Hydrogen Peroxide 20X) was added to 
each slide and the slides incubated for approximately 10min until a light brown 
background stain was achieved.  Apoptotic stained nuclei appeared as dark brown.  
Slides were rinsed several times in deionized water before being coverslipped with 
permanent mounting medium (Eukitt).   
Quantitative analysis of the number of TUNEL-positive cells was carried out 
for each individual animal by an observer using an Olympus BX-51 light microscope 
under 10X objective lens by means of manual counting with the aid of a hand held 
counter.  Three SCN images were examined per animal in order to assess the number 
of TUNEL positive stained cells in the SCN.  The Suprachiasmatic nuclei were 
measured at the mid rostro-caudal level, including the core and shell regions of these 
structures.  The observer was blinded to the experimental procedure for 
quantification of TUNEL positive cells per SCN.   The difference in the number of 
TUNEL stained cells that displayed clear staining in the SCN of all animal groups 
was evaluated for quantitative analysis. These values were calculated for each animal 
by two researchers blind to the experimental procedure and the means for each group 
were compared and analysed by independent samples t-test. Results are given as 
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mean values (cell number) + standard error of the mean, statistical significance was 
accepted at P<0.05. 
In order to further assess whether apoptosis had taken place following LPS 
5mg/kg treatment, the immunohistochemistry protocol (outlined in section 3.2.4) 
was used for staining for cleaved caspase-3.  Animals were perfused transcardially, 
brains were removed and then processed by immunohistochemistry as described in 
section 3.2.3.   For each individual animal, 3-6 SCN images were examined by 
means of assessment of the difference in IOD of antibody immunosignal in the SCN 
as previously outlined in section 3.2.5, and a mean value obtained for each animal 
for all SCN regions of interest. These values were calculated for each animal for 
each antibody in both groups by two researchers blinded to the experimental 
procedure during IOD measurements of the SCN and analysed by independent 
samples t-test.  Results are given as mean values (IOD) + standard error of the mean, 
statistical significance was accepted at P<0.05. 
3.2.8. The long-lasting effects of sepsis induction on SCN neurochemistry 
In order to assess whether or not the induction of sepsis causes long-lasting 
effects on the neurochemistry of the SCN, both LPS and saline treated animals used 
in experiments analysing circadian locomotor activity rhythms previously outlined in 
Chapter Two, were transferred into a 12:12 LD cycle (150 lux, lights on 0700) upon 
termination of behavioural monitoring.  Animals were maintained under this 
schedule for 14 days and then approximately 3months following the initial induction 
of sepsis were terminally anaesthetized and perfused transcardially as outlined in 
section 3.2.3.  Brains were carefully removed at ZT6 and processed for 
immunohistochemistry as outlined in section 3.2.4. Brains were then processed by 
immunohistochemistry for markers of glia, proinflammatory cytokines, immediate 
early genes, SCN neuropeptides and for signallers known to be induced by 
Neuroimmune processes (primary antisera outlined in Table 3).   
For each individual animal and each antibody, 3-6 SCN images were 
examined by means of manual quantification of the number of immunoreactive 
nuclei in the SCN or assessing the difference in integrated optical density of 
antibody immunosignal in the SCN as previously outlined in section 3.2.5, and a 
mean value obtained for each animal for each antibody for all SCN regions of 
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interest. These values were calculated for each animal by two researchers blind to the 
experimental procedure and the means for each group were compared and analysed 
by independent samples t-test.  Results are given as mean values (IOD or cell 
number) + standard error of the mean, statistical significance was accepted at 
P<0.05. 
3.2.9. Assessment of SCN neurochemistry following PDTC administration prior 
to LPS. 
In order to assess the involvement of NF-B in the LPS mediated effects on 
SCN neurochemistry, three experimental animal groups treated with either PDTC 
and LPS (n=10), PDTC and control (n=7) or control and LPS (n=10) used in 
experiments analysing circadian locomotor activity rhythms previously outlined in 
section 2.2.11, were transferred into a 12:12 LD cycle (150 lux, lights on 0700) upon 
termination of behavioural monitoring.  Animals were maintained under this 
schedule for 14 days and then approximately 3 months following the initial 
treatments were terminally anaesthetized and perfused transcardially as outlined in 
section 3.2.3.  Brains were carefully removed at ZT6 and processed for 
immunohistochemistry as outlined in section 3.2.4.  Brains were then processed by 
immunohistochemistry for IBA-1 (primary antisera outlined in Table 3).   
For each individual animal and each antibody, 3-6 SCN images were 
examined by means of manual quantification of the number of IBA-1 
immunoreactive cells in the SCN as previously outlined in section 3.2.5, and a mean 
value obtained for each animal for each antibody for all SCN regions of interest. 
These values were calculated for each animal by two researchers blind to the 
experimental procedure and the means for each group were compared and analysed 
by independent samples t-test. Immunoreactivity was compared between groups 
using One Way ANOVA. Results are given as mean values (immunoreactive cell 
number) + standard error of the mean, statistical significance was accepted at 
P<0.05. 
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3.3.  Results: 
3.3.1. Examination of immune mediators in the SCN 24hrs post LPS treatment 
24 hours following LPS 5mg/kg treatment while animals were still in the acute 
phase, Immunohistochemical (IHC) analysis was carried out to investigate whether 
there was any effect of LPS treatment on the expression of immune mediators in the 
SCN and whether these might be identified as being involved in mediating the 
effects of LPS on the circadian system. 
3.3.1.1. TNF-α expression in the SCN acutely following LPS treatment. 
TNF-α expression was assessed in the SCN 24hrs post LPS treatment or saline 
(Saline 4, LPS 4).  Immunohistochemical analysis followed by Integrated optical 
density measurements of immunoreactive TNF-α expression in the SCN and 
independent t-test analysis revealed no alterations in the SCN between saline 
controls (7.22 + 2.19 IOD/SCN) and post-septic animals (2.56 + 0.46 IOD/SCN, 
P>0.05; Figure 3.1), including no significant differences in expression of the 
proinflammatory mediator in the core region of the SCN (saline, 3.69 + 1.15 vs. LPS 
2.46 + 0.57 IOD/SCN, P>0.05) or  in the dorsomedial shell sub region (saline, 8.50 + 
2.64 vs. LPS, 2.75 + 0.48 IOD/SCN, P>0.05).  
 
Figure 3.1: TNF-α expression is not altered in the SCN 24hrs post LPS treatment.  
(a) Representative photomicrographs of TNF-α expression in the SCN of animals 
treated 24hrs previously with LPS (scale bar approx. 100 µm). Dashed line outlines 
the SCN and delineates the shell and core subdivisions.  (B) Bar graphs illustrating 
quantification of levels of TNF-α immunostained cells (n = 4 for each group) in the 
SCN of the control and LPS treated groups at 24hrs post LPS treatment.  
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3.3.1.2. LPS 5mg/kg treatment causes an increase in SCN NOS2 expression. 
The SCN was examined for the acute induction of inducible nitric oxide 
synthase (iNOS or NOS2) in the SCN 24hrs following peripheral LPS (n=4) or 
saline (n=4).  Integrated Optical Density analysis and assessment by independent t-
test found there to be a significant difference in the levels of NOS2 expression in the 
SCN between groups, with a significant upregulation of NOS2 immunosignal in the 
SCN of post-septic animals (29.67 + 3.19 IOD/SCN) compared to controls (12.67 + 
3.54 IOD/SCN, P<0.05; Figure 3.2) 24hrs post-treatment.  Immunostaining revealed 
no difference in ventrolateral core NOS2 expression between controls (22.24 + 10.29 
IOD/SCN) and LPS treated animals (60.28 + 16.56 IOD/SCN, P>0.05, independent 
t-test).  Integrated Optical Density measurements of immunoreactive NOS2 found 
the difference in NOS2 immunosignal to be statistically significant in the SCN shell 
between the groups, with significantly higher NOS2 immunoreactivity in LPS 
treated animals (23.09 + 4.07 IOD/SCN) and control animals (10.83 + 2.61 
IOD/SCN, P<0.05, independent t-test; Figure 3.2).  
Figure 3.2: NOS2 expression is altered in the SCN 24hrs following LPS treatment.  
(A) Representative photomicrographs of NOS2 expression in the SCN of animals 
treated 24hrs previously with LPS (scale bar approx. 100 µm).  (B) Bar graphs 
illustrating quantification of levels of NOS2 immunostained cells (n = 4 for each 
group) at the mid rostro-caudal level of the SCN, in the SCN ventrolateral core and 
in the dorsomedial shell of the SCN of control and post-septic animals at 24hrs post 
LPS treatment. (* P<0.05).  
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3.3.1.3.   LPS 5mg/kg treatment causes an increase in SCN IL-6 expression. 
24hrs post LPS 5mg/kg treatment, the expression of the proinflammatory 
cytokine interleukin-6 (IL-6) was seen to be altered in the SCN.  IOD measurements 
showed a significant difference in immunoreactive IL-6 expression in the SCN 
between control (1.47 + 0.28 IOD/SCN) and post-septic animals (3.58 + 0.52 
IOD/SCN, P<0.01; Figure 3.3) with the LPS treated animals showing significant 
upregulation of IL-6 immunoreactivity.  Upon SCN regional examination, this 
upregulation in expression was found to be statistically significant in the SCN core 
region of LPS treated animals (3.37 + 0.77 IOD/SCN) compared to saline controls 
(0.79 + 0.16 IOD/SCN, P<0.05, independent t-test), while expression in the SCN 
shell region was also seen to be statistically different between saline (1.74 + 0.35 
IOD/SCN) and LPS animals (3.79 + 0.61 IOD/SCN, P<0.05, independent t-test). 
 
 
 
 
 
 
 
 
Figure 3.3: IL-6 expression is altered in the SCN 24hrs following LPS treatment.  
(A) Representative photomicrographs of IL-6 expression in the SCN of animals 
treated 24hrs previously with LPS (scale bar = 100 µm).  (B) Bar graphs illustrating 
quantification of levels of IL-6 immunostained cells (n =5 for each group) at the mid 
rostro-caudal level of the SCN, in the SCN ventrolateral core and in the dorsomedial 
shell of the SCN of control and post-septic animals at 24hrs post LPS treatment (** 
P<0.01, * P<0.05) 
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3.3.2. Immediate Early Gene Expression 24hrs post LPS 5mg/kg treatment 
3.3.2.1.  The expression of ARC is not altered in the SCN 24hrs following LPS 
Comparison of ARC immunosignal in the SCN 24hrs post LPS 5mg/kg 
treatment by immunohistochemistry combined with manual quantification of 
immunoreactive nuclei and subsequent independent t-test analysis found levels of 
expression of ARC immunoreactive nuclei in the SCN of LPS treated animals (n=5) 
analogous to controls (n=5), with mean values of 0.82 + 0.67 and 0.57 + 0.19 ir. 
cells/SCN respectively (P>0.05; Figure 3.4).  Independent t-test analysis of levels of 
ARC immunoreactive cells revealed no difference in expression in the SCN 
subdivisions, with similar expression levels in the core (saline, 0.00 + 0.00 vs. LPS, 
0.10 + 0.10 ir. cells/SCN, P>0.05) and shell regions of the SCN (controls 0.50 + 0.17 
vs. LPS 0.72 + 0.57 ir. cells/SCN, P>0.05).  
 
 
 
Figure 3.4: ARC expression is not altered in the SCN 24hrs following LPS 
treatment.  (A) Representative photomicrographs of ARC staining in the 
hippocampus and SCN of animals treated 24hrs previously with LPS (scale bar = 
100 µm).  (B) Bar graphs illustrating quantification of levels of ARC immunostained 
cells (n = 5 for each group) in the SCN of the control and LPS treated groups at 
24hrs post LPS treatment. 
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3.3.2.2.  SCN EGR-1 immunoreactivity is increased acutely following LPS 5mg/kg 
treatment. 
Immunohistochemical analysis coupled with manual quantification of EGR-1 
expression in LPS treated animals (n=5) and vehicle treated controls (n=5) found 
EGR-1 expression to be significantly increased in the SCN of LPS treated animals 
(69.93 + 23.26, ir. nuclei/SCN) when compared to those treated with saline (2.27, + 
0.89 ir nuclei/SCN, P<0.05, independent t-test; Figure 3.5).  When analysing the 
separate subdivisions of the SCN by independent t-test, the mean number of 
immunoreactive EGR-1 cells in the ventrolateral core of the SCN was found to be 
significantly different between the treatment groups, with LPS treated animals 
displaying an upregulation of EGR-1, with a mean of 20.75 + 7.20 ir. cells/SCN and 
control animals displaying an mean of 0.40 + 0.17 ir. cells/SCN (P<0.05).  The 
difference in EGR-1 expression levels was also seen to be statistically significant in 
the dorsomedial shell portion of the SCN, with a significant increase in EGR-1 
expression levels in animals treated with LPS (49.18 + 16.08 ir. cells/SCN) 
compared to saline controls (1.91 + 0.83 ir. cells/SCN, P<0.05, independent t-test; 
Figure 3.5).  
Figure 3.5: The expression of the IEG EGR-1 is altered in the SCN 24hrs 
following LPS treatment.  (A) Representative photomicrographs of EGR-1 
immunoreactive cells in the SCN of animals treated 24hrs previously with LPS (scale 
bar = 100 mm).  (B) Bar graphs illustrating quantification of levels of EGR-1 
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immunoreactivity (n =5 for each group) in the SCN at the mid rostro-caudal level of 
the SCN, in the SCN ventrolateral core and in the dorsomedial shell of the SCN of 
control and post-septic animals 24hrs post LPS treatment. (*P<0.05). 
 
3.3.3. Microglial examination in the SCN 24hrs post-septic LPS treatment. 
3.3.3.1.  F4/80 is upregulated in the SCN 24hrs post LPS treatment 
Immunohistochemistry for the microglial marker F4/80 found there to be a 
significant increase in the expression of the microglial antigen throughout the brain 
(Figure 3.6) including the SCN in LPS treated animals (n=3) vs. saline controls 
(n=4).  Manual quantification of F4/80 immunoreactive cells in the SCN coupled 
with independent t-test analysis found a statistically significant difference in F4/80 
expression in the SCN between saline (7.13 + 1.14 IOD/SCN) and LPS treated 
animals (13.5 + 2.43 IOD/SCN; P<0.05).  IHC revealed this difference to be 
significantly significant at the level of the dorsomedial shell of LPS treated animals 
(10.56 + 1.79 IOD/SCN) and saline controls (5.38 + 0.97, P<0.05), while F4/80 
immunoreactivity was not found to be significantly different in the core region 
between control (1.75 + 0.43 IOD/SCN) and LPS treated animals (2.94 + 0.64 
IOD/SCN, P>0.05, independent t-test). 
 
 
 
 
 
 
 
 
Figure 3.6: 5mg/kg LPS treatment results in upregulation of the microglial 
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marker F4/80 in the SCN. (A) Representative photomicrographs of F4/80 
expression in the SCN and cortex of animals treated 24hrs previously with either 
saline or LPS (n = 3-4 for each group). Animals were sampled mid subjective day 
(ZT5-8) in a 12:12 L:D cycle.  Note the significant upregulation of F4/80 in the SCN 
and cortex of LPS treated animals, and also the activated, de-ramified morphology 
of the cells (scale bar = 100 µm). (B) Quantification of levels of immunoreactivity 
for F4/80 (n = 3-4 for both groups) at the mid rostro-caudal level of the SCN, in the 
SCN ventrolateral core and in the dorsomedial shell of the SCN of control and post-
septic animals 24hrs post LPS treatment. * P<0.05.  
 
3.3.4. Assessment of apoptosis 24hrs following induction of sepsis 
3.3.4.1.  Cleaved Caspase-3 expression in the acute phase following LPS treatment. 
Cleaved Caspase-3 expression was examined in the SCN 24hrs following LPS 
5mg/kg treatment (n=5) or saline (n=5).  In the SCN, IOD measurements of cleaved 
caspase-3 immunoreactive signal and subsequent analysis by independent t-test 
found levels to be similar between saline controls (0.76 + 0.26 IOD/SCN) and LPS 
animals (1.73 + 0.65 IOD/SCN, P>0.05; Figure 3.7).  IHC revealed no significant 
differences in cleaved caspase-3 expression in either the core (saline, 0.38 + 0.10 vs. 
LPS, 1.65 + 0.68 IOD/SCN, P>0.05, independent t-test), or in the shell portion of the 
SCN (saline 0.89 + 0.31 vs. LPS, 1.72 + 0.61 IOD/SCN, P>0.05, independent t-test) 
between treatment groups. 
3.3.4.2.  TUNEL analysis in the acute phase following LPS treatment. 
Following TUNEL analysis, manual quantification of TUNEL positive cells in 
the SCN of LPS treated animals (n=4) and vehicle treated controls (n=4) coupled 
with independent t-test analysis found no significant difference in TUNEL positive 
cells in the SCN of LPS treated animals (0.13 + 0.13, TUNEL+cells/SCN) when 
compared to those treated with saline (0.00 + 0.00 TUNEL+cells/SCN, P<0.05; 
Figure 3.7), and furthermore, examination of the separate subdivisions of the SCN 
found no difference in TUNEL + cells in either the ventrolateral core or dorsomedial 
shell regions of the SCN (P>0.05, independent t-test) between the treatment groups. 
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Figure 3.7: Examination of apoptotic markers 24hrs post LPS treatment. Animals 
were treated with either saline or LPS and sampled 24 hours later. There were no 
increases in the markers for apoptosis TUNEL and cleaved caspase-3 (A; n = 4–5 
for the saline and acute LPS groups). (A) Bar graphs illustrating quantification of 
levels of TUNEL and cleaved caspase-3 immunoreactivity in the SCN of control and 
post-septic animals 24hrs post LPS treatment, with no significant differences in 
expression of either apoptotic marker in the SCN in LPS treated animals vs. 
controls. 
3.3.5. Examination of glial markers in the SCN 3mths post  LPS treatment 
It‘s possible that immune mediators may be present in the SCN in the long 
term following sepsis induction, therefore the presence of various immune factors 
was investigated for three months following LPS 5mg/kg treatment.   
Three months following the initial peripheral immune challenge with a septic 
dose of LPS, the presence of chronic neuroinflammation throughout the brain and in 
the SCN was examined through Immunohistochemical analysis for the microglial 
antigens IBA-1, F4/80 and CD-11b and the astroglial marker GFAP.    
3.3.5.1.  GFAP expression  in the post-septic SCN 
Immunostaining combined with IOD followed by independent t-test analysis 
of GFAP immunoreactivity in the SCN (Saline 5, LPS 5) revealed immunosignal for 
the astroglial marker GFAP in the SCN to be similar between saline (0.88+ 0.21 
IOD/SCN) and post-septic animals (2.38+ 0.77 IOD/SCN, P>0.05; Figure 3.8).  In 
the SCN subdivisions, there were no statistically significant differences found in 
GFAP expression in the SCN core region (control, 0.74 + 0.19 vs. LPS, 1.38 + 0.42 
123 
 
IOD/SCN, P>0.05, independent t-test) or in the shell region (saline, 1.00 + 0.22 vs. 
LPS, 2.88 + 0.91 IOD/SCN, P>0.05, independent t-test) between groups.  
 
Figure 3.8: GFAP expression is not altered in the SCN 3mths following LPS 
treatment.  (a) Representative photomicrographs of GFAP staining in the cortex and 
SCN of animals treated 3mths previously with LPS (scale bar = 100 µm).  (B) Bar 
graphs illustrating quantification of levels of GFAP immunostained cells (n = 5 for 
each group) in the SCN of the control and LPS treated groups at 3mths post LPS 
treatment. 
3.3.5.2. Long-lasting alterations in CD-11b expression in the SCN. 
Immunohistochemical analysis combined with manual quantification of cells 
expressing the microglial marker CD-11b in the SCN of post-septic animals (n=5) 
and vehicle treated controls (n=3) followed by independent t-test analysis found 
there to be a highly significant increase in expression of activated CD-11b in the 
SCN of LPS treated animals (29.8 + 2.35, ir. cells/SCN) when compared to those 
treated with saline (6.77, + 1.49  ir cells/SCN, P<0.001; Figure 3.9).  Further 
examination of the separate subdivisions of the SCN by IHC, manual quantification 
and independent t-test of the mean number of immunoreactive CD-11b cells found 
the expression to be significantly different between the treatment groups at the level 
of the ventrolateral core of the SCN, with LPS treated animals displaying an 
upregulation of the microglial marker, with a mean of 10.55 + 0.44 ir. cells/SCN and 
control animals displaying an mean of 2.31 + 0.67 ir. cells/SCN (P<0.001; Figure 
3.9).  The difference in CD-11b immunoreactivity was also seen to be statistically 
significant at the levels of the dorsomedial shell of the SCN, with a significant 
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increase in expression levels in animals treated with LPS (17.8 + 2.29 ir.cells/SCN) 
compared to saline controls (4.47 + 0.83 ir.cells/SCN, P<0.01, independent t-test; 
Figure 3.9). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9:  Previous sepsis results in a long-lasting upregulation of the microglial 
marker CD-11b in the SCN. (A) Representative photomicrographs of CD-11b 
expression in the SCN of animals treated 3 months previously with either saline or 
LPS. Animals were sampled mid subjective day (ZT5-8) in a 12:12 L:D cycle. Note 
the significant upregulation of CD-11b in the SCN, and also the resting, ramified 
morphology of the cells in the post-septic SCN (scale bar = 100 µm).  These are 
shown in higher magnification in (B) in SCNs from LPS treated animals (scale bar 
approx. 50 µm).  (C) Quantification of levels of immunoreactivity for CD-11b (n =3-
5 for both groups) at the mid rostro-caudal level of the SCN, in the SCN 
ventrolateral core and in the dorsomedial shell of the SCN of control and post-septic 
animals at 3mths post LPS treatment. ** P<0.01; *** P<0.001. 
 
3.3.5.3. F4/80 expression is chronically altered in the SCN following a septic LPS 
treatment. 
Immunohistochemistry for the microglial marker F4/80 and comparison of 
F4/80 immunoreactive cells in the SCN found there to be a statistically significant 
increase in expression of the antigen in the SCN of post-septic animals (n=3) vs. 
controls (n=4).  Independent t-test showed a highly significant increase in the levels 
of F4/80 immunoreactivity in the SCN of post-septic animals (28.8 + 3.49 
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ir.cells/SCN) compared to control animals (8.3 + 1.57 ir.cells/SCN, P<0.01; Figure 
3.10).  IHC and subsequent analysis by independent t-test revealed significant 
upregulation in expression of the microglial marker in the core of LPS treated 
animals (11.5 + 1.5 ir.cells/SCN) vs. controls (2.6 + 0.82 ir.cells/SCN, P<0.01; 
Figure 3.10).  This difference in F4/80 immunoreactivity was also found to be 
significantly different in the dorsomedial shell region with significant alterations in 
expression between control (5.8 + 0.78 ir.cells/SCN) and post-septic animals (17.3 + 
2.73 ir.cells/SCN, P<0.01, independent t-test; Figure 3.10). 
 
 
 
 
 
 
 
Figure 3.10: Previous sepsis results in a long-lasting upregulation of the 
microglial marker F4/80 in the SCN. (A) Representative photomicrographs of 
F4/80 expression in the SCN of animals treated 3 months previously with either 
saline or LPS. Animals were sampled mid subjective day (ZT5-8) in a 12:12 L:D 
cycle. Note the significant upregulation of F4/80 in the SCN, and also the resting, 
ramified morphology of the cells in the post-septic SCN (scale bar = 100 µm).  These 
are shown in higher magnification in (B) in SCNs from LPS treated animals (scale 
bar approx. 50 µm).  (C) Quantification of levels of immunoreactivity for F4/80 (n 
=3-4 for both groups) at the mid rostro-caudal level of the SCN, in the SCN 
ventrolateral core and in the dorsomedial shell of the SCN of control and post-septic 
animals at 3mths post LPS treatment. ** P<0.01. 
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3.3.5.4. IBA-1 immunoreactivity in the post-septic SCN. 
Comparison of IBA-1 expression 3 months post-treatment (Saline 3, LPS 4) by 
immunostaining combined with manual quantification of IBA-1 immunoreactive 
cells and subsequent analysis by independent t-test revealed immunostaining for the 
microglial marker IBA-1 in the SCN to be similar between saline (4.78 + 2.63 
ir.cells/SCN) and post-septic animals (8.52 + 1.60 ir.cells/SCN, P>0.05).  
Examination of the SCN ventrolateral core, found there to be a statistically 
significant difference in microglial immunoreactivity in post-septic animals, with 
significantly higher mean values of 1.81 + 0.28 ir. cells/SCN in post-septic animals  
compared to controls 0.39 + 0.20 ir.cells/SCN (P<0.01, independent t-test).  There 
was no significant difference in IBA-1 immunosignal seen between groups in the 
SCN shell region (saline, 4.39 + 2.56 ir.cells/SCN vs. LPS, 6.71 + 1.76 ir.cells/SCN, 
P>0.05, independent t-test).   
Further assessment of the morphology of IBA-1 immunostained cells 3mths 
post-treatment in the SCN under high power followed by manual quantification 
found there to be a significant increase in the expression of hypertrophic glia in the 
SCN in post-septic animals (2.21 + 0.31 ir.cells/SCN) vs. vehicle treated controls 
(0.44 + 0.22 ir.cells/SCN; P<0.01, independent t-test; Figure 3.11).  Examination of 
the separate subdivisions of the SCN by independent t-test revealed this statistically 
significant difference not to be different in the different subregions between the 
groups, but to be statistically different in the SCN as a whole when taking the core 
and shell values together.   The mean number of IBA-1 immunoreactive 
hypertrophic microglia in the ventrolateral core of the SCN was found to be similar 
between the treatment groups, with LPS treated animals displaying an upregulation 
of activated microglia, with a mean of 0.38 + 0.16 ir. cells/SCN and control animals 
displaying a mean of 0.00 + 0.00 ir. cells/SCN (P>0.05; Figure 3.11).  While the 
difference in hypertrophic microglia was seen to approach significance in the 
dorsomedial shell of the SCN between groups, it was not seen to be statistically 
significant, with expression levels in post-septic animals of 1.65 + 0.45 ir.cells/SCN 
and saline controls 0.33 + 0.19 ir.cells/SCN  (P>0.05, independent t-test; Figure 
3.11). 
 
127 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11: Previous sepsis results in a long-lasting upregulation of IBA-1 
immunostained cells in the SCN. (A) Representative photomicrographs of IBA-1 
expression in the SCN of animals treated 3 months previously with either saline or 
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LPS (scale bar approx. 100 µm).  Animals were sampled mid subjective day (ZT5-8) 
in a 12:12 L:D cycle.  These IBA-1 immunostained microglia are shown in higher 
magnification in (B) in SCNs from LPS treated animals (scale bar approx. 50 µm).  
(C) Pictomicrographs of densely stained, activated microglia in the post-septic SCN 
(scale bar approx. 50 µm).  Note the very dense IBA-1 immunostained spherical cells 
without processes in the SCN of LPS treated animals, which were not evident in the 
SCN of the saline treated animals.  (D) Bar graphs illustrating quantification of 
levels of very dense IBA-1 microglial immunoreactive cells (n =3-4 for both groups) 
at the mid rostro-caudal level of the SCN, in the SCN ventrolateral core and in the 
dorsomedial shell of the SCN of control and post-septic animals. ** P<0.01.  
 
3.3.5.5. Examination of IBA-1 immunoreactivity in the SCN 3mths post-treatment 
following administration of PDTC prior to LPS treatment. 
Comparison of IBA-1 expression by immunostaining combined with manual 
quantification of IBA-1 immunoreactive cells and subsequent analysis by One Way 
ANOVA revealed immunostaining for the microglial marker IBA-1 in the SCN to be 
similar between groups (F2,24=3.07, P>0.05).  However, further assessment of the 
morphology of IBA-1 immunostained cells 3mths post-treatment in the SCN under 
high power followed by manual quantification coupled with  One Way ANOVA 
with the Tukey post-hoc test assessed statistically significant differences between 
groups in IBA-1 immunoreactive hypertrophic cells, and found a significant between 
groups effect (F2,24=6.05, P<0.01).  One Way ANOVA assessed statistically 
significant differences between groups in IBA-1 immunoreactive hypertrophic cells 
in the core and shell of the SCN, and found a significant between groups effect in the 
dorsomedial shell region of the SCN (F2,24=6.2, P<0.01), but not in the ventrolateral 
core (F2,24=0.82, P>0.05).  Post Hoc analysis (Tukey) revealed that the expression 
levels of IBA-1 immunoreactive hypertrophic glia of 0.68 + 0.17 ir. cells/SCN for 
control and LPS treated animals differed significantly to the levels of IBA-1 
immunoreactive hypertrophic glia seen for PDTC and LPS treated animals 0.14 + 
0.05 ir. cells/SCN (P<0.01).  Comparison of the IBA-1 hypertrophic glia 
immunoreactivity between control and LPS treated animals and those treated with 
200mg/kg PDTC prior to a control i.p. injection which displayed an average 
expression of hypertrophic glia of 0.27 + 0.08 ir. cells/SCN, revealed no significant 
differences between the groups (P>0.05). Further, IBA-1 immunoreactive 
hypertrophic glia expression levels were not found to be statistically different 
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between PDTC and LPS treated animals and PDTC and control treated animals 
(P>0.05). (Fig. 3.12).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12:  PDTC administration prior to LPS 5mg/kg decreases the long-
lasting upregulation of IBA-1 immunostained cells in the SCN. (A) Representative 
photomicrographs of IBA-1 expression in the SCN of animals treated 3 months 
previously with either PDTC + control, control + LPS or PDTC + LPS (scale bar = 
100 µm).  Animals were sampled mid subjective day (ZT5-8) in a 12:12 L:D cycle.  
These IBA-1 immunostained microglia are shown in higher magnification in (B) in 
SCNs from each treatment group (scale bar approx. 50 µm).  Note the very dense 
IBA-1 immunostained spherical cells without processes in the SCN of control + LPS 
treated animals which are not evident in the SCN of the PDTC + LPS treated 
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animals.  (C) Bar graph illustrating quantification of levels of very dense IBA-1 
microglial immunoreactive cells (n = 7-10 for each group) in the SCN.  ** P<0.01. 
 
3.3.6. Examination of immune factors in the post-septic SCN 
3.3.6.1.  TNF-α expression in the post-septic SCN. 
Three months following the initial treatment, Integrated Optical Density (OD) 
measurements and independent t-test analysis assessed the expression of TNF-α in 
the SCN (Saline 7, LPS 6), finding no significant difference in TNF-α expression in 
the SCN between saline controls (4.76 + 1.55 IOD/SCN) and post-septic animals 
(2.62 + 1.11 IOD/SCN, P>0.05; Figure 3.13), with no alterations in expression seen 
in the separate SCN subdivisions, with similar immunoreactivity levels between 
groups in the ventrolateral core SCN region (control, 3.99 + 1.47 IOD/SCN vs. post-
septic animals, 2.17 + 0.97 IOD/SCN, P>0.05) and the dorsomedial shell region 
(controls, 5.29 + 1.70 IOD/SCN vs. LPS, 2.92 + 1.22 IOD/SCN, P>0.05, 
independent t-test). 
 
 
 
 
 
 
 
Figure 3.13: TNF-α expression is not altered in the SCN 3mths following LPS 
treatment.  (a) Representative photomicrographs of TNF-α expression in the SCN of 
animals treated 3mths previously with LPS (scale bar approx. 100 µm).  (B) Bar 
graphs illustrating quantification of levels of TNF-α immunostained cells (n =6-7 for 
each group) in the SCN of the control and LPS treated groups at 3mths post LPS 
treatment. 
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3.3.6.2.   NOS2 expression in the post-septic SCN. 
Immunohistochemistry coupled with IOD measurements of NOS2 expression 
in the SCN of control (n=7) and post-septic animals (n=7) and subsequent analysis 
by independent t-test found similar levels of NOS2 immunosignal in the SCN of 
post-septic animals (3.07 + 0.61 IOD/SCN) and saline controls (3.91 + 0.69 
IOD/SCN, P>0.05; Figure 3.14).  Furthermore, there were no significant differences 
in NOS2 expression in the core SCN region of saline animals (2.98 + 0.64 
IOD/SCN) vs. LPS (2.86 + 0.90, P>0.05), or in the dorsomedial shell SCN subregion 
between post-septic animals (3.40 + 0.72 IOD/SCN) and controls (4.36 + 0.83 
IOD/SCN, P>0.05, independent t-test). 
 
Figure 3.14: NOS2 expression is not altered in the SCN 3mths following LPS 
treatment.  (a) Representative photomicrographs of NOS2 expression in the SCN of 
animals treated 3mths previously with LPS (scale bar approx. 100 µm).  (B) Bar 
graphs illustrating quantification of levels of NOS2 immunostained cells (n = 7 for 
each group) in the SCN of the control and LPS treated groups at 3mths post LPS 
treatment. 
3.3.6.3.   IL-1β expression in the post-septic SCN. 
IHC coupled with IOD measurements assessed the immunoreactivity of IL-
1β in the SCN 3mths following treatment with either saline (n=4) or LPS (n=4), 
finding no statistically significant difference in IL-1β expression in the SCN between 
control (3.06 + 1.21 IOD/SCN) and post-septic animals (4.65 + 0.33 IOD/SCN, 
P>0.05, independent t-test; Figure 3.15).  IOD followed by independent t-test 
analysis found no significant differences in the expression of the antigen in the 
dorsomedial shell SCN region of LPS treated animals (5.65 + 0.32 IOD/SCN) vs. 
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controls (3.15 + 1.39 IOD/SCN, P>0.05), nor were there any statistically significant 
differences in IL-1β expression in the ventrolateral core subdivision between post-
septic animals (2.75 + 0.29 IOD/SCN) and controls (2.62 + 0.48 IOD/SCN, P>0.05).  
 
 
 
Figure 3.15: IL-1β expression is not altered in the SCN 3mths following LPS 
treatment.  (a) Representative photomicrographs of IL-1β expression in the SCN of 
animals treated 3mths previously with LPS (scale bar = 100 µm).  (B) Bar graphs 
illustrating quantification of levels of IL-1β immunostained cells (n = 4 for each 
group) in the SCN of the control and LPS treated groups at 3mths post LPS 
treatment. 
 
3.3.6.4.   IL-6 expression in the post-septic SCN. 
Immunohistochemistry followed by IOD measurements and independent t-test 
analysis examined for statistically significant differences in IL-6 expression 3mths 
post-treatment in the SCN (Saline 5, LPS 5), finding no significant differences in 
expression between post-septic animals (1.60 + 1.13 IOD/SCN) and controls (3.05 + 
1.48 IOD/SCN, P>0.05; Figure 3.16).  Additional assessment of IL-6 immunosignal 
in the SCN regional subdivisions found no significant differences in expression in 
the core of LPS animals (0.71 + 0.59 IOD/SCN) when compared to controls (1.81 + 
0.96 IOD/SCN, P>0.05, independent t-test).  Furthermore, no alterations were seen 
in IL-6 expression between LPS and saline treated animals in the dorsomedial shell, 
with mean immunoreactivity levels of 1.92 + 1.37 IOD/SCN and 3.74 + 1.79 
IOD/SCN respectively (P>0.05, independent t-test). 
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Figure 3.16: IL-6 expression is not altered in the SCN 3mths following LPS 
treatment.  (a) Representative photomicrographs of IL-6 expression in the SCN of 
animals treated 3mths previously with LPS (scale bar = 100 µm).  (B) Bar graphs 
illustrating quantification of levels of IL-6 immunostained cells (n = 5 for each 
group) in the SCN of the control and LPS treated groups at 3mths post LPS 
treatment. 
 
3.3.7. Examination of components of the NF-κB pathway in the SCN 3mths 
following LPS treatment 
3.3.7.1.  Phosphorylated (p)-IκK expression in the post-septic SCN. 
Three months following the initial immune challenge, IHC followed by 
Integrated Optical Density measurements and independent t-test analysis assessed 
the expression of p-IκK in the SCN (Saline 5, LPS 5), finding no statistically 
significant alterations in the p-IκK immunosignal throughout the SCN as a whole 
between post-septic (6.04 + 1.97 IOD/SCN) and saline animals (11.18 + 2.47 
IOD/SCN, P>0.05; Figure 3.20).   
 
 
 
 
 
Figure 3.20:  p-IκK expression is not upregulated in the SCN 3mths following LPS 
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treatment.  (a) Representative photomicrographs of p-IκK expression in the SCN of 
animals treated 3mths previously with LPS (scale bar = 100 µm).  (B) Bar graphs 
illustrating quantification of levels of p-IκK immunostained cells (n = 5 for each 
group) in the SCN of the control and LPS treated groups at 3mths post LPS 
treatment. 
 
3.3.7.2.   p-IκB expression in the post-septic SCN. 
Similarly, 3mths post LPS treatment, immunostaining and Integrated Optical 
Density measurements followed by independent t-test analysis for p-IκB 
immunoreactivity in the SCN (Saline 5, LPS 5) found no significant differences in p-
IκB expression in the SCN sections overall between post-septic animals (6.45 + 1.13 
IOD/SCN) and saline animals (7.25 + 0.97 IOD/SCN, P>0.05, independent t-test; 
Figure 3.21).   
 
 
 
 
 
 
 
 
Figure 3.21: p-IκB expression is not altered in the SCN 3mths following LPS 
treatment.  (a) Representative photomicrographs of p-IκB expression in the SCN of 
animals treated 3mths previously with LPS (scale bar = 100 µm).  (B) Bar graphs 
illustrating quantification of levels of p-IκB immunostained cells (n = 5 for each 
group) in the SCN of the control and LPS treated groups at 3mths post LPS 
treatment. 
 
3.3.7.3.  p65 NF-κB expression in the post-septic SCN. 
Immunostaining combined with IOD and subsequent assessment by 
independent t-test of p65 NF-κB immunoreactivity in the SCN three months 
following initial treatment (Saline 4, LPS 4)  revealed the p65 NF-κB immunosignal 
to be similar in the SCN of saline controls (1.48 + 0.39 IOD/SCN) and post-septic 
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animals (1.13 + 0.46 IOD/SCN, P>0.05; Figure 3.22).  Analysis of the different SCN 
subdivisions found there to be no difference in p65 NF-κB immunoreactivity in the 
ventrolateral core region (control, 1.32 + 0.28 IOD/SCN vs. LPS, 1.11 + 0.54 
IOD/SCN, P>0.05, independent t-test) or in the dorsomedial shell region (saline, 
1.51 + 0.42 IOD/SCN vs. LPS, 1.19 + 0.51 IOD/SCN, P>0.05, independent t-test) 
between groups. 
 
 
 
 
 
 
 
 
 
Figure 3.22: p65 NF-κB expression is not altered in the SCN 3mths post LPS.    
(a) Representative photomicrographs of p65 NF-κB expression in the SCN of 
animals treated 3mths previously with LPS (scale bar = 100 µm).  (B) Bar graphs 
illustrating quantification of levels of p65 NF-κB immunostained cells (n = 4 for 
each group) in the SCN of the control and LPS treated groups at 3mths post LPS 
treatment. 
 
3.3.8. The long-lasting effects of sepsis induction on SCN neuropeptide 
expression 
The effects of chronic neuroinflammation on the circadian patterns of 
expression of the neuropeptides arginine vasopressin and vasoactive intestinal 
polypeptide were investigated.  These are recognised as playing vital roles in SCN 
function.  Perturbation of their expression by neuroinflammation could have 
significant consequences for circadian processes.   
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3.3.8.1.  VIP expression in the post-septic SCN. 
Immunostaining for VIP (Saline 6, LPS 6) combined with manual 
quantification of immunoreactive nuclei and subsequent analysis by independent t-
test revealed VIP expression levels to be similar in the SCN between saline (67.33 + 
11.31 ir.cells/SCN) and post-septic animals (48.16 + 12.63 ir.cells/SCN, P>0.05; 
Figure 3.23). Further examination of the levels of VIP ir. nuclei in the independent 
SCN subregions followed by independent t-test analysis revealed no difference in 
expression in the SCN subdivisions, with similar expression levels in the core 
(saline, 60.16 + 21.33 vs. LPS, 47.19 + 14.01 ir.cells/SCN, P>0.05) and shell regions 
of the SCN (controls, 55.97 + 8.42 vs. LPS, 47.89 + 12.02, P>0.05). 
3.3.8.2.  The expression of AVP in the post-septic SCN. 
Comparison of AVP immunosignal in the SCN 3 months post LPS 5mg/kg 
treatment (n=6) or vehicle (n=5) by immunohistochemistry combined with integrated 
optical density measurements of ir. nuclei found levels of expression of AVP 
immunoreactive nuclei in the SCN of post-septic animals analogous to controls, with 
mean values of 30.23 + 12.05 and 32.37 + 12.59 ir. cells/SCN respectively (P>0.05, 
independent t-test; Figure 3.23).  Independent t-test analysis of mean expression 
values of AVP immunostained sections revealed no difference in expression in the 
SCN subdivisions, with similar expression levels in the core (saline, 12.65 + 5.38 
ir.cells/SCN vs. LPS, 8.43 + 2.97 ir.cells/SCN, P>0.05) and shell regions of the SCN 
(controls 41.94 + 16.56 ir.cells/SCN vs. LPS 37.72 + 13.23 ir.cells/SCN, P>0.05). 
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Figure 3.23: SCN neuropeptide expression in the post-septic SCN.  (A) 
Representative photomicrographs of AVP expression in the SCN of animals treated 3 
months previously with either saline or LPS (scale bar = 100 µm) and bar graph 
illustrating quantification of levels of AVP immunostained cells (n = 5-6  for each 
group) in the SCN of the control and LPS treated groups, with no significant 
differences in the expression of AVP in the SCN between the treatment groups. (B) 
Representative photomicrographs of VIP 3 months following LPS or saline treatment 
(scale bar = 100 µm) and bar graph illustrating quantification of levels of VIP 
immunostained cells (n = 6 for each group) in the SCN of the control and LPS 
treated groups. 
 
3.3.9. Immediate Early Gene expression in the post-septic SCN. 
3.3.9.1.  ARC expression in the SCN 3mths post sepsis. 
Assessment of spontaneous expression of ARC in the SCN 3mths post LPS 
5mg/kg (n=5) or saline treatment (n=4) by immunohistochemistry combined with 
manual quantification of ir. nuclei found there to be no alterations in the levels of 
expression of ARC immunoreactive nuclei in the SCN of LPS compared to controls, 
with mean values of 2.98 + 2.18 and 2.33 + 0.70 ir. cells/SCN respectively (P>0.05, 
independent t-test; Figure 3.24).  Independent t-test analysis of measurements of 
ARC immunostained sections revealed no difference in expression in the SCN 
subdivisions, with similar expression levels in the core (saline, 0.79 + 0.43 
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ir.cells/SCN vs. LPS, 1.05 + 0.76 ir.cells/SCN, P>0.05) and shell regions of the SCN 
(controls, 1.54 + 0.66 ir.cells/SCN vs. LPS, 1.80 + 1.44 ir.cells/SCN, P>0.05). 
 
 
Figure 3.24: ARC expression is not altered in the SCN 3mths following LPS 
treatment.  (a) Representative photomicrographs of ARC staining in the cortex and 
SCN of animals treated 3mths previously with LPS (scale bar = 100 µm).  (B) Bar 
graphs illustrating quantification of levels of ARC immunostained cells (n = 4-5 for 
each group) in the SCN of the control and LPS treated groups at 3mths post LPS 
treatment. 
 
3.3.9.2.   EGR-1 expression in the SCN 3mths post sepsis. 
Comparison of spontaneously expressed EGR-1 in the SCN 3mths post LPS 
5mg/kg (n=4) or vehicle (n=4) treatment by immunohistochemistry combined with 
manual quantification of ir. cells and independent t-test analysis found levels of 
expression of EGR-1 ir. nuclei in the SCN of post-septic animals analogous to 
controls, with mean values of 0.54 + 0.21 and 1.17 + 0.73 ir. cells/SCN respectively 
(P>0.05; Figure 3.25).  Independent t-test analysis of measurements of EGR-1 
immunostained sections revealed no difference in expression in the SCN 
subdivisions, with similar expression levels in the core (saline, 0.25 + 0.25 vs. LPS, 
0.21 + 0.13 ir.cells/SCN, P>0.05) and shell regions of the SCN (controls, 0.92 + 0.53 
vs. LPS, 0.33 + 0.19 ir.cells/SCN, P>0.05). 
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Figure 3.25: EGR-1 expression is not altered in the SCN 3mths following LPS 
treatment.  (a) Representative photomicrographs of EGR-1 expression in the cortex 
and SCN of animals treated 3mths previously with LPS (scale bar = 100 µm).  (B) 
Bar graphs illustrating quantification of levels of EGR-1 immunostained cells (n = 4 
for each group) in the SCN of the control and LPS treated groups at 3mths post LPS 
treatment. 
 
3.4.  Discussion:  
The examination of SCN neurochemistry in the acute and chronic phase 
following LPS treatment in the current set of experiments show that the SCN is 
acutely responsive following LPS  treatment, showing an increase in the expression 
of inflammatory mediators, as well as displaying a long-lasting upregulation of 
microglial markers in the post-septic SCN.   
3.4.1. Examination of SCN Neurochemistry 24hrs post LPS treatment. 
These studies assessing changes in the SCN 24hrs following LPS treatment, 
show that the SCN responds in the acute phase to a substantial peripheral immune 
challenge. The current study reveals that LPS treatment induces a significant 
upregulation of immunoreactive EGR-1 in the SCN of LPS treated animals in 
comparison to controls 24hrs following treatment, highlighting the effect of the 
peripheral immune challenge on the SCN.  Various different studies have shown that 
acute LPS treatment can alter circadian/SCN function, and the SCN has been shown 
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to respond to LPS treatment (Beynon and Coogan, 2010; Nava et al., 2000; 
Marpegan et al., 2005). The SCN expresses cytokine receptors and regulatory 
molecules (Lundkvist et. al., 1999; Sadki et. al., 2007) and in this way, inflammatory 
mediators induced by peripheral LPS may impact upon the SCN causing functional 
changes and alterations in clock gene expression following LPS administration.  
Peripheral administration of low dose LPS in the early subjective night can result in 
phase shifts, along with an increase in c-Fos expression in the SCN (Marpegan et al., 
2005), and these LPS-induced effects appear to be dependent on TLR4 signalling 
(Paladino et al., 2010). AVP production is altered following direct treatment of SCN 
slice cultures with LPS, indicating that the SCN may express TLR4 and be capable 
of responding directly to LPS (Nava et al., 2000).   Further, peripheral septic LPS 
treatment has been shown to induce a substantial increase in the expression of the 
IEG c-Fos in the SCN acutely, as well as activation of the p65 subunit of the NF-κB 
pathway (Beynon and Coogan, 2010).  We also examined the effector IEG ARC in 
the SCN, since long-lasting neuroinflammation induced by chronic i.c.v. infusion of 
LPS has previously been associated with an upregulation of ARC in the dentate 
gyrus (Rosi et al., 2005), however, we observed no evidence of ARC upregulation in 
the SCN either in the acute phase following LPS treatment or 3 months post sepsis 
induction.  
It does not appear that the dose of LPS used in this study is inducing cell loss 
in the SCN, since no changes were observed in apoptotic markers, as assessed by 
TUNEL analysis or cleaved caspase-3 immunostaining 24 hours following LPS 
treatment.  It must be noted that we assessed the SCN alone for apoptosis, and that 
there may be alterations in other brain regions in TUNEL positive cells and cleaved 
caspase-3 immunoreactivity and this would require further investigation.  
Additionally, it is important to note that neither TUNEL anlaysis nor 
immunohistochemical analysis for cleaved caspase-3 expression would detect cell 
loss in the SCN as a result of necrosis and since we have not assessed neuronal 
numbers in the SCN in this study, this remains a possible consequence of septic LPS 
treatment. 
Studies assessing cell loss in the brain following LPS treatment have 
highlighted that apoptosis and neuronal loss following sepsis induction via endotoxin 
treatment is dose dependent, and further, appears to be region specific.  Following 
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10mg/kg LPS treatment in rats, TUNEL analysis revealed a significant increase in 
apoptotic cells in the brain 24hrs post-treatment in the hippocampus, cerebellum, 
midbrain and cortex (Semmler et al., 2005).  At 4hrs or 14days following repeated 
treatment with LPS (20µg/100µl), there was no observation of TUNEL-positive 
neurons in the thalamus, cortex or hippocampus (Terrazzino et al. 2002).  Further, 
treatment of mice with the same endotoxin dose as used here and subsequent 
assessment of neuronal loss in the cerebral cortex or in the hippocampus 8 weeks 
following sepsis induction, observed no evidence of cell loss at this chronic 
timepoint (Weberpals et al., 2009).  Other experimental work utilizing LPS 5mg/kg 
peripheral treatment has shown that neurodegeneration is only seen to occur in the 
CNS 7 months after LPS challenge, and that this loss appeared to be of the 
dopaminergic neurons in the substantia nigra alone (Qin et al., 2007).   
In line with the finding that there was no significant cell loss in the SCN 
24hrs post LPS treatment, assessment of SCN neuropeptides three months following 
the immune challenge did not find any changes in the expression of AVP or VIP in 
the long term in the post-septic SCN. Alterations in the expression of neuropeptides 
that play roles in input to (VIP) and output from (AVP) the SCN or communication 
between the SCN subdivisions could result in a decrease in the amplitude of the 
central pacemaker and could underlie post-septic circadian behavioural changes.  
Levels of SCN neuropeptide have previously been shown to be diminished in the 
SCN in ageing (Hofman et al., 2006), and therefore in relation to neuropeptide 
expression at this time, the post-septic SCN differs from that of the aged SCN.  
Other studies however, have shown the neurotransmitter AVP to be increased in the 
SCN following in vitro treatment of SCN slices with LPS (Nava et al., 2000).  We 
observe neither an increase nor a decrease in the post-septic SCN in neuropeptide 
expression and so the alterations exhibited in post-septic circadian behaviour cannot 
be attributed to this. 
These studies reveal a significant upregulation of F4/80 expressing cells in 
the SCN 24hrs post LPS treatment showing a de-ramified, activated microglial 
morphology.  These results are in line with findings from other studies where 
microglial activation and cytokine release in the CNS have previously been shown in 
response to LPS induced sepsis (Godbout et al., 2005; Van Dam et al., 1992).  
Further, in the acute phase following LPS treatment, significant upregulation of 
microglia and astrocytes have been shown to be evident in the cortex 8hrs following 
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treatment (Jacob et al., 2007), while others have also observed a significant 
upregulation of activated microglia following LPS treatment, along with an 
upregulation of NOS2 24hrs post-treatment in the striatum, cerebellum, 
hippocampus and midbrain, as well as a significant increase in GFAP positive 
astrocytes in the cortex, striatum and hippocampus (Semmler et al., 2005).  We have 
not assessed astrocytic activation in the acute phase in the SCN post LPS treatment 
and therefore further work would be required to assess whether reactive astrogliosis 
takes place in the SCN at this time.  The activation of microglia in the acute phase 
may exert effects on the SCN, since activated microglia are known to release a 
variety of neuroinflammatory mediators.  Microglia and astrocytes are known to 
synthesize complement proteins, and activation of the complement cascade has been 
shown to play roles in the brain following LPS treatment, leading to upregulation of 
CD45, TNF-α and TLR4, as well as an upregulation in activated microglia and 
NOS2 (Jacob et al., 2007).  Similarly, we find that LPS acutely alters NOS2 
expression in the SCN of LPS treated animals, with a significant upregulation of 
NOS2 in the SCN 24hours following peripheral LPS treatment.  NOS2 is the 
inducible isoform of nitric oxide synthase and is a source of nitric oxide during 
inflammatory processes and appears to play an important role in the pathogenesis of 
sepsis.  Similar to the significant upregulation of NOS2 in the SCN observed here 
24hours following a septic LPS treatment, NOS2 is shown to be up-regulated 
following the induction of sepsis by other groups (Polito et al., 2011).  Additionally, 
in mice lacking NOS2, septic shock and organ failure have been shown to be 
attenuated (Wei et al., 1995), highlighting the important role that NOS2 plays in 
sepsis.   
Nitric oxide has been shown to be involved in the long-lasting activation of 
the innate immune system following a peripheral immune insult (Weberpals et al., 
2009) and appears to play important roles in the development of neuroinflammation 
and cognitive alterations induced by peripheral inflammation. An increase in nitric 
oxide production has been associated with the activation of microglia (Zielasek and 
Hartung, 1996).  Indeed, we observe both an upregulation of NOS2 and microglial 
activation in the SCN 24hrs post-treatment. However, the upregulation of NOS2 
observed in the SCN in the acute phase following septic LPS treatment in these 
studies is seen to have returned to control levels 3mths after the peripheral immune 
challenge, while an upregulation in microglial markers remains evident within the 
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SCN at this time.  Studies performed by Weberpals and colleagues show that 8 
weeks post LPS treatment, there was a significant upregulation of activated 
microglia in the CNS, which was seen to be absent in NOS2-/- deficient LPS treated 
mice, indicating that nitric oxide derived from NOS2 plays a role in the sustained 
microglial changes and inflammatory state in the brain following LPS 5mg/kg 
treatment (Weberpals et al., 2009).  It is possible that NOS2 may mediate the effects 
of LPS on the SCN initially, leading to an upregulation in microglia, however the 
long-lasting microglial changes in the post-septic SCN must then be being mediated 
further by another mechanism.   
There are various mechanisms by which NOS2 might impact upon the 
circadian system.  Cytokines such as TNF-α stimulate glia to express NOS2 in 
models of SE (Jacob et al., 2007), leading to an increase in NO levels, which may 
play a role in neuronal dysfunction.  Excess NO can disturb the coupling between 
blood flow and metabolism by altering regulation of cerebral blood flow, and can 
alter synaptic transmission, leading to neuroendocrine, behavioural activity and 
memory formation perturbations (Jacob et al., 2011).  In rat models of SE, NOS2 
plays roles in systemic hemodynamic derangements (Kadoi and Goto, 2004).   
NOS2 induction may play roles in LPS induced apoptosis, and a variety of 
studies have highlighted that NOS2 causes apoptosis as well as delayed loss of 
neurons (Czapski et al., 2007; Arimoto and Bing, 2003). However, in the current 
study, we do not observe any evidence for neuronal loss in the SCN 24hrs following 
LPS treatment and therefore do not attribute any alterations in circadian function to 
NO induced neuronal loss in the SCN.  Additionally, NOS2 derived nitric oxide is 
suggested to be involved in long term LPS induced cognitive alterations (Weberpals 
et al., 2009), as well as the inflammatory suppression of LTP (Mori et al., 2001; 
Togashi et al., 2001; Wang et al., 2004).   
NOS2 synthesis has been suggested as a possible factor in impairment of the 
HPA axis that is seen in studies of septic shock in rats and in humans, whereby a 
reduction in ACTH synthesis is found (Polito et al., 2011), and NOS2 increase 
during septic shock could impact upon rhythmic corticosterone and feedback to the 
SCN.  Further, increases in NO levels have been shown to impact upon circadian 
resetting (Melo et al., 1997).  The specific inhibition of nitric oxide prior to treatment 
with LPS would be interesting along with long term assessment of circadian 
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resetting given the important role attributed to NOS2 by other studies in the long-
lasting activation of the innate immune system following a peripheral immune insult. 
3.4.2. Long-lasting increase in microglial markers in the post-septic SCN 
We observe long-lasting changes in the expression of microglial markers in 
post-septic animals in various regions of the brain, including in the SCN, with a 
significant upregulation of F4/80, CD-11b and IBA-1 in the SCN.  Importantly, in 
comparison to the expression of activated microglia we observe in the SCN acutely 
following LPS treatment, the morphology of the cells expressing F4/80 and CD-11b 
does not appear to be that of activated microglia at this time, 3mths post-treatment, 
but rather these cells exhibit a resting phenotype, expressing a ramified morphology.  
The current results are in line with recent studies by Puntener and colleagues 
(Puntener et al., 2012), who‘s Immunohistochemical analysis utilizing the antigens 
CD11c, MHC11 and MHC1 indicates that following peripheral infection, microglia 
within the CNS are activated transiently, appearing to return to their resting 
morphology 3 weeks following the peripheral immune challenge.  Studies have 
suggested that numbers of activated microglia can decrease upon resolution of the 
activating stimulus by apoptosis and/or these may lose their activation markers, 
subsequently returning to the resting state (Jones et al., 1997; Streit et al., 1999).  It 
is therefore possible that the previously activated microglia might change into a 
ramified form and this could account for the upregulation of F4/80 and CD-11b 
immunoreactive microglia exhibiting ramified morphology at 3mths post-treatment 
in the post-septic SCN. The use of another microglial marker was therefore required 
to further assess the state of the up-regulated microglia, and therefore, we further 
examined the morphology of the immunostained glia when assessing the levels of 
activated microglia in the SCN 3months post sepsis, further quantifying those 
appearing to be hypertrophic, as carried out in other studies assessing microglial 
activation (Lemstra et al., 2007), through the utilization of the ionized calcium 
binding adapter molecule 1 (Iba-1) immunoreactive microglial marker.  The 
activation of microglia sees the cells progress through a series of morphological 
phenotypes, the end stage of which they appear hypertrophic and are seen to 
resemble phagocytic cells (Kreutzberg, 1996).  Compared to resting microglia, 
activated microglia exhibit a larger cell body with processes that are shorter and 
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denser than those seen to project from resting microglia (Dheen et al. 2007; Kaur and 
Ling 1991; Kaur et al. 1985). Reactive microglia are generally evidenced as small, 
spherical cells with no processes, however an ameboid-like or rod-shaped 
morphology may also be observed (Davis et al. 1994).  Overall, there was no 
significant difference in the levels of IBA-1 microglial staining in the SCN 3mths 
following LPS 5mg/kg treatment.  However, both active and resting microglia 
express IBA-1 (Lalancette-Herbert et al., 2007), and this may account for why we do 
not observe a significant difference between saline treated and post-septic animals in 
IBA-1 immunoreactivity in the SCN.  Further examination of these sections under 
high power allowed inspection of the morphology of the IBA-1 immunostained cells, 
and it became clear that at 3 months post LPS treatment, these animals displayed 
small, spherical glia without processes, a morphology that has previously been 
described as the characteristic reactive microglial morphology (Davis et al., 1994), 
and the increased expression of these glia was found to be significant in the SCN at 
this 3 month time point in the LPS treated animals, but not in the SCN of saline 
treated controls.  Further, when IBA-1 immunoreactivity was assessed in the SCN of 
animals treated with PDTC prior to LPS compared to those treated with a control 
injection and LPS, it was found that this upregulation of reactive microglia was 
diminished following the administration of PDTC prior to LPS treatment, while the 
upregulation of the densely stained hypertrophic glia remained significant in the 
SCN of control and LPS treated animals.  In line with these results, studies have 
shown that LPS treatment results in a sustained microglial activation in the frontal 
cortex 8 weeks following the peripheral immune challenge (Weberpals et al., 2009), 
while other studies have shown that chronic i.c.v. infusion of LPS in rats has been 
shown to cause a long-lasting upregulation of microglia 37 days following the last 
LPS administration (Hauss-Wegrzyniak et al., 2000). Further, activated microglia 
have been shown in the brains of human sepsis patients, irrespective of age (Lemstra 
et al., 2007).    The current study finds no evidence of astrogliosis in the post-septic 
SCN, evidenced by no changes in expression of the astrocytic marker, GFAP, 
keeping our findings in line with those experiments undertaken by Weberpals and 
colleagues (Weberpals et al., 2009), who also do not observe any evidence for 
astroglial activation in the hippocampus, frontal cortex or cerebellum 8wks post-
septic LPS treatment (Weberpals et al., 2009).   
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Microglial activation in the CNS parenchyma seems to be vital for 
communication between the immune system and the brain (Konsman et al., 2002; 
Combrinck et al., 2002), playing either harmful or beneficial roles.  Following CNS 
insult, microglia activation may play a beneficial role by the release of neurotrophic 
molecules, promoting aspects of regeneration (Streit et al., 1999; Schwartz, 2003; 
Ekdahl et al., 2003).  In the current study, those immunomediators seen to be up-
regulated in the SCN 24hrs post sepsis, namely NOS2 and IL-6 are known to play 
important roles in the activation of microglia (Zielasek and Hartung, 1996; 
Kreutzberg, 1996), and NOS2 derived NO production or increased IL-6 expression 
may play a role in microglial activation in the SCN.  Additionally, activated 
microglia release inflammatory mediators which are shown to be neurotoxic in vitro 
(Ekdahl et al., 2003) such as IL-1β, IL-6, TNF-α, nitric oxide, and reactive oxygen 
species (Pocock and Liddle, 2001; Hanisch, 2002; Gebicke-Haerter, 2001; Vallieres 
et al., 2002) as well as induce the activation of the complement cascade, which has 
been shown to play roles in the brain following LPS treatment, leading to 
upregulation of CD45, TNF-α and TLR4, activated microglia and NOS2 (Jacob et 
al., 2007).  
Alterations in cognitive function are seen following the activation of 
microglia.  Peripheral LPS treatment and subsequent microglial activation and 
cytokine release is associated with behavioural deficits (Bluthe et al., 1992; Godbout 
et al., 2005; Combrinck et al., 2002).  Administration of low dose endotoxin to 
healthy volunteers results in an increase in levels of systemic proinflammatory 
cytokines, along with alterations in behaviour and memory perturbations 
(Reichenberg et al., 2001; Krabbe et al., 2005).  Further, neuroinflammation and 
microglial activation have been implicated in the pathogenesis of various disorders 
associated with cognitive impairment such as AD, Lewy body dementia, and AIDS 
dementia (Nelson et al., 2002; Katsuse et al., 2003; Perry et al., 2003).  
Assessment of the state these up-regulated microglia exist in warrants further 
investigation.  In situations of pre-existing pathology, such as in chronic 
neurodegenerative disease or in ageing whereby priming of microglia is observed, an 
enhanced consequence of neuroinflammation is seen (Godbout et al., 2005; Perry, 
2004; Cunningham et al., 2005).  Evidence points to systemic inflammation elicited 
by infection or injury in the periphery, in the activation of already primed microglia 
in the normal healthy ageing brain or in the brains of AD patients, and this can 
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subsequently impact upon the cognitive decline seen in these patients and further, 
can result in delerium (Perry et al., 2003). Studies have also shown an enhanced 
activation of microglia upon central administration of cytokines in old rats compared 
to young and middle aged rats (Deng et al., 2006).  Given the chronic alterations in 
the CNS in microglial markers following the induction of sepsis, it‘s possible that 
microglia in the post-septic SCN may show enhanced activation to further immune 
challenges. Further, some of the alterations we observe in circadian locomotor 
behaviour are similar to those exhibited in normal ageing, which exhibits a low grade 
neuroinflammation and priming of microglia.  Certain aspects of this will addressed 
in Chapter 5.   
It is not possible for us to confirm from the current study the role that the 
long-lasting activated microglial expression played in the alterations in circadian 
behaviour, or whether in fact it played any role at all.  Examination of additional 
inflammatory mediators that are known to be released by activated glia such as 
MCP-1 or reactive oxygen species is warranted in the post-septic SCN at this time. 
Further, assessment of phagocytic or fully activated microglia utilizing the ED-1 
antibody which is known not to stain ramified microglia may be beneficial (McClain 
et al., 2011).  It would be interesting to assess whether the LPS induced long-lasting 
upregulation of microglial markers in the SCN resolves itself over time, and if so, 
the exact period length of this increase in up-regulated microglial markers in the 
SCN, and whether normal circadian behavioural resetting might be restored upon 
resolution of the immunomodulation.  Further, it would be interesting to investigate 
whether administration of a specific inhibitor of activated microglia such as 
minocycline would ameliorate the long-lasting upregulation of microglial markers 
observed in the SCN and the long-lasting behavioural alterations, and would shed 
further light as to whether the chronic microglial activation played a role in the post 
sepsis circadian behavioural alterations, or whether these effects were being 
mediated by another mechanism.   
3.4.3. Proinflammatory cytokine expression in the SCN in the acute phase 
following LPS treatment and long term, in the post-septic SCN 
Examination of the SCN in the current study revealed there to be no changes 
in the expression of the proinflammatory cytokine, TNF-α either 24hrs following 
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LPS 5mg/kg treatment, or 3 months following the initial immune challenge.  TNF-α 
has previously been outlined to play a principal role in the mediation of the effects of 
LPS on the brain post sepsis, and has been proposed as a potent mediator of the 
chronic neuroinflammatory state (Qin et al., 2007; Bossu et al., 2012).  Previous 
studies utilizing LPS i.p. treatment have shown a long-lasting upregulation of TNF-α 
in brain homogenates for many months following the peripheral immune challenge, 
while levels of TNF-α in the periphery were shown to return to baseline levels within 
7 days following LPS treatment  (Qin et al., 2007).  TNF-α was also shown to be 
upregulated in the brain in the hippocampus and frontal cortex 7 days following LPS 
treatment and this significant upregulation was seen to remain up to ten months 
following LPS (Bossu et al., 2012).  Studies by Weberpals and colleagues 
(Weberpals et al., 2009), utilizing the same endotoxin dose used in this study, have 
shown a long-lasting upregulation of proinflammatory cytokines in specific regions 
in the CNS post sepsis, including a significant upregulation of TNF-α mRNA in the 
cerebellum, cortex and hippocampus 2 months post-treatment (Weberpals et al., 
2009).  Furthermore an increase in IL-1β is evident in the frontal cortex two months 
following septic LPS treatment (Weberpals et al., 2009). Examination of the 
proinflammatory cytokine IL-1β in the current study in the post-septic SCN revealed 
that there were no alterations in expression of this cytokine 3 months post-treatment.  
The expression of TNF-α and IL-1β in the SCN have not been previously examined 
in the long term following sepsis induction, and so it may be that TNF-α and IL-1β 
are only up-regulated in specific CNS regions following sepsis and that the SCN is a 
region that does not show alterations in IL-1β or TNF-α expression following LPS 
treatment.  That TNF-α is not found to be up-regulated in the SCN itself does not 
mean that it does not play a role in the LPS induced effects on circadian locomotor 
behaviour, acting outside of the SCN to induce changes in the early stages which 
then induce long-lasting effects.  TNF-α and IL-1 are known to activate the NF-κB 
signalling pathway (Beg et al., 1993), and the p65 NF-κB subunit has been shown to 
be acutely up-regulated in the SCN following peripheral LPS treatment (Beynon and 
Coogan, 2010)  and the role of TNF-α in mediating the effects of a septic LPS 
treatment has been documented, and suggested that the cytokine plays a role in the 
early stages following a septic LPS treatment activating microglia within the CNS, 
which then results in a self-propelling neuroinflammation (Qin et al., 2007).   
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The current study observes a significant upregulation of IL-6 in the SCN in 
the acute phase following a peripheral septic LPS treatment, however 3mths 
following the initial immune challenge, IL-6 expression levels are seen to be in line 
with those of controls. Similar to these findings, other studies have shown that in the 
acute phase, 4hrs following the induction of sepsis by peripheral LPS, levels of IL-6 
expression are significantly up-regulated in cortex, cerebellum and hippocampus 
(Beurel and Jope, 2009), as well as being up-regulated following central injection in 
the CNS (Beurel and Jope, 2009).   IL-6 is suggested to play a dual role within the 
CNS, with both detrimental and beneficial effects (Gruol and Nelson, 1997), 
probably determined by its level of expression and the duration of up-regulation 
(Beurel and Jope, 2009).  IL-6 carries out various functions including playing a role 
in the immune response, being involved in the regulation of inflammation, 
haematopoesis and cell differentiation, along with being considered a signal in the 
activation process of microglia (Kreutzberg, 1996).  Indeed, mice which overproduce 
human IL-6 in neurons known as NSEhIL6
+
 mice, spontaneously show increased 
microglial reactivity as well as spontaneous development of severe astrogliosis 
(Fattori et al, 1995).  Further, glia play a role in mediating the effects of IL-6 (Beurel 
and Jope, 2009).  The significant upregulation of IL-6 and activated microglia 
observed in the SCN 24hrs following LPS treatment in our experiments are in line 
with these studies.  Since IL-6 is known to play roles in the activation of microglia 
(Kreutzberg, 1996), this may play a role in the expression of activated microglia in 
the SCN following LPS treatment.  An increase in IL-6 has been associated with 
severe cognitive impairment (Campbell et al., 1993; Heyser et al., 1997; Dantzer et 
al., 2008) and additionally, in the CNS, IL-6 is suggested to be involved in the long-
lasting effects of sepsis on the brain, including cognitive and behavioural alterations 
and neuronal loss (Semmler et al., 2007). It may be that the significant upregulation 
of IL-6 in the acute phase following LPS treatment activates glia within the SCN, 
leading to further release of other proinflammatory cytokines, that may impact upon 
circadian timekeeping processes and behaviour, however since IL-6 is not 
upregulated in the long term the increased microglial expression at this time cannot 
be attributed to this.  
While we ourselves have not assessed the levels of proinflammatory 
cytokines in the periphery following LPS treatment, other studies using the same 
endotoxin dose as that used in these experiments have shown that proinflammatory 
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cytokines are seen to rise in the periphery and in the brain early following LPS 
treatment, but these levels are seen to subside in the periphery approximately one 
week following LPS treatment, after the acute response, but to stay elevated in the 
brain (Qin et al., 2007; Bossu et al., 2012).   Studies by Bossu and colleagues (2012) 
have shown TNF-α to be upregulated 7 days following a septic LPS treatment in the 
hippocampus and frontal cortex, but not in the hypothalamus.  These studies further 
highlight the region specificity of cytokine alterations following septic LPS 
treatment in the long term,  and have shown both TNF-α and IL-18 to be upregulated 
in the hippocampus, cerebellum and frontal cortex 10 months following treatment, 
however examination of these inflammatory mediators in the hypothalamus again at 
this time point does not reveal any significant upregulation.  At these timepoints, in 
the long-term following LPS treatment, when circulating levels of proinflammatory 
cytokines have returned to baseline levels, the elevation of inflammatory mediators 
in the brain is therefore independent of the initial systemic reaction, and is being 
propelled in the CNS itself, leading to the view of a self-propelling 
neuroinflammation (Qin et al., 2007; Bossu et al., 2012). We can therefore assume 
that any alterations observed in SCN neurochemistry or circadian locomotor 
behaviour, which are assessed following recovery from the acute phase of septic LPS 
treatment are not due to alterations in circulating cytokine levels. The molecular 
mechanisms underlying the potentiation of the chronic neuroniflammatory state have 
not been fully elucidated, but mechanisms have been put forward by other groups 
and suggest the involvement of TNF-α at the early stages in response to LPS 
treatment, activating microglia in the brain and leading to a self-propelling 
neuroinflammation by the further induction of cytokines in the CNS such as TNF-α, 
IL-1β (Qin et al., 2007) and IL-18 (Bossu et al., 2012), leading to a loss of neurons 
in the later stages following peripheral inflammation (Qin et al., 2007; Semmler et 
al., 2007) and lasting behavioural alterations (Bossu et al., 2012).   
In support of a self-propelling neuroinflammation, there may be alterations in 
inflammatory mediators in the long term following LPS treatment that are not seen 
in the early stages following treatment.  For example, IL-18 has recently been 
implicated in the long-lasting inflammatory response following a single LPS 
treatment, and is found to be significantly increased in the cerebellum, hippocampus 
and frontal cortex 10 months after peripheral LPS treatment, with no alterations in its 
expression 1 week following treatment (Bossu et al., 2012).  Furthermore, IL-18 has 
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been shown to be involved in delayed neuroinflammation in experimental models of 
trauma and brain ischemia (Jander et al., 2002; Yatsiv et al., 2002) and has also been 
found to be expressed following LPS treatment in microglia and astrocytes (Conti et 
al., 1999; Wheeler et al., 1999).  Assessment of IL-18 and other inflammatory 
cytokines in the SCN not undertaken in the current set of experiments would be 
interesting.  There may be alterations in regions of the brain that the SCN projects to 
such as the PVN, both acutely or 3mths following septic LPS treatment and these 
could mediate the chronic effects of LPS induced sepsis on locomotor behaviour.  
Indeed, in the PVN following both i.v. or i.p. LPS treatment, levels of TNF-α and IL-
6 are significantly increased in the acute phase following treatment, following an 
ACTH increase (Kakizaki et al., 1999).  The chemokine MCP-1 which acts as a 
chemoattractant for T cells, basophils, monocytes/macrophages, and NK cells (Jacob 
et al., 2011) is shown to be up-regulated in the brain in the acute phase following 
LPS treatment (Thompson et al., 2008; Qin et al., 2008).  MCP-1 may play important 
roles in the activation of the neuroinflammatory response following a peripheral 
immune challenge, since in MCP-1 KO mice treated with 5mg/kg LPS an 
exaggerated peripheral response has been shown, with an upregulation in cytokines, 
but a decrease in microglial activation, CNS levels of chemokines and the 
proinflammatory cytokines IL-1β and TNF-α, along with a reduction in serum 
corticosterone levels are also observed (Thompson et al., 2008).  
Attenuations in central cytokine expression may also impact upon the HPA 
axis and activation of the HPA axis is one of the key events in the inflammatory 
response (Mathias et al., 2000; Takebe et al., 1966). Indeed, inhibition of brain 
cytokine expression following a septic peripheral endotoxin treatment in MCP-1 KO 
mice has been shown to reduce serum corticosterone levels (Thompson et al., 2008). 
Further, in adrenalectomized mice there is an increase in plasma IL-1β and TNF-α 
levels after LPS treatment along with an increase in mortality which has been shown 
to be reversed by treatment with glucocorticoids (Beishuizen and Thijs, 2003) and 
glucocorticoids have been shown to inhibit the induction of NOS2 (Kleinert et al., 
1996), which is known to play roles in the long-lasting effects of sepsis (Weberpals 
et al., 2009), by decreasing cytokine-induced activity of NF-κB (Kleinert et al., 
1996), highlighting the importance of HPA axis activation in response to LPS 
treatment.  Alterations in cytokines and signallers such as NOS2 in the SCN may 
therefore impact upon the HPA axis, leading to attenuations in glucocorticoid 
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expression and neuroendocrine feedback to the SCN which could underlie the long-
lasting changes in the circadian system following the induction of sepsis.  
3.4.4. The involvement of the NF-κB pathway in the circadian system post-sepsis 
Although evidence suggests that the NF-κB signalling pathway is involved in 
the SCN in the acute phase following sepsis (Beynon and Coogan et al., 2010; Leone 
et al., 2006) we do not observe a significant upregulation in components of the NF-
κB pathway in the post-septic SCN.  The translocation of NF-κB to the nucleus from 
the cytosol is prevented by tight association with inhibitors known as the I-KappaB‘s 
(IκBs) (Baeuerle and Baltimore 1988).  In response to signals that activate NF-κB, 
the enzyme IkappaB kinase (IκK) becomes activated and subsequently 
phosphorylates IκB which dissociates from NF-κB and becomes degraded, allowing 
NF-κB to translocate to the nucleus and subsequent NF-κB DNA binding and the 
induction of the transcription of different components of the inflammatory response 
including cytokines such as IL-6, NOS,  immunoglobulins, Rel family proteins, IκB 
and neurotransmitters, along with various other genes (Beg et al., 1993; Verma, 
1995; Nomura, 2001; Marpegan et al., 2004).  Cytokine activation of the NF-κB 
complex might cause an upregulation in components of the NF-κB pathway in the 
SCN, however, in the long term following a septic LPS treatment, our assessment of 
three components of this pathway including the p65 NF-κB subunit, p-IκK and p-IκB 
found no significant upregulation of these in the post-septic SCN.  It does appear that 
the distribution of expression of both p-IκK and p-IκB may be altered in the post-
septic SCN, however this requires further investigation. 
NF-κB has been implicated in the LPS effects on the circadian system 
(Marpegan et al., 2004, 2005, Paladino et al., 2010) and application of sulfasalazine, 
an NF-κB inhibitor, has previously been shown to block peripheral LPS induced 
phase shifts in the early subjective night in mice (Marpegan et al., 2005), 
highlighting the role of NF-κB in mediating the effects of LPS on the SCN.  While 
the SCN itself does not show upregulation of NF-κB pathway components in the 
long term following LPS treatment, the NF-κB signalling pathway does appear to 
play a role in mediating the effects of LPS in the acute phase following LPS 
treatment, since its inhibition by administration of 200mg/kg PDTC, a potent 
inhibitor of the NF-κB pathway, prior to LPS 5mg.kg i.p. treatment ameliorates the 
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impact of the septic LPS treatment on the SCN and on circadian behaviour in the 
long term.  In line with this, reducing the inflammation that occurs during sepsis has 
been shown to alleviate the pathogenesis of sepsis (Jacob et al., 2010).  
Administration of PDTC, could prevent the inflammation associated with septic 
encephalopathy, thereby preventing post-septic neuroinflammation and inhibiting the 
alterations observed in the circadian pattern of locomotor activity and long-lasting 
microglial activation following the induction of sepsis.  As mentioned previously, 
PDTC treatment was also shown to prevent the high sepsis scores elicited in LPS 
treated animals, with a significant decrease in sepsis scores between animals treated 
with PDTC prior to LPS compared to those treated with a control injection prior to 
LPS, and this was probably due to a decrease in the induction of proinflammatory 
cytokines.  Additionally, the upregulation in hypertrophic microglial cells is shown 
to be attenuated by administration of PDTC prior to LPS treatment, and values were 
seen to be in line with control animals, along with the attenuations in circadian 
resetting exhibited by post-septic animals.  The possible decrease in the activation of 
the inflammatory mediators in the SCN may underlie the decrease in microglial 
activation in the SCN of animals treated with PDTC prior to LPS. Indeed, NF-κB is 
known to regulate IL-6 expression (Steinbrecher et al., 2005) and the induction of 
NOS2 following LPS treatment (Xie et al., 1994), therefore, inhibition of the NF-κB 
signalling pathway by PDTC administration may inhibit these in the SCN in the 
acute phase following sepsis.  A decrease in inflammatory mediators in the SCN 
might also account for the unaltered circadian resetting in PDTC + LPS treated 
animals. Further, NF-κB has been implicated in disruption of glucocorticoid function 
following its activation by cytokines (Pace et al., 2007), and this could possibly play 
a role in the LPS induced attenuated behavioural resetting and its inhibition by 
PDTC may account for why circadian resetting is in line with controls in PDTC and 
LPS treated animals. 
Assessment of NOS2 and IL-6 levels and microglial activation in the SCN in 
the acute phase following administration of PDTC prior to LPS 5mg/kg treatment 
would shed further light on this.  It is worth noting that NF-κB signalling mediates 
the transcription of a wide variety of mediators involved in the immune and 
inflammatory response (Beg et al., 1993; Verma, 1995; Nomura, 2001) and its 
inhibition may serve to prevent the induction of these, which may play a role in the 
expression of normal circadian behaviour following PDTC treatment prior to a 
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peripheral septic LPS dose.  Additionally, it would be interesting to assess whether 
PDTC administration prior to LPS might diminish the increased expression of the 
effector IEG, EGR-1 in the SCN at 24hrs post-treatment. Additional work must be 
carried out in order to establish the mechanisms by which NF-κB signalling is 
involved in the long-lasting alterations in the SCN and the circadian system. 
Overall, we observe that the SCN responds to the substantial peripheral 
immune challenge, however on the whole, there were no major alterations in the 
SCN between post-septic and LPS treated animals 3months following the initial 
immune insult.  Therefore, the observed alterations in circadian locomotor behaviour 
seen in post-septic animals at this time indicate that the long-lasting perturbations in 
circadian behavioural rhythmicity exemplified by these studies are being mediated 
by other factors.   
Attenuations in various other mechanisms may then underlie the 
perturbations in circadian resetting exemplified by these studies.  As previously 
suggested, cytokine mediated alterations of the function of the HPA axis and 
glucocorticoid receptor function may play a role, further modulating inflammation 
(Capuron and Miller, 2011), and this alteration in endocrine function may feedback 
to the SCN, impacting upon circadian function.  Inflammatory mediators induced by 
peripheral LPS may impact upon the SCN inducing functional changes and 
alterations in clock gene expression following LPS administration, and the ability of 
LPS to impact upon clock gene expression has been shown by various different 
studies (Takahashi et al., 2001; Marpegan et al., 2005; Palomba and Bentivoglio, 
2008; Okada et al., 2008).  The examination of clock gene expression in Chapter 4 
will clarify whether alterations in clock gene expression could underlie the long-
lasting changes in behavioural resetting post sepsis.    Additionally, in the SCN or 
regions it projects to such as the PVN, attenuations in the expression of other factors 
involved in the inflammatory response not examined in these studies may play roles 
in mediating the effects of LPS following the induction of sepsis.  The assessment of 
cholinergic transmission in the SCN post sepsis would be interesting. The 
cholinergic anti-inflammatory pathway plays roles in the modulation of 
inflammation, stimulating the parasympathetic nervous system to release 
acetylcholine which regulates the immune response (Pavlov et al., 2003).  Given that 
cholinergic input to the SCN is involved in the function of the circadian system (Hut 
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and Van der Zee, 2011), it‘s possible that alterations in the cholinergic system such 
as the loss of cholinergic fibres previously shown in rats following high dose 
endotoxin (Semmler et al., 2007) could play a role in the behavioural alterations.  
Attenuations in synaptic plasticity in the post-septic brain could play a role in the 
attenuations in circadian behaviour.  Two months following a single LPS treatment, 
synaptic alterations are evidenced in the post-septic brain, possibly mediated through 
nitric oxide production (Weberpals et al., 2009) and given the upregulation we 
observe in NOS2 expression in the acute phase following LPS treatment, it‘s 
possible that synaptic alterations could underlie the alterations in circadian behaviour 
exhibited post sepsis.  Further, microglia induced nitric oxide has been shown in 
vitro to affect the anterograde axonal transport of synaptophysin, which is a synaptic 
protein involved in synaptic plasticity (Stagi et al., 2005).  LPS induced cytokine 
modulations could also perturb neurotransmitter function or brain circuitry since 
alterations in neurotransmitter expression have been found in the rat brain during 
sepsis (Freund et al., 1985), and alterations in these may underlie the perturbations in 
behaviour in post-septic animals (Capuron and Miller, 2011).   
Additional studies assessing these parameters are required in order to fully 
assess the mechanisms by which LPS exerts its effects on the circadian system. The 
results from the assessment of the neurochemistry of the post-septic SCN do not 
show long-lasting expression of proinflammatory cytokines known to impact upon 
circadian rhythmicity in the SCN of post-septic mice, and assert again, that in the 
long term following a septic LPS treatment, an underlying mechanism is impacting 
upon circadian locomotor behaviour.  It would be tempting to speculate a mechanism 
whereby the action of TNF-α in the early stages as shown previously by other studies 
(Qin et al., 2007) leads to activation of the NF-κB signalling pathway, resulting in 
the transcription of inflammatory mediators, including the induction of NOS2 and 
IL-6 expression in the SCN, leading to either microglial activation that induces a 
long-term self-propelling neuroinflammation as outlined by other groups (Qin et al., 
2007; Bossu et al., 2012), or resulting in alterations in neuroendocrine feedback to 
the SCN through impairment of HPA axis function, or both.  Further extensive 
studies would be required in order to delineate a mechanism by which this LPS 
induced neuroinflammation impacts upon circadian timekeeping processes. 
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3.5. Supporting Information 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S.1.: Immunizing peptide blocking experiment (A) Representative SCN 
photomicrographs of animals treated one month previously with either saline or 
LPS, illustrating the comparison between normal PER1 IHC stained sections and the 
staining of sections when the  PER1 anibody was neutralized with the PER1 
immunizing blocking peptide, confirming that non-specific staining did not occur 
(scale bar = 100 µm).    
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Chapter Four 
Analysis of Clock gene and Immediate Early Gene product 
expression in the post-septic SCN. 
4.1.  Introduction: 
Inflammatory mediators induced by peripheral LPS may impact upon the 
SCN, inducing functional changes. Treatment with LPS and other inflammatory 
mediators may attenuate the molecular oscillations of clock gene expression that 
underpin circadian rhythmicity, both in the master pacemaker itself, and in the 
periphery, and in this way can impact upon timekeeping processes. 
4.1.1. LPS treatment impacts upon central and peripheral clock gene expression 
Treatment with endotoxin impacts upon rhythmic clock gene expression both 
in the SCN and in the periphery, and the ability of LPS to influence molecular 
oscillations and timekeeping processes has been shown by various different studies 
(Takahashi et al., 2001; Marpegan et al., 2005; Murphy et al., 2007; Okada et al., 
2008).  While a low dose LPS treatment is seen not to affect Per1 or Per2 expression 
in the SCN (Takahashi et al., 2001), peripheral 1mg/kg LPS treatment temporarily 
suppresses both Per2 and DBP mRNA expression levels in the SCN in rats, as well 
as the expression of Per1, Per2 mRNA and other genes under circadian control in 
the periphery, with restoration of expression patterns on the second day after the 
immune challenge, showing that endotoxin treatment transiently suppresses 
circadian timekeeping molecular oscillations (Okada et al., 2008).  Yamamura and 
colleagues (2010), have shown that LPS treatment causes a phase dependent 
reduction in the expression of Per1 and Per2 genes in the heart and the liver.  Both 
Per2 and Bmal1 have been shown to be significantly upregulated in the periphery in 
equine blood following LPS treatment (Murphy et al., 2007).  Further, these studies 
have shown LPS induced clock gene alterations to be inhibited by treatment with a 
cyclooxygenase inhibitor known to reduce PGE2 levels, implicating a role for these 
in circadian resetting (Murphy et al., 2007).  Additionally, human subjects treated 
with endotoxin in vivo show acute alterations in expression levels of various clock 
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genes in peripheral blood leukocytes (PBL) (Haimovich et al., 2010).  Treatment of 
PER2::luc SCN cultures with either TNF-α or LPS in vitro does not affect rhythmic 
expression patterns (Guenthner et al., 2009). Clock gene expression has also been 
shown to be altered in other CNS regions in response to LPS treatment.  Treatment 
with 50 μg/kg LPS injection in the subjective night has been shown to induce PER1 
expression in the PVN region at CT15 (Paladino et al., 2010) and at ZT22 
(Takahashi et al., 2001), and studies have shown stress signals such as LPS to induce 
upregulation of the Per1 gene in the PVN CRF neurons, but not in the SCN, in mice 
(Takahashi et al., 2001).   
4.1.2. Inflammatory mediators attenuate clock gene expression in the SCN and in 
the periphery. 
In the SCN, IFN-α is seen to act directly upon SCN neurons, and impact 
upon clock gene rhythmicity.  Mice treated with IFN-α display a time dependent 
response, with no alterations observed following IFN-α administration at ZT0, while 
at ZT12, IFN-α treatment causes alterations in the expression of Bmal1, Per 1, 2 and 
3 (Ohdo et al., 2001).  Repetitive administration of IFN-α resulted in alterations in 
photically induced Per expression (Ohdo et al., 2001).  Further, studies have shown 
the expression of Bmal1 and Clock to be dampened in the SCN following IFN-α 
administration, and additionally, this has been seen to cause perturbations in the 
expression of the clock controlled gene vasopressin which is involved in mediating 
output from the SCN (Koyanagi and Ohdo, 2002).  Administration of TNF-α which 
is known to be induced following peripheral LPS treatment (Zetterstrom et al., 1998) 
and is involved in mediating the effects of LPS on the circadian system (Qin et al., 
2007) impacts upon clock gene rhythmicity in the SCN, and subcutaneous TNF-α 
has been shown to alter SCN Dbp expression (Cavadini et al., 2007), and it has been 
suggested that TNF-α which has been shown to be necessary for LPS induced phase 
delays of locomotor behaviour may elicit these by altering the expression of clock 
genes (Leone et al., 2012).  
A wealth of literature has shown the ability of administration of 
inflammatory mediators to impact upon clock gene expression in the periphery, both 
in vivo and in cell lines in vitro.  Continuous IFN-α administration is seen to reduce 
Per1 and Per2 mRNA levels in the liver at ZT14 (Shinohara et al., 2008).  Treatment 
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with IFN-γ at ZT12, but not ZT0, for 6 days was seen to result in alterations in Per 
expression (Ohdo et al., 2001), while in transgenic Per1-luc cultures, chronic 
treatment (4 weeks) with IFN-γ has been shown to significantly reduce rhythm 
amplitude in individual rat neurons (Kwak et al., 2008).  Clock gene expression in 
mice has been shown to be altered by the proinflammatory prostaglandins, and PGE2 
is suggested to act as an in vivo-clock resetting stimulus, since peripheral PGE2 
treatment is known to phase shift clock genes in the periphery in vivo, altering the 
expression levels of Per1, Rev-erb-α  and DBP (Tsuchiya et al., 2005).  In vitro, 
NIH3T3 murine fibroblast cells treated with PGE2 induced acute and transient 
expression of Per1 mRNA in a dose dependent manner (Tsuchiya et al., 2005). TNF-
α also impacts upon peripheral molecular oscillations.  TNF-α interacting with 
TNFR1 causes the upregulation of Per1, Per2, Dec (differentiated embryo 
chondrocytes)-1 and Cry1, and the downregulation of Dbp in fibroblasts in vitro 
(Petrzilka et al., 2009).  In fibroblasts in vitro, and in the liver of mice in vivo, the 
expression of clock genes that contain E box regulatory elements, i.e. the PAR bZip 
genes (Hlf, Tef and Dbp) and the Per 1, 2 and 3 genes have been shown to be 
suppressed by TNF-α (Cavadini et al., 2007).  Further highlighting that TNF-α 
directly affects clock gene expression, treatment of both the human hepatoma HuH7 
cell line and human hepatocarcinoma HepG2 cell lines with TNF-α overnight results 
in dose dependent increase in CRY1 expression (Tong et al., 2012).  These authors 
show that TNF-α upregulates Usp (Ubiquitin Specific Protease) 2a, a 
deubiquitination enzyme which is responsible for TNF-α induced CRY1 protein 
stabilization, and suggest that in this way, Usp2a disrupts the circadian clock in 
response to TNF-α and additionally, suggest that this mechanism may be responsible 
for chronic TNF-α suppression of the circadian clock. DBP expression was also 
shown to be decreased following TNF-α treatment, and the Per2 promoter-driven 
luciferase reporter activation by BMAL1/CLOCK overexpression was shown to be 
suppressed in the Huh7 cell line (Tong et al., 2012). More recently, treatment of 
human fibroblast cells with TNF-α in vitro has been shown to significantly increase 
the expression of PER3 and DBP, while reducing the expression of NPAS2 and 
ARNTL2 (Kouri et al., 2013). 
Both IL-1β and IL-6 which are known to be induced in response to LPS both 
centrally and peripherally (Zetterstrom et al., 1998) impact upon clock gene 
expression.  IL-1β has been found to cause significant alterations in the expression of 
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Dbp and Per3 in fibroblasts in vitro (Cavadini et al., 2007), and treatment of a 
human hepatoma cell line (HuH-7) with IL-6 results in significant induction of Per1 
gene expression (Motzkus et al., 2002).   
In vivo, the activation of CD40 leads to the production of proinflammatory 
cytokines, and CD40 stimulation has been shown to lead to alterations in clock gene 
expression in the liver and is dependent on TNFR1 signalling (Taraborelli et al., 
2011).  Upon induction of experimental arthritis in mice using a mixture of anti-type 
II collagen (anti-CII) mAb and LPS, clock gene mRNA expression was disrupted in 
the spleen, including that of Bmal1, Per1 and Per2 and Dbp, while PER2 protein 
expression was disturbed in the nuclei of synovial cells (Hashiramoto et al., 2010). 
Recent studies by Bellet et al (2012) have suggested there to be communication 
between the NF-κB pathway and clock gene expression, since RelB-deficient mouse 
embryonic fibroblasts show alterations in the transcription of clock genes.  In Clock 
mutant mouse embryonic fibroblasts that express alterations in the NF-κB pathway 
component, RelB, attenuations in the transcription of clock genes are shown in 
response to TNF-α treatment, with lower levels of both Per2 and Dbp mRNAs 
observed in comparison to TNF-α treated wild type cells, indicating that interplay 
between the circadian clock and NF-κB pathway components is important in 
regulating clock gene expression (Bellet et al., 2012). 
Together, these studies highlight the impact of immune mediators on 
molecular clock gene oscillations, highlighting the ability of these factors to impact 
upon timekeeping processes. 
4.1.3. Clock gene alterations are observed in chronic inflammatory conditions 
Attenuations in the expression of clock genes have been observed in 
conditions with an inflammatory component, both in humans and experimental 
animal models.  In male patients with acute Q fever as a result of bacterial infection 
with the Coxiella burnetii (C. burnetii), Per2 has been demonstrated to be up-
regulated in the blood (Mehraj et al., 2012), while in female mice infected with C. 
burnetii, the expression of the clock genes Clock and Arntl was shown to be reduced 
in the liver, accompanied by an upregulation of Per2 (Textoris et al., 2010). In both 
preclinical and clinical AD, the rhythmic expression of clock genes Per1, Cry1 and 
Bmal1 is diminished in the pineal, while Cry1 mRNA was increased in clinical AD 
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(Wu et al., 2006). Obesity is associated with systemic inflammation (Yaffe et al., 
2004), and the expression patterns of Bmal1 and Rev-erbα were seen to be altered in 
the brainstem of obese mice (Kaneko et al., 2009). More recently, the expression of 
clock genes has been shown to be disturbed in the synovial membrane of 
Rheumatoid Arthritis (RA) patients (Kouri et al., 2013), while experimental arthritis 
is seen to be exacerbated in Cry deficient mice, resulting in increased serum levels of 
matrix metalloproteinase-3, TNF-α, IL-6 and IL-1β, indicating that circadian 
rhythmicity plays a role in the pathogenesis of arthritis (Hashiramoto et al., 2010).  
The expression of Per2 has been shown to be altered in the periphery in the liver of 
mice with experimental autoimmune encephalomyelitis (EAE) which is 
characterized by the infiltration of immune cells into the CNS and the presence of 
inflammatory lesions as well as axonal loss in the brain (Buenafe, 2012).  In an 
experimental rodent model of African trypanosomiasis, Trypanosoma brucei brucei 
(Tb brucei) has been shown to impact upon clock gene expression in peripheral 
oscillators, to induce alterations in Clock mRNA in the pineal gland, as well as a 
reduction in Bmal1 mRNA in the spleen in vitro (Lundkvist et al., 2010).  Further, 
these authors observe a shortened Per1-luc period in the pituitary gland, however 
only 21% of SCN tissues showed flat Per1-luc rhythms. In ageing, which is 
associated with a low-grade central neuroinflammation (Godbout and Johnson, 
2009), BMAL1 and CLOCK have been shown to be altered both in the SCN (Asai et 
al., 2001) and in extra-SCN sites (Wyse and Coogan, 2010).   Taken together, these 
studies highlight the impact of inflammatory conditions and diseases on circadian 
timekeeping processes. 
Given that oscillations of components of the molecular clock in both the SCN 
and sites of other oscillators are known to drive circadian rhythms of behaviour, and 
that immune mediators, including LPS, have been shown cause functional alterations 
in the SCN (Marpegan et al., 2005; Beynon and Coogan, 2010; Palomba and 
Bentivoglio, 2008; Sadki et al., 2007), and to alter clock gene rhythmicity, and the 
current study observes perturbations in behavioural circadian rhythms in response to 
a septic LPS treatment, we examined the oscillations of core molecular clock 
components in the SCN to determine whether a molecular correlate exists for the 
behavioural phenotype shown by post-septic animals.  These experiments examine 
the diurnal expression of the clock gene protein products PER1, PER2 and CLOCK 
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and further, examine c-Fos expression patterns in the SCN, to assess post-septic 
SCN responsiveness and function.  Perturbations in these parameters could be 
responsible for attenuated behavioural resetting in post-septic animals. 
4.2.  Materials & Methods 
4.2.1. Animals and Housing: 
For assessment of IEG and clock gene expression in SCN by 
immunohistochemical analysis, male C57Bl/6 (obtained at 6-8 weeks old) mice from 
either Harlan (UK) or Charles River (UK) were used that had been group housed as 
outlined in section 2.2.2. For the purposes of real-time reporting of circadian gene 
expression, B6.129S6-Per2
tm1Jt
/J mice were utilized.  B6.129S6-Per2
tm1Jt
/J have a 
firefly luciferase (luc) gene inserted in-frame into the 3‘ end of the endogenous 
mPer2 gene between exon 23 and the three prime untranslated region (3‘ UTR) (Yoo 
et al., 2004).  This allows the observation of the expression of the 
PERIOD2::LUCIFERASE (or mPER2::LUC) fusion protein in real-time.  The 
mPer2
Luc
 knock-in mice are therefore utilized as a real time reporter of circadian 
rhythms in mice. Homozygous individuals were then obtained from JAX mice 
(USA) via Charles River (U.K), and a breeding colony established in NUI 
Maynooth.  Mice homozygous for this mutation show no alterations in the circadian 
behaviour or in entrainment parameters (Yoo et al., 2004).   At the beginning of each 
experiment these animals were between 8 and 10 weeks old and were used for the 
duration of these experiments up until the age of approximately 4 months. 
4.2.2. Analysis of clock gene expression following induction of sepsis 
In order to assess whether previous induction of sepsis has long-lasting 
effects on the profiles of clock genes expression in the SCN across the 24hr circadian 
cycle, adult male mice were group housed in colonies of ten in cages equipped with 
appropriate environmental enrichment under a 12:12 LD (150 lux, lights on 0700h) 
cycle for two weeks prior to treatment to allow for habituation. Animals were then 
treated with either LPS 5mg/kg i.p. injection (n=3 or 4 per time point) or saline 
vehicle (n=3 or 4 per time point).  The animals were allowed to recover from the 
immune challenge for one month, during which time they were maintained under the 
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12:12 LD cycle. Following this, they were transferred into constant darkness (0 lux) 
for two cycles. 
On the third cycle, the animals were sampled in dim red light (<1 lux) every 
4 hours across the twenty four hour circadian cycle.  Animals were terminally 
anaesthetized with 0.1ml i.p. sodium pentobarbital under dim red light (<1 lux) and 
underwent transcardiac perfusion (outlined in section 3.2.3) at CT2, CT6, CT10, 
CT14, CT18 and CT22 as outlined previously (Beynon and Coogan, 2010). All 
brains gathered were subsequently processed for immunohistochemical staining 
(outlined in section 3.2.4) for the clock gene protein products PER1, PER2, and 
CLOCK and the immediate early gene c-Fos.  Details of all primary antibodies used 
are detailed in Table 4.  
 
Table 4: Primary Antisera used for Immunohistochemical analysis: 
Antibody Dilution Raised in Supplier Product Code 
c-Fos (4) 1:2000 Rabbit Santa Cruz 
Biotechnology 
sc-52 
Per1(N20) 1:500 Goat Santa Cruz 
Biotechnology 
sc-7724 
Per2 (E-
20) 
1:1000 Rabbit Alpha Diagnostics, 
Texas USA.  
PER21-A 
Clock (H-
276) 
1:500 Goat Santa Cruz 
Biotechnology 
sc-25361 
 
For each individual animal and each antibody, 3-6 SCN images were 
examined by means of visual quantification of the number of immunoreactive nuclei 
in the SCN, viewed with the light microscope as previously outlined in section 3.2.5, 
and a mean value obtained for each animal at each time point for each clock gene 
protein antibody for all SCN regions of interest. These values were calculated for 
each animal by two researchers.  The observers were blinded to the experimental 
procedure during quantification of immunoreactive cells per SCN. The means 
calculated for each animal in both groups at each time point were compared and 
analysed by two way between groups ANOVA, with circadian time and treatment as 
the between groups factors.  Results are given as mean values (immunoreactive cell 
number per SCN slice) + standard error of the mean, statistical significance was 
accepted at P<0.05. 
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4.2.3. Cosinor Analysis:  
In order to analyze the individual 24-h cycle of expression of each clock gene 
protein products in the SCN and confirm if the rhythm was indeed circadian in 
nature, a previously described cosinor method was utilized (Nelson et al., 1979).  
The CircWave 1.4 analyses software (developed by Dr. R.A. Hut, 2007, 
http://www.euclock.org) employs a forward linear harmonic regression to calculate 
the profile of the wave with a 24hr period for independent samples utilizing the 
following function: 
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 Where: a=average; i=1, 2, 3, indicating the fundamental wave, the first harmonic, 
the second harmonic, …. (i-1)th harmonic; pi is the sine coefficient of the (i-1)
th
 
harmonic and qi the coefficient of the (i-1)
th
 harmonic; t=timepoint value (modulo τ); 
f(t) is the calculated function value at time point t.  Where: y is the fitted value for 
time point t; a and b are linear estimates for the sine and cosine contribution to a flat 
line (when i=0), the fundamental wave (i=1), first harmonic (i=2), second harmonic 
(i=3), etc.  A 24 hour rhythm was confirmed if the null amplitude hypothesis was 
rejected from an F test producing a significant value P<0.05.  Values for the 
amplitude, acrophase and rhythm adjusted mean level during the 24 hour cycle were 
also provided through the cosinor analysis. 
4.2.4. PER2::LUC Experiments 
In order to assess circadian dynamics in real-time in post-septic animals and 
saline controls, adult male mPer2
Luc
 knock-in (B6.129S6-Per2
tm1Jt
/J) mice from the 
NUI Maynooth breeding colony were utilized.  Adult male and female 
mPer2
Luc
 knock-in (B6.129S6-Per2
tm1Jt
/J) mice previously obtained from Charles 
River, UK., were bred in-house.  After weaning, animals were group housed 
according to sex in colonies of 3 in cages equipped with appropriate environmental 
enrichment and habituated to a 12:12 LD cycle for 2 weeks (150 lux, lights on 
0700h) prior to experimentation.  The animals were treated with either LPS 5mg/kg 
intra peritoneal injection (n=4) or saline (n=5).  The animals were allowed to recover 
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following the induction of sepsis and were maintained for 1 month under a 12:12 LD 
cycle. 
For the purposes of culturing SCN explants, 70% ethanol was used to 
sterilize any reusable equipment prior to use, these were then placed for 30min under 
ultraviolet (UV) light in a sterile tissue culture hood to ensure sterilization.  All 
procedures described below were carried out rapidly to ensure the tissue remained 
living. 
One month following the initial LPS 5mg/kg treatment, at ZT4-5, animals 
were culled by means of cervical dislocation, brains were carefully and rapidly 
removed and placed on filter paper (Whatman, Sigma, UK) and a few drops of ice 
cold Hank‘s Balanced Salt Solution (HBSS, consisting of 100ml Hanks‘ balanced 
salt solution 10X, H1641, Sigma, U.S.A.; 4.7ml sodium bicarbonate solution (7.5%, 
Sigma); 10ml 1M HEPES buffer (Sigma) and 10ml penicillin-streptomycin (10,000 
unit/ml-10,000 µg/ml, Gibco, Invitrogen, U.S.A., dissolved in autoclaved Milli-Q 
water with the total volume adjusted to 1 litre and kept at 4°C prior to use) added 
immediately.  The brain was cut caudally removing the cerebellum and rostrally to 
remove the preoptic region with a single edged razor blade.  The brain was then 
fixed onto the metal block of a manual advance Vibratome (World Precision 
Instruments), using the least amount of cyanoacrylate glue necessary (Bostik) with 
the caudal cut surface attached to the block.  The ventral aspect of the brain was 
positioned to face the vibrating double edged blade, which was angled at 180°. The 
block was then fixed in place in the vibroslice, and the block and attached tissue 
submerged in ice cold HBSS for sectioning.  2-3 coronal sections of 300µm 
thickness containing the SCN were cut through the live brain.  The 300µm live brain 
slice containing the optimum mid SCN region was selected and viewed under a 
dissecting microscope (Accuscope) and the paired SCN nuclei and retrochiasmatic 
area identified and isolated from the slice with the aid of two scalpels.  Each 
individual tissue sample was then placed aseptically onto a Millicell culture 
membrane (Millipore, Ireland) in a 35mm petri dish (Corning, U.S.A.) with 1ml of 
sterile recording medium consisting of Dulbeccos Modified Eagles Medium 
(DMEM, with L-glutamine, 1000mg glucose, without phenol red, supplemented with 
3.5g of D-glucose powder, Sigma), 4.7ml sodium bicarbonate solution, (7.5%, 
Sigma), supplemented with 10 mM Hepes buffer (pH 7.2, Sigma), and  2.5ml 
Penicillin-streptomycin (10,000 unit/ml-10,000 µg/ml, Gibco).  All contents were 
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dissolved in autoclaved Milli-Q water and the final volume adjusted to 1 litre and 
stored at 4°C prior to use. 0.1 mM beetle luciferin potassium salt (Promega, U.S.A.) 
was then added just prior to the luciferase activity assay.  The medium was used at a 
temperature of 37°C.  Autoclaved vacuum grease (Sigma) was applied around the 
edge of the culture dish and a 40mm coverslip lid (VWR) placed on top to seal the 
dish, providing an airtight environment, preventing evaporation of the medium and 
therefore equipped with the appropriate nutrition, moisture and oxygen supply for 
maintenance of the slice.  A waterproof, light tight, 37°C incubator (Memmert, 
Schwaback) fitted with Photomultiplier Tube (PMT) detector assemblies (Hamamtsu 
Photonics. U.K., LTD.) was utilized for continuous monitoring of bioluminescence 
rhythms from individual SCN culture explants for each animal in both treatment 
groups for a period of ten days. 
The bioluminescence emitted from each individual SCN tissue culture was 
immediately calculated using Living Image 3.2 software (PMTmonTTL Software by 
Dr. Shin Yamazaki) and bioluminescence value recorded for one of every two 
minutes over a period of ten days.  An adjacent averaging method with three hour 
running means was utilized to smooth the data.  Data sets were de-trended, whereby 
the 24hr running average was subtracted from the raw data.  A twenty four hour 
running average was then calculated from the de-trended data, from which a 3hr 
running average was subsequently calculated.  The 3hr running average data was 
then used for analysis with software developed by Dr. R. Refinetti downloaded from 
www.circadian.org.  The Cosinor software (Cosinor.exe, version 2.03; designed by 
Dr. Refinetti) utilizes the cosinor method to calculate the mean amplitude and 
acrophase of the rhythm.  The LSP software (Lsp.exe, version 2.07; designed by Dr. 
Refinetti) utilizes the Lomb-Scargle periodogram procedure to calculate the 
circadian period of the rhythm.  A mean value was therefore obtained for each 
individual culture for the period, amplitude and acrophase of the bioluminescence 
rhythm.  The means calculated for each culture for each treatment group were 
compared and analysed by independent samples t-test.  Results are given as mean 
values + standard error of the mean, statistical significance was accepted at P<0.05. 
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4.2.5. Photic induction of immediate early gene expression in the SCN. 
In order to assess the long-lasting effects of sepsis induction on SCN 
functional activity, neuronal activation was examined following photic stimulation.  
In order to examine circadian function in this case, two groups of experimental 
animals were analysed under different experimental protocols, one where photic 
stimulation occurred while the animals were held under constant dark conditions, 
and the other where the experimental animals were maintained under a 12:12 LD 
cycle.   All animals were treated with either LPS 5mg/kg i.p. injection or Saline and 
were left to recover from the immune challenge prior to experimentation.  
For the purposes of the experiments under a 12:12 LD cycle, animals were 
group housed in colonies of ten with appropriate environmental enrichment and 
habituated to a 12:12 light dark cycle (150lux, light on 0700) for 14 days prior to 
treatment.  One month after treatment animals received a 30min light pulse (150 lux) 
at either ZT15 (Saline 7, LPS 5) or ZT22 (Saline 4, LPS 4). Animals were placed 
back in darkness for 30 min to allow for expression of c-Fos and were culled by 
means of cervical dislocation one hour after commencement of the light pulse.   
Brains were carefully removed and, immersion fixed in 4% PFA and processed for 
immunohistochemistry as outlined in section 3.2.4. 
For assessment of photic stimulation under constant dark conditions, 16 adult 
male mice singly housed in running wheel cages used for construction of the phase 
response curve were placed into a 12:12 LD cycle and maintained under this 
photoperiod for 14days.  The animals were transferred into constant darkness (0 lux) 
conditions for two cycles. On the third cycle, animals received a 150 lux, 30 min 
light pulse at either CT15 (Saline 4, LPS 4) or CT22 (Saline 4, LPS 4).  Animals 
were placed back in darkness for 30 min to allow for expression of the immediate 
early genes c-Fos, Arc and Egr-1, before being culled by means of cervical 
dislocation one hour after commencement of the light pulse.   Brains were carefully 
removed, immersion fixed and processed for immunohistochemistry as outlined in 
sections 3.2.3 and 3.2.4. 
For each individual animal, 3-6 SCN images were examined by means of 
manual quantification of the number of immunoreactive nuclei in the SCN as 
previously outlined in section 3.2.5, and a mean value obtained for each animal for 
each antibody for all SCN regions of interest. These values were calculated for each 
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animal by two researchers blind to the experimental procedure and the means for 
each groups were compared and analysed by independent samples t-test.  Results are 
given as mean values (cell number) + standard error of the mean, statistical 
significance was accepted at P<0.05. 
 
4.3. Results 
4.3.1. Analysis of clock gene expression following the induction of sepsis 
The molecular correlates of behavioural circadian rhythmicity were examined 
by assessing the rhythmic expression of clock genes following sepsis induction.  
Changes in the behavioural rhythm may be mimicked by the cycle of clock gene 
expression in the SCN. The experiment examined whether the induction of sepsis 
alters the expression of clock gene protein products PER1, PER2 and CLOCK and 
the IEG expression patterns in the SCN post-sepsis.   
4.3.1.1.  PER1 expression across the 24hr circadian cycle  
Two Way Repeated Measures ANOVA was utilized to assess statistically 
significant differences between groups in the mean expression of the clock gene 
protein product PER1 across the circadian cycle. There was a main effect of time on 
PER1 expression in the SCN (F5,26=14.77, P<0.001), but no effect of treatment 
(F1,26=2.32, P>0.05) and no significant interaction effect (F5,26=0.60, P>0.05).  
Analysis of the separate SCN subdivisions found there to be a significant effect of 
time on PER1 expression in the SCN core (F5,26=11.91, P<0.001), but no effect of 
treatment (F1,26=0.35, P>0.05), and no interaction effect (F5,26=0.54, P>0.05). There 
was a significant effect of time on PER1 expression in the SCN shell (F5,26=14.47, 
P<0.001), but no effect of treatment (F1,26=3.25, P>0.05) and no interaction effect 
(F5,26=1.44, P>0.05).  (Figure 4.1).   
Co-sinor analysis of PER1 expression in the SCN revealed the acrophase of 
expression to be at CT15.87 in controls and CT 16.27 in post-septic animals. The 
percentage of variance in PER1 expression accounted for by a 24 hour co-sine wave 
was found to be 91% in controls and 66% in post-septic animals.  
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Figure 4.1: Effects of previous sepsis on the expression of the clock gene product, 
PER1 in the SCN across the 24hr circadian cycle.  Expression patterns of PER1, 
were examined in the SCN of animals treated one month previous with either saline 
or LPS and then sampled every 4 hours across the 24 hour cycle in DD. (A) 
Representative photomicrographs of PER1 expression in the SCN of post-septic 
animals (n=3-4 per timepoint) and control animals (n=3-4 per timepoint) at CT2, 
CT6, CT10, CT14, CT18 and CT22 (scale bar = 100 µm).  (B) Graph illustrating 
quantification of levels of PER1 immunoreactive nuclei in the SCN at CT2, CT6, 
CT10, CT14, CT18 and CT22 and illustrating the expression pattern across the 
circadian cycle.  (C) Graphs illustrating quantification of levels of PER1 
immunoreactive nuclei in the SCN core and shell subdivisions at CT2, CT6, CT10, 
CT14, CT18 and CT22, illustrating the expression pattern across the circadian 
cycle.  
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4.3.1.2.  CLOCK expression across the 24hr circadian cycle 
Two Way Repeated Measures ANOVA was utilized to assess statistically 
significant differences between groups in the mean expression of the clock gene 
protein product CLOCK across the circadian cycle. There was no effect of time on 
CLOCK expression in the SCN (F5,29=1.99, P>0.05), no effect of treatment 
(F1,29=1.22, P>0.05) and no interaction effect (F5,29=0.23, P>0.05).   Analysis of the 
separate SCN subdivisions found there to be no effect of time on CLOCK expression 
in the SCN core (F5,29=1.20, P>0.05), no effect of treatment (F1,29=2.02, P>0.05), and 
no interaction effect (F5,29=0.79, P>0.05). There was no effect of time on CLOCK 
expression in the SCN shell (F5,29=2.33, P>0.05), no effect of treatment (F1,29=1.01, 
P>0.05) and no interaction effect (F5,29=0.20, P>0.05).  (Figure 4.2). 
Assessment of CLOCK expression in the SCN across the circadian cycle by 
Co-sinor analysis found the percentage of variance in CLOCK expression accounted 
for by a 24 hour co-sine wave to be similar in control (0%) and in post-septic 
animals (0%), since CLOCK is not rhythmically expressed in the SCN (Gekakis et 
al., 1998). 
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Figure 4.2: Effects of previous sepsis on the expression of the clock gene product 
CLOCK in the SCN across the 24hr circadian cycle.  Expression patterns of 
CLOCK, were examined in the SCN of animals treated one month previous with 
either saline or LPS and then sampled every 4 hours across the 24 hour cycle in DD. 
(A) Representative photomicrographs of CLOCK expression in the SCN of post-
septic animals (n=3-4 per timepoint) and control animals (n=3-4 per timepoint) at 
CT2, CT6, CT10, CT14, CT18 and CT22 (scale bar = 100 µm).  (B) Graph 
illustrating quantification of levels of CLOCK immunoreactive nuclei in the SCN at 
CT2, CT6, CT10, CT14, CT18 and CT22 and illustrating CLOCK expression across 
the circadian cycle.  (C) Graphs illustrating quantification of levels of CLOCK 
immunoreactive nuclei in the SCN core and shell subdivisions at CT2, CT6, CT10, 
CT14, CT18 and CT22, illustrating the expression pattern across the circadian 
cycle.  
 
4.3.1.3. PER2 expression across the 24hr circadian cycle  
Two Way Repeated Measures ANOVA assessed there to be a statistically 
significant between groups effect in the mean expression of PER2 in the SCN across 
the 24hr circadian time period, finding alterations in PER2 expression in the SCN of 
post-septic animals compared to controls.  There was a significant main effect of 
time on PER2 expression in the SCN (F5,30=16.23, P<0.001).  A main effect of 
treatment (F1,30=4.72, P<0.05) on PER2 expression in the SCN was found along with 
a significant time x treatment interaction (F5,30=4.26, P<0.01). Analysis of the 
separate SCN subdivisions found there to be a significant effect of time on PER2 
expression in the SCN core (F5,29=7.19, P<0.001), but no effect of treatment 
(F5,29=3.05, P>0.05) and no time treatment interaction effect (F5,29=1.5, P>0.05). 
There was a significant effect of time on PER2 expression in the SCN shell 
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(F5,30=17.87, P<0.001), but no effect of treatment (F5,30=3.95, P>0.05) and no time 
treatment interaction effect. (F5,30=4.61, P>0.05). (Figure 4.3).   
Additionally, independent t-test analysis of SCN PER2 expression at CT14 
found a statistically significant difference between groups, with significantly lower 
levels of PER2 immunoreactive cells in the SCN of post-septic animals (110.88 + 
46.5 ir. cells/SCN) vs. controls (287.17 + 9.73 ir. cells/SCN; P<0.05). When 
analysing the separate subdivisions of the SCN by independent t-test at CT14, the 
mean number of immunoreactive PER2 cells was found not to be significantly 
different in the ventrolateral core of the SCN between the groups (saline, 66.89 + 
9.77 ir. cells/SCN vs. LPS, 32.21 + 16.08 ir. cells/SCN; P>0.05), but was found to be 
significantly different at the level of the dorsomedial shell between groups (saline, 
212.06 + 6.9 ir. cells/SCN vs. LPS, 78.5 + 31.54 ir. cells/SCN; P<0.05). 
Examination of PER2 expression in the SCN by co-sinor analysis revealed 
the acrophase of PER2 expression to be shifted from CT15.9 in control animals to 
CT17.5 in post-septic animals, and that the percentage of variance in PER2 
expression accounted for by a 24 hour co-sine wave is reduced from 91% in controls 
to 38% in post-septic animals.  
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Figure 4.3: Effects of previous sepsis on the expression of the clock gene product, 
PER2 in the SCN across the 24hr circadian cycle.  Expression patterns of PER2, 
were examined in the SCN of animals treated one month previous with either saline 
or LPS and then sampled every 4 hours across the 24 hour cycle in DD. (A) 
Representative photomicrographs of PER2 expression in the SCN of post-septic 
animals (n=3-4 per timepoint) and control animals (n=3-4 per timepoint) at CT2, 
CT6, CT10, CT14, CT18 and CT22 (scale bar = 100 µm).  (B) Graph illustrating 
quantification of levels of PER2 immunoreactive nuclei in the SCN at CT2, CT6, 
CT10, CT14, CT18 and CT22 and illustrating the expression pattern across the 
circadian cycle. Note the significant change of expression of PER2 in the SCN of 
LPS treated animals. (C) Graphs illustrating quantification of levels of PER2 
immunoreactive nuclei in the SCN core and shell subdivisions at CT2, CT6, CT10, 
CT14, CT18 and CT22, illustrating the expression pattern across the circadian 
cycle.   
 
4.3.1.4.  c-Fos expression across the 24hr circadian cycle  
Two Way Repeated Measures ANOVA was utilized to assess statistically 
significant differences between groups in the mean expression of the IEG c-Fos 
across the 24hr circadian cycle. There was no effect of time on c-Fos expression in 
the SCN (F5,31=0.45, P>0.05), as well as no effect of treatment (F1,31=0.21, P>0.05) 
and no interaction effect (F5,31=0.71, P>0.05). Analysis of the separate SCN 
subdivisions found a main effect of time on c-Fos expression in the SCN core 
(F5,31=0.33, P<0.05), no effect of treatment (F1,31=0.14, P>0.05), and no interaction 
effect (F5,31=0.86, P>0.05). There was also a main effect of time on c-Fos expression 
in the SCN shell (F5,31=0.03, P<0.05), no effect of treatment (F1,31=0.40, P>0.05) and 
no interaction effect (F5,31=0.80, P>0.05).  (Figure 4.4) 
Co-sinor analysis of c-Fos expression in the SCN revealed the acrophase of 
expression to be at CT2.07 in controls and CT9.9 in post-septic animals. The 
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percentage of variance in c-Fos expression accounted for by a 24 hour co-sine wave 
was found to be similar in control (0%) and in post-septic animals (0%).  
 
Figure 4.4: Effects of previous sepsis on the expression of the IEG c-Fos in the 
SCN across the 24hr circadian cycle.  Expression patterns of c-Fos, were examined 
in the SCN of animals treated one month previous with either saline or LPS and then 
sampled every 4 hours across the 24 hour cycle in DD. (A) Representative 
photomicrographs of c-Fos expression in the SCN of post-septic animals (n=3-4 per 
timepoint) and control animals (n=3-4 per timepoint) at CT2, CT6, CT10, CT14, 
CT18 and CT22 (scale bar = 100 µm).  (B) Graph illustrating quantification of 
levels of c-Fos immunoreactive nuclei in the SCN at CT2, CT6, CT10, CT14, CT18 
and CT22 and illustrating c-Fos expression across the circadian cycle.  (C) Graphs 
illustrating quantification of levels of c-Fos immunoreactive nuclei in the SCN core 
and shell subdivisions at CT2, CT6, CT10, CT14, CT18 and CT22, illustrating the 
expression pattern across the circadian cycle.  
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4.3.2. PER2::LUC Experiments 
The cosinor method was used to calculate the mean period, amplitude and 
acrophase of the PER2::LUC rhythm for both saline treated controls and post-septic 
animals, and a mean value was obtained for each individual culture for the period, 
amplitude and acrophase of the bioluminescence rhythm and subsequently assessed 
between groups by independent t-test analysis. Rhythm amplitude was not found to 
be significantly different between post-septic animals (7830.00 + 2654.51) and 
saline controls (9225.00 + 2705.05, P>0.05).  The acrophase values for the 
PER2::LUC rhythms were found to be similar between post-septic animals (10.11 + 
0.87) and controls (10.98 + 0.68, P>0.05, independent t-test).  The Lomb-Scargle 
periodogram procedure was used to calculate the circadian period of the PER2::LUC 
rhythm for both saline treated controls and post-septic animals, and a mean value 
obtained for each individual culture for the period of the bioluminescence rhythm 
and subsequently assessed between groups by independent t-test analysis.  
Comparison of mean PER2::LUC period values between post-septic treated animals 
and saline controls by independent t-test found there to be no significant differences 
between the treatment groups (saline, 24.27 + 0.23 hrs vs. LPS, 24.54 +  0.17 hrs , 
P>0.05).  (Figure 4.5). 
 
 
 
 
 
 
Figure 4.5: Circadian rhythms in PER2::LUC expression in post-septic animals 
and saline treated controls. (A) Representative plots of de-trended PER2::LUC 
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bioluminescence rhythms from SCN cultures from animals treated one month 
previous with either saline (n=5) or LPS (n=4) and maintained under 12:12 L:D 
conditions. Bioluminescence is plotted as time from culture preparation. (B) Bar 
graphs illustrating PER2::LUC amplitude, acrophase and period values.  
 
4.3.3. Analysis of circadian function through examination of SCN neuronal 
activation 
4.3.3.1.  Photically induced c-Fos expression following a 30min light pulse at ZT15 
c-Fos expression was assessed in the SCN following a 30min LP at ZT15 by 
immunohistochemistry, and subsequent analysis of levels of Fos immunoreactivity 
between the treatment groups by manual quantification found there to be no 
significant differences in c-Fos immunoreactive nuclei in the SCN between post-
septic animals (178.0 + 15.47 ir.cells/SCN) and vehicle treated controls (197.57 + 
18.86 ir.cells/SCN; P>0.05, independent t-test).  Independent t-test analysis of mean 
expression values of c-Fos in the SCN subdivisions revealed no statistically 
significant differences in mean expression between groups in the different SCN 
subregions, with similar expression levels in the core (saline, 47.49 + 10.37 vs. LPS, 
38.60 + 5.16 ir.cells/SCN, P>0.05) and shell regions of the SCN (controls 160.78 + 
5.95 vs. LPS 144.04 + 4.90 ir.cells/SCN, P>0.05). (Figure 4.6). 
 
 
 
 
 
 
Figure 4.6: c-Fos expression is not altered in the SCN of post-septic animals 
following photic stimulation at ZT15.  (A) Representative photomicrographs of c-
Fos expression in the SCN of post-septic animals (n=5) and control animals (n=7) 
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following 30 minute light pulses delivered at ZT15 (scale bar = 100 µm).  Dashed 
line outlines the SCN and delineates the shell and core subdivisions. (B) Bar graphs 
illustrating quantification of levels of c-Fos immunoreactive nuclei in the SCN of 
control and post-septic animals in response 30min light pulses at ZT15.   
4.3.3.2. Assessment of photically induced c-Fos expression at ZT22   
In response to 30min photic stimulation at ZT22, immunohistochemistry for 
c-Fos expression and subsequent analysis of  levels of Fos immunoreactivity 
between the treatment groups, found there to be a significant difference in c-Fos 
immunoreactive nuclei in the SCN of post-septic animals (43.5 + 2.40 ir.cells/SCN) 
when compared to saline treated controls (78.0 + 6.12 ir.cells/SCN; P<0.01, 
independent t-test).  A significant difference in c-Fos expression was also found in 
the SCN subdivisions, with a downregulation in the mean values of photically 
induced Fos in post-septic animals both in the ventrolateral core of the SCN (15.8 + 
1.16 ir.cells/SCN) compared to saline controls (27.0 + 1.54 ir.cells/SCN; P<0.001, 
independent t-test) and in the dorsomedial shell, (LPS, 29.67 + 2.44 ir.cells/SCN vs. 
saline controls, 50.75 + 5.21 ir.cells/SCN; P<0.01, independent t-test). (Figure 4.7).   
 
 
 
 
 
 
 
 
 
Figure 4.7: Alterations in neuronal activation in the SCN of post-septic animals 
following photic stimulation at ZT22.  (A) Representative photomicrographs of c-
Fos expression in the SCN of post-septic animals (n=4) and control animals (n=4) 
following photic stimulation at ZT22 (scale bar = 100 µm).  (B) Bar graphs 
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illustrating quantification of levels of c-Fos immunoreactive nuclei at the mid rostro-
caudal level of the SCN, in the SCN ventrolateral core and in the dorsomedial shell 
of the SCN of control and post-septic animals.  **P<0.01, ***P<0.001. 
 
4.3.4. IEG expression following photic stimulation at CT15 and CT22 
4.3.4.1.  c-Fos expression in the SCN of post-septic animals following photic 
stimulation at either CT15 or CT22. 
In response to 30min photic stimulation at CT15, immunohistochemistry for 
c-Fos expression and subsequent analysis of  levels of Fos immunoreactivity 
between the treatment groups found there to similar levels of c-Fos immunoreactive 
nuclei in the SCN of post-septic animals (171.08 + 7.08 ir.cells/SCN) and saline 
treated controls (161.86 + 11.35 ir.cells/SCN, P>0.05, independent t-test; Figure 
4.8).  Independent t-test analysis of mean expression values of c-Fos in the SCN 
subregions assessed there to be no statistically significant differences in mean 
expression between groups in the different subregions, with similar expression levels 
in the core (saline, 77.42 + 6.67 vs. LPS, 80.25 + 4.27 ir.cells/SCN, P>0.05) and 
shell regions of the SCN (controls, 84.46 + 12.43 vs. LPS 90.83 + 4.59 ir.cells/SCN, 
P>0.05). 
Comparison of photically induced c-Fos expression at CT22 combined with 
independent t-test analysis of  levels of Fos immunoreactive nuclei levels in the SCN 
between the treatment groups found there to similar levels of c-Fos immunoreactive 
nuclei in the SCN of post-septic animals (117.85 + 13.07 ir.cells/SCN) and saline 
treated controls (113.17 + 5.57 ir.cells/SCN, P>0.05; Figure 4.8).  Independent t-test 
analysis of mean expression values of c-Fos in the different SCN subregions 
assessed there to be no statistically significant differences in mean expression 
between groups, with similar expression levels in the core (saline, 48.96 + 2.89 vs. 
LPS, 52.73 + 6.38 ir.cells/SCN, P>0.05) and shell regions of the SCN (controls 
64.21 + 4.23 vs. LPS 65.13 + 7.42 ir.cells/SCN, P>0.05). 
179 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: c-Fos expression in the SCN of post-septic animals following photic 
stimulation at either CT15 or CT22.  (A) Representative photomicrographs of c-Fos 
expression in the SCN of post-septic animals (n=4 per timepoint) and control 
animals (n=4 per timepoint) following 30 minute light pulses delivered at either 
CT15 or CT22 (scale bar = 100 µm).  (B) Bar graphs illustrating quantification of 
levels of c-Fos immunoreactive nuclei in the SCN of control and post-septic animals 
in response to 30min light pulses at both CT15 and CT22.   
 
4.3.4.2.  EGR-1 expression in the SCN of post-septic animals following photic 
stimulation at either CT15 or CT22. 
In response to a 30min light pulse (LP) at CT15, immunohistochemistry for 
EGR-1 expression and subsequent analysis of levels of EGR-1 ir nuclei in the SCN 
by manual quantification coupled with independent t-test analysis found levels of 
EGR-1 ir nuclei in the SCN of post-septic animals to be analogous to controls, with 
mean levels of 190.67 + 18.35 and 142.44 + 23.14 ir. cells/SCN respectively 
(P>0.05; Figure 4.9).  Independent t-test analysis of mean expression values of EGR-
1 in the different SCN subdivisions found there to be no differences in mean 
expression levels between groups, with similar expression levels in the 
retinorecipient core (saline, 80.38 + 16.27 vs. LPS, 106.79 + 16.33 ir.cells/SCN, 
P>0.05) and in the dorsomedial shell regions of the SCN (controls, 62.06 + 14.38 vs. 
LPS, 83.88 + 7.94 ir.cells/SCN, P>0.05). 
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In response to 30min photic stimulation at CT22, EGR-1 
immunohistochemical analysis coupled with manual quantification of EGR-1 ir 
nuclei in the SCN followed by independent t-test analysis found levels of EGR-1 ir 
nuclei in the SCN of post-septic animals to be similar between control and post-
septic animals with mean levels of 60.83 + 10.52 and 87.00 + 8.39 ir. cells/SCN 
respectively (P>0.05; Figure 4.9). Furthermore, there were no statistically significant 
differences in mean expression levels of EGR-1 in the different SCN subdivisions, 
with similar expression levels in the retinorecipient core (saline, 30.42 + 4.36 vs. 
LPS, 39.96 + 4.58 ir.cells/SCN, P>0.05) and in the dorsomedial shell regions of the 
SCN (controls, 30.42 + 6.66 vs. LPS 47.04 + 6.03 ir.cells/SCN, P>0.05). 
 
 
 
 
 
 
 
 
 
Figure 4.9: EGR-1 expression in the SCN of post-septic animals following photic 
stimulation at either CT15 or CT22.  (A) Representative photomicrographs of EGR-
1 expression in the SCN of post-septic animals (n=4 per timepoint) and control 
animals (n=4 per timepoint) following 30 minute light pulses delivered at either 
CT15 or CT22 (scale bar = 100 µm).  (B) Bar graphs illustrating quantification of 
levels of EGR-1 immunoreactive nuclei in the SCN of control and post-septic 
animals in response to 30min light pulses at both CT15 and CT22.   
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4.3.4.3. ARC expression in the SCN of post-septic animals following photic 
stimulation at either CT15 or CT22. 
Photic stimulation at CT15 and Immunohistochemical analysis of ARC 
expression and subsequent analysis of  levels of ARC immunoreactive nuclei by 
manual quantification between the treatment groups, found there to similar levels of 
ARC ir nuclei levels in the SCN of post-septic animals (23.31 + 4.91 ir.cells/SCN) 
and saline treated controls (22.88 + 4.64 ir.cells/SCN, P>0.05, independent t-test; 
Figure 4.10).  Independent t-test analysis of ARC ir. nuclei in the SCN subdivisions 
revealed no statistically significant differences in mean expression values between 
groups in the independent subdivisions, with similar expression levels in the core 
(saline, 11.38 + 2.34 vs. LPS, 9.54 + 2.41 ir.cells/SCN, P>0.05) and shell regions of 
the SCN (controls 11.50 + 2.41 vs. LPS, 13.77 + 2.57 ir.cells/SCN, P>0.05). 
Photically induced ARC expression following a 30min light pulse at CT22 
was assessed by immunohistochemistry and manual quantification of ir. nuclei 
between the treatment groups, finding no differences in the levels of ARC ir nuclei 
in the SCN of post-septic animals (15.88 + 5.39 ir.cells/SCN) and saline treated 
controls (11.17 + 3.33 ir.cells/SCN, independent t-test; Figure 4.10).  Independent t-
test analysis found no statistically significant differences in mean expression values 
between groups in the different SCN subdivisions, with similar ARC expression 
levels in the SCN core (saline, 4.91 + 2.07 vs. LPS, 7.75 + 3.27 ir.cells/SCN, 
P>0.05) and shell regions (controls 6.25 + 1.27 vs. LPS 8.13 + 2.19 ir.cells/SCN, 
P>0.05). 
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Figure 4.10: ARC expression in the SCN of post-septic animals following photic 
stimulation at either CT15 or CT22.  (A) Representative photomicrographs of ARC 
expression in the SCN of post-septic animals (n=4 per timepoint) and control 
animals (n=4 per timepoint) following 30 minute light pulses delivered at either 
CT15 or CT22 (scale bar = 100 µm).  (B) Bar graphs illustrating quantification of 
levels of ARC immunoreactive nuclei in the SCN of control and post-septic animals 
in response to 30min light pulses at both CT15 and CT22.   
 
4.4. Discussion  
Oscillations of components of the molecular clock in both the SCN and the 
sites of other oscillators are known to drive circadian rhythms of behaviour.  Since 
various studies have shown that proinflammatory mediators induced in response to 
LPS treatment impact upon the expression of clock genes, we examined the 
oscillations of core molecular clock components in the SCN to determine whether a 
molecular correlate existed for the behavioural phenotype exhibited by our LPS 
treated animals.  To the best of our knowledge, the current study is the first to 
describe long-lasting alterations in the circadian expression of clock genes in the 
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SCN following a sepsis inducing procedure, as well as perturbations in photically 
induced IEG expression. 
The current set of studies set out to examine the two different patterns of c-
Fos expression known to occur in the SCN, that in the SCN core which is observed 
in response to photic stimulation (Cai et al., 1997; Guido et al., 1999b; Schwartz et 
al., 1995; Schwartz et al., 2000) and is suggested to be involved in photic 
entrainment (Aronin and Schwartz, 1991; Colwell and Foster, 1992;  Schwartz et al., 
2000) and in rhythm maintenance, and that in the dorsomedial shell which is 
spontaneously expressed across the circadian cycle under constant conditions  
(Guido et al., 1999b; Schwartz et al., 2000; Sumova et al., 1998), and has been 
suggested to possibly play a role in the generation of endogenous rhythms (Guido et 
al., 1999a; Schwartz et al., 2000).  Alterations in the pattern of spontaneous c-Fos 
expression might parallel alterations in behavioural rhythmicity, however the current 
study observes no alterations in spontaneous c-Fos expression in post-septic animals, 
and the rhythmic pattern observed in both treatment groups is in line with that 
described by other studies (Sumova et al., 1998), showing rhythmic expression in the 
SCN shell (Chambille et al., 1993; Guido et al., 1999b; Schwartz et al., 2000), and 
peak expression at CT2 (Guido et al., 1999b, Sumova et al., 1998).  These findings 
might reflect the observations from the current study that there are no alterations in 
any of the core circadian behavioural parameters examined in post-septic animals 
under constant conditions.  The post-septic behavioural attenuations observed all 
involve interactions with light (Chapter 2), and it is therefore more likely that 
alterations in photically induced c-Fos would be observed in post-septic animals. 
SCN pacemaker function was assessed by examining IEG expression as 
molecular markers of SCN neuronal activation in response to a light pulse in post-
septic animals and saline controls. Photic stimulation during the subjective night 
causes rapid induction of c-Fos in the SCN within an hour of exposure and is 
associated with photic induced phase shifts of free running locomotor activity 
(Kornhauser et al., 1990; Rusak et al., 1990; Ebling et al., 1991; Mead et al., 1992).  
Given that these studies observe alterations in photic phase advance resetting, it was 
somewhat surprising that when photically induced c-Fos expression was examined in 
the SCN in the late subjective night at CT22, paralleling the conditions under which 
photically induced phase advance resetting attenuations were observed, there were 
184 
 
no alterations in c-Fos immunoreactivity in the SCN of post-septic animals. 
Similarly, there were no alterations in immunoreactivity of the photically inducible 
IEG EGR-1 in the SCN in response to photic stimulation at either timepoint in the 
subjective night in post-septic animals compared to controls.   Additionally, we 
examined the effector IEG product ARC in the SCN, since chronic 
neuroinflammation induced by centrally delivered LPS has been shown to impact 
upon the expression of ARC in the hippocampus (Rosi et al., 2005), however ARC 
was not found to be altered in the SCN.  These findings may be in line with those of 
Palomba and Bentivolgio (Palomba and Bentivoglio, 2008), who have shown 
photically induced c-Fos in the early subjective night to be attenuated 7 days after 
the final LPS treatment of a 2 month treatment regime consisting of weekly 
injections with LPS 1mg/kg, but similar to what is described in these studies, they 
observed no alterations in photically induced c-Fos 30 days after the last LPS 
treatment.  Studies have suggested that the levels of Fos induced in the SCN 
correlate with the magnitude of the daily phase shift required for stable entrainment 
(Beaule and Amir, 1999) and the current study therefore highlights a dissociation in 
the relationship between phase shift magnitude and c-Fos expression in response to 
light in the late subjective night under DD conditions, however in line with this, we 
do not observe any alterations between the treatment groups in c-Fos induction in the 
SCN in response to a phase delaying light pulse in either DD or in LD in response to 
photic stimulation in the early subjective night. 
Moreover, these studies highlight a dissociation between photically induced 
c-Fos expression in response to light in the late subjective night under steady state 
LD conditions and light induced c-Fos expression under housing in constant 
environmental conditions (DD). In general, photic stimulation at ZT22 results in 
lower levels of c-Fos induction in the SCN in both post-septic animals and controls 
compared to levels induced in response to photic stimulation at CT22.  However, 
under steady state LD, photic stimulation at ZT22 caused a statistically significant 
decrease in levels of photically induced c-Fos activation in the SCN of post-septic 
animals  in response to photic stimulation in the late subjective night (ZT22), but not 
in the early subjective night (ZT15), highlighting a marked alteration in neuronal 
activation and hence a functional attenuation in the master pacemaker of these 
animals under these conditions. Further, this shows alterations in post-septic SCN 
responsiveness at the portion of the phase response curve during which attenuations 
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in circadian behaviour are observed, since assessment of immediate early gene 
expression highlights variations in the responsiveness of neurons in the SCN (Mead 
et al., 1992). This altered c-Fos activation would tie in with the altered phase 
advancing light pulse responses shown in post-septic animals and with the 
attenuations in resynchronization to a phase advancing shift of the photoperiod.  
However it may be more likely that the photic stimulation during the subjective night 
while maintained under steady state LD conditions more closely reflects that of the 
post-septic animals when subjected to phase shifts of the photoperiod. 
Any perturbations found in SCN responsiveness and behavioural rhythmicity 
of post-septic animals were specific to phase advancing stimuli and all involve 
interactions between light and the timekeeping system.  It remains unclear why the 
current study observes alterations in photically induced c-Fos at ZT22, but no 
alterations in c-Fos expression when the light pulse was administered at CT22.  c-
Fos is thought to be involved in entrainment of the circadian system to the 
environmental LD cycle (Kornhauser et al., 1990) and this might reflect the altered 
re-entrainment rates observed in response to a phase advance of the photoperiod.  
Post-sepsis late subjective night photic Fos induction under DD and LD clearly 
varies, possibly owing to modification of an underlying mechanism that plays a role 
under conditions of stable entrainment but not under DD, since the alterations in 
photically induced c-Fos are only seen when maintained under a 12:12 LD cycle.  
Under DD conditions, the effects of light on the circadian system are only for the 
duration of the light pulse, whereas under an LD cycle, the animals are subject to a 
regular entraining photic influence and it is possible that the differences we observe 
in c-Fos expression at ZT22 could be due to the long-term presence of an entraining 
stimulus, and it may be that we are observing a prior effect of housing on post-septic 
SCN photically induced neuronal activation, however what underlies this remains to 
be investigated.  
While c-Fos is associated with circadian function and entrainment 
(Kornhauser et al., 1990), the precise role of c-Fos in the SCN in the generation of 
circadian oscillations is not fully understood and has yet to be clearly defined.  These 
studies observe dissociations between light induced Fos expression and the 
magnitude of phase shifts of behavioural rhythmicity, a situation which has been 
described by other experimental groups. It has previously been suggested that c-Fos 
expression levels do not directly determine phase shift amplitudes (Shimomura et al., 
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1998) and shown that increased c-Fos expression within the SCN is not necessary for 
all phase shifts of circadian locomotor activity (Mead et al., 1992), indicating that the 
relationship between phase-shifting and c-Fos induction is not completely inter-
reliant, and that light induced c-Fos may be involved in photic induced phase shifts 
but is not necessarily essential and therefore may simply contribute to normal 
entrainment.  Studies with mice lacking the PACAP-1 receptor, have shown 
exaggerated magnitude of phase delays in the early subjective night accompanied by 
a decrease in c-Fos induction (Hannibal et al., 2001), while in mice lacking the c-fos 
gene, photic responses are still seen and photic entrainment still occurs, however a 
blunted phase response curve with photic induced phase-shifting responses 
displaying a decrease in magnitude is observed (Honrado et al., 1996).  Additonally, 
photic c-Fos induction is seen to be maximal in the transition between the delay 
portion of the phase response curve and the advance portion, however during this 
time no photic induced phase shifts take place (Sutin and Kilduff, 1992).  Transgenic 
hypertensive TGR (mRen2)27 rats show no induction of c-Fos in response to light 
but display phase shifts of locomotor activity (Lemmer et al., 2000). Further, tau 
mutant hamsters display significant increases in phase shift amplitude after long 
periods, 49 cycles in DD, as opposed to the phase shift amplitudes shown when 
maintained under DD for 2 cycles, while c-Fos induction amplitude is similar 
irrespective of time spent in DD (Shimomura et al., 1998). Under the same irradiance 
levels, c-Fos amplitude has also been shown to be unaffected by certain 
pharmacological agents and anaesthetics, while phase shift amplitude is diminished 
(Colwell et al., 1993a, b).  Further, transgenic mice lacking rods, show Fos induction 
proportional to photon levels under varying irradiances, similar to that displayed by 
wildtype animals, while the amplitude of the phase shifts differ between the strains 
(Lupi et al., 1999).  Based on these studies, the photic induction of c-Fos has been 
suggested to be tightly correlated with direct input of light to the clock, and circadian 
locomotor activity output responses to be dependent on processes subsequent to this, 
such as feedback or neural integration from the molecular clockworks (Dkhissi-
Benyahya et al., 2000).  Indeed, this situation could explain the observations of the 
current study, where post sepsis, there is either no alteration in c-Fos induction in the 
SCN at CT22, or a decrease in c-Fos induction at ZT22 paralleling exaggerated 
phase shift magnitude and circadian resetting.  Our SCN locomotor output may be 
being influenced by mechanisms downstream from the initial SCN response, 
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resulting in alterations in behavioural rhythmicity.  Further, investigation is required 
to establish whether an input influence might play a role in post-septic SCN 
responsiveness under stable entrainment conditions. 
These findings could also indicate alterations in light processing, masking of 
the endogenous rhythm, or altered responsiveness of the circadian system across the 
24hr cycle.  Further, it is clear that all the alterations in behavioural rhythms and IEG 
expression are seen during the advance portion of the phase response curve, and 
alterations in the shape of the PRC could account for the changes seen both at a 
molecular level and behaviourally in the late subjective night.  The behavioural 
analysis and construction of the photic PRC of post-septic animals previously 
performed however indicate that this is not the case.  The PRC of post-septic animals 
is seen to be similar to that of controls, and therefore we cannot attribute molecular 
and functional alterations to perturbations in this. Addtionally, the behavioural 
studies have shown locomotor behaviour to be truly entrained and not seemingly 
entrained due to the effects of negative masking.  It does not appear that the dose of 
LPS used in this study is inducing cell loss in the SCN, since no changes were 
observed in apoptotic markers, as assessed by TUNEL analysis or cleaved caspase-3 
immunostaining 24 hours following LPS treatment, and therefore we do not believe 
that this could account for the reduced c-Fos expression in the SCN.  Given that IEG 
responses to photic stimulation are not altered in the SCN following photic 
stimulation in DD, it also appears as though there are no gross problems in light-
sensing or retinohypothalamic tract transmission to the SCN.  However, as 
previously mentioned, it‘s possible that when maintained under steady state LD 
conditions, there may be alterations in the photic sensitivity of the post-septic SCN 
across the circadian cycle, and this requires further investigation.  
It is reasonable to suggest that the presence and action of inflammatory 
mediators on the post-septic SCN may be impacting upon photically induced c-Fos.  
In trypanosome infected rats, photically induced c-Fos in the subjective night is 
significantly reduced in the SCN (Peng et al., 1994), indicating alterations in photic 
entrainment during infection and neuroinflammatory states.  Nitric Oxide has been 
suggested to play a role in photic induced phase shifts of the circadian system and its 
inhibition has been shown to attenuate SCN c-Fos induction following phase 
resetting photic stimulation, resulting in a decrease in expression (Amir and 
Edelstein, 1997).  Light induced phase advances at CT18, but not phase delays, and 
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photic induced c-Fos immunoreactivity at ZT18 have previously been shown to be 
blocked following administration of the NO scavenger  2-phenyl-4,4,5,5-
tetramethylimidazoline-1-oxyl-3-oxide  (Plano et al., 2007).  While the current study 
does not observe long-term alterations in nitric oxide expression in the post-septic 
SCN, alterations are evident in nitric oxide in the SCN in the acute phase following 
sepsis induction, and it‘s possible that alterations in nitric oxide signalling may 
initially impact upon or potentiate another mechanism which may be involved in the 
long-term alterations in photically induced c-Fos expression in the post-septic SCN 
that accompanies alterations in photic phase advance resetting. 
Various possibilities exist that could underlie this enhanced response in post-
septic animals.  There may be altered input to the SCN such as alterations in light 
input or in the threshold response of the SCN to light, variations within the SCN 
itself such as perturbations in the expression of clock genes, important SCN 
neuropeptides or intercellular coupling alterations within the nucleus, or 
modifications in the electrophysiological properties or coupling of SCN output to 
effector systems, or a combination of these. Factors restricting re-entrainment rates, 
limiting the photic responsiveness of the master pacemaker may be altered in post-
septic animals, however these are factors that remain unknown (LeGates et al., 
2009). Further assessment of these parameters is warranted in post-septic animals.   
Photic entrainment involves the activation of proteins that participate in the 
resetting of the transcription-translation feedback loop underpinning circadian 
oscillations (Meijer and Schwartz, 2003).  Alterations in clock gene expression in the 
post-septic SCN could account for altered behavioural resetting in post-septic 
animals, since oscillations of components of the molecular clock in both the SCN 
and the sites of other oscillators are known to drive circadian rhythms of behaviour, 
and these studies therefore examined the oscillations of core molecular clock 
components in the SCN, assessing the diurnal expression of the clock gene protein 
products PER1, PER2 and CLOCK in vivo. While normal patterns of CLOCK and 
PER1 expression were seen in post-septic animals, alterations in the PER2 
expression rhythm were found in the post-septic SCN, and the acrophase of PER2 
expression was delayed relative to controls.  A phase delay of PER2 expression 
would be expected to result in alterations of the free running period, since alterations 
in components of the clock should result in alterations of basic clock properties 
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(Dunlap, 1996) which would then be reflected under constant conditions where the 
properties of the endogenous oscillator can be observed.  Interestingly, however, 
there were no alterations in free running circadian parameters, despite SCN PER2 
expression being altered, and it is therefore possible that as opposed to the PER2 
rhythm being phase delayed, that it may be a reduction in peak PER2 expression that 
is observed in post-septic animals.  Somewhat surprisingly, there were no alterations 
in diurnal expression patterns of PER1 in the SCN between the treatment groups, 
and while reduction in PER1 expression in post-septic animals trended towards 
significance at CT14, this was not reached in our sample.  It is unclear why PER1 
and PER2 expression are not similarly affected in the post-septic SCN. Per2 is 
suggested to regulate Per1 in vivo (Zheng et al., 1999), and both PER1 and PER2 are 
involved in photic entrainment (Yan and Silver, 2004), and it might then be expected 
that alterations in expression would be present in PER1 in post-septic animals, since 
altered photic resetting responses are observed.  Studies assessing clock gene 
expression following low dose LPS treatment have shown neither Per1 nor Per2 
expression to be altered in the SCN (Takahashi et al., 2001), while LPS 1mg/kg 
treatment has been shown to acutely alter Per2 expression in the SCN, with a return 
to rhythmic expression levels the day after treatment (Okada et al., 2008), however 
these effects have not been examined in the long term following LPS administration. 
A disconnect between Per1 and Per2 expression perturbations has been shown in 
other studies in response to LPS treatment, with Per2 displaying significant 
reduction in expression in peripheral tissues while Per1 is only weakly reduced, and 
the reasons behind this remain unclear and the mechanisms remain to be established 
(Yamamura et al., 2010). Modulation through different signalling mechanisms may 
play a role in this.  Although these studies are in the periphery, it is possible that this 
is a situation which may be analogous to the observations of the current study.  
Further, other studies assessing the effects of chronic stress on SCN clock gene 
expression also observe a dampened PER2 expression in the SCN but no alterations 
in PER1 (Jiang et al., 2011).  PER1 and PER2 have differential functions in 
circadian rhythm regulation (Bae et al., 2001), as well as independent roles in 
circadian output (Zheng et al., 2001).  The differential effects of LPS treatment on 
clock gene protein product expression may reflect the differential involvement of 
these proteins in functions of the circadian system that may be attenuated post-
sepsis.   These clock genes display alternate functions in phase resetting and re-
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entrainment, showing differential responses to light, and this differential photic 
regulation further indicates distinct functions in the SCN (Zylka et al., 1998).   While 
studies have shown PER1 to be photically induced (Yan and Silver, 2004) and 
antisense oligonucleotides to Per1 can block resetting (Akiyama et al., 1999), mice 
lacking PER1 still show entrainment (Bae et al., 2001; Zheng et al., 2001), and 
studies by Reddy and colleagues (Reddy et al., 2002), have shown that PER1 may 
not be required for resetting following abrupt photoperiod shifts. PER2 is thought to 
play a critical role in the maintenance of circadian behavioural rhythmicity in both 
mice and humans.  Targeted disruption of Per2 involving deletion of 87 residues 
from the protein dimerization PAS domain (Per2
Brdm1
 mouse strain) has been shown 
to affect free running rhythms of locomotor behaviour, causing delayed loss of 
circadian rhythmicity in mice and unstable circadian rhythms (Zheng et al., 1999).  
Furthermore, PER2 expression in the SCN has previously been shown to have a 
direct link with behavioural circadian rhythms as evidenced by RNAi mediated 
knockdown of Per2 in the SCN, which has been shown to disrupt locomotor activity 
(Gavrila et al., 2008).  Since SCN PER2 plays important roles in rhythmic locomotor 
output, it is possible that the perturbations in PER2 expression in the current study 
underlie the altered circadian locomotor behavioural resetting in post-septic animals.  
Studies have suggested that attenuations in phase shift responses could be as 
a result of changes in clock genes or their protein products (Reddy et al., 2002; Yan 
and Silver, 2002; Yan and Silver, 2004), and it may be that the alterations in PER2 
expression in the post-septic SCN underlie the perturbations in circadian resetting.  
The subjective day is the time when maximal endogenous Per gene expression is 
observed, while peak protein product expression is 6-8hours after this (Reppert and 
Weaver, 2001), and both PER1 and PER2 proteins show the same endogenous 
circadian profile, with peak expression levels at the end of the subjective day and in 
the early subjective night, after which they decline and low levels of expression are 
observed in the late subjective night (Field et al., 2000).  Photic induced phase-
shifting of the molecular clock is seen to result in photically-induced Per1 gene 
expression in the dorsomedial shell following a phase advancing light pulse, while 
Per2 gene expression is seen to be induced in the SCN shell in association with 
phase delays (Yan and Silver, 2002).  The PER proteins have been shown to be 
differentially increased in the different SCN subregions in response to phase 
resetting photic stimulation depending on the portion of the PRC at which photic 
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stimulation occurs, and PER2 induction has been suggested to be important for phase 
delays, while PER1 induction is important for phase advances (Yan and Silver, 
2004). Given that Per2 induction appears to be involved in photic induced phase 
delays (Yan and Silver, 2002), it seems likely that alterations in PER2 expression 
might cause altered phase delays of locomotor behaviour.  In contrast to this, we 
observe no alterations in photic induced delay resetting in post-septic animals, and it 
is altered photic phase advance resetting that we observe in the current set of 
experiments.  Alterations in endogenous levels of PER expression could impact upon 
PER induction levels following the application of a phase resetting light pulse, 
resulting in alterations in photic phase-shifting responses.  Previous studies have 
shown a correlation between phase shift magnitude and light induced Per mRNA 
expression level (Shigeyoshi et al., 1997).  A molecular corollary exists between 
Per2 induction and the direction of the behavioural response to photic stimulation. 
Per2 is differentially induced in response to a phase resetting light pulse, with levels 
increasing slowly in response to a phase delaying light pulse, peaking at 2hrs 
following exposure and returning to baseline levels after 6 hours, while in response 
to a phase advancing light pulse at CT23, rapid induction of Per2 is observed within 
30 minutes of the LP, with levels returning to baseline levels within 2hrs (Zykla et 
al., 1998).  It‘s possible that there are alterations in Per2 induction in response to a 
phase advancing light pulse since perturbations in the induction could underlie why 
the differences observed in post-septic animals are all in the advance portion of the 
phase response curve or in response to advance resetting.   Additionally, the PER 
photic induction shows time dependant induction depending on the portion of the 
phase response curve at which light is applied (Yan and Silver, 2004), and it is 
possible that alterations in the rate of induction of PER proteins following a light 
pulse could underlie alterations in photic resetting.   
Further work is required to establish whether alterations in induction levels 
and/or induction rates of PER proteins, in particular PER2, are observed in post-
septic animals, and whether this might play a role in altered photic phase resetting.  
It would be interesting to assess PER2 expression in response to photic stimulation 
in both the advance and delay portions of the phase response curve in post-septic 
animals, since this could shed light on the mechanisms underlying altered resetting 
in post-septic animals.  
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Studies by Reddy et al., (Reddy et al., 2002) on clock gene expression 
following abrupt photoperiod shifts suggest that alterations in Per2/PER2 may be 
involved in the regulation of circadian entrainment, since the induction of Per2 
mRNA and PER2-IR has been shown during both advance and delay resetting to 
phase shifts of the photoperiod (Reddy et al., 2002).  These authors suggest that Per2 
is essential for photic entrainment, and the indirect photic regulation of Cry1 
expression in the SCN has previously been suggested to be a possible rate-limiting 
factor in behavioural re-entrainment during experimental jetlag. Following a photic 
phase advance, Per expression in the SCN resets rapidly and Cry1 expression 
synchronizes slowly, paralleling the transient resetting of locomotor activity seen in 
response to a phase advance, while the expression of Per and Cry was found to 
synchronously adjust rapidly in the SCN following a phase delay of the photoperiod, 
with the rapid readjustment of Cry expression suggested to underlie the rapid re-
entrainment of locomotor behaviour following a phase delay (Reddy et al., 2002).  
It‘s possible that the current studies observe alterations in the readjustment of clock 
gene expression following a phase advance of the light dark cycle, which could 
account for the significantly more rapid re-entrainment of post-septic animals to an 
advance of the photoperiod.  Additionally, it has been suggested that the dissociation 
of clock gene expression and their subsequent readjustment rates might play a role in 
phase advance resetting following single light pulses in free running DD conditions, 
however this remains to be examined (Reddy et al., 2002).  In the case of abrupt 
shifts of the photoperiod, these authors have shown that PER2 expression is 
endogenously high during resetting following a 6hr delay of the photoperiod, and 
light exposure maintains this expression, and at this time PER2 may impact upon 
Cry1 expression, since Cry1 and Per2 show synchronous expression.   However, 
PER2 levels are low initially following a 6hr advance, and photic induction of PER2 
levels may take time in this instance and impact upon Cry1 induction.  It would be 
interesting to assess the expression of these clock gene protein products following a 
phase advance of the photoperiod to examine whether alterations are present in the 
resetting of these which could play a role in the attenuation of locomotor behaviour 
seen in post-septic animals.  Further, alterations in endogenous levels of expression 
are seen in the current study and might cause alterations in induction levels and 
readjustment rates.  It is possible that the attenuation in PER2 oscillations revealed 
by these experiments could lead to altered output signals from the master pacemaker 
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and underlie the perturbations seen in circadian resetting responses in post-septic 
animals.   
It is important to establish whether the alterations in the post-septic circadian 
system are due to alterations within SCN properties, or are due to alterations in input 
to or output from the SCN.  Examination of the SCN in isolation would allow us to 
identify whether alterations in properties within the SCN itself are responsible for 
altered molecular oscillations and attenuated circadian locomotor rhythmicity in 
post-septic animals, as opposed to as a result of other influences outside of the SCN.  
Additionally, it was expected that examination of PER2::LUC post-septic SCN 
rhythms in vitro would clarify whether PER2 expression is truly delayed in post-
septic animals, or instead shows dampened expression at the peak of the rhythm.  
However, our assessment of PER2::LUC rhythmicity in vitro found there to be no 
alterations in PER2 oscillation properties between post-septic animals and saline 
controls.  In comparison to the in vivo assessment, in vitro, the SCN tissue is in 
isolation and not subject to the influence of signalling from any peripheral or non-
SCN oscillator site.  The time point at which PER2::LUC rhythms were examined 
coincides with time post sepsis induction at which perturbations were observed in 
circadian resetting, as well as with the attenuations in PER2 expression in the SCN, 
and photically induced IEG expression in vivo. These in vitro experiments therefore 
indicate that when the post-septic alterations in advance resetting take place that 
these are not due to perturbations manifesting within the SCN itself, but due to 
outside SCN in vivo influences. Therefore, the alterations in PER2 expression in the 
SCN in vivo, may be due to an in vivo influence.  In the long term post LPS induced 
sepsis, alterations may manifest in the circadian system at levels downstream from 
the SCN, by altering molecular oscillations in non-SCN central or peripheral 
oscillators that are important in the regulation of behaviour and physiological 
function.  Further, it may be that alterations are present at the level of input to the 
SCN.  Influences from oscillators outside of the SCN with post-septic attenuations 
may be feeding back to the SCN impacting upon the expression of PER2 and post-
septic circadian activity rhythms.   Therefore, while the changes in clock gene 
expression within the SCN may underlie attenuated post-septic circadian resetting, it 
appears that the mechanism responsible for the alterations in PER2 expression 
rhythms is outside of the SCN itself.  These results tie in with the previously 
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discussed late subjective night photically induced c-Fos observations which were 
also indicative of an underlying mechanism impacting upon the post-septic SCN, or 
attenuations in circadian timekeeping processes downstream of the SCN underlying 
alterations in post-sepsis behavioural resetting. 
It is clear that Per2 plays various roles in physiology, and a variety of studies 
have shown that Per2 mutant mice show alterations in physiological parameters.  
Per2 mutant mice show arrhythmic circadian locomotor behaviour in DD (Zheng et 
al., 1999), consume more alcohol (Spanagel et al., 2005), display enhanced 
sensitivity to cocaine (Abarca et al., 2002) and show altered feeding rhythms (Yang 
et al., 2009), with food consumption patterns in line with those seen in Clock mutant 
animals (Turek et al., 2005).   Further, mutant Per2 animals show a higher incidence 
of tumour development following ionizing radiation, displaying an abnormal 
response to DNA damage, highlighting the importance of Per2 in tumour 
suppression (Fu et al., 2002). Additionally, a mutation in Per2 in humans affecting 
the phosphorylation of hPER2 by casein kinase 1epsilon is implicated in familial 
advanced sleep phase syndrome (Toh et al., 2001). Relevant to the current studies, 
Per2 is suggested to play a unique role in the regulation of innate immune function 
(Liu et al., 2006) and Per2 mutant animals have been shown to be resistant to LPS 
induced endotoxic shock (Halberg et al., 1960), highlighting involvement of the 
clock gene in sepsis.  Further, Per2 expression has been shown to be altered in a 
variety of conditions with an inflammatory component, which could be why the 
current study observes altered PER2 expression in the post-septic SCN.   Treatment 
with endotoxin has been shown to transiently repress expression of Per2 and Dbp in 
the SCN, as well as the expression of Per2 and Per1 and other genes under circadian 
control in the periphery, with restoration of expression patterns 2days post the 
immune challenge (Okada et al., 2008; Cadivini et al., 2007).  In the liver of mice 
with experimental autoimmune encephalomyelitis which is characterized by the 
infiltration of immune cells into the CNS and the presence of inflammatory lesions 
as well as axonal loss in the brain, Per2 expression has been shown to be attenuated 
(Buenafe, 2012). In male patients with acute Q fever as a result of bacterial infection 
with the Coxiella burnetii (C. burnetii), Per2 has been demonstrated to be up-
regulated in the blood (Mehraj et al., 2012), while in female mice infected with C. 
burnetii, the expression of the clock genes Clock and Arntl were shown to be 
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reduced in the liver, while Per2 was shown to be up-regulated (Textoris et al., 2010).  
Continuous IFN-α administration is seen to reduce Per2 mRNA levels in the liver at 
ZT14 (Shinohara et al., 2008), while in fibroblasts in vitro and in the liver of mice in 
vivo, Per2 expression, as well as that of other clock genes, have been shown to be 
suppressed by TNF-α (Cavadini et al., 2007). More recently, in mouse embryonic 
fibroblasts deficient in Clock and expressing alterations in the NF-κB pathway 
component, RelB, TNF-α treatment results in lower levels of both Per2 and Dbp in 
comparison to TNF-α treated wild type cells (Bellet et al., 2012).  Further, the 
proinflammatory cytokines that are known to impact upon clock gene expression 
have also been shown to impact upon circadian behaviour, including TNF-α 
(Cavadini et al., 2007; Nygard et al., 2009), IL-6 (Motzkus et al., 2002), IL-1β 
(Cavadini et al., 2007), IFN-α (Ohdo et al., 2001; Koyanagi and Ohdo, 2002) and 
IFN-γ (Lundkvist et al., 2002; Kwak et al., 2008). Indeed, alterations in Per2 
expression following LPS treatment have been shown to coincide with alterations in 
circadian locomotor activity (Okada et al., 2008).  Together these studies highlight 
the impact inflammatory mediators exert on clock gene expression, including that of 
Per2, and it is possible that the long-term alterations we observe in PER2 expression 
in the post-septic SCN are due to the action of immune mediators on the SCN either 
directly or indirectly. 
While we do not observe any long-lasting alterations in the 
immunomediators examined in current set of experiments in the post-septic SCN, 
there may be long-lasting alterations in the expression of other immune mediators in 
the SCN that could potentially impact upon clock gene expression and underlie the 
chronic alterations observed in these studies.  Further, studies have shown long-
lasting upregulation of immune mediators in other regions of the CNS post LPS 
induced sepsis (Qin et al., 2007; Weberpals et al., 2009; Bossu et al., 2012) which 
could be impacting upon clock gene expression in extra-SCN sites within the CNS or 
regions that project to the SCN or are involved in the regulation of behavioural or 
physiological processes downstream from the SCN.  It is possible that cytokines are 
altering circadian timekeeping mechanisms through their action at extra-SCN sites, 
since the dorsomedial hypothalamaus, the arcuate nucleus, the habenula and the 
olfactory bulb are known to be sites of semi-autonomous oscillators (Guilding and 
Piggins, 2007), and additionally, these CNS regions are known to possess cytokine 
receptors (reviewed in Coogan and Wyse, 2008). Alterations in sites of other 
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oscillators might impair the ability of this site to efficiently process timing 
information communicated to it by the SCN, or impair synchronization to this 
information, and circadian rhythmicity may therefore be affected downstream from 
the SCN in regions such as these, thereby impacting upon output processes, 
modulating certain physiological and behavioural functions. Alterations in these 
CNS regions could in turn feedback and impact upon clock gene expression in the 
SCN itself.  This would be in line with the notion that it is an in vivo, outside of SCN 
influence impacting upon the post-septic SCN, since it is only in vivo that we 
observe altered PER2 expression, but not in vitro when the SCN is in isolation and 
not influenced by other oscillators in non-SCN central sites or in the periphery.  
The PVN is involved in regulation of autonomic and endocrine outputs, 
including the production of glucocorticoids (Kalsbeek et al., 2006). Marpegan and 
colleagues (Marpegan et al., 2005) have shown induction of c-Fos in the PVN 
following a phase resetting LPS treatment, and further, PER1 expression has also 
been shown to be induced in the PVN following administration of a phase resetting 
LPS dose (Paladino et al., 2010), indicating that the PVN may play roles in 
entrainment, however this remains to be examined (Marpegan et al., 2005).  Other 
studies in mice have shown stress signals such as LPS to induce upregulation of the 
Per1 gene in the PVN CRF neurons (Takahashi et al., 2001).  Given that the PVN 
has previously been suggested to be involved in mediating output information 
communicated from the SCN (Kalsbeek et al., 2010), it would be interesting to 
examine whether changes were evident in clock gene expression or neuronal 
activation within the PVN in the post-septic animals, since this could play roles in 
rhythmic outputs.  Assessment of these regions and the roles they play, if any, in 
impacting upon post-septic circadian rhythmicity may be warranted. 
Studies have suggested that endocrine signals can impact upon the SCN 
(Buijs et al., 2006) and it‘s possible that clock gene expression may be impacted by 
alterations in endocrine function such as glucocorticoid rhythms which subsequently 
feed back to the SCN.  Inflammatory mediators have been shown to alter 
corticosterone rhythms (Shinohara et al., 2008), and glucocorticoid treatment or 
attenuations in GC rhythms alter the expression of clock genes in peripheral tissues 
(Koyanagi et al., 2006, Yamamoto et al., 2005; Son et al., 2008; Balsalobre et al., 
2000a, 2000b; Hayasaka et al., 2007; Pezuk et al., 2012).  Further, GC signalling is 
important for clock gene expression in CNS regions outside of the SCN (Malek et 
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al., 2007; Lamont et al., 2005; Amir et al., 2004), with a role for adrenal GCs 
suggested in the regulation of PER2 oscillations in these areas (Lamont et al., 2005).  
Additionally, attenuations in PER2 rhythms due to GC alterations can be restored by 
corticosterone replacement (Segall et al., 2006).  Glucocorticoids have also been 
shown to target Per2 in the periphery (So et al., 2009).   
Alterations in GC rhythms may affect circadian behaviour.  Per2 deficient 
mice do not display a diurnal serum corticosterone rhythm (Yang et al., 2009) and 
flattened GC rhythms have been shown to be capable of altering circadian behaviour 
(Koyanagi et al., 2006; Malek et al., 2007), and have been suggested to play a role in 
behavioural alterations in other studies (Son et al., 2008).  In an experimental rodent 
model of Tb. brucei where perturbations in locomotor activity parameters and body 
temperature rhythms are observed, clock gene alterations are present in peripheral 
oscillators and in the pineal, as well as attenuations in Per1-luc rhythms in the 
pituitary and in some SCN tissues, and these authors suggest that disturbed 
endocrine signals as a result of alterations in the pineal and pituitary glands may 
influence rhythms of locomotor activity and temperature via feedback signalling to 
the SCN (Lundkvist et al., 2010).    Together, these studies highlight a link between 
clock genes, including Per2, and corticosterone rhythms and behaviour.  It is 
possible that attenuations in corticosterone rhythms and clock gene expression in 
other regions, including regions in the CNS, could feedback onto the SCN, and could 
be playing a role in post-septic animals in long-term alterations in clock gene 
expression which could underlie post-septic behavioural perturbations. 
Long-lasting alterations in glial function may serve to modulate clock 
processes, since clock gene oscillations have been shown in SCN derived astrocytes 
in vitro (Prolo et al., 2005).  Further, these are known to respond to inflammatory 
signals (Leone et al., 2006) and it is therefore possible that inflammatory signals 
might in this way impact upon clock gene expression in these glial cells.  Further, 
TGF-α which has previously been described as a sectretory signal that may be 
involved in SCN output communication (Kramer et al., 2001) is known to be 
released by astrocytes (Li et al., 2002), and alterations in clock gene expression in 
astrocytes in response to inflammatory mediators might in this way impact upon 
post-septic SCN output. 
Clock genes within the SCN generate circadian rhythms in physiology and 
behaviour by synchronizing peripheral oscillators and their expression of clock genes 
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via neural and endocrine signalling (Terazono et al., 2003; McNamara et al., 2001; 
Balsalobre et al., 2000a), as well as entraining  non-SCN central oscillators involved 
in the regulation of behavioural or physiological processes.  The molecular clocks at 
the site of these oscillators then provide circadian modulation of physiological 
processes, and alterations in the expression of clock genes in the master pacemaker 
could therefore impact upon molecular oscillations in these extra-SCN sites 
attenuating physiological output and behaviour.   
It is possible that alterations in clock gene protein product expression in the 
post-septic SCN could lead to alterations in SCN electrical firing rhythms. SCN 
neuronal firing rhythms are crucial in transmitting circadian timing information to 
the brain and periphery (Schwartz et. al., 1987), and perturbations in electrical SCN 
activity as a result of alterations in clock gene expression could lead to altered SCN 
output.  The SCN clockworks most likely regulate downstream events via their 
regulation of clock controlled genes (ccgs) and their products, and in this way, the 
core molecular oscillations within the SCN could regulate electrical activity (Reppert 
and Weaver, 2001). AVP is a clock controlled gene and is suggested to be involved 
in electrical firing, since during the subjective day, endogenous AVP has been shown 
to increase the amplitude of SCN neuronal firing (Mihai et al., 1994).  The ccg PK2 
has been shown to be involved in the regulation of electrical activity of SCN neurons 
(Ren et al., 2011) and in the generation of circadian locomotor behaviour (Cheng et 
al., 2002).  Individual SCN neurons dissociated in culture show independent firing 
rhythms (Welsh et al., 1995), and these individual oscillators must be synchronized 
together, resulting in rhythmic electrical activity and the generation of rhythmic, 
coherent circadian output rhythms such as behavioural outputs (Schwartz et al., 
1987).  In Clock mutant mice, individual oscillators do not show rhythmic electrical 
activity, and this is correlated with the arrhythmic locomotor behaviour exhibited by 
these animals (Herzog et al., 1998).   The electrophysiological examination of post-
septic SCN neurons might shed light on whether the post-septic SCN functional state 
is altered as a result of altered clock gene product rhythms. 
Further, neural activity and synaptic activity may be required for the 
generation of circadian oscillations in the core clock genes in the SCN, since various 
studies have shown that perturbations in these lead to alterations in molecular 
oscillations. Further the presence of immune mediators may impact upon the 
electrical activity of the post-septic SCN.  Indeed, it has been previously shown that 
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TNF-α may act through the induction of nitric oxide to modulate the electrical output 
of the SCN, thereby altering circadian rhythmicity (Nygard et al., 2009).  In 
transgenic mice and Drosophila models where clock cells are hyperpolarized, 
perturbations have been observed in behavioural and molecular rhythms (Nitabach et 
al., 2002; Pakhotin et al., 2006).  Molecular oscillations have been shown to be 
attenuated or inhibited by hyperpolarizing Ca
2+
 neurons in culture, or by blocking 
Ca
2+ 
channels (Lundkvist et al., 2005).  Other studies by Yamaguchi and colleagues 
(Yamaguchi et al., 2003) have shown electrical firing rhythms to be involved in the 
generation of robust rhythmic clock gene expression in individual neurons in SCN 
cultures.  Electrophysiological examination of the post-septic SCN neurons is 
warranted, since attenuations in this could underlie perturbations in clock gene 
expression and in post-septic behavioural rhythmicity. 
Attenuations in synaptic plasticity in the post-septic brain could play a role in 
the attenuations in post-septic SCN molecular oscillations.  Studies where 
pharmacological treatments have blocked synaptic transmission in the SCN without 
affecting membrane depolarization or action potential generation have resulted in 
attenuations in clock gene expression (Colwell et al., 2011).  Assessment of 
PER2::LUC rhythms in vitro revealed perturbations in the expression of clock genes 
both within individual SCN neurons and across the SCN network, following 
manipulation of synaptic vesicle recycling, by treatment of SCN slices with either 
dynasore or botulinum toxin A to inhibit exocytosis and endocytosis (Deery et al., 
2009).  Further, rhythmic clock gene expression and neural activity were seen to be 
altered in studies where the secretory vesicle proteins receptor-type tyrosine-protein 
phosphastase-like N (IA-2) and IA-2β were deleted (Kim et al., 2009).  In vitro, 
Stagi and colleagues (Stagi et al., 2005) have shown microglial induced nitric oxide 
to affect the anterograde axonal transport of synaptophysin, which is a synaptic 
protein involved in synaptic plasticity, while other studies assessing the long term 
effects of LPS on the CNS have shown there to be alterations in synaptic proteins 
involved in synaptic plasticity (Weberpals et al., 2009) and these authors show that 
these alterations are possibly mediated through nitric oxide production.  Given the 
upregulation we observe in NOS2 expression in the acute phase following LPS 
treatment, it‘s possible that synaptic alterations could underlie the alterations in clock 
gene expression post sepsis.  Taken together, these studies highlight the impact of 
alterations in synaptic properties on clock gene expression and therefore it‘s possible 
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that alterations in synaptic properties could impact upon clock gene expression in the 
post-septic SCN. 
It is further highlighted from these experiments, that all the alterations in 
photic IEG induction and behavioural rhythms are seen during the advance portion 
of the phase response curve.  The results from the current set of studies in post-septic 
animals again point to an underlying mechanism influencing long-lasting changes in 
the SCN post sepsis, involved both in rhythmic clock gene expression and in SCN 
responsiveness.  These experiments cannot currently establish a mechanism by 
which clock gene expression is altered in the post-septic SCN, however they 
highlight that these alterations are due to an in vivo influence.  Further work is 
required to delineate the mechanisms by which alterations in clock gene expression 
occur in vivo and to fully characterise their impact on post-septic circadian 
behavioural rhythms. To the best of our knowledge, the current study is the first to 
describe long-lasting alterations in circadian clock gene expression in the SCN 
following sepsis induction. 
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Chapter Five 
Post-septic circadian responsiveness to a further immune 
stimulus. 
5.1. Introduction 
5.1.1. Interactions between pre-existing neuroinflammation and subsequent 
immune challenge 
Interactions have been demonstrated between pre-existing neuroinflammation 
and a peripheral immune challenge (Combrinck et al., 2002).  Exposure to a single 
acute systemic challenge is not very likely to occur in humans and animals, it is more 
likely that an infectious pathogen that replicates in vivo will be encountered or that 
they will be exposed to low concentrations of LPS over an extended period of time 
(Puntener et al., 2012) and systemic infections occur frequently in nature and can 
exacerbate disease within the CNS (Holmes et al., 2009; Buljevac et al., 2002). The 
use of a single challenge with LPS, to mimic a single episode Gram-negative 
bacterial infection has been performed on a background of pre-existing 
neuroinflammation. A hypersensitive (primed) (Greer and Rietschel, 1978) or 
hyporesponsive (tolerant) state (Ziegler-Heitbrock, 1995) can ensue following LPS 
treatment.  Cells of the innate immune system of both mice and humans including 
macrophages, monocytes and fibroblasts are seen to display both endotoxin tolerance 
and LPS priming (Fu et al., 2012).  The function of endotoxin priming and tolerance 
may be to confer a survival advantage upon organisms, stimulating cells of the innate 
immune system to react vigorously to further inflammatory challenges in the case of 
LPS priming, or in the case of tolerance, promoting homeostasis following a 
substantial immune insult and the accompanying immune response (Fu et al., 2012).  
However, endotoxin priming and tolerance may play other roles within an organism, 
since these states have also been associated with the pathogenesis of acute and 
chronic disease.  In septic shock, endotoxin tolerance results in an 
immunosuppressed state, during which time the occurrence of secondary infections 
and mortality is seen to increase (West and Heagy, 2002).  Endotoxin priming is 
suggested to be involved in low-grade metabolic endotoxemia, at which time levels 
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of LPS are elevated in the bloodstream causing an increased frequency of insulin 
resistance and diabetes, as well as atherosclerosis (Moreno-Navarrete et al., 2010; 
Wiesner et al., 2010; Kiechl et al., 2001; Slofstra et al., 2006). Both hypo and hyper 
responsiveness have previously been exemplified in response to LPS treatment in 
chronic neuroinflammatory conditions. 
5.1.2. Hypo-responsiveness following further immune stimuli in conditions of 
pre-existing CNS immune activation. 
Excessive or prolonged activation of the immune system can be detrimental. 
Endotoxin tolerance is observed in response to secondary immune stimuli, and 
serves to regulate responses of the innate immune system, preventing over-
responsiveness, and is characterized by transient cellular, metabolic and behavioural 
hypo-responsiveness to recurring or chronic systemic infections (West and Heagy, 
2002).  In vivo and in vitro, low LPS doses have been shown to result in a tolerant 
state where the immune response to further challenge with LPS is altered (Cavaillon 
and Adib-Conquy, 2006; Biswas and Lopez-Collazo, 2009).  A reprogramming of 
the dose-response relationship between LPS and the induction of cytokines can occur 
in response to two successive LPS treatments, resulting in a reduction of cytokine 
production (Fu et al., 2012). Negative regulators of the TLR4 signalling pathway 
including signalling molecules, transcriptional modulators and soluble factors, as 
well as epigenetic changes and chromatin modifications of specific genes have been 
suggested to be involved in endotoxin tolerance (Biswas and Lopez, 2009;  
Kobayashi  et al., 2002; Brint et al., 2004; Sly et al., 2004; Foster et al., 2007; Chang 
et al., 2009; El Gazzar et al., 2007; Li et al., 2000; Jacinto et al., 2002 Chen et al., 
2009a; Chen et al., 2009b). During LPS induced tolerance, sickness behaviours are 
attenuated following repeated LPS injections as a survival mechanism (Franklin et 
al., 2007).  The stimulation of TLR4 expressing cells has previously been suggested 
to be required for the induction of endotoxin tolerance (Faggioni et al., 1995). 
Stimulation of TLR4 which signals to NF-κB results in the transcription of 
proinflammatory cytokines, while a second LPS stimulation is seen to suppress the 
induction of these, leading to a decrease in fever, anorexia and lethality (Beutler, 
2002; Fraker et al., 1988; Mengozzi and Ghezzi, 1993).  Further, LPS tolerant 
macrophages show a downregulation in surface TLR4 expression (Nomura et al., 
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2000).  Endotoxin tolerance is characterized by inhibition of TNF-α, attenuations in 
IL-6 and IL-1, COX2 alterations, perturbations in NF-κB translocation and inhibition 
of mitogen-activated protein kinase activation (West and Heagy, 2002).  However, 
endotoxin tolerance is not simply a case of down regulated responsiveness, indeed 
components of the immune response such as the NF-κB p50 subunit, the anti-
inflammatory cytokine IL-10 and the TNF receptor type II are in fact increased 
during tolerance and are seen to be involved in proinflammatory cytokine down 
regulation (Ziegler-Heitbrock, 1995).  Anti-inflammatory cytokines including TGF-β 
and IL-10 are also thought to play a primary role in the tolerance state (Randow et 
al., 1995).  Additionally, IL-1β has been shown to play a role in vivo in LPS 
tolerance, whereby a down regulation of TLR4 is observed, along with an increase in 
both glucocorticoid levels and the levels of GC receptors (Alves-Rosa et al., 2002). 
The HPA axis is involved in endotoxin tolerance (Beishuizen and Thijs, 2003; 
Cavaillon et al., 2003), and glucocorticoids are thought to play a primary role in the 
tolerant state induced by endotoxin treatment (Ikeda et al., 2006). Indeed, 
adrenalectomized mice do not display endotoxin tolerance (Evans and Zuckerman, 
1991; Parrillo et al., 1993; Zuckerman and Qureshi, 1992), highlighting the 
importance of glucocorticoid activity in this process.  
Various studies have described tolerance in response to secondary immune 
stimuli. In rats, a single LPS treatment 3 weeks prior to induction of adjuvant 
arthritis is seen to cause resistance to inflammation (Harbuz et al., 2002).  In whole 
blood of sepsis patients treated ex vivo with LPS a decreased expression of the 
proinflammatory cytokines TNF-α, IL-6 and IL-1β was observed for up to 10 days 
(Ertel et al., 1995).  Treatment of macrophages with a high dose of LPS in vitro sees 
a reduction in proinflammatory cytokine induction upon subsequent stimulation with 
a high dose of LPS (Biswas and Lopez-Callazo, 2009). The effects of endotoxin 
tolerance have been shown to persist up to three weeks in vivo (West and Heagy, 
2002).  In vitro, in response to low levels of LPS, both mouse macrophages and 
human monocytes have been shown to be unable to respond to further challenge with 
LPS (Dobrovolskaia and Vogel, 2002; del Fresno et al., 2009; Foster et al., 2007), 
while in vivo, endotoxin tolerance has been shown in mice, and 
monocytes/macrophages were shown to be responsible for this (Cavaillon and Adib-
Conquy, 2006). Further, in vitro, the epigenetic changes associated with gene 
activation were not observed in cultured cells previously treated with LPS in 
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response to an additional LPS challenge (Chan et al., 2005).   Additionally, i.c.v. 
administration of LPS upon four consecutive days has been shown to cause reduced 
production of systemic TNF-α (Faggioni et al., 1995), while studies in rats show that 
repeated LPS treatment for 6 consecutive days reduces HPA axis responsiveness 
(Takemura et al., 1997).   
Variations have been shown between the periphery and the CNS during 
endotoxin tolerance.  In the periphery during endotoxin tolerance, peripheral 
cytokines are no longer seen to be induced, while studies have shown that LPS 
induced cytokine expression can remain evident in the CNS at this time (Chen et al., 
2005; Faggioni et al., 1995).  Additionally, Puntener et al. (2012) have recently 
shown that in response to systemic infection, innate immune cells in the CNS do not 
become tolerant, but rather become primed.  Other studies have shown that in the 
CNS, the responsiveness of the inflammatory mediators MCP-1, TNF-α, IL-6 and 
IL-1α can be exacerbated following multiple frequent LPS challenges (Erickson and 
Banks, 2011), further highlighting the alternative response induced in the CNS 
during the LPS tolerant state.  
5.1.3. Hyper-responsiveness during chronic neuroinflammatory states in 
response to further stimuli.   
The sensitization or priming of the CNS in conditions of neuroinflammation 
aims to stimulate cells of the innate immune system to react vigorously to further 
inflammatory challenges (Fu et al., 2012), however systemic infection is known to 
have a detrimental effect on both humans and animals that suffer from chronic 
neurodegeneration (Cunningham et al., 2009; Holmes et al., 2009).  Further, there is 
evidence to suggest that priming of the brain occurs in chronic inflammatory 
conditions (Drake et al., 2011) such as arthritis, diabetes, atherosclerosis and obesity 
and these conditions are known to be associated with systemic inflammation (Yaffe 
et al., 2004). The molecular mechanisms underlying endotoxin priming are not 
currently understood but may involve both intra-cellular and inter-cellular processes 
(Zhang and Morrison, 1993; Fu et al., 2012).  In primed conditions, cells of the 
innate immune system display altered responsiveness to inflammatory stimuli.  Low 
dose treatment with LPS is seen to result in the priming of macrophages due to 
reprogramming of their responsiveness, and following a subsequent challenge with a 
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high dose of LPS, an enhanced proinflammatory cytokine production is seen 
(Hirohashi and Morrison, 1996; Shnyra et al., 1998; West and Koons, 2008; Zhang 
and Morrison, 1993; Henricson et al., 1993).  Human blood cells primed by pre-
exposure to a low dose of LPS show attenuations in the expression of the 
proinflammatory cytokine IL-6 upon subsequent challenge with a high dose of LPS 
(Nakamura et al., 2004). It has been suggested that glucocorticoid action within the 
brain could result in exaggerated inflammatory responses to stimulation of the 
immune system (de Pablos et al., 2006; Munhoz et al., 2010).  Both adrenelectomy 
and GC receptor function inhibition with RU486 have been shown to inhibit primed 
microglial responses to LPS ex vivo following in vivo psychological stress (Frank et 
al., 2012), implicating a role for glucocorticoids in microglial priming. 
Microglia are suggested to play a prominent role in the priming of the CNS 
during conditions with neuroinflammatory components. On-going pathology within 
the CNS primes microglia, whereby these are excessively reactive to subsequent 
immune challenges including those in the periphery (Cunningham et al., 2005; 
Lunnon et al., 2011).   In aging, evidence points to the presence of ―primed‖ 
microglia, which are seen to be excessively reactive to immune challenges or 
noxious stimuli (Dilger and Johnson, 2008) including in response to LPS treatment 
(Godbout et al., 2005).  Additionally, obesity which is characterized by chronic 
inflammation is also seen to exhibit more reactive microglial cells in response to an 
immune challenge, in line with a ―primed‖ state (Bilbo and Tsang, 2010).  In 
Alzheimer‘s Disease patients with systemic infection or inflammation, primed 
microglia have been suggested to play a role in the exaggeration of clinical 
symptoms (Holmes et al., 2009; Holmes et al., 2011). Further, morbidity is seen in 
patients with AD following a systemic immune challenge due to an infection in the 
periphery such as pneumonia, or a urinary tract infection (Burns et al., 1990), and 
these may subsequently cause an increase in cytokine expression in the CNS 
(Combrick et al., 2002).   
Epigenetic changes have been suggested to play a role in priming of the innate 
immune system (Puntener et al., 2012). A trained immunity mediated by epigenetic 
changes in the immune system has been suggested to exist in vertebrates, 
invertebrates and plants, and in mammals this is due to cells of the innate immune 
system appearing to display an immunological memory of past immune insults 
(Netea et al., 2011).  Early life infections have been shown to be capable of 
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attenuating the threshold of IL-1β production in the hippocampus via long-lasting 
priming of microglia (Williamson et al., 2011).  A hyper-responsiveness has been 
shown in animals maintained in standard animal house conditions compared to those 
raised and maintained in a specific pathogen free (SPF) environment in response to 
adenoviral vector, including a stronger inflammatory response and reduced reporter 
gene synthesis (Ohmoto et al., 1999).  
5.1.4. Alterations in behaviour during chronic neuroinflammatory states in 
response to further stimuli.   
Alterations in cognitive function and mood are observed in humans in 
response to systemic infection or inflammation, along with changes in activity in 
certain CNS regions, and this is due to communication between the brain and the 
peripheral immune system (Reichenberg et al., 2001; Krabbe et al., 2005; Bucks et 
al., 2008).  However, in chronic neurodegenerative conditions, systemic infection 
has been shown to have a detrimental effect on both humans and animals 
(Cunningham et al., 2009; Holmes et al., 2009).  In animal models, acute working 
memory impairments are observed following a systemic inflammatory stimulus in 
both animals with pre-existing neurodegenerative disease (Murray et al., 2012) and 
in aged animals (Chen et al., 2008).  Systemic inflammation elicited by infection or 
injury in the periphery may activate already primed microglia in the normal healthy 
ageing brain or in the brains of AD patients, and this can impact upon the cognitive 
decline observed in these patients and additionally, can result in delirium (Perry et 
al., 2003). Acute cognitive impairments are seen to occur in association with 
peripheral infection in the elderly population (Wofford et al., 1996; Chiovenda et al., 
2002) and in the demented, and often results in delirium, whereby transient 
perturbations in attention and cognition are evidenced (Elie et al., 1998). Elderly 
patients often exhibit symptoms consistent with delirium when suffering from 
pneumonia (Janssens and Krausse, 2004).  Further, systemic viral or bacterial 
infections are seen to significantly contribute to morbidity in the elderly population 
(Aw et al., 2007). In experimental rodent models, an exaggerated behavioural 
response is seen in aged rodents in response to viral or bacterial infections (Godbout 
et al., 2005, Barrientos et al., 2006).  Further, in comparison to younger cohorts, 
aged mice have been shown to exhibit exaggerated deficits in hippocampal-
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dependent learning and memory, depression like behaviours and anorexia following 
peripheral challenge with LPS (Godbout et al., 2005; Chen et al., 2008; Godbout et 
al., 2008; Dilger and Johnson, 2008).  In response to LPS treatment, aged animals 
have been shown to exhibit primed microglial responses (Godbout et al., 2005) and 
this may be involved in predisposing this population to enhanced features of 
depression (Godbout et al., 2008). In the ME7 mouse model of prion disease, A 
500µg/kg i.p. LPS challenge 15weeks following disease inoculation was seen to 
result in acute neurological alterations followed by the earlier development of 
progressive irreversible neurological impairments  that were shown to be more 
severe in these animals in comparison to wild-type ME7 mice (Cunningham et al., 
2009).  
5.1.5. Experimental administration of LPS and primed responsiveness 
The use of a single challenge with LPS to mimic a Gram-negative bacterial 
infection has been performed in previous studies in order to assess the impact of a 
systemic challenge on chronic disease states exhibiting a neuroinflammatory 
component.  APP expression has been shown to be altered following 500µg/kg 
peripheral LPS treatment (Brugg et al., 1995). Additionally, a 500µg/kg i.p. LPS 
challenge to the ME7 mouse model of prion disease is seen to increase neuronal 
apoptosis (Cunningham et al., 2005), while a single LPS 200µg/kg treatment 
administered to aged mice is seen to cause tyroxine hydroxylase (TH)-positive 
neuronal death in the SN (L‘Episcopo et al., 2011).  Further, peripheral 1mg/kg LPS 
induces long term iNOS, NADPH oxidase labelling and TH-positive neuronal loss in 
a mouse model of PD (Gao et al., 2011).  Discordant cytokine responsiveness is 
observed in conditions of healthy ageing which exhibits a low-grade 
neuroinflammation, in response to peripheral LPS treatment (Godbout et al., 2005; 
Chen et al., 2008), and activated microglia are shown to be increased in the brain in 
this state (Godbout et al., 2005). Further, studies in aged rats have shown an 
exaggerated cytokine response following administration of E. coli (Barrientos et al., 
2006).  In aged mice in response to i.c.v. LPS administration an enhanced cytokine 
response is observed in the brain, highlighting that the response of the innate 
immune system in the CNS in this state is due to factors within the CNS (Huang et 
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al., 2008).  Together, these studies highlight an exaggerated responsiveness to 
noxious stimuli in conditions where a long-lasting neuroinflammation is evident. 
 
Given that in conditions of chronic neuroinflammation ―priming‖ is observed 
in the CNS and subsequent immune stimuli result in exaggerated cytokine 
responsiveness and exaggerations of cognitive impairment, the current set of 
experiments examine the possibility that a single septic LPS treatment, known to 
induce chronic inflammation within the CNS (Qin et al., 2007; Weberpals et al., 
2009; Bossu et al., 2012) may result in priming or sensitization of the CNS, and in 
response to a secondary stimulus such as peripheral infection, an exaggerated or 
more vigorous response may be elicited. There may be an on-going activity of the 
innate immune system in the post-septic CNS which would in turn lead to an 
increased immunological risk upon subsequent exposure to an immune challenge, 
and given the interactions between the circadian system and inflammatory mediators, 
an exaggerated response of the master pacemaker may be observed in post-septic 
animals as well as enhancement of circadian resetting properties.  Assessment of the 
SCN and circadian system responsiveness in further immune challenged post-septic 
animals would be interesting and may provide insight into whether there are 
similarities between the post-septic brain and that of other chronic 
neuroinflammatory states.  
In mice, systemic low doses of LPS result in photic-like phase delays of 
circadian locomotor behaviour when administered at CT15, but it has no significant 
effect when injected at other circadian times (Marpegan et al., 2005).  Given the low 
does used in these experiments and the alteration in circadian output, we used this 
LPS induced phase delay as a method for assessing a priming effect of previous CNS 
insult following a subsequent immune challenge. 
5.2. Materials & Methods 
5.2.1. Animals and Housing: 
For assessment of the SCN in both post-septic and saline treated animals in 
response to low dose peripheral LPS treatment, adult C57BL/6 male mice (8-10wks 
old) were group housed as outlined in section 2.2.2.  For the purpose of behavioural 
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monitoring, animals were individually housed in polypropylene cages (33cm long x 
15cm wide x 13cm high) equipped with steel running wheels (11.5cm diameter) with 
food and water available ad libitum.  
5.2.2. Behavioural responses following low dose LPS treatment after previous 
induction of sepsis 
In order to establish whether an altered behavioural response would be seen in 
post-septic animals compared to controls following a second immune insult, 22 adult 
male mice were individually housed in cages equipped with running wheels and 
habituated to a 12:12 LD cycle for 2 weeks (150 lux, lights on 0500h).  The animals 
were treated with either LPS 5mg/kg i.p injection (n=12) or saline (n=10) and were 
allowed to recover for two weeks following the induction of sepsis prior to being 
transferred into constant darkness. Animals were maintained under these constant 
darkness conditions for 14 days and allowed to free run.  Animals then received 
either i.p. saline or a second (i.p.) injection of LPS at a  dose of 100 µg/kg at CT15, 
the early subjective night, the time at which administration of low dose LPS has 
previously been shown to induce photic like phase delays of locomotor activity 
(Marpegan et al., 2005).  Following treatment, the animals were maintained in DD 
for a further 14 days and their actogram data monitored to allow for assessment of 
phase shifts, before receiving a third treatment of either LPS or saline at CT15.  
Those that received saline vehicle upon the second treatment occasion were then 
treated with i.p. LPS 100µg/kg and those having received low dose LPS as second 
treatment were administered saline control.  Following the third treatment, the 
animals‘ activity patterns in DD were followed for 14 days and phase shifts of 
locomotor activity rhythms assessed.   
The line of best fit method was used to assess the phase shift magnitudes from 
the actogram data, fitting the line through activity onsets 7 days before and 10 days 
after treatment with LPS 100µg/kg or vehicle.  The differences between the lines 
from the actograms were rated by two independent researchers blind to the 
experimental procedure.  Following each CT15 treatment, the circadian parameters 
of free running period and rhythm amplitude were calculated for each animal using 
the Chronobiology Kit Chi Squared procedure and analysed by mixed between-
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within groups ANOVA and for each group by Bonferroni corrected independent 
samples t-test. 
5.2.3. Assessment of SCN neurochemistry in post-septic animals following an 
LPS 100µg/kg i.p. treatment 
In order to establish whether altered neurochemical responses would be seen in 
the SCN in post-septic animals compared to controls following a second immune 
insult, 6 week old male mice were group housed in colonies of three in cages 
equipped with appropriate environmental enrichment and habituated to a 12:12 LD 
cycle for 2 weeks (150 lux, lights on 0500h) prior to experimentation.  The animals 
were treated with either LPS 5mg/kg i.p injection (n=4-5) or saline (n=7-9).  One 
month later, both treatment groups received a second treatment, an (i.p.) injection of 
LPS at a dose of 100 µg/kg at ZT1-2, 4 hours after which (ZT5-6) they were 
perfused transcardially and processed for immunohistochemistry as outlined 
previously in sections 3.2.3 and 3.2.4. Immunohistochemistry was carried out for the 
immediate early genes c-Fos and EGR-1 and the microglial markers CD-11b and 
F4/80 (details of primary antisera outlined in Table 3). 
For each individual animal and each antibody, 3-6 SCN images were 
examined by means of IOD or manual quantification of the number of 
immunoreactive nuclei in the SCN, viewed with the light microscope as previously 
outlined in section 3.2.5, and a mean value obtained for each animal for each 
antibody for all SCN regions of interest. These values were calculated for each 
animal by two researchers.  The observers were blinded to the experimental 
procedure during quantification of immunoreactive cells per SCN. The means 
calculated for each group were compared and analysed by independent samples t-
test.  Results are given as mean values (IOD or cell number) + standard error of the 
mean, statistical significance was accepted at P<0.05. 
5.2.4. Assessment of SCN neuronal activity in post-septic animals 2hrs and 9hrs 
following an LPS 100µg/kg treatment 
In order to establish whether post-septic animals would exhibit altered 
neuronal activity in the SCN following a further low dose LPS treatment compared 
to controls, 6 week old male mice were group housed in colonies of three in cages 
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equipped with appropriate environmental enrichment and habituated to a 12:12 LD 
cycle for 2 weeks (150 lux, lights on 0500h) prior to experimentation.  The animals 
were treated with either LPS 5mg/kg i.p injection (n=3-4) or saline (n=4-5).  The 
animals were allowed to recover following the induction of sepsis and were 
maintained for 3 months under a 12:12 LD cycle. Both post-septic and saline treated 
controls then received an i.p. injection of LPS at a smaller dose of 100 µg/kg at ZT1-
2 and held under the 12:12 LD cycle.  Animals were then terminally anaesthetized 
and perfused transcardially (as outlined previously in section 3.2.3) in order to 
examine whether alterations are seen in the SCN at different time points when LPS 
100 µg/kg treatment is administered 3 months following LPS5mg/kg or saline.  The 
first group of animals (no sepsis + LPS 4, post-sepsis + LPS 3) were perfused 2 
hours after LPS 100 µg/kg treatment (ZT3-4), while the second group of animals (no 
sepsis + LPS 5, post-sepsis + LPS 4) were perfused 9 hours later (ZT10-11). 
Immunohistochemistry was carried out as described previously in section 3.2.4 for 
the IEGs c-Fos and EGR-1 (details of primary antisera outlined in Table 3). 
For each individual animal and each antibody, 3-6 SCN images were 
examined by means of manual quantification of the number of immunoreactive 
nuclei in the SCN, viewed with the light microscope as previously outlined in 
section 3. 2.5, and a mean value obtained for each animal for each antibody for all 
SCN regions of interest. These values were calculated for each animal by two 
researchers blinded to the experimental procedure during quantification of 
immunoreactive cells per SCN. The means calculated for each group were compared 
and analysed by independent samples t-test.  Results are given as mean values (cell 
number) + standard error of the mean, statistical significance was accepted at 
P<0.05. 
 
5.3. Results: 
5.3.1. Circadian behavioural response following low dose LPS treatment after 
previous induction of sepsis 
We examined the phase shifts elicited by an LPS 100µg/kg i.p. treatment or 
saline following administration at CT15 in post-septic animals and those originally 
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treated with saline.  Mixed between–within groups ANOVA revealed a main effect 
for shift magnitude elicited by the different treatments (F1,20=6.79, P<0.05) and an 
interaction effect for prior condition and acute treatment (F1,20=8.65, P<0.01).  4 or 6 
weeks following the initial treatment with LPS 5mg/kg or saline as control, LPS 
100µg/kg i.p. treatment at CT15 induced phase delays with a mean phase delay 
magnitude of 0.68 + 0.14 hrs in animals initially treated with saline prior to a low 
dose LPS treatment, and this was found to be statistically different to the phase delay 
magnitude induced in post-septic animals, who displayed a significantly lower 
average phase delay value of 0.22 + 0.08 hrs (P<0.01, independent t-test).  
Subsequent independent t-test analysis revealed that 4 or 6weeks following the initial 
treatment with LPS 5mg/kg or saline as control, saline vehicle administered at CT15 
did not induce significant differences between the groups in phase shift magnitude 
elicited, with a mean phase delay magnitude of 0.10 + 0.07 hrs in animals initially 
treated with saline prior to a low dose LPS treatment, and a mean phase delay 
magnitude of  0.25  + 0.13 hrs induced in post-septic animals (P>0.05, independent 
t-test).   Further, paired t-test analysis revealed a significant difference in phase 
response elicited following low dose peripheral LPS treatment and that following 
saline control injection in no sepsis animals (P<0.05) but not in post-septic animals 
(P>0.05). (Figure 5.1).   
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Figure 5.1: Phase resetting is attenuated following low dose LPS in post-septic 
animals. (A) and (B) Sample double plotted actograms from saline (n=10) and post-
septic animals (n=12) respectively, free running in DD and treated i.p. with either 
100µg/kg LPS at CT15 (CT15 LPS treatment indicated by purple circle, with lines 
indicating the line of best-fit through activity onsets for the 7 days before and 10 
days after LPS treatment) followed 14 days later by saline injection at CT15 (CT15 
saline treatment indicated by green circle, with lines indicating the line of best-fit 
through activity onsets for the 7 days before and 10 days after saline treatment). 
Note suppression of locomotor behaviour in the hours following the low dose 
peripheral LPS treatment.  (C) Bar graph illustrating phase shift magnitude in post-
septic animals and those treated with saline control originally, not having been 
subjected to sepsis. (*=P<0.05). 
 
5.3.2. The Free Running Periods and Rhythm Amplitudes following LPS 
100µg/kg i.p. or control treatments in the early subjective night. 
The free running periods and rhythm amplitudes were examined for 7 days 
following each CT15 treatment by Chi
2
 periodogram analysis and subsequent 
assessment by ANOVA for both treatment groups.   
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Mixed between within ANOVA was used to assess statistically significant 
differences between groups in the mean rhythm amplitudes in the 7 days prior to 
treatment and in the 7 days following both the LPS 100µg/kg i.p. treatment and the 
saline treatment, revealing a main effect of time for rhythm amplitude (F2,19=14.15, 
P<0.001), however finding no between groups effect (F2,19=1.02, P>0.05).  Mean 
rhythm amplitude values for saline and LPS 100µg/kg treated animals and post-
septic animals treated with LPS 100µg/kg did not differ during the 7 days following 
the LPS 100µg/kg treatment or following the saline treatment at CT15 (P>0.05, 
independent t-test). (Table 5). 
Mixed between within ANOVA was used to assess statistically significant 
differences between groups in the mean FRP in the 7 days prior to treatment and in 
the 7 days following both the LPS 100µg/kg i.p. treatment and the saline treatment, 
finding neither a main effect of time for FRP (F2,19=0.15, P>0.05), nor a between 
groups effect (F2,19=1.84, P>0.05).  Mean FRP values for saline and LPS 100µg/kg 
treated animals and for post-septic animals treated with LPS 100µg/kg did not differ 
during the 7 days following the LPS 100µg/kg treatment (P>0.05, independent t-
test), nor was there any statistically significant difference in mean FRP between the 
groups following saline treatment at CT15 (P>0.05, independent t-test). (Table 5). 
 
Table 5: Assessment of FRP and rhythm amplitude prior to and following CT15 
treatments. Table illustrating the average free running period and rhythm amplitude 
values for saline and post-septic animals prior to CT15 treatments and in the 7 days 
following CT15 saline treatment and CT15 LPS 100µg/kg treatments.  (n.s.) denotes 
not significant.  
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5.3.3. Assessment of SCN neurochemistry in post-septic animals following an 
LPS 100µg/kg i.p. treatment 
5.3.3.1. c-Fos expression in response to LPS 100µg/kg i.p. one month following 
sepsis or no sepsis. 
Immunohistochemical analysis coupled with manual quantification of c-Fos 
expression in post-septic and saline treated controls that received peripheral LPS 
100µg/kg, revealed that c-Fos expression was significantly increased in the SCN of 
post-septic animals (80.72 + 6.62 ir. nuclei/SCN) when compared to those treated 
with saline originally (58.04 + 6.30 ir nuclei/SCN, P<0.05, independent t-test; Fig. 
5.2).  When analysing the separate subdivisions of the SCN by independent t-test, 
the mean number of immunoreactive c-Fos cells in the ventrolateral core of the SCN 
was not found to be significantly different between the treatment groups, with post-
septic animals displaying a mean of 21.88 + 4.54 ir. cells/SCN and control animals 
displaying an mean of 15.89 + 1.93 ir. cells/SCN (P>0.05; Fig. 5.2).  The difference 
in c-Fos expression levels was seen to be statistically significant in the dorsomedial 
shell region of the SCN, with a significant increase in expression levels in post-
septic animals (58.83 + 3.83 ir.cells/SCN) compared to saline controls (41.30 + 4.74 
ir.cells/SCN, P<0.05, independent t-test; Fig. 5.2). 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: Alterations in neuronal activation in the SCN of post-septic animals 
following low dose peripheral LPS treatment.  (A) Representative 
photomicrographs of c-Fos expression in the SCN of post-septic animals (n=5) and 
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animals treated originally with saline (n=9) 4hrs following low dose LPS 100µg/kg 
treatment at ZT1-2 (scale bar = 100 µm).  Dashed line outlines the SCN and 
delineates the core and shell subdivisions. (B) Bar graphs illustrating quantification 
of levels of c-Fos immunoreactive nuclei at the mid rostro-caudal level of the SCN, 
in the SCN ventrolateral core and in the dorsomedial shell of the SCN of control and 
post-septic animals treated with 100µg/kg LPS treatment.  (* P<0.05). 
 
5.3.3.2. EGR-1 expression in response to LPS 100µg/kg i.p. one mth following 
sepsis or no sepsis. 
Immunohistochemical analysis of EGR-1 followed by quantification of the 
immediate early gene protein product‘s expression in post-septic and saline treated 
controls that received a second treatment of LPS 100µg/kg, found no significant 
differences in expression levels in the SCN between post-septic animals (17.90 + 
4.74 ir. nuclei/SCN) and saline controls (19.92 + 4.01 ir nuclei/SCN, P>0.05, 
independent t-test; Figure 5.3).  When analysing the separate subdivisions of the 
SCN by independent t-test, there were no statistically significant differences found in 
the mean number of immunoreactive EGR-1 cells in either the ventrolateral core of 
the SCN (LPS, 4.60 + 2.52 vs. controls 4.91 + 1.56 ir.cells/SCN, P>0.05) or in the 
dorsomedial shell region of the SCN (LPS, 13.30 + 2.34 vs. 15.01 + 2.66 
ir.cells/SCN, P>0.05, independent t-test).  
 
 
 
 
 
 
 
 
 
Figure 5.3: EGR-1 expression in the SCN of post-septic and no sepsis animals 
following low dose peripheral LPS treatment. (A) Representative photomicrographs 
of EGR-1 expression in the SCN of post-septic animals (n=5) and animals treated 
originally with saline (n=8) following low dose LPS 100µg/kg treatment at ZT1-2 
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(scale bar = 100 µm).  (B) Bar graphs illustrating EGR-1 expression in the SCN of 
post-septic animals and animals treated originally with saline 4hrs following low 
dose peripheral LPS 100µg/kg treatment at ZT1-2. 
 
5.3.3.3. CD-11b expression in response to LPS 100µg/kg i.p. one month following 
sepsis or no sepsis. 
Immunohistochemical analysis for the microglial marker CD-11b followed by 
IOD of the immunostain in the SCN of both post-septic animals and saline treated 
controls that received peripheral LPS 100µg/kg, found no significant differences in 
expression levels in the SCN between post-septic animals (2.21 + 0.25 ir./SCN) and 
saline controls (1.95 + 0.36  ir./SCN, P>0.05, independent t-test; Figure 5.4).  When 
analysing the separate subdivisions of the SCN by independent t-test, there were no 
statistically significant differences found in the mean CD-11b immunosignal in 
either the ventrolateral core of the SCN (LPS, 2.56 + 0.27 vs. controls 2.02 + 0.40 
ir./SCN; P>0.05) or in the dorsomedial shell region of the SCN (LPS, 2.03 + 0.36 vs. 
1.93 + 0.36 ir./SCN, P>0.05, independent t-test). 
 Quantification of the number of immunostained microglial cells in post-septic 
and saline treated controls that received a second treatment of LPS 100µg/kg, was 
also performed, and similarly, found no significant differences in microglial 
expression in the SCN between post-septic animals (7.96 + 3.48 ir.cells/SCN) and 
saline controls (8.91 + 2.83 ir. cells/SCN, P>0.05, independent t-test).  Further 
assessment of the morphology of CD-11b immunostained cells under high power 
and by manual quantification in post-septic and saline treated controls that received a 
second treatment of LPS 100µg/kg, found no significant differences in microglial 
morphology or in the expression of activated glia in the SCN between post-septic 
animals (0.79 + 0.31 ir.cells/SCN) and saline controls (0.49 + 0.40 ir.cells/SCN, 
P>0.05, independent t-test).   
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Figure 5.4: CD-11b expression in the SCN of post-septic and no sepsis animals 
following low dose peripheral LPS treatment. (A) Representative photomicrographs 
of CD-11b expression in the SCN of post-septic animals (n=4) and animals treated 
initially with saline (n=8) following low dose LPS 100µg/kg treatment at ZT1-2 
(scale bar approx. 100 µm).  (B) Bar graphs illustrating CD-11b expression in the 
SCN of post-septic animals and no sepsis animals 4hrs following low dose 
peripheral LPS 100µg/kg treatment at ZT1-2. 
 
5.3.3.4. F4/80 expression in response to LPS 100µg/kg i.p. one mth post sepsis or no 
sepsis. 
Immunohistochemical analysis for the microglial marker F4/80 followed by 
IOD of the immunosignal in the SCN of both post-septic animals and saline treated 
controls that received peripheral LPS 100µg/kg, found no significant difference in 
microglial expression in the SCN between post-septic animals (2.14 + 0.64 
IOD/SCN) and saline controls (1.87 + 0.26 IOD/SCN, P>0.05, independent t-test; 
Figure 5.5).  When analysing the separate subdivisions of the SCN by independent t-
test, there were no statistically significant differences found in the mean F4/80 
immunosignal in either the ventrolateral core of the SCN (LPS, 1.80 + 0.55 vs. 
controls 1.94 + 0.62 IOD/SCN P>0.05) or in the dorsomedial shell region of the 
SCN (LPS, 2.23 + 0.68 vs. 2.12 + 0.31 IOD/SCN, P>0.05, independent t-test). 
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Manual quantification of immunostained microglial cells in post-septic and 
saline treated controls that received a second treatment of LPS 100µg/kg, was also 
performed and similarly found no significant differences in microglial expression in 
the SCN between post-septic animals (7.5 + 2.26 ir.cells/SCN) and saline controls 
(6.12 + 3.15 ir. cells/SCN, P>0.05, independent t-test).  Further assessment of the 
morphology of F4/80 immunostained cells under high power and by manual 
quantification in post-septic and saline treated controls that received a second 
treatment of LPS 100µg/kg, found no significant differences in microglial 
morphology or in the expression of activated glia in the SCN between post-septic 
animals (0.60 + 0.37 ir.cells/SCN) and saline controls (0.21 + 0.08 ir. cells/SCN, 
P>0.05, independent t-test).   
 
 
 
Figure 5.5: F4/80 expression in the SCN of post-septic and no sepsis animals 
following low dose peripheral LPS treatment. (A) Representative photomicrographs 
of F4/80 expression in the SCN of post-septic animals (n=5) and animals treated 
initially with saline (n=7) following low dose LPS 100µg/kg treatment at ZT1-2 
(scale bar = 100 µm).  (B) Bar graphs illustrating F4/80 expression in the SCN of 
post-septic animals and animals treated initially with saline 4hrs following low dose 
peripheral LPS 100µg/kg treatment at ZT1-2. 
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5.3.4. Assessment of SCN neuronal activity in post-septic animals 2hrs and 9hrs 
following an LPS 100µg/kg treatment 3mths post-sepsis or no sepsis. 
Neuronal activation was assessed 2 and 9hrs following an LPS 100µg/kg i.p. 
treatment 3mths following sepsis or no sepsis.  Immunohistochemical analysis of the 
immediate early genes c-Fos and EGR-1 coupled with the manual quantification of 
their expression in the SCN was performed at ZT3-4 and ZT10-11, 2hrs and 9hrs 
post-treatment respectively.  
5.3.4.1. c-Fos expression 2hrs and 9hrs following LPS 100µg/kg i.p. 3mths post 
sepsis or no sepsis. 
Mixed between within repeated measures ANOVA was used to assess whether 
there were alterations in the expression of c-Fos in the SCN following LPS 100µg/kg 
at different time points and whether there was an effect of treatment.  There was no 
statistically significant effect of time (F1,4=2.85, P>0.05) or between groups effect 
(F1,4=0.29, P>0.05) on c-Fos expression levels in the SCN, with c-Fos expression 
levels at two hours (LPS, 28.00 + 4.75 vs. saline, 30.97 + 2.39 ir.cells/SCN) and at 
nine hours (LPS, 49.78 + 13.93 vs. saline, 42.22 + 7.46 ir.cells/SCN) post-treatment 
similar between groups (P>0.05).  (Figure 5.6). 
 
 
Figure 5.6: c-Fos expression in the SCN of post-septic and no sepsis animals 2 
and 9 hrs following low dose peripheral LPS treatment. (A) Representative 
photomicrographs of c-Fos expression in the SCN of post-septic animals (n=3-4) 
and animals treated originally with saline (n=4-5) 2 and 9 hrs following low dose 
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LPS 100µg/kg treatment at ZT1-2 (scale bar = 100 µm).  (B) Bar graphs illustrating 
expression levels of the IEG c-Fos in the SCN of post-septic animals and animals 
treated originally with saline 2 and 9hrs following low dose peripheral LPS 
100µg/kg treatment at ZT1-2. 
 
5.3.4.2. EGR-1 expression 2hrs and 9hrs following LPS 100µg/kg i.p. 3mths post 
sepsis or no sepsis. 
The EGR-1 expression following LPS 100µg/kg was assessed between groups 
across time by Mixed between within repeated measures ANOVA, finding a 
statistically significant effect of time (F1,4=31.81, P<0.01) on EGR-1 expression in 
the SCN, with EGR-1 levels decreasing from 2hrs post-treatment to 9hrs hours post 
LPS in both treatment groups, however analysis found no between groups effect 
(F1,4=6.92, P>0.05). (Figure 5.7). 
 
 
Figure 5.7: EGR-1 expression in the SCN of post-septic and no sepsis animals 2 
and 9 hrs following low dose peripheral LPS treatment.  (A) Representative 
photomicrographs of EGR-1 expression in the SCN of post-septic animals (n=3-4) 
and animals treated originally with saline (n=4-5) 2 and 9hrs following low dose 
LPS 100µg/kg treatment at ZT1-2 (scale bar = 100 µm). (B) Bar graphs illustrating 
expression levels of the IEG EGR-1 in the SCN of post-septic animals and animals 
treated originally with saline 2 and 9hrs following low dose peripheral LPS 
100µg/kg treatment at ZT1-2. 
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5.4.  Discussion: 
In order to fully characterise the state of the post-septic SCN and circadian 
system and discern whether similarities exist between it and other conditions 
displaying a chronic neuroinflammatory component in response to further immune 
stimuli, we examined whether subsequent exposure to a peripheral immune 
challenge would result in a primed response as has been shown in ageing and 
neurodegenerative disease states.  Additionally, examination of the brain in this 
manner would shed further light on post-septic circadian timekeeping mechanisms.  
To the best of our knowledge, these are the first studies assessing the responsiveness 
of the post-septic circadian system to a further peripheral immune challenge. 
Peripheral LPS treatment has been shown to induce photic like phase delays of 
circadian locomotor behaviour when administered in the early subjective night at 
CT15 (Marpegan et al., 2005). A phase delaying LPS treatment did not result in a 
primed responsiveness in the post-septic circadian system, in fact the current study 
observes a significant reduction in phase delay magnitude in post-septic animals 
compared to animals initially treated with saline in response to a phase delaying LPS 
treatment.  Animals previously treated with saline and subjected to a peripheral 
100µg/kg LPS treatment over four weeks later show a phase delay in line with those 
shown by Marpegan et al (2005), who show that a 25 µg/kg LPS treatment induces a 
phase delay of approximately 43 minutes, while 250µg/kg treatment induces larger 
phase delays in the range of 60 minutes, but there is no significant difference in the 
delay magnitudes induced by the different doses. There was a decrease in rhythm 
amplitude following both low dose LPS and control treatments, however this was not 
due to an effect of prior treatment. Additionally, in the current study, LPS i.p. 
treatment caused a transient suppression of locomotor wheel running activity that 
was seen to last for a few hours following the peripheral CT15 treatment, and this 
suppression is as expected and has previously been observed in response to low dose 
peripheral LPS treatments shown by other studies (Marpegan et al., 2005; Paladino 
et al., 2010; Leone et al., 2012).   
Various studies have shown the LPS induced phase delay to be decreased or 
inhibited in response to manipulation of immune signalling mechanisms.  
Administration of sulfasalazine, an NF-κB inhibitor prior to peripheral 25µg/kg LPS 
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treatment at CT15 reduced the LPS induced phase delay to approximately 15 
minutes (Marpegan et al., 2005), a phase delay magnitude similar to that observed 
for the animals previously subjected to sepsis in the current study. Following 
50µg/kg LPS peripheral treatment at CT15, TLR4-/- mice display significantly 
reduced LPS induced behavioural phase delays and do not show the LPS induced 
wheel running inhibition, while c-Fos and PER1 induction in the PVN were found to 
be significantly lower than in control animals (Paladino et al., 2010).  Additionally, 
inhibition of TNF-α (but not of IL-1β) is shown to prevent the phase delays in 
wheel-running activity induced by peripheral LPS treatment, highlighting that TNF-
α acts at the level of the hypothalamus to mediate the effects of a peripheral immune 
challenge on circadian behaviour (Leone et al., 2012).  While administration of i.c.v 
TNF-α inhibitor blocked the LPS induced phase delay, the inhibition of locomotor 
activity was not blocked, indicating that LPS acts via alternate mechanisms to inhibit 
locomotion and to induce behavioural phase delays (Leone et al., 2012).  The 
inhibition of LPS induced phase delays following administration of an inhibitor of an 
immune signalling pathway has been suggested to be possibly due to suppression of 
the release of LPS induced proinflammatory cytokines within the hypothalamus or in 
the periphery (Marpegan et al., 2005) and further, given the dependence of the LPS 
induced phase delay on TNF-α, TLR4 and NF-κB signalling mechanisms (Marpegan 
et al., 2005; Paladino et al., 2010; Leone et al., 2012), it is possible that alterations in 
the immune response of post-septic animals are indicated by the attenuations of LPS 
induced phase delays.  Indeed the data presented by Leone et al (2012) following 
inhibition of TNF-α is analogous to the observations of the current study, whereby 
the LPS induced phase delay was significantly blunted in the post-septic animals, but 
the transient suppression of locomotor behaviour was still evident.  It may be that the 
current study observes alterations in TNF-α release in the post-septic SCN in 
response to a further peripheral LPS treatment which could account for the 
attenuation in the LPS induced phase delay observed in post-septic animals. Further, 
the electrical activity of SCN neurons is altered following TNF-α treatment, with an 
increase observed in spontaneous firing rate, and inhibition of nitric oxide was seen 
to abolish these effects, indicating that TNF-α may act through the induction of nitric 
oxide to modulate the electrical output of the SCN, thereby altering circadian 
rhythmicity (Nygard et al., 2009).  The assessment of SCN electrical activity in post-
septic animals and saline controls following low dose LPS treatment would be 
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interesting, and may shed further light on post-septic circadian responsiveness. 
Further, it‘s possible that in the post-septic SCN alterations may be present in NF-κB 
signalling. The p65 NF-κB subunit has been shown to be acutely up-regulated in the 
SCN following peripheral LPS treatment (Beynon and Coogan, 2010) and 
administration of sulfasalazine, an NF-κB inhibitor, has been shown to block the 
LPS induced phase delay (Marpegan et al., 2005).   
The current study observed an altered neuronal activation in the SCN of post-
septic animals, with a significant upregulation of c-Fos activation evidenced in the 
SCN of post-septic animals following a peripheral low dose LPS treatment, over 4 
weeks following the initial septic LPS treatment. This upregulation is indicative of 
an enhanced activation of neurons within the SCN, showing that the SCN 
responsiveness of these animals is attenuated, and therefore there are alterations in 
the circadian timekeeping system of these animals in response to stimulation by the 
peripheral innate immune system. In contrast to this, at 3mths following the initial 
LPS treatment, assessment of IEG expression 2 and 9 hrs post low dose peripheral 
LPS treatment showed there to be no significant differences between groups in IEG 
expression levels.  It may be that this altered SCN neuronal activation dissipates with 
time and further work is required to establish whether this is the case.  However the 
assessment of neuronal activation at 3mths post the initial treatment was at different 
times of the circadian cycle to that over 4 weeks following the initial treatment, and 
this could possibly play a role in SCN responsiveness and neuronal activation, since 
it has previously been shown that cytokine induction of Fos in the SCN varies 
depending on the time of the circadian cycle at which cytokine administration takes 
place (Sadki et al., 2007), and therefore further investigation is warranted to discern 
whether this is due to the period of time between subsequent LPS treatment or due to 
CT of assessment.  
LPS treatment has been shown to impact upon the SCN and cause alterations 
in c-Fos expression. Palomba and Bentivolgio (2008) have shown photically induced 
c-Fos in the early subjective night to be attenuated 7 days after the final LPS 
treatment of a 2 month treatment regime consisting of weekly injections with LPS 
1mg/kg.  Additionally, a septic treatment of LPS has been shown in the acute stages 
following administration to induce significant expression of c-Fos in the SCN, along 
with expression of the P65 subunit of the NF-κB pathway, although this dose is 
much higher than that used in the current set of experiments (Beynon and Coogan, 
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2010).  While c-Fos is associated with circadian function (Kornhauser et al., 1990), 
the precise role of c-Fos in the SCN in the generation of circadian oscillations is not 
fully understood and has yet to be clearly defined.  Assessment of immediate early 
gene expression highlights variations in the responsiveness of neurons in the SCN 
(Mead et al., 1992).  The dorsomedial shell has been suggested to have a role in 
synchronization via non-visual stimuli (Moga and Moore, 1997; Moore et al., 2002), 
and this SCN region has been suggested as a possible site for interaction between 
endogenous stimuli and the circadian system, and further, studies have suggested the 
SCN dorsomedial shell region to be the site where immune-circadian interactions 
take place, since low dose peripheral LPS induces c-Fos expression in the 
dorsomedial shell of the SCN (Marpegan et al., 2005).  The current studies also 
support the notion that the dorsal portion of the SCN is involved in immune-
circadian interactions, given that it is in the shell region of the SCN that c-Fos 
induction is observed following the peripheral LPS treatment. However, this dorsal 
SCN activation is altered in post-septic animals, since we observe significantly 
higher c-Fos expression in the dorsomedial shell of the post-septic SCN in response 
to a peripheral low dose of LPS, which in this context might indicate alterations in 
circadian-immune interactions at the level of the SCN.  We do not observe any 
alterations in EGR-1 expression following low dose peripheral LPS treatment 
between the treatment groups. 
A decreased neuronal activation in the post-septic SCN in response to 
subsequent LPS treatment might be expected since blunted LPS induced phase 
delays are observed in post-septic animals, and might reflect a decreased circadian 
responsiveness.  However, we have not assessed neuronal activation in the SCN at 
CT15 in DD, the time at which the phase delaying LPS treatment was administered, 
and this would be interesting, since it may be that alterations exist at this time in 
post-septic animals in SCN responsiveness.  It is clear however, that the SCN is 
indeed responding to the LPS treatment and therefore, it does not appear as though 
the induction of proinflammatory cytokines are suppressed in the post-septic CNS.  
Studies assessing c-Fos expression in the PVN in response to LPS at CT15 have 
shown decreased neuronal activation as evidenced by Fos induction in TLR4-/- mice 
(Paladino et al., 2010), showing that manipulation of immune signalling mechanisms 
appears to affect c-Fos induction in response to CT15 LPS treatment.  It‘s possible 
that the enhanced post-septic SCN activation to a low dose LPS treatment could be 
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due to an exaggeration in cytokine levels within the post-septic SCN, indeed Sadki 
and colleagues (Sadki et al., 2007) have suggested that c-Fos expression in the SCN 
in response to cytokine treatment could possibly be dose dependent, and therefore an 
exaggerated cytokine release within the CNS might impact upon SCN c-Fos 
induction.  However, an exaggerated proinflammatory cytokine release might also 
result in an exaggerated phase resetting in post-septic animals and in contrast to this, 
the current study observes a significant reduction in the LPS induced phase delay 
magnitude.  Suppressors of cytokine signalling (SOCS) molecules play roles in 
regulating the intracellular effects of cytokines (Alexander, 2002) and SOCS 1 and 3 
show diurnal variation in expression in the SCN, and have been suggested to be 
involved in the regulation of the sensitivity of the SCN to immune stimuli, since the 
time at which their expression is low correlates with both the phase at which 
cytokine induced c-Fos SCN expression is high (Sadki et al., 2007) and the time at 
which LPS induces circadian phase delays of locomotor behaviour take place 
(Marpegan et al., 2005).  Examination of SOCS expression in the post-septic SCN 
might be interesting and may shed light on post-septic SCN responsiveness to further 
inflammatory stimuli as well as the post-septic innate immune system within the 
CNS. 
It may be that we are observing long term alterations in the SCN or in the 
circadian timekeeping system specifically in the post-septic animals.  Analysis of the 
PVN might provide further insight into the effects of small dose LPS on the post-
septic circadian system. The SCN projects to the PVN which is involved in 
regulation of autonomic and endocrine outputs, including production of 
glucocorticoids (Kalsbeek et al., 2006) and it has been suggested that in this way the 
circadian system may be involved in the modulation of the immune system (Coogan 
and Wyse, 2008). The LPS receptor TLR4 is expressed in the PVN (Laflamme and 
Rivest, 2001), indicating that the PVN may be directly stimulated by and respond to 
an immune challenge with LPS (Leone et al., 2012), and further, administration of 
cytokines or LPS, causes c-Fos activation in the PVN (Marpegan et al., 2005; Sadki 
et al., 2007). Marpegan and colleagues (Marpegan et al., 2005) have shown strong 
induction of c-Fos in the PVN following LPS administration at CT15, and further, 50 
μg/kg LPS treatment in the subjective night has been shown to induce PER1 
expression in this hypothalamic region at CT15 (Paladino et al., 2010).  Other 
studies have shown stress signals such as LPS to induce upregulation of the Per1 
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gene in the PVN CRF neurons, but not in the SCN (Takahashi et al., 2001).  Given 
that the PVN has previously been suggested to be involved in mediating output 
information communicated from the SCN (Kalsbeek et al., 2010), it would be 
interesting to examine whether changes were evident in clock gene expression or 
neuronal activation within the PVN in the post-septic animals following low dose 
LPS treatment. 
 
In these studies, a chronic upregulation of the microglial markers F4/80 and 
CD-11b has been observed in the post-septic SCN, however, in comparison to 
immunostaining at twenty four hours following LPS treatment, the microglia 
observed at the 3 month time point post-sepsis are morphologically distinct and do 
not appear traditionally activated, but rather display a resting phenotype.  In response 
to an immune challenge in the CNS, microglia become activated and are seen to 
transition from a resting, ramified state to an active ameboid, de-ramified 
morphology and then through an intermediate ―primed‖ state  (Perry, 2004).  It has 
previously been suggested that microglial priming may play roles in the 
neuroinflammatory state which is characterized by low cytokine levels, an increase 
in markers for activated microglia and an over-response to inflammatory stimuli 
(Hains et al., 2010).  Certain aspects of this primed condition appear to correlate with 
the present studies, as well as the long-lasting neuroinflammatory state outlined by 
other groups using the same model as used here (Qin et al., 2007; Weberpals et al., 
2009; Bossu et al., 2012).  We therefore sought to examine whether primed 
microglia existed in the SCN of post-septic animals and would show an enhanced 
responsiveness to further inflammatory stimuli, since the CNS in these animals had 
previously shown an innate immune response, as well as altered SCN 
neurochemistry with a long-lasting upregulation of microglial markers, but no long-
lasting alterations in cytokines or inflammatory mediators examined.  However, 
following low dose peripheral LPS treatment, microglial examination through 
immunohistochemical staining for F4/80 and CD-11b revealed neither a significant 
change in the expression of microglial markers in the post-septic SCN compared to 
saline controls, or a difference in microglial morphology.   
That we do not observe an alteration in microglial number or morphology in 
response to further LPS treatment does not necessarily mean that the microglia we 
observe in the post-septic SCN are not primed.  In line with the microglial 
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observations in these studies, studies in ME7 mice have proposed microglia to be in 
a primed but not proinflammatory state, since microglia appearing to be activated in 
this instance do not significantly express the pro-infammatory cytokines IL-6 or IL-
1β (Walsh et al., 2001) but do synthesise prostaglandin E2 (Minghetti et al., 2000).  
The long-lasting upregulation of microglial markers observed in the SCN in the 
current study is in the absence of an increased expression of proinflammatory 
cytokines examined at the three month time point, and so while the microglia in the 
post-septic SCN might not be traditionally activated, they may be in a primed state. 
Other studies utilizing tomato lectin immunohistochemistry to assess activated 
microglia in an ME7 mouse model of prion disease following an intracerebral 
injection of LPS, do not show alterations in microglial morphology in these animals 
subject to chronic neurodegeneration compared to controls (Cunningham et al., 
2005), however while these microglia appear similar, those in the ME7 mice are 
shown to exhibit IL-1β staining (Cunningham et al., 2005). While CD-11b and F4/80 
immunohistochemical analysis in the post-septic SCN does not reveal a 
morphologically activated phenotype, IBA-1 immunohistochemical staining has 
previously shown hypertrophic microglia at the three month time point in the post-
septic brain.  In line with this, morphologically activated microglia have been shown 
in the aged brain of both humans and rodents, and these show increased expression 
of CD68 and MHC II (Godbout and Johnson, 2009; Lucin et al., 2009), and it has 
previously been described that microglia may be primed or reactive and exhibit an 
increased expression of MHC II, and not necessarily produce inflammatory 
cytokines (Perry et al., 2003). Additionally, in aged mice, peripheral LPS resulted in 
overexpression of TLR2 in microglia and subsequently caused exaggerated induction 
of pro-inflammatory cytokines compared to young adults (Henry et al., 2009).  
Examination of markers such as MHC II and TLR2, which have shown to be 
upregulated on the surface of primed microglia is deserved in the post-septic SCN. 
Further, we have not examined IBA-1 immunostaining in the post-septic SCN 
following further LPS challenge, and it would be interesting to further assess 
microglial morphology using this marker.  Given the exaggerated induction of 
proinflammatory cytokines by primed microglia in response to further stimulation, 
examination of proinflammatory cytokine expression in the post-septic SCN may be 
warranted following a peripheral low dose LPS treatment, and would help to clarify 
the state of the post-septic microglia within the SCN. 
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It is important to point out that we do not observe any alterations in microglial 
expression between post-septic animals and those treated with saline initially, despite 
post-septic animals having previously shown chronic upregulation of SCN 
microglia.  It may be that the animals not having undergone septic LPS treatment are 
showing an increase in microglial expression in response to low dose LPS treatment.  
Indeed, various studies have shown the ability of low dose LPS treatment to induce a 
microglial increase in the CNS.  Assessment of the neocortex following a single low 
dose peripheral 0.5mg/kg LPS treatment in mice has shown a significant 
upregulation in microglia both acutely and chronically, at 2, 7 and 28 days post-
treatment (Kondo et al., 2011), while other studies in mice have shown 0.1mg/kg 
peripheral LPS treatment increases brain mRNA expression levels of MAC-1, a 
marker for microglial activation, and treatment with minocycline reduces this 
(Masocha, 2009). Given that we have previously observed significantly increased 
microglial expression in the post-septic SCN compared to controls, it might be 
expected that following low dose LPS treatment there would be higher levels of 
microglia in the post-septic SCN, were the low dose LPS treatment increasing SCN 
microglial expression, however this is not seen in post-septic animals.  It may be 
then that there are alterations in the post-septic SCN in response to inflammatory 
mediators and further investigation of the low dose LPS microglial increase in the 
SCN is warranted. 
Studies have shown that in situations of pre-existing pathology, 
proinflammatory cytokine expression is increased following a peripheral LPS 
treatment (Cunningham et al., 2005), examination of the expression of 
proinflammatory cytokines in the post-septic brain following a 100µg/kg LPS 
treatment would be interesting. In rats, peripheral LPS 100ug/kg has been shown not 
to cross the blood brain barrier, however to be capable of inducing proinflammatory 
responses as well as an increase in iNOS, through binding of specific receptors in the 
cerebral vascular endothelium (Singh and Jiang, 2004) and this could result in an 
innate immune hyper-responsiveness within a primed CNS, as well as enhanced 
behavioural responses.  It has previously been indicated that the release of cytokines 
following LPS treatment which go on to act on the SCN is the method by which LPS 
impacts upon circadian function (Leone et al., 2006) and it is known that direct 
administration of immune factors affects locomotor behaviour (Crnic and Segall, 
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1992; Koyanagi and Ohdo, 2002) and is capable of phase-shifting SCN rhythmicity 
(Marpegan et al., 2005; Sadki et al., 2007; Boggio et al., 2003).  Given the enhanced 
post-septic SCN neuronal activation observed in response to 100µg/kg LPS 
treatment, it may be that alterations in pro-inflammatory cytokine responses take 
place in the post-septic CNS and SCN at this time, accounting for the enhanced SCN 
neuronal activation.  As already mentioned, the SCN in mice is seen to express 
mRNAs for TNF receptors I and II, and TNF-α has been suggested to act through the 
induction of nitric oxide to modulate the electrical output of the SCN, thereby 
altering circadian rhythmicity (Nygard et al., 2009), and further, it is TNF-α that has 
been shown to be required for the LPS induced CT15 phase delay (Leone et al., 
2012).  Alterations in TNF-α release in the post-septic SCN in response to a 
subsequent peripheral LPS treatment could possibly account for the attenuation in 
the LPS induced phase delays observed in post-septic animals. Indeed, various 
studies in conditions of pre-existing CNS pathology have highlighted altered 
proinflammatory cytokine responsiveness in response to both central and peripheral 
LPS treatment.  ME7 mice treated with intracerebral LPS show marked microglial 
iNOS and IL-1β expression, as well as substantial neutrophil infiltration in 
comparison to controls (Cunningham et al., 2005).  iNOS is commonly observed in 
neuroinflammatory studies, and further, the presence of the inflammatory mediator 
and NO synthesis hallmarks subsequent activation of primed microglia (Cunningham 
et al., 2005) and macrophages (Johnson et al., 1983). Increases in the levels of 
cytokine mRNA expression are seen in the brain following peripheral LPS treatment 
in both presenilin-1 mutant mice (Lee et al., 2002) and in amyloid precursor protein 
(APP) overexpressing mice (Sly et al., 2001).  Further, ME7 mice treated i.p. with 
500 µg/kg LPS resulted in the increased expression of IL-1β in microglia, and the 
induction of IL-6, TNF-α, PTX3 (pentraxin 3), and iNOS compared to control 
animals, along with neuronal apoptosis (Cunningham et al., 2005).  Additionally, 
upon administration of a second systemic LPS challenge, microglia are seen to be the 
primary source of IL-12 that is produced (Stalder et al., 1997).    
Together, these studies highlight the extent to which cells within the CNS are 
primed during conditions of chronic neurodegeneration and inflammation, showing 
enhanced cytokine responses to subsequent inflammatory challenges.  Examination 
of proinflammatory cytokine expression in the post-septic SCN may prove beneficial 
following a peripheral low dose LPS treatment, helping to clarify whether the 
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microglia within the SCN at this time are in a primed state, and further, would help 
discern whether the alterations observed in the LPS induced phase delays in post-
septic animals were due to alterations in the post-septic innate immune 
responsiveness, or due to alterations at the level of the SCN or circadian timekeeping 
system. Were there an exaggerated induction of proinflammatory cytokines, either 
higher levels do not have an effect on the phase delay magnitude at this time, or 
alterations within the post-septic SCN or output from it might result in the effects of 
this not being reflected in behavioural resetting. 
It has been suggested that glucocorticoid action within the brain could result in 
exaggerated inflammatory responses to stimulation of the immune system (de Pablos 
et al., 2006; Munhoz et al., 2010). Further, peripheral administration of LPS 
activates HPA axis activity, increasing circulating levels of corticosterone and 
ACTH (Linthorst and Reul, 1998) and the HPA axis through the production and 
release of glucocorticoids from the adrenal cortex exert potent immunosuppressive 
and anti-inflammatory effects (Munck and Guyre, 1991; Auphan et al., 1995; Meier, 
1996; Barnes, 1998; Sternberg, 2001; Webster et al., 2002).  Additionally, the HPA 
axis and glucocorticoids have been suggested to play a role in endotoxin tolerance 
(Beishuizen and Thijs, 2003; Cavaillon et al., 2003; Ikeda et al., 2006; Evans and 
Zuckerman, 1991; Parrillo et al., 1993; Zuckerman and Qureshi, 1992) and in primed 
microglial responses to LPS (Frank et al., 2012).  Together these studies highlight 
the GC involvement in LPS and CNS immune responses. A long-term increased 
HPA axis sensitivity is observed following cytokine treatments.  IL-1β is induced by 
LPS treatment, and a single IL-1β treatment induces an increased responsiveness of 
the HPA axis which is seen to last up to 22 days, but not at 42 days post-treatment 
and involves the PVN (Schmidt et al., 2001).  Further, TNF-α, also known to be 
involved in LPS responses (Qin et al., 2007) was seen to cause long-lasting HPA 
sensitization which was associated with increased intra-PVN noradrenergic storage 
(Hayley et al., 1999).  Cytokine mediated alterations of the function of the HPA axis 
and glucocorticoid receptor function may further modulate inflammation (Capuron 
and Miller, 2011), and this alteration in endocrine function could feedback to the 
SCN, impacting upon circadian immune function and SCN responsiveness, and have 
implications for circadian resetting in response to further immune stimuli, and 
therefore examination of a possible role for glucocorticoids in the post-septic 
responses to further LPS treatment would be interesting. 
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Since prior LPS administration and activation of the innate immune response 
could result in either a hyper or hypo response within the CNS in response to further 
immune challenges, and both in vivo and in vitro, low LPS doses have been shown to 
result in a tolerant state where the immune response to further challenge with LPS is 
altered (Biswas and Lopez-Collazo, 2009; Yoza and McCall, 2011),  the possibility 
that endotoxin tolerance may account for the attenuations in the post-septic circadian 
system in response to a subsequent immune stimulus must be addressed.  Indeed, the 
suppression of the LPS induced phase delay would indicate that the LPS effects upon 
the circadian system are attenuated, and it‘s possible that this could be due to a 
tolerant state within the CNS induced by the previous septic LPS challenge.  Further, 
endotoxin tolerance has been shown to be acutely induced in studies utilizing the 
same LPS dose as that used in the current study followed by CLP (Wheeler et al., 
2008).  The diminished LPS induced phase delay might be observed in states of 
endotoxin tolerance as a result of suppression of the expression of pro-inflammatory 
mediators known to phase shift the clock (Leone et al., 2012) upon subsequent 
exposure to LPS.  However, we do not believe the results from the current set of 
studies can be explained by endotoxin tolerance, since the effects of endotoxin 
tolerance have only been shown to persist in vivo up to three weeks (West and 
Heagy, 2002), and therefore upon further peripheral LPS treatment over four weeks 
following the initial LPS treatment, it is unlikely that endotoxin tolerance is 
accountable for the attenuation in LPS induced phase delays of the circadian 
locomotor rhythm.  In line with this assessment, endotoxin tolerance was not 
observed following two peripheral 50ug/kg LPS treatments at CT15 29 days apart 
(Leone et al., 2012).  Further, were the post-septic CNS in a state of endotoxin 
tolerance at this time, then it is unlikely that an exaggerated SCN c-Fos 
responsiveness would be observed following a peripheral immune treatment, given 
that this highlights that the SCN is responding to the inflammatory challenge and it 
therefore appears as though the induction of proinflammatory cytokines is not 
prevented in the post-septic CNS.  Moreover, studies have shown that while in the 
periphery during endotoxin tolerance peripheral cytokines are no longer induced, 
LPS induced cytokine expression remains evident in the CNS (Chen et al., 2005; 
Faggioni et al., 1995) and therefore the impact of cytokine induction may still allow 
a phase delay and the suppression of this could not be explained by endotoxin 
tolerance. 
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The alterations observed in clock gene expression in the post-septic SCN could 
play a role in the effects of a low dose LPS treatment on the post-septic SCN and on 
circadian behaviour. Inflammatory mediators induced by peripheral LPS may impact 
upon the SCN inducing functional changes and alterations in clock gene expression 
following LPS administration, and the ability of LPS to impact upon clock gene 
expression has been shown by various different studies (Takahashi et al., 2001; 
Marpegan et al., 2005; Palomba and Bentivoglio, 2008; Okada et al., 2008).  
Additionally, alterations in clock genes have been shown to affect immune 
responses.  Murine studies using chronic jet lag paradigms or SCN ablation to induce 
impairment of molecular clock function have shown an increased rate of tumour 
growth, linked to perturbations in circadian oscillations in the levels of circulating 
lymphocytes (Filipski et al., 2003, 2006).   CJL mice show altered clock gene 
expression in the periphery, the SCN and in immune cells, as well as enhanced 
sensitivity to endotoxin administration (Castanon-Cervantes et al., 2010).  Loss of 
IFN-γ circadian expression is seen in mutant Per2 animals (Arjona and Sarkar, 
2006a, b) along with alterations in NK cell function and decreases in 
proinflammatory cytokine production of IL-1β and endotoxic shock resistance 
following LPS treatment (Liu et al., 2006), indicating a role for the clock gene in 
mediating the LPS induced immune response.  Since TNF-α has been shown to 
impact upon clock gene expression (Cavadini et al., 2007; Petrzilka et al., 2009), and 
to be necessary for the LPS induced phase delays at CT15, it has been suggested to 
elicit phase shifts by altering the expression of clock genes (Leone et al., 2012), it is 
therefore possible that TNF-α release following low dose peripheral LPS treatment 
could further alter clock gene expression in the post-septic SCN, impacting upon the 
phase shifts induced.  Alterations in clock gene expression in the post-septic SCN 
could account for altered responsiveness in the post-septic animals to further 
endotoxin treatment, and given that the current study finds alterations in the 
expression of PER2 in the post-septic SCN in vivo, it‘s possible that these 
attenuations could play a role in the immune response or the response of the SCN in 
post-septic animals to phase-shifting immune stimuli. 
It seemed a likely consequence that in response to further peripheral immune 
stimulation, a primed response would be seen within the post-septic brain.  Systemic 
infection has been shown to lead to sustained upregulation of microglial markers 
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(Weberpals et al., 2009) and prolonged cytokine synthesis within the CNS (Qin et 
al., 2007; Weberpals et al., 2009; Bossu et al., 2012, Puntener et al., 2012), and more 
recently, with priming of brain innate immune cells to subsequent focal 
inflammatory challenge by LPS in the brain parenchyma (Puntener et al., 2012). 
Further, since ageing is associated with a low-grade central neuroinflammation 
(Godbout and Johnson, 2009), including in the SCN (Deng et al., 2010) and the 
current study observes similarities between circadian resetting in post-septic animals, 
and those in studies assessing the effects of healthy ageing on circadian resetting 
(Rosenberg et al., 1991; Zee et al., 1992), and the ageing CNS also exhibits primed 
responsiveness to inflammatory stimuli, it seemed plausible that the post-septic SCN 
might be primed and that further perturbations in circadian resetting might be 
observed in the post-septic brain to immune stimuli.  Additionally, conditions of 
chronic neurodegenerative disease known to have an inflammatory component 
exhibit primed responses within the CNS as well as exaggerated behavioural 
responses to peripheral immune insults, and LPS administration through both i.p. 
routes and direct administration to the CNS have been used to model chronic 
neurodegenerative disease states. Chronic i.c.v. infusion of 0.25µg/h of LPS has 
been used to model Alzheimer‘s Disease (Hauss-Wegrzyniak et al., 1998), while 2µg 
intranigral LPS delivery has been used to model Parkinson‘s Disease (PD) (Herrera 
et al., 2000), and the single peripheral septic LPS treatment used in the current set of 
studies has been used to model pathological features of both AD and PD (Qin et al., 
2007).  However, it has been suggested that these models do not fully represent the 
pathogenesis of these neuroinflammatory diseases (Cunningham, 2013).  While both 
the CNS of chronic neuroinflammatory diseases and that following LPS treatment 
show increased microglial cells, the levels of proinflammatory cytokines induced by 
LPS are much higher than those in the chronic disease states and may therefore not 
fully reflect the pathogenesis of these diseases (Cunningham et al., 2013), for 
example, low expression levels of IL-1β, TNF-α and IL-6 are seen in animal models 
of PD and AD (Sly et al., 2001; Depino et al., 2003), similar to the CNS of the ME7 
prion disease model (Walsh et al., 2001; Cunningham et al., 2002; Betmouni et al., 
1996).  With this in mind, long-term primed responses may not be exhibited by the 
cells of the innate immune system within the post-septic CNS, and it is clear that 
primed behavioural responses are not shown by the post-septic circadian system in 
response to a phase delaying LPS treatment. 
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Overall, the current results indicate that either the innate immune response of 
the post-septic animals is altered in how it responds to a low dose LPS challenge, or 
that the altered response can be explained by perturbations specific to the SCN or the 
circadian system itself.  Immune factors have been suggested to play roles as 
entraining factors of the circadian system, given their ability to phase shift circadian 
locomotor rhythms (Marpegan et al., 2005) and the current study observes an 
alteration in circadian resetting properties in post-septic animals in response to 
peripheral LPS treatment.  The results of the current study are reminiscent of those 
where components of the innate immune system are inhibited or immune receptors 
absent (Marpegan et al., 2005; Paladino et al., 2010; Leone et al., 2012). 
Additionally, alterations are observed in the induction of c-Fos expression in the 
SCN in post-septic animals and while this could be indicative of altered input to the 
SCN, is may also be due to an altered SCN response to immunomodulation.  Further, 
it may be that circadian resetting alterations are due to perturbations within the SCN 
itself, or output from the SCN, or further, that it is downstream from the SCN that 
alterations are manifested, such as at the level of the PVN resulting in alterations in 
output. 
As well as the mechanisms previously mentioned, there are multiple routes by 
which peripheral LPS may affect the CNS (Capuron and Miller, 2011), and 
therefore, there are a variety of parameters that may be attenuated and could impact 
upon the way in which the post-septic CNS reacts to additional challenge, or 
previous attenuations may be further modulated following subsequent exposure to 
inflammatory stimuli, and these could underlie the post-septic circadian resetting 
alterations.  Peripheral infections may propel the process of degeneration in the CNS 
(Combrick et al., 2002). In models of chronic neurodegeneration subjected to 
subsequent immune stimuli, acute neuronal death is observed (Cunningham et al., 
2005) and so assessment of apoptosis in the post-septic SCN following a low dose 
peripheral LPS treatment may be warranted, given that the model used in this study 
is one which shows delayed neuronal loss in the substantia nigra (Qin et al., 2007), 
and subsequent inflammatory stimuli may exacerbate this or indeed induce apoptosis 
in other CNS regions.  Additionally, it would be interesting to assess the 
electrophysiological properties of SCN neurones post-sepsis, and to further examine 
the neurochemical composition of the SCN in post-septic animals, since changes in 
the GABAergic network have been shown in the SCN in ageing (Palomba et al., 
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2008), and such alterations could explain alterations in SCN function and 
responsiveness. 
Attenuations in neurotransmission in the post-septic brain could cause 
alterations within the CNS as a result of LPS induced cytokine modulations, since 
studies of the CNS in sepsis have observed evidence for altered neurotransmission 
(Van der Poll et al., 1996, Van der Poll, 2000; Toklu et al., 2009; Freund et al., 1985) 
and alterations in these parameters could underlie the perturbations in phase delays 
in post-septic animals in response to further LPS treatment. The outflow of the 
neurotransmitter Acetylcholine (Ach) has been shown to be affected by IL-1β 
expression (Taepavarapruk and Song, 2010), which is known to be released in 
response to LPS treatment.  Further, the assessment of cholinergic transmission in 
the SCN post sepsis would be interesting. The cholinergic anti-inflammatory 
pathway plays roles in the modulation of inflammation, stimulating the 
parasympathetic nervous system to release acetylcholine which regulates the 
immune response (Pavlov et al., 2003).  Given that cholinergic input to the SCN is 
involved in the function of the circadian system (Hut and Van der Zee, 2011), it‘s 
possible that alterations in the cholinergic system such as the loss of cholinergic 
fibres previously shown in rats following high dose endotoxin (Semmler et al., 2007) 
could play a role in the altered responses to LPS and attenuations in LPS induced 
phase delays in the current experiment.  In animals with pre-existing cholinergic 
neuronal loss, acute working memory impairments are observed following a 
systemic LPS challenge and this can be inhibited by administration of donepezil, an 
acetylcholinersterase inhibitor (Field et al., 2012).  Together, these studies highlight 
that alterations in cholinergic pathways and neurotransmission could potentially play 
a role in attenuated responses following LPS treatment.   
The current studies further illustrate that there are long-term perturbations in 
the post-septic circadian system, however the data from the current study cannot 
elucidate the mechanism by which this happens.   It‘s possible that these attenuations 
could be due to alterations within the post-septic innate immune system within the 
CNS, or indeed may be due to changes in the post-septic SCN or circadian 
timekeeping mechanisms themselves. Further, given that there are altered responses 
in the long term post sepsis to peripheral immune stimuli, it may be that there are 
alterations in circadian-immune cross talk.  Further work is required to delineate the 
mechanisms underlying this altered circadian responsiveness. 
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Chapter Six 
General Discussion 
The overall goal of these studies at the outset was to examine the long-term 
effect of a substantial immune challenge on timekeeping processes.  The model used 
in the current set of studies is one that exerts a long-lasting impact on the innate 
immune system in the CNS, and this long-lasting neuroinflammation causes 
alterations within the CNS including delayed neurodegeneration, alterations in 
learning and memory, alterations at the level of synaptic proteins, as well as changes 
in cerebral metabolism (Weberpals et al., 2009; Qin et al., 2007; Bossu et al., 2012), 
however, there are no studies that investigate the chronic alterations at the level of 
the master pacemaker or the impact upon circadian timekeeping mechanisms. These 
studies have fulfilled the original objective, and have characterized the long-lasting 
impact of a profound immune insult on circadian behaviour, on SCN molecular 
oscillations and SCN responsiveness.  The core circadian locomotor behaviour 
parameters and circadian resetting behaviour were assessed in the long-term post-
sepsis, and attenuations in post-septic photic resetting and reentrainment have been 
described.  Further, these studies have highlighted chronic changes in post-septic 
SCN clock gene protein product expression, attenuations in post-septic SCN 
functional activation in response to both photic and immune stimulation, as well as 
alterations in post-septic circadian resetting in response to phase resetting immune 
stimuli.  The current set of studies therefore add to the experimental evidence 
describing the long-lasting impact of a systemic immune challenge on CNS function, 
and address a gap in the literture as to the chronic effects of a profound immune 
challenge on the circadian timekeeping system. 
Strong links have been shown in recent years in communication between the 
immune system and the circadian system.  The data presented here highlights 
important influences between the immune system and the circadian system, and adds 
to the literature on peripheral immune signals reaching the SCN.  The acute impact 
of immune mediators on the circadian system has been well documented, and 
immune mediators have been shown to affect various circadian parameters including 
electrical firing rhythms (Nygard et al., 2009), behavioural phase resetting 
(Marpegan et al., 2005; Paladino et al., 2010; Leone et al., 2012) and clock gene 
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expression both centrally and peripherally (Okada et al., 2008; Koyanagi and Ohdo, 
2002; Cavadini et al., 2007).  Studies assessing the impact of immune mediators on 
the SCN clock all appear to have shown a decrease in the expression of clock and 
clock controlled genes, in line with the dampening of clock gene protein product 
expression observed in the long-term in the current studies (Okada et al., 2008; 
Koyanagi and Ohdo, 2002; Cavadini et al., 2007; Logan and Sarkar, 2012), therefore 
the results presented here are in line with, and contribute to, the literature 
highlighting the repression of clock gene expression following immune activation. 
Further, the effects of chronic LPS treatment have been shown to impact upon the 
master pacemaker (Palomba and Bentivoglio, 2008), and the current studies now add 
to this, outlining the chronic effects of a single septic LPS challenge on the SCN and 
circadian timekeeping processes, and support the notion that chronic inflammation 
might underlie circadian timekeeping perturbations, since circadian alterations have 
been shown in studies of chronic neuroinflammatory states and chronic infection 
(Hatfield et al., 2004; Rosenberg et al., 2001; Huitron-Resendiz et al., 2007;  
Lundkvist et al., 2002; Kennedy, 2009; Kristensson et al., 2010).  It was thought that 
a chronic neuroinflammation could possibly occur within the SCN, given the long-
lasting neuroinflammation induced in other regions of the CNS by the septic 
endotoxin model (Qin et al., 2007; Weberpals et al., 2009; Bossu et al., 2012), and 
that this could play a role long term in circadian timekeeping processes, however, the 
experimental results obtained cannot attribute the long-lasting perturbations of the 
post-septic circadian system to the chronic presence and action of the examined 
proinflammatory mediators at the site of the SCN, but do show long term microglial 
changes, the significance of which requires further investigation. 
Overall, the results from these studies point to an as yet unknown mechanism 
underpinning the long-lasting changes in the post-septic circadian system.  These 
studies cannot currently elucidate a mechanism by which timekeeping processes are 
impacted post-sepsis, and raise many new questions which could form the basis of 
future investigations addressing whether the post-septic perturbations are due to an 
altered input to the SCN, given the alterations in post-septic SCN responsiveness, 
due to perturbations in output from the SCN, or whether it may be downstream from 
the SCN that alterations are manifested.  Further extensive studies would be required 
in order to delineate a mechanism by which LPS induced sepsis chronically impacts 
upon circadian timekeeping processes. 
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An interesting future endeavour would be to examine electrical neuronal firing 
rhythms in the post-septic SCN, since these are crucial in the generation of coherent 
circadian output and transmitting circadian timing information to the brain and 
periphery (Schwartz et. al., 1987).  Intercellular synchronization can influence phase-
shifting responses (VanderLeest et al., 2009), and inflammatory mediators are 
known to impact upon the SCN at the electrophysiological level (Kwak et al., 2008; 
Nygard et al., 2009; Lundkvist et al., 2002), and therefore perturbations in post-
septic SCN electrical activity could potentially underlie alterations in circadian 
resetting post-sepsis.   
Additionally, it would be insightful to examine SCN functional activation in 
response to low dose LPS treatment at CT15, as would the examination of what 
underlies the perturbations in photic SCN functional activation observed under LD 
conditions but not under DD, and would further add to our knowledge of the post-
septic circadian system.   
Due to the specificity of photic induced perturbations and SCN photic 
responsiveness post-sepsis all involving phase advances or occurring during the 
advance portion of the PRC, future studies should examine parameters whose 
perturbation could underlie these phase specific attenuations, such as examination of 
the NO-cGMP-PKG pathway (Plano et al., 2012).  Enhanced late subjective night 
photic induced phase advances of locomotor activity (Plano et al., 2012) and  
accelerated resetting following a 6h phase advance of the photocycle (Agostino et 
al., 2007) are seen following prevention of cGMP degradation, and it may be that 
perturbations in this pathway could underlie the attenuations in post-septic photic 
phase advance resetting and photoperiod advance reentrainment.  The examination 
of the degree of molecular desynchrony in the SCN that is suggested to underlie 
gradual phase advance resetting (Reddy et al., 2002) would also be interesting in 
post-septic animals.   
Further, glucocorticoid rhythms have been demonstrated to influence the speed 
of re-entrainment to shifts in phase (Davidson et al., 2009), and studies have pointed 
to a role of the corticosterone rhythm in entrainment of behavioural rhythmicity 
through modulation of light effects on the pacemaker.  The SCN responds to 
glucocorticoid information (Briski et al., 1997) and an SCN-adrenal gland feedback 
loop has been suggested (Kiessling et al., 2010), whereby the SCN receives photic 
information and subsequently signals to the adrenal gland through neuronal 
240 
 
connections influencing the expression of clock genes in the adrenal, the adrenal in 
turn feeds back via the indirect communication to the SCN, possibly via 
glucocorticoid sensitive serotonergic neurons in the midbrain raphe (Sage et al., 
2004), regulating the SCN‘s control of locomotor rhythmicity (Kiessling et al., 
2010).   
In situations where corticosterone levels or rhythms are attenuated, faster 
resetting kinetics in rhythmic behavioural locomotor activity (Kiessling et al., 2010; 
Sage et al., 2004; Mohawk et al., 2005), as well as more rapid resetting of the phase 
in the periphery and in brain regions, including the SCN (Pezuk et al., 2012), are 
seen in response to phase shifts of the photoperiod.  Stable entrainment can be seen 
in cases where underlying glucocorticoid rhythms are out of phase with the natural 
rhythm and its relationship to the light dark photoperiod (Albers et al., 1985), and 
experimental manipulation of the glucocorticoid rhythm does not impact upon 
locomotor behaviour under DD or conditions of stable entrainment, including no 
effect on locomotor behavioural synchronization or entrainment properties (Sage et 
al., 2004).  Further, restoration of rhythmic corticosterone secretion in phase with the 
new photocycle following the photoperiod shift re-establishes normal rates of 
synchronization (Sage et al., 2004).  
It has been suggested that circulating glucocorticoids act to stabilise rhythmic 
locomotor behaviour, by strengthening the resistance of the timekeeping system to 
photoperiodic manipulations (Sage et al., 2004), or preventing uncoupling following 
phase shifts of the photoperiod (Pezuk et al., 2012), and that when normal rhythmic 
glucocorticoid secretion is absent, the animals are dependent on the L:D cycle alone 
and so reentrain faster to the phase shift (Sage et al., 2004).  Similarities exist 
between the above studies and the data we have obtained on locomotor behaviour in 
post-septic animals, with no alterations in locomotor entrainment properties or core 
circadian parameters, but attenuated resetting kinetics.  Further, impairment of the 
HPA axis is seen in humans and in experimental sepsis studies in rodents, both in the 
acute and post-acute phase (Carlson et al., 2006; Polito et al., 2011), and 
inflammatory mediators have been shown to alter corticosterone rhythms (Shinohara 
et al., 2008).  Therefore, it‘s possible that alterations in these rhythms could underlie 
the changes seen in the behavioural experiments post-sepsis during advance re-
entrainment and further studies assessing rhythmic corticosterone following the 
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induction of the sepsis and during the time course at which manipulations of the light 
dark cycle resulted in altered resetting would be interesting. 
 
The sepsis inducing endotoxin model used in the current set of studies 
provides important insights into the long-lasting impact of a profound immune insult 
on the circadian system in mice, however currently, we can only speculate what 
effects this might have in nature and in the human population.   Care must be taken 
when interpreting translatability of results between experimental animal models and 
human sepsis patients, since human sepsis patients are treated with a variety of 
therapies, while many animal models, such as that used in these studies, show a lack 
of supportive interventions (Buras et al., 2005).  Furthermore, LPS induced sepsis in 
animal models may not accurately replicate some important features of human 
sepsis, such as the rate of disease progression, the magnitude and rate of induction  
of cytokine responses, and the initial hyperdynamic cardiovascular state observed in 
human sepsis  (Buras et al., 2005; Deitch, 1998; Hollenberg, 2005; Fink et al., 1990; 
Nemzek et al., 2008). Mice have also been shown to be more resistant to endotoxin 
treatment than humans, and this may limit the extrapolation of results (Copeland et 
al., 2005), and previous studies assessing sepsis treatments in experimental animal 
sepsis models did not translate in human clinical trials (Buras et al., 2005; Deitch, 
1998). Additionally, these studies are performed in a nocturnal animal model, the 
results from which may not directly translate to diurnal species and further, the 
animal model used in these studies is naturally deficient in melatonin, and melatonin 
rhythms play strong roles in the circadian regulation of the immune response (Logan 
and Sarkar, 2012), and the attenuation of melatonin rhythms has been shown in the 
early stages of sepsis in humans (Li et al., 2013).  It might be pertinent for 
extrapolation of results and transferability to examine the long-lasting impact of 
sepsis on circadian timekeeping processes in a diurnal animal model, and in the 
presence of rhythmic melatonin.   
Immunohistochemistry is a widely used method of protein detection that is fast 
and is adequately sensitive when utilizing an appropriate detection antibody, 
however IHC only allows qualitative or semiquantitative analysis of protein 
expression, and a further limitation of this method lies in the fact that quantification 
of immunostaining may be somewhat subjective (Guardigli et al., 2005).  Protein 
detection by other methods such as Western blotting and ELISA allows quantitative, 
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objective analysis.  Additionally, real-time PCR is a very sensitive technique 
allowing the quantification of the mRNA encoding the protein of interest (Bustin, 
2000; Guardigli et al., 2005).  It might be interesting to utilize these protein detection 
techniques to further assess the post-septic CNS, however these methods have their 
own associated limitations (Guardigli et al., 2005).  The main advantage of 
Immunohistochemistry over these other protein detection techniques is the ability of 
IHC not only to detect the presence of a particular protein, but to demonstrate the 
location of this within a tissue or cell, and further, antigens can be detected in the 
context of cellular morphology (Ramos-Vara, 2011; Webster et al., 2009) which was 
required for, and proved informative in the current set of studies. 
Recently, studies in septic patients have shown circadian attenuations in the 
acute phase following sepsis induction, and have highlighted a potential link between 
the progression of early stage sepsis and circadian rhythms (Li et al., 2013).  The 
current studies now add to the literature concerning circadian perturbations and 
sepsis, and illustrate for the first time the long-lasting effects of sepsis on circadian 
rhythms in mice.  Up to 50% of sepsis survivors are seen to suffer from post-septic 
encephalopathy which is characterized by long-lasting cognitive impairment 
including attenuations in concentration, attention and memory and/or a global loss of 
cognitive function (Streck et al., 2008), and neuroinflammation has been implicated 
in the pathogenesis of various disorders associated with cognitive impairment 
(Nelson et al., 2002; Katsuse et al., 2003; Perry et al., 2003), including Septic 
Encephalopathy (Jacob et al., 2010).  Further, circadian rhythms have been 
suggested to play various roles in cognition (Schmidt et al., 2007). In light of the 
results of the current study which show long-lasting perturbations in circadian 
timekeeping following utilization of the septic endotoxin model, along with the fact 
that this model is known to cause a long-lasting neuroinflammation in the CNS, it is 
possible that circadian attenuations could be involved in the long term cognitive 
impairment that persist following recovery from the acute phase of septic shock. 
 
These studies have highlighted the long-lasting impact of LPS induced sepsis 
on the circadian timekeeping system, but it is important to note, that these studies 
have not shown any major perturbations in the post-septic SCN‘s ability to 
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coordinate timekeeping processes under conditions of stable entrainment or under 
constant conditions, so on a daily basis, post-septic animals do not show obvious 
behavioural attenuations, and in fact, their behaviour appears similar to controls.  It 
is in response to photic manipulations, specifically phase advancing stimuli and 
advances of the photoperiod, and phase resetting immune stimulation that post-septic 
circadian responses are attenuated.  Immune factors have been suggested to play 
roles as entraining factors of the circadian system, given their ability to phase shift 
circadian locomotor rhythms (Marpegan et al., 2005) and the results from the 
priming experiments superimposing phase resetting immune stimulation onto a 
background of attenuated circadian responses and SCN molecular rhythms were 
interesting, and pose questions regarding immune communication with the circadian 
system following recovery from the acute phase of sepsis. It may be that there are 
alterations in circadian-immune cross talk post-sepsis, and is possible that a 
profound immune challenge such as sepsis results in a disconnect between the 
circadian system and the immune system, perturbing the bidirectional 
communication.    
Chronic circadian disruption has been shown to significantly perturb immune 
responses, and circadian coordination of the immune system has been suggested to 
promote responsiveness to an immune challenge, and disruption of this coordination 
could impose vulnerability upon organisms (Castanon-Cervantes et al., 2010).  
Immune mediators have been shown to impact upon the organisation of the clock 
and timekeeping processes, which could in turn result in further perturbation of the 
immune system through dysregulated clock processes, and vulnerability of an 
organism to future challenge (Logan and Sarkar, 2012).  Interestingly, experimental 
evidence indicates that the response to phase-advancing schedules, as opposed to 
phase delay schedules, appears to be more detrimental for health (Davidson et al., 
2006).  The responsiveness of the post-septic circadian system may be restricted or 
modulated in circumstances where perturbations of circadian timing which could 
impact upon immune function are encountered in a system already attenuated and 
vulnerable having been subjected to a severe immune challenge.  However, it‘s 
possible that this might also detrimentally impact upon circadian responsiveness 
post-sepsis to the external environment, given the necessity of accurate phase-
shifting responses of the circadian system to perturbing stimuli for adequate 
entrainment and adaptation of organisms. 
244 
 
In conclusion, the findings from this project provide further insight into 
immune circadian communication, however there is still much work to be done 
assessing the impact of the immune response on circadian timekeeping processes.  
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